FN	ISI Export Format
VR	1.0

PT	J
AU	Liu, J Chen, SC Tan, XY
AF	Liu, Jun Chen, Songcan Tan, Xiaoyang
TI	Fractional order singular value decomposition representation for face recognition
SO	PATTERN RECOGNITION
LA	English
DT	Article
DE	singular value decomposition (SVD); Fractional order singular value decomposition representation (FSVDR); face representation (FR); intermediate representation (IR); face recognition
ID	EXPRESSION VARIANT FACES; FEATURE-EXTRACTION; COMMON VECTORS; IMAGE; IDENTIFICATION; EIGENFACES; RETRIEVAL; COMPUTER; FEATURES; SAMPLE
AB	Face representation (FR) plays a typically important role in face recognition and methods such as principal component analysis (PCA) and linear discriminant analysis (LDA) have been received wide attention recently. However, despite of the achieved successes, these FR methods will inevitably lead to poor classification performance in case of great facial variations such as expression, lighting, occlusion and so on, due to the fact that the image gray value matrices on which they manipulate are very sensitive to these facial variations. In this paper, we take notice of the facts that every image matrix can always have the well-known singular value decomposition (SVD) and can be regarded as a composition of a set of base images generated by SVD, and we further point out that the leading base images (those corresponding to large singular values) on one hand are sensitive to the aforementioned facial variations and on the other hand dominate the composition of the face image. Then based on these observations, we subtly deflate the weights of the facial variation sensitive base images by a parameter a and propose a novel fractional order singular value decomposition representation (FSVDR) to alleviate facial variations for face recognition. Finally, our experimental results show that FSVDR can: (1) effectively alleviate facial variations; and (2) form an intermediate representation for many FR methods such as PCA and LDA to significantly improve their classification performance in case of great facial variations. (C) 2007 Pattern Recognition Society. Published by Elsevier Ltd. All rights reserved.
C1	Nanjing Univ Aeronaut & Astronaut, Dept Comp Sci & Engn, Nanjing 210016, Peoples R China.
RP	Chen, SC, Nanjing Univ Aeronaut & Astronaut, Dept Comp Sci & Engn, Nanjing 210016, Peoples R China.
EM	j.liu@nuaa.edu.cn s.chen@nuaa.edu.cn x.tan@nuaa.edu.cn
CR	BELHUMEUR PN, 1997, IEEE T PATTERN ANAL, V19, P711 BOLME D, 2003, 3 INT C COMP VIS SYS, P303 BRUCE V, 1998, FACE RECOGNITION THE BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042 CEVIKALP H, 2005, IEEE T PATTERN ANAL, V27, P4 CHELLAPPA R, 1995, P IEEE, V83, P705 CHENG Y, 1991, INTELLIGENT ROBOTS C, P85 COX I, 1996, IEEE C COMP VIS PATT, P209 DONATO G, 1999, IEEE T PATTERN ANAL, V21, P974 DUDA RO, 2000, PATTERN CLASSIFICATI EDELMAN S, 1999, REPRESENTATION RECOG ER MJ, 2005, IEEE T NEURAL NETWOR, V16, P679, DOI 10.1109/TNN.2005.844909 FISHER RA, 1936, ANN EUGENIC 2, V7, P179 GOLDSTEIN A, 1992, PATTERN RECOGN, V25, P65 GOLDSTEIN AJ, 1971, P IEEE, V59, P748 GOLUB GH, 1995, MATRIX COMPUTATIONS HARMON LD, 1978, PATTERN RECOGN, V10, P301 HARMON LD, 1981, PATTERN RECOGN, V13, P97 HONG ZQ, 1991, PATTERN RECOGN, V24, P211 KIRBY M, 1990, IEEE T PATTERN ANAL, V12, P103 KONG SG, 2005, COMPUT VIS IMAGE UND, V97, P103, DOI 10.1016/j.cviu.2004.04.001 LEONARDIS A, 2003, PATTERN RECOGN, V36, P1925, DOI 10.1016/S0031-3203(03)00055-4 LIU CJ, 2000, IEEE T IMAGE PROCESS, V9, P132 LIU CJ, 2002, IEEE T IMAGE PROCESS, V11, P467 LIU CJ, 2003, IEEE T NEURAL NETWOR, V14, P919, DOI 10.1109/TNN.2003.813829 LIU J, 2005, 18 AUSTR JOINT C ART, P1221 LIU J, 2006, IMAGE VISION COMPUT, V24, P249, DOI 10.1016/j.imavis.2005.11.007 LIU J, 2006, PATTERN RECOGN LETT, V27, P1002, DOI 10.1016/j.patrec.2005.11.013 MARTIN AM, 1998, FACE DATABASE MARTINEZ AM, 2001, IEEE T PATTERN ANAL, V23, P228 MARTINEZ AM, 2002, IEEE T PATTERN ANAL, V24, P748 MARTINEZ AM, 2005, IEEE T PATTERN ANAL, V27, P1934 PHILLIPS PJ, 1998, IMAGE VISION COMPUT, V16, P295 SWETS DL, 1996, IEEE T PATTERN ANAL, V18, P831 TAN XY, 2005, IEEE T NEURAL NETWOR, V16, P875, DOI 10.1109/TNN.2005.849817 TARR M, 1999, OBJECT RECOGNITION O TIAN Y, 2003, PATTERN RECOGN, V36, P649 TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71 WISKOTT L, 1997, IEEE T PATTERN ANAL, V19, P775 YANG J, 2004, IEEE T PATTERN ANAL, V26, P131 YE J, 2004, ICML, P887 YE JP, 2005, IEEE T PATTERN ANAL, V27, P929 ZHANG DQ, 2005, APPL MATH COMPUT, V163, P895, DOI 10.1016/j.amc.2004.04.016 ZHAO W, 1998, INT C AUT FAC GEST R, P336 ZHAO W, 1999, SUBSPACE LINEAR DISC ZHAO W, 2003, ACM COMPUT SURV, V35, P399
NR	46
TC	0
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0031-3203
J9	PATT RECOG
JI	Pattern Recognit.
PD	JAN
PY	2008
VL	41
IS	1
BP	378
EP	395
PG	18
SC	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic
GA	218PZ
UT	ISI:000250028700029
ER

---

PT	J
AU	Duman, O
AF	Duman, Oktay
TI	Regular matrix transformations and rates of convergence of positive linear operators
SO	CALCOLO
LA	English
DT	Article
DE	regular infinite matrices; A-statistical convergence; rates of A-statistical convergence; positive linear operators; the Korovkin theorem; modulus of continuity
ID	STATISTICAL CONVERGENCE
AB	This paper investigates the effects of matrix summability methods on the A-statistical approximation of sequences of positive linear operators defined on the space of all 27 pi-periodic and continuous functions on the whole real axis. The two main tools used in this paper are A-statistical convergence and the modulus of continuity.
C1	TOBB Econ & Technol Univ, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey.
RP	Duman, O, TOBB Econ & Technol Univ, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey.
EM	oduman@etu.edu.tr
CR	ALTOMARE F, 1994, GRUYTER STUDIES MATH, V17 BLEIMANN G, 1980, NEDERL AKAD WETENSCH, V42, P255 DEVORE RA, 1972, LECT NOTES MATH, V293 DUMAN O, 2003, DEMONSTRATIO MATH, V36, P873 DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 HARDY GH, 1949, DIVERGENT SERIES KHAN MK, 1989, J APPROX THEORY, V57, P90 KHAN MK, 1998, J APPROX THEORY, V92, P22 KOLK E, 1993, ANALYSIS, V13, P77 KOROVKIN PP, 1960, LINEAR OPERATORS APP MILLER HI, 1995, T AM MATH SOC, V347, P1811 SRIVASTAVA HM, 2003, MATH COMPUT MODEL, V37, P1307
NR	16
TC	0
PU	SPRINGER
PI	NEW YORK
PA	233 SPRING STREET, NEW YORK, NY 10013 USA
SN	0008-0624
J9	CALCOLO
JI	Calcolo
PY	2007
VL	44
IS	3
BP	159
EP	164
PG	6
SC	Mathematics
GA	216IT
UT	ISI:000249872400003
ER

---

PT	J
AU	Duman, O
AF	Duman, O.
TI	A Korovkin type approximation theorems via I-convergence
SO	CZECHOSLOVAK MATHEMATICAL JOURNAL
LA	English
DT	Article
DE	I-convergence; positive linear operator; the classical Korovkin theorem
ID	POSITIVE LINEAR-OPERATORS; STATISTICAL CONVERGENCE; SUMMABILITY
AB	Using the concept of I-convergence we provide a Korovkin type approximation theorem by means of positive linear operators defined on an appropriate weighted space given with any interval of the real line. We also study rates of convergence by means of the modulus of continuity and the elements of the Lipschitz class.
C1	TOBB Univ Econ & Technol, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey.
RP	Duman, O, TOBB Univ Econ & Technol, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey.
EM	oduman@etu.edu.tr
CR	BOJANIC R, 1983, CANADIAN MATH SOC C, V3, P5 BOJANIC R, 1992, J NAT SCI MATH, V32, P5 CHLODOVSKY I, 1929, FUND MATH, V13, P62 CONNOR J, 1989, CAN MATH BULL, V32, P194 DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 DUMAN O, 2004, STUD MATH, V161, P187 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1991, ANALYSIS, V11, P59 HARDY GH, 1949, DIVERGENT SERIES KHAN MK, 1998, J APPROX THEORY, V92, P22 KOLK E, 1993, ANALYSIS, V13, P77 KOROVKIN PP, 1960, LINEAR OPERATORS THE KOSTYRKO P, 2000, REAL ANAL EXCHANGE, V26, P669 KURATOWSKI C, 1958, TOPOLOGIE, V1 MILLER HI, 1995, T AM MATH SOC, V347, P1811 NIVEN I, 1991, INTRO THEORY NUMBERS ROYDEN HL, 1968, REAL ANAL
NR	19
TC	0
PU	CZECHOSLOVAK MATHEMATICAL JOURNAL
PI	PRAGUE 1
PA	ZITNA 25, PRAGUE 1 115 67, CZECH REPUBLIC
SN	0011-4642
J9	CZECH MATH J
JI	Czech. Math. J.
PY	2007
VL	57
IS	1
BP	367
EP	375
PG	9
SC	Mathematics
GA	177ZU
UT	ISI:000247191800027
ER

---

PT	J
AU	Chen, CP Chang, CT
AF	Chen, Chang-Pao Chang, Chi-Tung
TI	Tauberian conditions under which the original convergence of double sequences follows from the statistical convergence of their weighted means
SO	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
DE	Tauberian conditions; weighted means; statistical convergence
ID	POINTWISE CONVERGENCE; TRIGONOMETRIC SERIES; THEOREMS
AB	In this paper, we introduce a new type of slow oscillation and slow decrease conditions. We prove that these or their variants are Thuberian conditions from s(mn) (st)under right arrow s to s(mn) -> s. We also prove that they are Tauberian conditions from t(mn)(11) (st)under right arrow s to s(mn) -> s, where t(mn)(11) are the weighted means of the double sequence {s(mn)}(m,n=0)(infinity). Our results not only generalize well-known results, but also solve the conjecture of M6ricz,n, posed in [F. Moricz, Tauberian theorems for double sequences that are statistically summable (C, 1, 1), J. Math. Anal. Appl. 286 (2003) 340-350]. (C) 2006 Elsevier Inc. All rights reserved.
C1	Natl Tsing Hua Univ, Dept Math, Hsinchu 300, Taiwan.
RP	Chen, CP, Natl Tsing Hua Univ, Dept Math, Hsinchu 300, Taiwan.
EM	cpchen@math.nthu.edu.tw
CR	BARON S, 1997, J MATH ANAL APPL, V211, P574 CHEN CP, 1993, J MATH ANAL APPL, V172, P582 CHEN CP, 1994, J MATH ANAL APPL, V185, P629 CHEN CP, 2000, ANAL MATH, V26, P243 CHEN CP, 2007, IN PRESS TAIWANESE J FRIDY JA, 2000, P AM MATH SOC, V128, P2347 HARDY GH, 1949, DIVERGENT SERIES MORICZ F, 1994, STUD MATH, V110, P83 MORICZ F, 2003, J MATH ANAL APPL, V286, P340, DOI 10.1016/S0022-247X(03)00529-8 MORICZ F, 2004, C MATH, V99, P207
NR	10
TC	0
PU	ACADEMIC PRESS INC ELSEVIER SCIENCE
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0022-247X
J9	J MATH ANAL APPL
JI	J. Math. Anal. Appl.
PD	AUG 15
PY	2007
VL	332
IS	2
BP	1242
EP	1248
PG	7
SC	Mathematics, Applied; Mathematics
GA	176YK
UT	ISI:000247120600035
ER

---

PT	J
AU	Douroudis, K Tarassi, K Athanassiades, T Giannakopoulos, F Kominakis, A Thalassinos, N Papasteriades, C
AF	Douroudis, K. Tarassi, K. Athanassiades, T. Giannakopoulos, F. Kominakis, A. Thalassinos, N. Papasteriades, Ch.
TI	HLA alleles as predisposal factors for postmenopausal osteoporosis in a Greek population
SO	TISSUE ANTIGENS
LA	English
DT	Article
DE	BMD; HLA; osteoporosis; polymorphisms
ID	MAJOR HISTOCOMPATIBILITY COMPLEX; DEPENDENT DIABETES-MELLITUS; NECROSIS-FACTOR-ALPHA; ANKYLOSING-SPONDYLITIS; RHEUMATOID-ARTHRITIS; BONE MASS; GENETIC-DETERMINANTS; MONONUCLEAR-CELLS; FACTOR-BETA; TNF-ALPHA
AB	It is well established that genetic factors play an important role in the pathogenesis of osteoporosis, a common condition characterized by reduced bone mass and increased fracture risk. The major histocompatibility complex in humans, known as human leukocyte antigen (HLA) region, is the most polymorphic human genetic system and it is known as a cluster of genetic markers, associated with several diseases. In order to evaluate the contribution of HLA alleles in bone mass loss, polymorphisms in the HLA class I (-A, -B and -Cw) and class II (-DR and -DQ) antigens were studied in 126 postmenopausal women of Greek origin. It was found that HLA-B7 (P = 0.069), -DR15 (P = 0.019) and -DQ6 (P = 0.026) were associated with a lower bone mineral density measured at the forearm. This study shows a significant association between HLA alleles and bone mass loss in the population studied.
C1	Evangelismos Med Ctr, Dept Immunol & Histocompatibil, Athens, Greece. Evangelismos Med Ctr, Dept Diabet Endocrinol & Metab, Athens, Greece. Agr Univ Athens, Dept Anim Breeding, Athens, Greece.
RP	Douroudis, K, Univ Tartu, Fac Med, Ctr Mol & Clin Med, Ravila 19, EE-51014 Tartu, Estonia.
EM	drkmb@email.com
CR	1993, AM J MED, V94, P644 ANGELSEN A, 1998, SCAND J UROL NEPHROL, V32, P7 BECK S, 1999, NATURE, V401, P921 BECKER Y, 1995, VIRUS GENES, V10, P195 BENDTZEN K, 1988, SCAND J IMMUNOL, V28, P599 CEDOZ JP, 1995, J RHEUMATOL, V22, P1884 ERSHLER WB, 1997, DEV COMP IMMUNOL, V21, P487 ESCALANTE A, 1993, J RHEUMATOL, V20, P320 GONZALEZROCES S, 1997, TISSUE ANTIGENS, V49, P116 GRUBER HE, 1991, P SOC EXP BIOL MED, V197, P219 GUR A, 2002, RHEUMATOL INT, V22, P194, DOI 10.1007/s00296-002-0223-x GUR A, 2003, YONSEI MED J, V44, P99 HILL AVS, 1992, NATURE, V360, P434 KANIS JA, 1994, J BONE MINER RES, V9, P1137 KELLY PJ, 1990, OSTEOPOROSIS INT, V1, P56 KHAN MA, 1986, DIS MARKERS, V4, P77 MACDONALD BR, 1992, BRIT J RHEUMATOL, V31, P149 MATEO L, 1990, ANN RHEUM DIS, V49, P821 MCMANUS R, 1996, EUR J IMMUNOL, V26, P2113 NATALE VM, 1997, MECH AGEING DEV, V94, P14 PACIFICI R, 1996, J BONE MINER RES, V11, P1043 PAPASTERIADES C, 2004, GENES IMMUN, V5, P58 POCIOT F, 1993, EUR J IMMUNOL, V23, P224 POCOCK NA, 1987, J CLIN INVEST, V80, P706 RIZZOLI R, 2001, J MOL ENDOCRINOL, V26, P79 ROODMAN GD, 1993, CALCIF TISSUE INT S1, V53, P94 SLEMENDA CW, 1991, J BONE MINER RES, V6, P561 SPIES T, 1986, P NATL ACAD SCI USA, V83, P8699 TARASSI K, 2001, EUR J IMMUNOGENET, V28, P346 TOUBERT A, 1988, BRIT J RHEUMATOL S2, V27, P19 TSUJI S, 1998, HUM IMMUNOL, V59, P243 VINASCO J, 1997, TISSUE ANTIGENS, V49, P74 WALLACH S, 1993, CALCIFIED TISSUE INT, V53, P293 WHICHELOW CE, 1996, EUR J IMMUNOGENET, V23, P425 WILL R, 1989, LANCET, V2, P1483 WINCHESTER R, 1994, ADV IMMUNOL, V56, P389 YAO ZB, 1996, J IMMUNOL, V156, P3260
NR	37
TC	0
PU	BLACKWELL PUBLISHING
PI	OXFORD
PA	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN	0001-2815
J9	TISSUE ANTIGEN
JI	Tissue Antigens
PD	JUN
PY	2007
VL	69
IS	6
BP	592
EP	596
PG	5
SC	Cell Biology; Immunology; Pathology
GA	166RQ
UT	ISI:000246398100006
ER

---

PT	J
AU	Erkus, E Duman, O Srivastava, HM
AF	Erkus, Esra Duman, Oktay Srivastava, H. M.
TI	Statistical approximation of certain positive linear operators constructed by means of the Chan-Chyan-Srivastava polynomials
SO	APPLIED MATHEMATICS AND COMPUTATION
LA	English
DT	Article
DE	Chan-Chyan-Srivastava multivariable polynomials; Lagrange polynomials; A-statistical convergence; positive linear operators; Korovkin approximation theorem; Fourier series; Gibbs phenomenon; modulus of continuity; lipschitz class
ID	CONVERGENCE
AB	In this study, by obtaining some Korovkin type approximation results in statistical sense for certain positive linear operators constructed by means of the Chan-Chyan-Srivastava multivariable polynomials [W.-C.C. Chan, C.-J. Chyan, H.M. Srivastava, The Lagrange polynomials in several variables, Integral Transform. Spec. Funct. 12 (2001) 139-148], we show that our approximation method is stronger than the corresponding classical aspects in the approximation theory settings. Furthermore, we investigate their statistical rates by means of the modulus of continuity and the elements of the Lipschitz class. (c) 2006 Elsevier Inc. All rights reserved.
C1	Univ Victoria, Dept Math & Stat, Victoria, BC V8W 3P4, Canada. Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey. Canakkale Onsekiz Mart Univ, Fac Sci & Arts, Dept Math, TR-17020 Terzioglu Kampusu, Canakkale, Turkey. TOBB Univ Econ & Technol, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey.
RP	Srivastava, HM, Univ Victoria, Dept Math & Stat, Victoria, BC V8W 3P4, Canada.
EM	erkus@comu.edu.tr oduman@etu.edu.tr harimsri@math.uvic.ca
CR	BOJANIC R, 1992, J NAT SCI MATH, V32, P5 BOOS J, 2000, CLASSICAL MODERN MET CHAN WCC, 2001, INTEGR TRANSF SPEC F, V12, P139 DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 ERDELYI A, 1955, HIGHER TRANSCENDENTA, V3 ERKUS E, 2006, IN PRESS STUD SCI MA, V43 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 KOLK E, 1993, ANALYSIS, V13, P77 KUTTNER B, 1944, J LOND MATH SOC, V19, P153 SRIVASTAVA HM, 1984, TREATISE GENERATING
NR	13
TC	0
PU	ELSEVIER SCIENCE INC
PI	NEW YORK
PA	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN	0096-3003
J9	APPL MATH COMPUT
JI	Appl. Math. Comput.
PD	NOV 1
PY	2006
VL	182
IS	1
BP	213
EP	222
PG	10
SC	Mathematics, Applied
GA	146EG
UT	ISI:000244916700023
ER

---

PT	J
AU	Zeng, XM Chen, X
AF	Zeng, Xiao-Ming Chen, X.
TI	Pointwise approximation by the modified Szasz-Mirakyan operators
SO	JOURNAL OF COMPUTATIONAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
DE	rate of convergence; functions of bounded variation; class of functions; modified Szasz-Mirakyan operators; Lebesgue-Stieltjes integral
ID	BOUNDED VARIATION; CONVERGENCE
AB	In this paper we obtain an estimate on the rate of convergence of modified Szasz-Mirakyan operators for bounded functions satisfying certain growth condition. In the case of functions of bounded variation our result is better than the known results due to Sahai and Prasad (1993, Publ. Inst. Math. (Beograd) (N.S.) 53, 73-80) and Gupta and Pant (1999, J. Math. Anal. Appl. 233, 476-483). More important, by means of new metric form, our result successfully deals with the pointwise approximation of more general class of functions than the class of functions of bounded variation considered in the references as mentioned above.
C1	Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
RP	Zeng, XM, Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
EM	xmzeng@jingxian.xmu.edu.cn
CR	CHENG F, 1984, J APPROX THEORY, V40, P226 GUO SS, 1989, J APPROX THEORY, V58, P90 GUPTA V, 1999, J MATH ANAL APPL, V233, P476 KAHN MK, 2002, REND CIRC MAT PA 2 S, V68, P539 MAZHAR SM, 1985, ACTA SCI MATH, V49, P257 OMEY E, 1996, THEOR PROBAB APPL, V41, P178 PYCHTABERSKA P, 2003, J APPROX THEORY, V123, P256, DOI 10.1016/S0021-9045(03)00106-0 SAHAI A, 1993, PUBL I MATH BEOGRAD, V53, P73 ZENG XM, 2000, J APPROX THEORY, V102, P1 ZENG XM, 2001, J INEQUAL APPL, V6, P563
NR	10
TC	0
PU	EUDOXUS PRESS, LLC
PI	CORDOVA
PA	1424 BEAVER TRAIL DRIVE, CORDOVA, TN 38016 USA
SN	1521-1398
J9	J COMPUT ANAL APPL
JI	J. Comput. Anal. Appl.
PD	OCT
PY	2007
VL	9
IS	4
BP	421
EP	429
PG	9
SC	Computer Science, Theory & Methods; Mathematics, Applied
GA	145OT
UT	ISI:000244875100007
ER

---

PT	J
AU	Mansour, M Cheema, GS Naguwa, SM Greenspan, A Borchers, AT Keens, CL Gershwin, ME
AF	Mansour, Mark Cheema, Gurtej S. Naguwa, Stanley M. Greenspan, Adam Borchers, Andrea T. Keens, Carl L. Gershwin, M. Eric
TI	Ankylosing spondylitis: A contemporary perspective on diagnosis and treatment
SO	SEMINARS IN ARTHRITIS AND RHEUMATISM
LA	English
DT	Review
DE	seronegative spondyloarthritis; computed tomography; TNF blocking agents; sacroilitis; HLA B27
ID	TUMOR-NECROSIS-FACTOR; RESONANCE-IMAGING EXAMINATIONS; RANDOMIZED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; DISEASE-ACTIVITY INDEX; HIGH-RESOLUTION CT; RHEUMATOID-ARTHRITIS; SELF-PEPTIDE; FACTOR-ALPHA; SERONEGATIVE SPONDYLOARTHROPATHIES
AB	Objectives: In recent years, great progress has been made in the development of diagnostic tools, therapeutic approaches, and validated outcome measures in the understanding of the pathogenesis of ankylosing spondylitis (AS). The purpose of this review was to summarize these developments. Methods: We performed a PubMed search for the period 1978 to 2005, using the keyword, "ankylosing spondylitis," resulting in a total of 4878 publications, including 778 reviews. Articles were then selected based on their discussion of recent diagnostic tools and new treatment approaches in the pathogenesis of AS, leading to a final total of 104 articles. Results: In recent years, there have been 2 major developments in the management of AS that make earlier diagnosis possible and offer the hope of alleviating pain and preventing structural changes that result in loss of function. These developments include the use of magnetic resonance imaging to visualize the inflammatory changes in the sacroiliac joint and the axial spine, and the demonstration that tumor necrosis factor blocking agents are highly efficacious in reducing spinal inflammation and possibly in slowing radiographic progression. Conclusions: There have been major advances in both the diagnostic tools and the therapeutic regimens available for patients with AS. (c) 2007 Elsevier Inc. All rights reserved.
C1	Univ Calif Davis, Dept Rheuamtol Allergy & Clin Immunol, Sch Med, Davis, CA 95616 USA. Univ Calif Davis, Div Rheumatol Allergy & Clin Immunol, Davis, CA USA.
RP	Gershwin, ME, Univ Calif Davis, Dept Rheuamtol Allergy & Clin Immunol, Sch Med, 451 E Hlth Sci Dr,suite 6510, Davis, CA 95616 USA.
EM	megershwin@ucdavis.edu
CR	ALLEN RL, 1999, J IMMUNOL, V162, P5045 ANDERSON JJ, 2001, ARTHRITIS RHEUM, V44, P1876 ARNETT FC, 2001, ARTHRITIS ALLIED CON, P1311 AUFDERMAUR M, 1989, ANN RHEUM DIS, V48, P628 BAEK HJ, 2004, RHEUMATOLOGY, V43, P1526, DOI 10.1093/rheumatology/keh373 BAETEN D, 2000, ANN RHEUM DIS, V59, P945 BALL EJ, 2001, JOINT BONE SPINE, V68, P378 BARALIAKOS X, 2005, ANN RHEUM DIS, V64, P1462, DOI 10.1136/ard.2004.033472 BARALIAKOS X, 2005, ANN RHEUM DIS, V64, P730, DOI 10.1136/ard.2004.029298 BARALIAKOS X, 2005, ARTHRITIS RES THER, V7, R439 BARALIAKOS X, 2005, ARTHRITIS RHEUM, V52, P1216, DOI 10.1002/art.20977 BENITEZDELCASTILLO JM, 2000, EYE 3A, V14, P340 BENJAMIN M, 2001, J ANAT 5, V199, P503 BOSTAN EE, 2003, RHEUMATOL INT, V23, P121, DOI 10.1007/s00296-002-0261-4 BOYLE LH, 2001, J IMMUNOL, V167, P2619 BOYLE LH, 2004, IMMUNOLOGY, V112, P54, DOI 10.1111/j.1365-2567.2004.01857.x BRANDT J, 2003, ARTHRITIS RHEUM, V48, P1667 BRANDT J, 2005, RHEUMATOLOGY, V44, P342, DOI 10.1093/rheumatology/keh475 BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 2002, BEST PRACT RES CL RH, V16, P573, DOI 10.1053/berh.2002.0250 BRAUN J, 2002, CLIN EXP RHEUMATOL, V20, P16 BRAUN J, 2002, LANCET, V359, P1187 BRAUN J, 2003, ARTHRITIS RHEUM, V48, P1126, DOI 10.1002/art.10883 BRAUN J, 2005, ANN RHEUM DIS, V65, P316 BRAUN J, 2005, ARTHRITIS RHEUM, V52, P2447, DOI 10.1002/art.21197 BRAUN J, 2005, RHEUMATOLOGY, V44, P670, DOI 10.1093/rheumatology/keh584 BRAUN J, 2005, SCAND J RHEUMATOL, V34, P97, DOI 10.1080/03009740510018679 BROPHY S, 2004, J RHEUMATOL, V31, P1775 BROWN MA, 1997, ARTHRITIS RHEUM, V40, P1823 CALIN A, 1994, J RHEUMATOL, V21, P2281 CALIN A, 2004, ANN RHEUM DIS, V63, P1594, DOI 10.1136/ard.2004.020875 CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186 CREEMERS MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503 DAGFINRUD H, 2005, J RHEUMATOL, V32, P1899 DANGORIA NS, 2002, J BIOL CHEM, V277, P23459 DAVIS JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325 DAVIS JC, 2005, ANN RHEUM DIS, V64, P1557, DOI 10.1136/ard.2004.035105 DAVIS JC, 2005, J RHEUMATOL, V32, P1751 DORAN MF, 2003, J RHEUMATOL, V30, P316 DUCHMANN R, 2001, CLIN EXP IMMUNOL, V123, P315 FELDTKELLER E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4 FIORILLO MT, 2000, J CLIN INVEST, V106, P47 FIORILLO MT, 2005, J BIOL CHEM, V280, P2962, DOI 10.1074/jbc.M410807200 FRAUENDORF E, 2003, CLIN EXP IMMUNOL, V134, P351, DOI 10.1046/j.1365-2249.2003.02289.x GARRETT S, 1994, J RHEUMATOL, V21, P2286 GEIJER M, 1998, ACTA RADIOL, V39, P265 GORMAN JD, 2002, NEW ENGL J MED, V346, P1349 GRAN JT, 1997, BRIT J RHEUMATOL, V36, P766 HAMMER RE, 1990, CELL, V63, P1099 HEUFTDORENBOSCH L, 2004, ARTHRIT RHEUM-ARTHR, V51, P154 HOCHBERG MC, 1978, MEDICINE, V57, P463 HULSMEYER M, 2004, J EXP MED, V199, P271, DOI 10.1084/jem.20031690 HULSMEYER M, 2005, J MOL BIOL, V346, P1367, DOI 10.1016/j.jmb.2004.12.047 JOSHI AB, 2002, J ARTHROPLASTY, V17, P427 KELLER C, 2003, ANN RHEUM DIS, V62, P1128, DOI 10.1136/ard.2003.011023 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1998, SPONDYLARTHRITIDES, P17 KIM TH, 2005, CURR OPIN RHEUMATOL, V17, P400 KIRIS A, 2003, EUR J RADIOL, V47, P71 LALOUX L, 2001, ANN RHEUM DIS, V60, P316 LAMBERT RGW, 2004, ARTHRIT RHEUM-ARTHR, V51, P681, DOI 10.1002/art.20681 LUTHRAGUPTASARMA M, 2004, FEBS LETT, V575, P1, DOI 10.1016/j.febslet.2004.08.037 MACKAY K, 1998, ARTHRITIS RHEUM, V41, P2263 MADER R, 1999, SEMIN ARTHRITIS RHEU, V29, P191 MAGHRAOUI AE, 2003, CLIN RHEUMATOL, V22, P94 MCGONAGLE D, 1998, ARTHRITIS RHEUM, V41, P694 MEAR JP, 1999, J IMMUNOL, V163, P6665 MONNET D, 2004, OPHTHALMOLOGY, V111, P802, DOI 10.1016/j.ophtha.2003.07.011 MONTENEGRO V, 2000, J RHEUMATOL, V27, P411 MUNDINGER A, 1991, RHEUMATOL INT, V11, P183 OLIVIERI I, 1998, BAILLIERE CLIN RHEUM, V12, P665 PARVIZI J, 2001, J BONE JOINT SURG A, V83, P1312 PETERS MJ, 2004, SEMIN ARTHRITIS RHEU, V34, P585, DOI 10.1016/j.semarthrit.2004.07.010 PETTY RE, 2004, J RHEUMATOL, V31, P390 POOLE AR, 1998, AM J MED SCI, V316, P228 RAMOS M, 2002, J BIOL CHEM, V277, P37573, DOI 10.1074/jbc.M205470200 RESNICK D, 1981, DIAGNOSIS BONE JOINT, P1040 REVEILLE JD, 2001, CURR OPIN RHEUMATOL, V13, P265 REVEILLE JD, 2005, AM J MED, V118, P592, DOI 10.1016/j.amjmed.2005.01.001 ROBERTSON LP, 2004, RHEUMATOLOGY, V43, P1565, DOI 10.1093/rheumatology/keh386 RODRIGUE T, 2001, NEUROSURG CLIN N AM, V12, P311 RUDWALEIT M, 2004, ANN RHEUM DIS, V63, P535, DOI 10.1136/ard.2003.011247 RUDWALEIT M, 2004, ANN RHEUM DIS, V63, P665, DOI 10.1136/ard.2003.016386 SAMPAIOBARROS PD, 2001, J RHEUMATOL, V28, P560 SARAUX A, 2005, ANN RHEUM DIS, V64, P1431, DOI 10.1136/ard.2004.029207 SIEPER J, 2002, ANN RHEUM DIS S3, V61, P8 SIEPER J, 2005, ANN RHEUM DIS, V64, P659, DOI 10.1136/ard.2004.028753 SIEPER J, 2005, RHEUMATOLOGY, V44, P1525, DOI 10.1093/rheumatology/kei046 SOUZA AS, 2004, J THORAC IMAG, V19, P259 STONE MA, 2004, RHEUMATOLOGY, V43, P148, DOI 10.1093/rheumatology/keg482 STROBEL ES, 1998, CLIN RHEUMATOL, V17, P524 SUKENIK S, 1987, CLIN RHEUMATOL, V6, P588 TRONTZAS P, 2005, CLIN RHEUMATOL, V24, P583, DOI 10.1007/s10067-005-1106-9 VANDERHEIJDE D, 1999, J RHEUMATOL, V26, P951 VANDERHEIJDE D, 2005, ARTHRITIS RHEUM, V52, P582, DOI 10.1002/art.20852 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDERLINDEN S, 1998, RHEUM DIS CLIN N AM, V24, P663 VINJE O, 1985, SCAND J RHEUMATOL, V14, P279 WANDERS A, 2005, ARTHRITIS RHEUM, V52, P1756, DOI 10.1002/art.21054 YAGAN R, 1983, CLIN RHEUMATOL, V2, P285 YU W, 1998, SKELETAL RADIOL, V27, P311 ZOCHLING J, 2005, ANN RHEUM DIS, V65, P442 ZOU J, 2003, RHEUMATOLOGY, V42, P846, DOI 10.1093/rheumatology/keg230
NR	104
TC	1
PU	W B SAUNDERS CO-ELSEVIER INC
PI	PHILADELPHIA
PA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN	0049-0172
J9	SEMIN ARTHRITIS RHEUM
JI	Semin. Arthritis Rheum.
PD	FEB
PY	2007
VL	36
IS	4
BP	210
EP	223
PG	14
SC	Rheumatology
GA	139HV
UT	ISI:000244423800002
ER

---

PT	J
AU	Balcerzak, M Dems, K Komisarski, A
AF	Balcerzak, Marek Dems, Katarzyna Komisarski, Andrzej
TI	Statistical convergence and ideal convergence for sequences of functions
SO	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
DE	I-uniform convergence; equi-statistical convergence; statistical Egorov's theorem; statistical convergence in measure
AB	Let I subset of P(N) stand for an ideal containing finite sets. We discuss various kinds of statistical convergence and I-convergence for sequences of functions with values in R or in a metric space. For real valued measurable functions defined on a measure space (X, M, mu), we obtain a statistical version of the Egorov theorem (when mu(X) < infinity). We show that, in its assertion, equi-statistical convergence on a big set cannot be replaced by uniform statistical convergence. Also, we consider statistical convergence in measure and I-convergence in measure, with some consequences of the Riesz theorem. We prove that outer and inner statistical convergences in measure (for sequences of measurable functions) are equivalent if the measure is finite. (c) 2006 Elsevier Inc. All rights reserved.
C1	Tech Univ Lodz, Math Inst, PL-93005 Lodz, Poland. Tech Univ Lodz, Ctr Math & Phys, PL-00924 Lodz, Poland. Univ Lodz, Fac Math, PL-90238 Lodz, Poland.
RP	Balcerzak, M, Tech Univ Lodz, Math Inst, ul Wolczanska 215, PL-93005 Lodz, Poland.
EM	mbalce@p.lodz.pl kasidems@p.lodz.pl andkom@math.uni.lodz.pl
CR	BALCERZAK M, 2004, REAL ANAL EXCHANGE, V30, P267 BARTLE R, 1980, AM MATH MONTHLY, V87, P628 CONNOR J, 2000, J MATH ANAL APPL, V244, P251 COOKE RG, 1950, INFINITE MATRICES SE DEMS K, 2004, REAL ANAL EXCHANGE, V30, P123 FARAH I, 2000, MEM AM MATH SOC, V148 FAST H, 1951, C MATH, V2, P241 FEDERER H, 1969, GEOMETRIC MEASURE TH FREMLIN DH, 2001, MEASURE THEORY, V2 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1998, J MATH ANAL APPL, V228, P73 HARTMAN S, 1951, C MATH, V2, P245 KATETOV M, 1968, COMMENT MATH U CAROL, V9, P173 KATETOV M, 1972, THEORY SETS TOPOLOGY, P265 KOSTYRKO P, 2000, REAL ANAL EXCHANGE, V26, P669 LAHIRI BK, 2003, MATH COMMUN, V8, P151 MILLER HI, 1995, T AM MATH SOC, V347, P1811 MILLER HI, 2001, ACTA MATH HUNG, V93, P135 NURRAY F, 2000, J MATH ANAL APPL, V245, P513 PAPANASTASSIOU N, 2002, ATTI SEM MATH FIS U, V50, P355 PEHLIVAN S, 2004, J MATH ANAL APPL, V299, P333, DOI 10.1016/j.jmaa.2004.04.049 ROZYCKI EP, 1965, FUND MATH, V56, P289 RUDIN W, 1976, PRINCIPLES MATH ANAL SALAT T, 1980, MATH SLOVACA, V30, P139 STEINHAUS H, 1951, C MATH, V2, P73
NR	25
TC	0
PU	ACADEMIC PRESS INC ELSEVIER SCIENCE
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0022-247X
J9	J MATH ANAL APPL
JI	J. Math. Anal. Appl.
PD	APR 1
PY	2007
VL	328
IS	1
BP	715
EP	729
PG	15
SC	Mathematics, Applied; Mathematics
GA	130LC
UT	ISI:000243800100052
ER

---

PT	J
AU	Khuri, AI Mukherjee, L Sinha, BK Ghosh, M
AF	Khuri, Andre I. Mukherjee, Bhramar Sinha, Bikas K. Ghosh, Malay
TI	Design issues for generalized linear models: A review
SO	STATISTICAL SCIENCE
LA	English
DT	Review
DE	Bayesian design; dependence on unknown parameters; locally optimal design; logistic regression; response surface methodology; quantal dispersion graphs; sequential design
ID	BAYESIAN EXPERIMENTAL-DESIGN; BINARY RESPONSE EXPERIMENTS; STOCHASTIC APPROXIMATION PROCEDURES; OPTIMUM EXPERIMENTAL-DESIGNS; PARAMETER NONLINEAR MODELS; EXPONENTIAL-GROWTH MODEL; LOGISTIC-REGRESSION; QUANTAL RESPONSE; SEQUENTIAL ESTIMATION; SURFACE METHODOLOGY
AB	Generalized linear models (GLMs) have been used quite effectively in the modeling of a mean response under nonstandard conditions, where discrete as well as continuous data distributions can be accommodated. The choice of design for a GLM is a very important task in the development and building of an adequate model. However, one major problem that handicaps the construction of a GLM design is its dependence on the unknown parameters of the fitted model. Several approaches have been proposed in the past 25 years to solve this problem. These approaches, however, have provided only partial solutions that apply in only some special cases, and the problem, in general, remains largely unresolved. The purpose of this article is to focus attention on the aforementioned dependence problem. We provide a survey of various existing techniques dealing with the dependence problem. This survey includes discussions concerning locally optimal designs, sequential designs, Bayesian designs and the quantile dispersion graph approach for comparing designs for GLMs.
C1	Univ Florida, Dept Stat, Gainesville, FL 32611 USA. Indian Stat Inst, Div Theoret Stat & Math, Calcutta 700108, India.
RP	Khuri, AI, Univ Florida, Dept Stat, Gainesville, FL 32611 USA.
EM	ufakhuri@stat.ufl.edu mukherjee@stat.ufl.edu sinhabikas@yahoo.com ghoshm@stat.ufl.edu
CR	ABDELBASIT KM, 1983, J AM STAT ASSOC, V78, P90 ABDELHAMID SN, 1973, ANN STAT, V1, P1158 ANBAR D, 1973, ANN STAT, V1, P1175 ASHTON WD, 1972, LOGIT TRANSFORMATION ATKINSON AC, 1992, OPTIMUM EXPT DESIGNS ATKINSON AC, 1993, BIOMETRICS, V49, P325 ATKINSON AC, 1995, APPL STAT-J ROY ST C, V44, P213 ATKINSON AC, 1996, DESIGN ANAL EXPT, P437 BERGER JO, 1985, STAT DECISION THEORY BERNARDO JM, 1979, ANN STAT, V7, P686 BERRY DA, 1985, BANDIT PROBLEMS SEQU BERRY DA, 1985, STAT MED, V4, P497 BOX GEP, 1959, BIOMETRIKA, V46, P77 BOX GEP, 1987, EMPIRICAL MODEL BUIL BROOKS RJ, 1972, BIOMETRIKA, V59, P563 BROOKS RJ, 1974, BIOMETRIKA, V61, P303 BROOKS RJ, 1976, METRIKA, V23, P221 BROOKS RJ, 1977, BIOMETRIKA, V64, P319 BURRIDGE J, 1992, J ITAL STAT SOC, V1, P183 BURRIDGE J, 1994, BIOMETRIKA, V81, P295 CHALONER K, 1984, ANN STAT, V12, P283 CHALONER K, 1987, MODEL ORIENTED DATA, P3 CHALONER K, 1988, OPTIMAL DESIGN ANAL, P207 CHALONER K, 1989, J STAT PLAN INFER, V21, P191 CHALONER K, 1993, J STAT PLAN INFER, V37, P229 CHALONER K, 1995, STAT SCI, V10, P273 CHEN K, 2000, ANN STAT, V28, P1452 CHERNOFF H, 1953, ANN MATH STAT, V24, P586 CHERNOFF H, 1972, SEQUENTIAL ANAL OPTI CLYDE M, 1995, LECT NOTES STAT, V105, P278 CLYDE M, 1996, J AM STAT ASSOC, V91, P1236 CLYDE M, 2002, J STAT PLAN INFER, V104, P175 CLYDE MA, 1993, 587 U MINN SCH STAT CLYDE MA, 1993, THESIS U MINNESOTA DAS P, 2003, DELAGARZA PHENOMENON DASGUPTA A, 1991, ANN STAT, V19, P1244 DASGUPTA A, 1992, J STAT PLAN INFER, V32, P363 DASGUPTA A, 1996, DESIGN ANAL EXPT, P1099 DAWID AP, 1999, ANN STAT, V27, P65 DEGROOT MH, 1986, RECENT DEV F UTILITY, P265 DELAGARZA A, 1954, ANN MATH STAT, V25, P123 DETTE H, 1994, S AFR STAT J, V28, P103 DETTE H, 1996, J STAT PLAN INFER, V52, P17 DIAZ MP, 2002, J APPL STAT, V29, P685 DIXON WJ, 1948, J AM STAT ASSOC, V43, P109 DOBSON AJ, 2002, INTRO GEN LINEAR MOD DRAPER NR, 1967, BIOMETRIKA, V54, P662 DUBOV EL, 1977, REGRESSION EXPT, P103 DUMOUCHEL W, 1994, TECHNOMETRICS, V36, P37 ETZIONI R, 1993, J AM STAT ASSOC, V88, P1404 FABIAN V, 1968, ANN MATH STAT, V39, P1327 FABIAN V, 1983, LECT NOTES STAT, V20, P43 FEDOROV VV, 1972, THEORY OPTIMAL EXPT FLOURNOY N, 1993, LECT NOTES STAT, V83, P324 FORD I, 1992, J R STAT SOC B, V54, P569 FREEMAN PR, 1970, BIOMETRIKA, V57, P79 FREES EW, 1990, J AM STAT ASSOC, V85, P1123 GILL PE, 1986, 862 SOL STANF U DEP HAINES LM, 1995, J R STAT SOC B, V57, P575 HATZIS C, 1992, BIOMETRICS, V48, P1235 HEISE MA, 1996, BIOMETRICS, V52, P613 HERN A, 2001, PHYSIOL ENTOMOL, V26, P381 JEWELL NP, 1990, BIOMETRICS, V46, P1133 KHAN MK, 1988, J STATISTICAL PLANNI, V18, P83 KHURI AI, 1993, J COMBINATORICS INFO, V18, P193 KHURI AI, 1996, RESPONSE SURFACES KIEFER J, 1952, ANN MATH STAT, V23, P462 KUO L, 1983, ANN STAT, V11, P886 KUO L, 1999, BAYESIAN STAT, V6, P795 LAI TL, 1979, ANN STAT, V7, P1196 LAUTER E, 1974, MATH OPERATIONSFORSC, V5, P379 LAUTER E, 1976, MATH OPERATIONSFORSC, V7, P51 LEE YJ, 2002, STAT MED, V21, P191 LINDLEY DV, 1956, ANN MATH STAT, V27, P986 LINDLEY DV, 1991, J AM STAT ASSOC, V86, P933 LINDSEY JK, 1997, APPL GEN LINEAR MODE LISKI EP, 2002, LECT NOTES STAT, V163 MARKS BJ, 1962, J ROY STAT SOC B MET, V24, P393 MARKUS RA, 1995, STAT MED, V14, P841 MATHEW T, 2001, J STAT PLAN INFER, V93, P295 MATTHEWS JNS, 1999, AM STAT, V53, P254 MCCULLAGH P, 1989, GEN LINEAR MODELS MCCULLOCH CE, 2001, GEN LINEAR MIXED MOD MEHRABI Y, 1998, BIOMETRICS, V54, P1398 MINKIN S, 1987, J AM STAT ASSOC, V82, P1098 MINKIN S, 1993, J AM STAT ASSOC, V88, P410 MUKHOPADHYAY S, 1995, J STAT PLAN INFER, V44, P385 MULLER P, 1995, J AM STAT ASSOC, V90, P1322 MULLER P, 1999, BAYESIAN STAT, V6, P459 MYERS RH, 1989, TECHNOMETRICS, V31, P137 MYERS RH, 1995, RESPONSE SURFACE MET MYERS RH, 1999, J QUAL TECHNOL, V31, P30 MYERS RH, 2002, GEN LINEAR MODELS NELDER JA, 1965, COMPUT J, V7, P308 NELDER JA, 1972, J ROYAL STATISTICA A, V135, P370 OWEN RJ, 1970, ANN MATH STAT, V41, P1917 OWEN RJ, 1975, J AM STAT ASSOC, V70, P351 PALMER JL, 1998, STAT MED, V17, P1613 PARMIGIANI G, 1993, J AM STAT ASSOC, V88, P622 PARMIGIANI G, 1994, ASPECTS UNCERTAINTY, P329 PARMIGIANI G, 1995, MODA, V4, P37 PILZ J, 1991, BAYESIAN ESTIMATION PRONZATO L, 1987, MODEL ORIENTED DATA, P77 PUKELSHEIM F, 1993, OPTIMAL DESIGN EXPT RIDOUT MS, 1995, APPL STAT-J ROY ST C, V44, P153 ROBBINS H, 1951, ANN MATH STAT, V22, P400 ROBBINS H, 1971, OPTIMIZING METHODS S, P233 ROBINSON KS, 2003, COMPUT STAT DATA AN, V43, P47 ROSENBERGER WF, 1997, STAT MED, V16, P2245 RUPPERT D, 1984, BIOMETRICS, V40, P535 SEBASTIANI P, 1997, J STAT PLAN INFER, V59, P359 SEBASTIANI P, 1998, J STAT PLAN INFER, V74, P177 SIELKEN RL, 1973, Z WAHRSCH VERW GEBIE, V26, P67 SILVEY SD, 1980, OPTIMAL DESIGN SITTER RR, 1992, BIOMETRICS, V48, P1145 SITTER RR, 1993, SCAND J STAT, V20, P329 SITTER RR, 1995, STAT SINICA, V5, P405 SITTER RR, 1997, STAT SINICA, V7, P941 SITTER RR, 1999, BIOMETRICS, V55, P396 SMITH DM, 1998, COMPSTAT98, P455 SMITH DM, 2003, J STAT PLAN INFER, V113, P617 SMITH DM, 2005, J STAT PLAN INFER, V133, P463, DOI 10.1016/j.jspi.2004.01.017 SPEARS FM, 1997, BIOMETRICS, V53, P1 STEINBERG DM, 1985, BIOMETRIKA, V72, P513 STORER BE, 1989, BIOMETRICS, V45, P925 STORER BE, 1990, STAT MED, V9, P229 STROUP DF, 1982, Z WAHRSCHEINLICHKEIT, V60, P535 SUN DC, 1996, J STAT PLAN INFER, V52, P289 TIERNEY L, 1990, LISP STAT OBJECT ORI TOMAN B, 1993, J STAT PLAN INFER, V35, P383 TOMAN B, 1994, STAT SINICA, V4, P603 TSUTAKAWA R, 1980, APPL STATIST, V29, P25 TSUTAKAWA RK, 1972, J AM STAT ASSOC, V67, P584 VENTER JH, 1967, ANN MATH STAT, V38, P181 WEI CZ, 1985, ANN STAT, V13, P1498 WETHERILL GB, 1963, J ROY STAT SOC B MET, V25, P1 WHITE LV, 1973, BIOMETRIKA, V60, P345 WHITE LV, 1975, THESIS U LONDON WHITTLE P, 1973, J ROY STAT SOC B MET, V35, P123 WIJESINHA MC, 1987, COMM STAT SIMULATION, V16, P239 WIJESINHA MC, 1987, J STAT PLAN INFER, V16, P179 WU CFJ, 1985, J AM STAT ASSOC, V80, P974 WU CFJ, 1988, OPTIMAL DESIGN ANAL, P213 YAN ZW, 2002, J CLIMATE, V15, P2073 ZACKS S, 1977, MULTIVARIATE ANAL, V4, P209 ZHU W, 1998, COMMUN STAT-THEOR M, V27, P1581 ZHU W, 2001, STAT MED, V20, P123 ZOCCHI SS, 1999, BIOMETRICS, V55, P437
NR	148
TC	0
PU	INST MATHEMATICAL STATISTICS
PI	BEACHWOOD
PA	PO BOX 22718, BEACHWOOD, OH 44122 USA
SN	0883-4237
J9	STAT SCI
JI	Stat. Sci.
PD	AUG
PY	2006
VL	21
IS	3
BP	376
EP	399
PG	24
SC	Statistics & Probability
GA	130CG
UT	ISI:000243776200006
ER

---

PT	J
AU	Pincus, T Sokka, T
AF	Pincus, Theodore Sokka, Tuulikki
TI	Quantitative measures to assess patients with rheumatic diseases: 2006 update
SO	RHEUMATIC DISEASE CLINICS OF NORTH AMERICA
LA	English
DT	Review
ID	HEALTH-ASSESSMENT QUESTIONNAIRE; SYSTEMIC-LUPUS-ERYTHEMATOSUS; CORE DATA SET; LONG-TERM OUTCOMES; FIBROMYALGIA IMPACT QUESTIONNAIRE; ERYTHROCYTE SEDIMENTATION-RATE; ARTHRITIS CLINICAL-TRIALS; VASCULITIS ACTIVITY SCORE; PROSPECTIVE FOLLOW-UP; ACUTE-PHASE RESPONSE
C1	Vanderbilt Univ, Sch Med, Div Rheumatol & Immunol, Med Ctr,Sch Med, Nashville, TN 37232 USA. Vanderbilt Univ, Sch Med, Div Rheumatol & Immunol, Dept Med,Med Ctr, Nashville, TN 37232 USA. Jyvaskyla Cent Hosp, Dept Rheumatol, Jyvaskyla, Finland.
RP	Pincus, T, Vanderbilt Univ, Sch Med, Div Rheumatol & Immunol, Med Ctr,Sch Med, 203 Oxford House,Box 5, Nashville, TN 37232 USA.
CR	*AM RHEUM ASS, 1982, DIC RHEUM DIS, V1 *COOP CLIN COMM AM, 1965, ARTHRITIS RHEUM, V8, P302 *VET ADM COOP STUD, 1970, JAMA-J AM MED ASSOC, V213, P1143 ALETAHA D, 2005, CLIN EXP RHEUMAT S39, V23, S100 BACON PA, 1995, CLIN EXP RHEUMATOL, V13, P275 BAER AN, 1983, JAMA-J AM MED ASSOC, V249, P3350 BELLAMY N, 1988, J RHEUMATOL, V15, P1833 BELLAMY N, 2005, CLIN EXP RHEUMAT S39, V23, S148 BENCIVELLI W, 1992, CLIN EXP RHEUMATOL, V10, P549 BENNETT R, 2005, CLIN EXP RHEUMAT S39, V23, S154 BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728 CALIN A, 1994, J RHEUMATOL, V21, P2281 CALIN A, 1999, J RHEUMATOL, V26, P988 CALIN A, 1999, RHEUMATOLOGY, V38, P878 CALLAHAN LF, 1989, ARTHRIT CARE RES, V2, P122 CALLAHAN LF, 1992, J CLIN EPIDEMIOL, V45, P127 CALLAHAN LF, 1995, ARTHRIT CARE RES, V8, P229 CALLAHAN LF, 1996, ARTHRIT CARE RES, V9, P463 CALLAHAN LF, 1997, ARTHRIT CARE RES, V10, P381 CHOI HK, 2002, LANCET, V359, P1173 CLAWSON DK, 1971, CLIN ORTHOP RELAT R, V77, P203 CLEGG DO, 1996, ARTHRITIS RHEUM, V39, P2004 CREEMERS MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503 DECKER JL, 1983, ARTHRITIS RHEUM, V26, P1029 DEODHAR SD, 1973, QUART J MED, V42, P387 DOUGADOS M, 1988, J RHEUMATOL, V15, P302 EGGER MJ, 1985, ARTHRITIS RHEUM, V28, P613 EGSMOSE C, 1995, J RHEUMATOL, V22, P2208 EMERY P, 1995, ANN RHEUM DIS, V54, P944 EXLEY AR, 1997, ARTHRITIS RHEUM, V40, P371 FELSON DT, 1993, ARTHRITIS RHEUM, V36, P729 FEX E, 1996, BRIT J RHEUMATOL, V35, P1106 FLEISCHER AB, 1996, J INVEST DERMATOL, V107, P26 FRANSEN J, 2000, RHEUMATOLOGY, V39, P321 FRANSEN J, 2005, CLIN EXP RHEUMAT S39, V23, S93 FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137 FUCHS HA, 1988, ARTHRITIS RHEUM, V31, P44 FUCHS HA, 1989, ARTHRITIS RHEUM, V32, P531 GENANT HK, 1983, AM J MED, V75, P35 GLADMAN DD, 1997, ARTHRITIS RHEUM, V40, P809 GOLDSMITH CH, 1993, J RHEUMATOL, V20, P575 GORDON DA, 1973, AM J MED, V54, P445 GRAUDAL N, 2000, J RHEUMATOL, V27, P47 HASSELBACHER P, 1987, ARTHRITIS RHEUM, V30, P637 HAWKER G, 1993, J RHEUMATOL, V20, P657 HAWLEY DJ, 1992, ARTHRIT CARE RES, V5, P130 HAY EM, 1993, Q J MED, V86, P447 JENKINSON TR, 1994, J RHEUMATOL, V21, P1694 KAARELA K, 1997, J RHEUMATOL, V24, P1285 KAVANAUGH A, 2005, CLIN EXP RHEUMAT S39, V23, S142 KAVANAUGH AF, 2002, ARTHRIT RHEUM-ARTHR, V47, P429, DOI 10.1002/art.10381 KAVANAUGH AF, 2002, ARTHRIT RHEUM-ARTHR, V47, P546, DOI 10.1002/art.10558 KAYE JJ, 1987, INVEST RADIOL, V22, P303 KAYE JJ, 1987, INVEST RADIOL, V22, P41 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 2000, J RHEUMATOL, V27, P1110 KRAUSE D, 2000, ARTHRITIS RHEUM, V43, P14 KRISHNAN E, 2004, ARTHRITIS RHEUM, V50, P953, DOI 10.1002/art.20048 LAM GKW, 2005, CLIN EXP RHEUMAT S39, V23, S120 LANDEWE R, 2005, CLIN EXP RHEUMAT S39, V23, S63 LANSBURY J, 1956, AM J MED SCI, V232, P150 LARSEN A, 1974, RADIOLOGICAL METHOD LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481 LARSEN A, 1995, J RHEUMATOL, V22, P1974 LEE P, 1974, SCAND J RHEUMATOL, V3, P17 LEIGH JP, 1991, J RHEUMATOL, V18, P1307 LEIRISALOREPO M, 1999, ARTHRITIS RHEUM S, V42, S130 LICHTENSTEIN MJ, 1988, J GEN INTERN MED, V3, P435 LUBECK DP, 1986, ARTHRITIS RHEUM, V29, P488 LUQMANI RA, 1994, Q J MED, V87, P671 MASON JH, 1992, ARTHRITIS RHEUM, V35, P156 MEENAN RF, 1987, J RHEUMATOL, V14, P411 MOSCA M, 2000, LUPUS, V9, P445 MULHERIN D, 1996, BRIT J RHEUMATOL, V35, P1263 MUNVES EF, 1983, ARTHRITIS RHEUM, V26, P848 NANCE EP, 1986, INVEST RADIOL, V21, P922 PETRI M, 1992, J RHEUMATOL, V19, P53 PINALS RS, 1981, ARTHRITIS RHEUM, V24, P1308 PINCUS T, 1983, ARTHRITIS RHEUM, V26, P1346 PINCUS T, 1984, ARTHRITIS RHEUM, V27, P864 PINCUS T, 1986, J RHEUMATOL, V13, P841 PINCUS T, 1987, J RHEUMATOL, V14, P240 PINCUS T, 1989, ANN INTERN MED, V110, P259 PINCUS T, 1992, J AUTOIMMUN A, V5, P209 PINCUS T, 1992, J RHEUMATOL, V19, P1051 PINCUS T, 1993, PRIMARY CARE, V20, P795 PINCUS T, 1994, ANN INTERN MED, V120, P26 PINCUS T, 1995, BRIT J RHEUMATOL, V34, P196 PINCUS T, 1997, J RHEUMATOL, V24, P2106 PINCUS T, 1997, RHEUMATOLOGY, V10, P1 PINCUS T, 1999, ARTHRITIS RHEUM, V42, P2220 PINCUS T, 1999, J RHEUMATOL, V26, P473 PINCUS T, 2000, J RHEUMATOL, V27, P2727 PINCUS T, 2002, ARTHRITIS RHEUM, V46, P851 PINCUS T, 2002, CLIN EXP RHEUMAT S27, V20, S42 PINCUS T, 2003, ARTHRITIS RHEUM, V48, P625, DOI 10.1002/art.10824 PINCUS T, 2003, BEST PRACT RES CL RH, V17, P753, DOI 10.1016/S1521-6942(03)00077-9 PINCUS T, 2004, ARTHRITIS RHEUM, V50, P1351, DOI 10.1002/art.20161 PINCUS T, 2004, RHEUM DIS CLIN N AM, V30, P725, DOI 10.1016/j.rdc.2004.08.001 PINCUS T, 2005, ARTHRITIS RHEUM, V52, P1031, DOI 10.1002/art.20995 PINCUS T, 2005, CLIN EXP RHEUMAT S39, V23, S1 PINCUS T, 2005, CLIN EXP RHEUMAT S39, V23, S109 PINCUS T, 2005, J RHEUMATOL, V32, P1432 PINCUS T, 2005, J RHEUMATOL, V32, P575 PINCUS T, 2006, J RHEUMATOL, V33, P448 PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44 PUOLAKKA K, 2004, ARTHRITIS RHEUM, V50, P55, DOI 10.1002/art.11436 PUOLAKKA K, 2005, ANN RHEUM DIS, V64, P130, DOI 10.1136/ard.2003.019034 PUOLAKKA K, 2005, ARTHRITIS RHEUM, V52, P36, DOI 10.1002/art.20716 RAU R, 1995, J RHEUMATOL, V22, P1976 RAU R, 1998, J RHEUMATOL, V25, P2094 RAU R, 2001, J RHEUMATOL, V28, P2608 RITCHIE DM, 1968, QUART J MED, V37, P393 SCOTT DL, 1984, ANN RHEUM DIS, V43, P8 SCOTT DL, 1996, BRIT J RHEUMATOL S2, V35, P14 SEO P, 2005, ARTHRITIS RHEUM, V52, P2168, DOI 10.1002/art.21137 SHAMOON H, 1993, NEW ENGL J MED, V329, P977 SHARP JT, 1971, ARTHRITIS RHEUM, V14, P706 SHARP JT, 1982, ARTHRITIS RHEUM, V25, P540 SHARP JT, 1983, CLIN RHEUM DIS, V9, P541 SHARP JT, 1989, J RHEUMATOL, V16, P568 SHARP JT, 1991, ARTHRITIS RHEUM, V34, P660 SHARP JT, 1995, J RHEUMATOL, V22, P1787 SMOLEN JS, 2005, ARTHRITIS RHEUM, V52, P1020, DOI 10.1002/art.20982 SODERLIN MK, 1998, J RHEUMATOL, V25, P1895 SOKKA T, 1999, J RHEUMATOL, V26, P1681 SOKKA T, 2000, ARTHRITIS RHEUM, V43, P386 SOKKA T, 2003, ARTHRITIS RHEUM, V48, P313, DOI 10.1002/art.10817 SOKKA T, 2003, J RHEUMATOL, V30, P1138 SOKKA T, 2004, ANN RHEUM DIS, V63, P494, DOI 10.1136/ard.2003.009530 SOKKA T, 2005, CLIN EXP RHEUMAT S39, V23, S58 SOLOMON DH, 2002, ARTHRIT RHEUM-ARTHR, V47, P434, DOI 10.1002/art.10561 STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659 STONE JH, 2001, ARTHRITIS RHEUM, V44, P912 SWAAK AJG, 2001, LUPUS, V10, P51 THOMPSON PW, 1987, ARTHRITIS RHEUM, V30, P618 TUGWELL P, 1993, J RHEUMATOL, V20, P527 TUGWELL P, 2000, ARTHRITIS RHEUM, V43, P506 VANDERHEIJDE D, 1999, J RHEUMATOL, V26, P743 VANDERHEIJDE D, 2005, ANN RHEUM DIS, V64, P1582, DOI 10.1136/ard.2004.034371 VANDERHEIJDE DMFM, 1992, ARTHRITIS RHEUM, V35, P26 VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579 VANLEEUWEN MA, 1997, J RHEUMATOL, V24, P20 VANRIEL PLCM, 1992, BRIT J RHEUMATOL, V31, P793 WARE JE, 1992, MED CARE, V30, P473 WEINBLATT ME, 1996, ANN INTERN MED, V124, P773 WELLS GA, 2005, J RHEUMATOL, V32, P2016 WELSING PMJ, 2001, ARTHRITIS RHEUM, V44, P2009 WHITINGOKEEFE QE, 1999, ARTHRITIS RHEUM, V42, P2365 WOLFE F, 1988, J RHEUMATOL, V15, P1480 WOLFE F, 1991, J RHEUMATOL, V18, P1298 WOLFE F, 1994, J RHEUMATOL, V21, P1227 WOLFE F, 1998, ARTHRITIS RHEUM, V41, P1072 WOLFE F, 1998, J RHEUMATOL, V25, P2108 WOLFE F, 1999, ARTHRITIS RHEUM, V42, P1797 WOLFE F, 2004, ARTHRITIS RHEUM, V50, P3296 WOLFE F, 2005, J RHEUMATOL, V32, P2410 ZOCHLING J, 2005, CLIN EXP RHEUMAT S39, V23, S133
NR	158
TC	0
PU	W B SAUNDERS CO-ELSEVIER INC
PI	PHILADELPHIA
PA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA
SN	0889-857X
J9	RHEUM DIS CLIN N AMER
JI	Rheum. Dis. Clin. North Am.
PD	DEC
PY	2006
VL	32
SU	Suppl. 1
BP	29
EP	36
PG	8
SC	Rheumatology
GA	126TW
UT	ISI:000243539400005
ER

---

PT	J
AU	Duman, O Ozarslan, MA Dogru, O
AF	Duman, O. Oezarslan, M. A. Dogru, O.
TI	On integral type generalizations of positive linear operators
SO	STUDIA MATHEMATICA
LA	English
DT	Article
DE	A-statistical convergence; Durrmeyer type generalization; Kantorovich type generalization; Korovkin type theorem; modulus of continuity; Lipschitz class
ID	STATISTICAL CONVERGENCE; APPROXIMATION
AB	We introduce a sequence of positive linear operators including many integral type generalizations of well known operators. Using the concept of statistical convergence we obtain some Korovkin type approximation theorems for those operators, and compute the rates of statistical convergence. Furthermore, we deal with the local approximation and the rth order generalization of our operators.
C1	TOBB Econ & Technol Univ, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey. Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey. Eastern Mediterranean Univ, Fac Art & Sci, Dept Math, Gazimagusa, Turkey.
RP	Duman, O, TOBB Econ & Technol Univ, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey.
EM	oduman@etu.edu.tr ozarslan@mail.emu.edu.tr dogru@science.ankara.edu.tr
CR	AGRATINI O, 2001, MATH NOTES MISKOLE, V2, P3 ALTOMARE F, 1994, DEGRUYTER STUD MATH, V17 DERRIENNIC MM, 1981, J APPROX THEORY, V31, P325 DEVORE RA, 1972, LECT NOTES MATH, V293 DOGRU O, 1998, MATH BALKANICA, V12, P359 DOGRU O, 2003, STUD SCI MATH HUNG, V40, P359 DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 DUMAN O, 2004, STUD MATH, V161, P187 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1991, ANALYSIS, V11, P59 FRIDY JA, 1997, P AM MATH SOC, V125, P3625 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 HARDY GH, 1949, DIVERGENT SERIES HEILMANN M, 1989, APPROX THEORY APPL, V5, P105 KANTOROVICH LV, 1938, STUD MATH, V7, P49 KIROV GH, 1993, MATH BALKANICA, V7, P149, UNSP MR 95I:41048 KOLK E, 1991, ACTA COMMENT U TARTU, V928, P41 KOLK E, 1993, ANALYSIS, V13, P77 KOROVKIN PP, 1960, LINEAR OPERATORS THE LI S, 1997, J APPROX THEORY, V88, P139 MILLER HI, 1995, T AM MATH SOC, V347, P1811 ROYDEN HL, 1968, REAL ANAL
NR	24
TC	0
PU	POLISH ACAD SCIENCES INST MATHEMATICS
PI	WARSAW 10
PA	SNIADECKICH 8, PO BOX 21,, 00-956 WARSAW 10, POLAND
SN	0039-3223
J9	STUD MATH
JI	Studia Math.
PY	2006
VL	174
IS	1
BP	1
EP	12
PG	12
SC	Mathematics
GA	086RN
UT	ISI:000240690800001
ER

---

PT	J
AU	Duman, O Erkus, E Gupta, V
AF	Duman, Oktay Erkus, Esra Gupta, Vijay
TI	Statistical rates on the multivariate approximation theory
SO	MATHEMATICAL AND COMPUTER MODELLING
LA	English
DT	Article
DE	A-statistical convergence; positive linear operators; statistical rates; modulus of continuity; the Korovkin theorem
ID	CONVERGENCE; OPERATORS; SUMMABILITY
AB	Statistical rates of approximations by means of positive linear operators defined on the space of multivariate continuous functions are studied. Furthermore, displaying an example, it is shown that our statistical rates are more efficient than the classical aspects in the approximation theory. (c) 2006 Elsevier Ltd. All rights reserved.
C1	Canakkale Onsekiz Mart Univ, Fac Sci & Arts, Dept Math, TR-17020 Canakkale, Turkey. TOBB Univ Econ & Technol, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey. Netaji Subhas Inst Technol, Sch Appl Sci, New Delhi 110075, India.
RP	Erkus, E, Canakkale Onsekiz Mart Univ, Fac Sci & Arts, Dept Math, TR-17020 Canakkale, Turkey.
EM	oduman@etu.edu.tr erkus@comu.edu.tr vijaygupta2001@hotmail.com
CR	BOJANIC R, 1983, CANADIAN MATH SOC C, V3, P5 BOJANIC R, 1992, J NAT SCI MATH, V32, P5 BOOS J, 2000, CLASSICAL MODERN MET CHENEY EW, 1964, CAN J MATH, V16, P241 DEVORE RA, 1993, CONSTRUCTIVE APPROXI DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 ERKUS E, IN PRESS STUDIA SCI FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1978, CAN J MATH, V30, P808 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 2003, ACTA SCI MATH SZEGED, V69, P147 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 GUPTA V, 1999, J MATH ANAL APPL, V233, P476 HARDY GH, 1949, DIVERGENT SERIES KOLK E, 1993, ANALYSIS, V13, P77 KOROVKIN PP, 1960, LINEAR OPERATORS APP KUTTNER B, 1944, J LOND MATH SOC, V19, P153 MILLER HI, 1983, RAD ODJELJ PRIROD MA, V22, P39 SRIVASTAVA HM, 2003, MATH COMPUT MODEL, V37, P1307 SZASZ O, 1950, T AM MATH SOC, V69, P440
NR	21
TC	0
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0895-7177
J9	MATH COMPUT MODELLING
JI	Math. Comput. Model.
PD	NOV
PY	2006
VL	44
IS	9-10
BP	763
EP	770
PG	8
SC	Computer Science, Interdisciplinary Applications; Computer Science, Software Engineering; Mathematics, Applied
GA	084UJ
UT	ISI:000240559600001
ER

---

PT	J
AU	Khan, MA
AF	Khan, Muhammad Asim
TI	Ankylosing spondylitis: A dual perspective of current issues and challenges
SO	JOURNAL OF RHEUMATOLOGY
LA	English
DT	Article
DE	ankylosing spondylitis; diagnosis; treatment
ID	WORK DISABILITY; HLA-B27; DIAGNOSIS; SPONDYLOARTHROPATHIES; THERAPY; DISEASE; LIFE; NEED
AB	This series of articles on ankylosing spondylitis (AS) provides insight into the burden of disease and focuses on early diagnosis and effective management. AS leads to progressive functional impairment over time and has tremendous impact on society at large in terms of economic costs and indirect costs associated with physical impairment and loss of employment. Early diagnosis is crucial now that we have more effective therapy with tumor necrosis factor (TNF) antagonists, which suppress disease activity and improve the functional ability of patients whose disease is refractory to conventional drug therapy. Early identification. of variables that help predict severe disease with bad functional prognosis is needed. If biological therapy with TNF inhibitors is proven to retard disease progression and prevent or delay functional limitations, insight into such prognosticators will help us offer the correct treatment to the correct patient at the correct time. There is also a need to demonstrate longterm benefits of such a therapy as well as a favorable cost/benetit ratio to help convince healthcare authorities, insurance companies, and others of the utility of these drugs for treating patients with AS refractory to conventional drug therapy.
C1	Case Western Reserve Univ, Div Rheumatol, Metrohlth Med Ctr, Cleveland, OH 44109 USA.
RP	Khan, MA, Case Western Reserve Univ, Div Rheumatol, Metrohlth Med Ctr, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.
EM	mkhan@metrohealth.org
CR	BARKHAM N, 2005, RHEUMATOLOGY, V44, P1277, DOI 10.1093/rheumatology/keh713 BOONEN A, 2001, ANN RHEUM DIS, V60, P1033 BOONEN A, 2001, ANN RHEUM DIS, V60, P353 BOONEN A, 2005, EXPERT REV PHARMACOE, V5, P163 BOONEN A, 2006, J RHEUMATOL S78, V33, P4 CLEGG DO, 2006, J RHEUMATOL S78, V33, P24 DAVIS JC, 2005, ARTHRIT RHEUM-ARTHR, V53, P494, DOI 10.1002/art.21330 DOUGADOS M, 2002, ANN RHEUM DIS S3, V61, P40 ELYAN M, 2006, J RHEUMATOL S78, V33, P12 FELDTKELLER E, 2000, CURR OPIN RHEUMATOL, V12, P239 FELDTKELLER E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4 FELTKAMP TEW, 1996, IMMUNOL TODAY, V17, P5 KHAN MA, 1977, ARTHRITIS RHEUM, V20, P909 KHAN MA, 1977, J RHEUMATOL S3, V4, P39 KHAN MA, 1981, J RHEUMATOL, V8, P86 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1985, ARTHRITIS RHEUM, V28, P40 KHAN MA, 1990, SEMIN ARTHRITIS RHEU, V20, P107 KHAN MA, 1990, SPINE STATE ART REV KHAN MA, 1992, SPONDYLOARTHROPATHEI KHAN MA, 1995, CURR OPIN RHEUMATOL, V7, P263 KHAN MA, 2002, ANN INTERN MED, V136, P896 KHAN MA, 2002, CLIN EXP RHEUMAT S28, V20, S6 KHAN MA, 2003, RHEUMATOLOGY, P1161 KHAN MA, 2005, ATLAS RHEUMATOLOGY, P151 NEWMAN PA, 2003, RHEUM DIS CLIN N AM, V29, P561, DOI 10.1016/S0889-857X(03)00046-2 RUDWALEIT M, 2004, ANN RHEUM DIS, V63, P535, DOI 10.1136/ard.2003.011247 RUDWALEIT M, 2004, ANN RHEUM DIS, V63, P665, DOI 10.1136/ard.2003.016386 RUDWALEIT M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990 VANROYEN BJ, 2006, ANKYLOSING SPONDYLIT WEISMAN MH, 2006, ANKYLOSING SPONDYLIT
NR	31
TC	0
PU	J RHEUMATOL PUBL CO
PI	TORONTO
PA	920 YONGE ST, SUITE 115, TORONTO, ONTARIO M4W 3C7, CANADA
SN	0315-162X
J9	J RHEUMATOL
JI	J. Rheumatol.
PD	SEP
PY	2006
VL	33
SU	Suppl. 78
BP	1
EP	3
PG	3
SC	Rheumatology
GA	083PD
UT	ISI:000240469800001
ER

---

PT	J
AU	Boonen, A van der Linden, SM
AF	Boonen, Annelies van der Linden, Sjef M.
TI	The burden of ankylosing spondylitis
SO	JOURNAL OF RHEUMATOLOGY
LA	English
DT	Article
DE	ankylosing spondylitis; morbidity; mortality; cost of illness
ID	QUALITY-OF-LIFE; GENERAL-POPULATION; WORK DISABILITY; RHEUMATOID-ARTHRITIS; EPIDEMIOLOGICAL SURVEY; FUNCTIONAL DISABILITY; VERTEBRAL FRACTURES; COST-EFFECTIVENESS; DISEASE-ACTIVITY; BOWEL-DISEASE
AB	The acute as well as chronic clinical features of ankylosing spondylitis (AS) are a burden to the patient and society. Apart from the axial and articular manifestations, extraarticular AS-related comorbidities such as uveitis, inflammatory bowel disease, and psoriasis contribute to the burden of the disease. In addition, a large proportion of patients have osteoporosis or osteopenia, which may be associated with fractures and contribute to kyphosis. All these features result in decreased quality of life. Moreover, patients with AS have an increased mortality rate. The impact of this disease also can be seen in various aspects of workforce participation, from requiring more assistance at paid work to withdrawal from the workforce. Further, patients with AS and, subsequently, society are affected by substantial healthcare costs related to medications and healthcare provider expenses. Early diagnosis and management of patients will likely prevent functional disability and improve patient outcomes.
C1	Univ Hosp Maastricht, Dept Med, Div Rheumatol, NL-6202 AZ Maastricht, Netherlands. Univ Maastricht, CAPHRI Res Inst, Maastricht, Netherlands.
RP	Boonen, A, Univ Hosp Maastricht, Dept Med, Div Rheumatol, POB 5800, NL-6202 AZ Maastricht, Netherlands.
EM	aboo@sint.azm.nl
CR	AKKOC N, 2005, ARTHRITIS RHEUM, V52, P4048, DOI 10.1002/art.21492 ALAMANOS Y, 2004, RHEUMATOLOGY, V43, P615, DOI 10.1093/rheumatology/keh133 ALARANTA H, 2002, CLIN EXP RHEUMATOL, V20, P66 ARIZAARIZA R, 2003, ARTHRIT RHEUM-ARTHR, V49, P483, DOI 10.1002/art.11197 BAETEN D, 2002, BEST PRACT RES CL RH, V16, P537, DOI 10.1053/berh.2002.0249 BANARES A, 1998, RHEUM DIS CLIN N AM, V24, P771 BARLOW JH, 2001, ARTHRIT RHEUM-ARTHR, V45, P424 BOONEN A, 2001, ANN RHEUM DIS, V60, P1033 BOONEN A, 2001, ANN RHEUM DIS, V60, P353 BOONEN A, 2001, J RHEUMATOL, V28, P1056 BOONEN A, 2002, ANN RHEUM DIS, V61, P429 BOONEN A, 2002, ANN RHEUM DIS, V61, P658 BOONEN A, 2003, ANN RHEUM DIS, V62, P732 BOONEN A, 2003, ANN RHEUM DIS, V62, P741 BOONEN A, 2005, EXPERT REV PHARMACOE, V5, P163 BOONEN A, 2006, ANN RHEUM DIS, V65, P201, DOI 10.1136/ard.2004.032565 BOYER GS, 1994, J RHEUMATOL, V21, P2292 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BROPHY S, 2001, J RHEUMATOL, V28, P2667 CARBONE LD, 1992, ARTHRITIS RHEUM, V35, P1476 CARTER ET, 1979, ARTHRITIS RHEUM, V22, P365 CHORUS AMJ, 2002, ANN RHEUM DIS, V61, P693 CHORUS AMJ, 2003, ANN RHEUM DIS, V62, P1178, DOI 10.1136/ard.2002.004861 COOPER C, 1994, J RHEUMATOL, V21, P1877 DAGFINRUD H, 2005, ARTHRIT RHEUM-ARTHR, V53, P5, DOI 10.1002/art.20910 DAI SM, 2003, J RHEUMATOL, V30, P2245 DARBY SC, 1987, BRIT J CANCER, V55, P179 DAVIS JC, 2005, ARTHRIT RHEUM-ARTHR, V53, P494, DOI 10.1002/art.21330 DOWARD LC, 2003, ANN RHEUM DIS, V62, P20 EDMUNDS L, 1991, J RHEUMATOL, V18, P696 ELMAGHRAOUI A, 1999, J RHEUMATOL, V26, P2205 ELMAGHRAOUI A, 2004, JOINT BONE SPINE, V71, P291, DOI 10.1016/j.jbspin.2003.06.002 FELDTKELLER E, 2006, RHEUMATOL INT, V26, P234, DOI 10.1007/s00296-004-0556-8 GEUSENS P, 2001, J RHEUMATOL, V28, P1856 GRAN JT, 1984, CLIN RHEUMATOL, V3, P467 GRAN JT, 1984, J RHEUMATOL, V11, P788 GRAN JT, 1985, ANN RHEUM DIS, V44, P359 GRAN JT, 1997, BRIT J RHEUMATOL, V36, P766 GUILLEMIN F, 1990, ARTHRITIS RHEUM, V33, P1001 HOLLAN I, 2005, ARTHRITIS RHEUM S, V52, S213 HUKUDA S, 2001, J RHEUMATOL, V28, P554 KAIPIANENSEPPANEN O, 1997, J RHEUMATOL, V24, P496 KHAN MA, 1981, J RHEUMATOL, V8, P86 KHAN MA, 2002, ANN INTERN MED, V136, P896 KHAN MA, 2002, ATLAS RHEUMATOLOGY, P141 KHAN MA, 2005, ATLAS RHEUMATOLOGY, P151 KOBELT G, 2004, RHEUMATOLOGY, V43, P1158, DOI 10.1093/rheumatology/keh271 KOTANIEMI K, 2001, J RHEUMATOL, V28, P309 LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174 MAU W, 2005, J RHEUMATOL, V32, P721 MYLLYKANGASLUOSUJARVI R, 1998, BRIT J RHEUMATOL, V37, P688 OZGUL A, 2006, CLIN RHEUMATOL, V25, P168, DOI 10.1007/s10067-005-1150-5 PETERS MJ, 2004, SEMIN ARTHRITIS RHEU, V34, P585, DOI 10.1016/j.semarthrit.2004.07.010 RADFORD EP, 1977, NEW ENGL J MED, V297, P572 ROBERTSON LP, 2004, RHEUMATOLOGY, V43, P1565, DOI 10.1093/rheumatology/keh386 ROUSSOU E, 1997, J RHEUMATOL, V24, P908 SIEPER J, 2002, ANN RHEUM DIS S3, V61, P8 SUN JP, 1992, INT J CARDIOL, V37, P65 SYMMONS DPM, 2004, ARTHRITIS RHEUM S, V50, S477 TRONTZAS P, 2005, CLIN RHEUMATOL, V24, P583, DOI 10.1007/s10067-005-1106-9 VANDERLINDEN S, 2005, KELLEYS TXB RHEUMATO, P1125 VANDERLINDEN SM, 1984, ARTHRITIS RHEUM, V27, P241 VANTUBERGEN A, 2002, ARTHRIT RHEUM-ARTHR, V47, P459, DOI 10.1002/art.10658 VANTUBERGEN A, 2002, ARTHRIT RHEUM-ARTHR, V47, P8 VOSSE D, 2004, J RHEUMATOL, V31, P1981 VOSSE D, 2006, ANN RHEUM DIS, V65, P770, DOI 10.1136/ard.2005.044081 WARD MM, 1999, ARTHRIT CARE RES, V12, P247 WARD MM, 2001, J RHEUMATOL, V28, P315 WARD MM, 2002, ARTHRITIS RHEUM, V46, P223 WARD MM, 2002, J RHEUMATOL, V29, P1420 WEISS HA, 1994, INT J CANCER, V59, P327 ZINK A, 2000, J RHEUMATOL, V27, P613
NR	72
TC	2
PU	J RHEUMATOL PUBL CO
PI	TORONTO
PA	920 YONGE ST, SUITE 115, TORONTO, ONTARIO M4W 3C7, CANADA
SN	0315-162X
J9	J RHEUMATOL
JI	J. Rheumatol.
PD	SEP
PY	2006
VL	33
SU	Suppl. 78
BP	4
EP	11
PG	8
SC	Rheumatology
GA	083PD
UT	ISI:000240469800002
ER

---

PT	J
AU	Elyan, M Khan, MA
AF	Elyan, Mazen Khan, Muhammad Asim
TI	Diagnosing ankylosing spondylitis
SO	JOURNAL OF RHEUMATOLOGY
LA	English
DT	Review
DE	ankylosing spondylitis; diagnosis; imaging; spondyloarthritis; spondyloarthropathies; radiography
ID	HLA-B27 POSITIVE INDIVIDUALS; CAUDA-EQUINA SYNDROME; C-REACTIVE PROTEIN; FOLLOW-UP; SERONEGATIVE SPONDYLOARTHROPATHIES; RHEUMATOID-ARTHRITIS; PSORIATIC-ARTHRITIS; GENERAL-POPULATION; DISEASE-ACTIVITY; SPINAL MOBILITY
AB	This article focuses on the early diagnosis and effective management of ankylosing spondylitis (AS), a disease that is not uncommon and that can cause early retirement and severe functional disability. AS, like most other rheumatologic diseases, has no diagnostic gold standard. Correct diagnosis depends largely on a constellation of clinical symptoms and signs in addition to radiological findings. Early diagnosis has become all the more important because effective therapies are available: tumor necrosis factor antagonists that suppress disease activity and improve functional ability in patients with AS refractory to conventional drug therapy. The biologic agents are probably even more effective if given early. Inflammation of the sacroiliac joints and the spine is a common, early feature and possibly the most frequent first manifestation of disease. Therefore, its early detection is important, and magnetic resonance imaging has proven useful in this regard. To optimize diagnostic accuracy of early disease, it is crucial to use a comprehensive approach and have a deep understanding of the disease and its clinical picture. The clinician should gather a complete history, paying close attention to all the elements of this multisystem disease, as well as judiciously ordering laboratory testing and imaging. New strategies are being developed to assist primary care physicians in their screening for these patients, which in turn should result in early referral to rheumatologists and early diagnosis.
C1	Case Western Reserve Univ, Div Rheumatol, Metrohlth Med Ctr, Cleveland, OH 44109 USA.
RP	Khan, MA, Case Western Reserve Univ, Div Rheumatol, Metrohlth Med Ctr, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.
EM	mkhan@metrohealth.org
CR	AHLSTROM H, 1990, ARTHRITIS RHEUM, V33, P1763 AKKOC N, 2005, ARTHRITIS RHEUM, V52, P4048, DOI 10.1002/art.21492 ALAMANOS Y, 2004, RHEUMATOLOGY, V43, P615, DOI 10.1093/rheumatology/keh133 AMOR B, 1990, REV RHUM MAL OSTEO, V57, P85 AMOR B, 2000, JOINT BONE SPINE, V67, P502 BANARES A, 1998, RHEUM DIS CLIN N AM, V24, P771 BARALIAKOS X, 2005, ANN RHEUM DIS, V64, P1141, DOI 10.1136/ard.2004.031609 BAROZZI L, 1998, EUR J RADIOL S1, V27, S12 BENJAMIN M, 2001, J ANAT 5, V199, P503 BENNETT DL, 2004, RADIOL CLIN N AM, V42, P121, DOI 10.1016/S0033-8389(03)00156-8 BERGSTROM TF, 1997, HEREDITAS, V127, P1 BILGEN IG, 1999, NEURORADIOLOGY, V41, P508 BOYER GS, 1994, J RHEUMATOL, V21, P2292 BOYER GS, 1997, ARCH INTERN MED, V157, P2111 BRANDT J, 1999, RHEUMATOLOGY, V38, P831 BRAUN J, 1994, ARTHRITIS RHEUM, V37, P1039 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 1998, RHEUM DIS CLIN N AM, V24, P697 BRAUN J, 2002, ANN RHEUM DIS S3, V61, P51 BRAUN J, 2002, BEST PRACT RES CL RH, V16, P573, DOI 10.1053/berh.2002.0250 BROPHY S, 2002, J RHEUMATOL, V29, P1236 BROWN MA, 1996, ANN RHEUM DIS, V55, P268 CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613 CALIN A, 1988, J RHEUMATOL, V15, P1234 CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186 CATS A, 1987, CLIN EXP RHEUMATOL, V5, P167 DAGFINRUD H, 2005, ARTHRIT RHEUM-ARTHR, V53, P5, DOI 10.1002/art.20910 DAI SM, 2003, J RHEUMATOL, V30, P2245 DAWES PT, 1988, POSTGRAD MED J, V64, P27 DEKEYSER F, 2002, CURR RHEUMATOL REP, V4, P525 DIVECHA H, 2005, CLIN SCI, V109, P171 DOMJAN L, 1990, J RHEUMATOL, V17, P663 DOODADS M, 1995, BR J RHEUMATOL, V34, P301 DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218 DOUGADOS M, 1999, J RHEUMATOL, V26, P971 FELDTKELLER E, 2000, CURR OPIN RHEUMATOL, V12, P239 FELDTKELLER E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4 FERNANDEZMELON J, 2004, J RHEUMATOL, V31, P524 FRANCOIS RJ, 2001, CURR OPIN RHEUMATOL, V13, P255 GINSBURG WW, 1997, J RHEUMATOL, V24, P1417 GOFTON JP, 1966, ANN RHEUM DIS, V25, P528 GRAN JT, 1985, ANN RHEUM DIS, V44, P359 GRAN JT, 1995, J MED GENET, V32, P497 GRATACOS J, 1999, ARTHRITIS RHEUM, V42, P2319 HAYWOOD KL, 2004, RHEUMATOLOGY, V43, P750, DOI 10.1093/rheumatology/keh169 HELEWA A, 2001, CLIN CARE RHEUMATIC, P105 HERMANN KGA, 2005, J RHEUMATOL, V32, P2056 HEUFTDORENBOSCH L, 2004, J RHEUMATOL, V31, P1779 HITCHON PW, 2002, J NEUROSURG S, V97, P218 HUKUDA S, 2001, J RHEUMATOL, V28, P554 KAIPIANENSEPPANEN O, 1997, J RHEUMATOL, V24, P496 KETTERING JM, 1996, SEMIN ROENTGENOL, V31, P220 KHAN MA, 1977, ARTHRITIS RHEUM, V20, P909 KHAN MA, 1977, J RHEUMATOL S3, V4, P39 KHAN MA, 1980, ARCH INTERN MED, V140, P177 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1985, ARTHRITIS RHEUM, V28, P40 KHAN MA, 1990, SEMIN ARTHRITIS RHEU, V20, P107 KHAN MA, 1995, CURR OPIN RHEUMATOL, V7, P263 KHAN MA, 1997, HLA B27 DEV SPONDYLO, P95 KHAN MA, 2002, ANN INTERN MED, V136, P896 KHAN MA, 2002, ANN RHEUM DIS S3, V61, P3 KHAN MA, 2002, ATLAS RHEUMATOLOGY, P141 KHAN MA, 2002, CLIN EXP RHEUMAT S28, V20, S6 KHAN MA, 2003, RHEUMATOLOGY, P1161 KIDD BL, 1988, BR J RHEUMATOL, V27, P230 LANGE U, 2001, OSTEOPOROSIS INT, V12, P1031 LANGLOIS S, 2005, JOINT BONE SPINE, V72, P248, DOI 10.1016/j.jbspin.2004.05.015 MAU W, 1990, Z RHEUMATOL, V49, P82 MOLL JMH, 1972, ANN RHEUM DIS, V31, P1 MOLL JMH, 1973, RHEUMATOL REHABIL, V12, P115 MONNET D, 2004, OPHTHALMOLOGY, V111, P802, DOI 10.1016/j.ophtha.2003.07.011 MOSES S, ANKYLOSING SPONDYLIT OLIVIERI I, 1998, EUR J RADIOL S1, V27, S3 OOSTVEEN J, 1999, J RHEUMATOL, V26, P1953 ORY PA, 2005, ANN RHEUM DIS S2, V64, P55, DOI 10.1136/ard.2004.033928 ROSENOW EC, 1977, MAYO CLIN PROC, V52, P641 RUDWALEIT M, COMMUNICATION RUDWALEIT M, 2004, ANN RHEUM DIS, V63, P535, DOI 10.1136/ard.2003.011247 RUDWALEIT M, 2005, ARTHRITIS RHEUM, V52, P1000, DOI 10.1002/art.20990 SAIDNAHAL R, 2000, ARTHRITIS RHEUM, V43, P1356 SHIM SC, 1998, J RHEUMATOL, V25, P2464 SIEPER J, 2002, ANN RHEUM DIS S3, V61, P8 SMALE S, 2001, ARTHRITIS RHEUM, V44, P2728 SPOORENBERG A, 1999, J RHEUMATOL, V26, P980 STONE M, 2005, ARTHRIT RHEUM-ARTHR, V53, P445, DOI 10.1002/art.21174 THOMPSON GH, 1982, SPINE, V7, P78 TICO N, 1998, SPINAL CORD, V36, P349 TRONTZAS P, 2005, CLIN RHEUMATOL, V24, P583, DOI 10.1007/s10067-005-1106-9 TURETSCHEK K, 2000, CLIN RADIOL, V55, P632 VANDERHEIJDE D, 1999, J RHEUMATOL, V26, P951 VANDERHEIJDE D, 2004, CURRENT RHEUM REP, V6, P98 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDERLINDEN S, 2005, KELLEYS TXB RHEUMATO, P1125 VANDERLINDEN SM, 1984, ARTHRITIS RHEUM, V27, P241 VANDERLINDEN SM, 1984, J RHEUMATOL, V11, P727 VANDERLINDEN SM, 1988, J RHEUMATOL, V15, P836 VANTUBERGEN A, 2003, ANN RHEUM DIS, V62, P519 VOSSE D, 2004, J RHEUMATOL, V31, P1981 ZEIDLER H, 1985, Z RHEUMATOL, V44, P249 ZINK A, 2000, J RHEUMATOL, V27, P613
NR	101
TC	1
PU	J RHEUMATOL PUBL CO
PI	TORONTO
PA	920 YONGE ST, SUITE 115, TORONTO, ONTARIO M4W 3C7, CANADA
SN	0315-162X
J9	J RHEUMATOL
JI	J. Rheumatol.
PD	SEP
PY	2006
VL	33
SU	Suppl. 78
BP	12
EP	23
PG	12
SC	Rheumatology
GA	083PD
UT	ISI:000240469800003
ER

---

PT	J
AU	Erkus, E Duman, O
AF	Erkus, Esra Duman, Oktay
TI	A Korovkin type approximation theorem in statistical sense
SO	STUDIA SCIENTIARUM MATHEMATICARUM HUNGARICA
LA	English
DT	Article
DE	A-statistical convergence; positive linear operator; the Korovkin theorem
ID	CONVERGENCE
AB	In this study, using the concept of A-statistical convergence we investigate a Korovkin type approximation result for a sequence of positive linear operators defined on the space of all continuous real valued functions on any compact subset of the real m-dimensional space.
C1	Canakkale Onsekiz Mart Univ, Fac Sci & Arts, Dept Math, TR-17020 Terzioglu Kampusu, Canakkale, Turkey. TOBB Univ Econ & Technol, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey.
RP	Erkus, E, Canakkale Onsekiz Mart Univ, Fac Sci & Arts, Dept Math, TR-17020 Terzioglu Kampusu, Canakkale, Turkey.
EM	erkus@comu.edu.kr oduman@etu.edu.tr
CR	BOJANIC R, 1983, CANADIAN MATH SOC C, V3, P5 BOJANIC R, 1992, J NAT SCI MATH, V32, P5 CHENEY EW, 1964, CAN J MATH, V16, P241 CONNOR JS, 1988, ANALYSIS, V8, P47 DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 HARDY GH, 1949, DIVERGENT SERIES KOLK E, 1991, TARTU UL TOIMETISED, V928, P41, UNSP MR 93C:40003 KOLK E, 1993, ANALYSIS, V13, P77 KOROVKIN PP, 1960, LINEAR OPERATORS THE MILLER HI, 1995, T AM MATH SOC, V347, P1811 ZYGMUND A, 1959, TRIGONOMETRIC SERIES, V2
NR	15
TC	1
PU	AKADEMIAI KIADO
PI	BUDAPEST
PA	PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN	0081-6906
J9	STUD SCI MATH HUNG
JI	Stud. Sci. Math. Hung.
PY	2006
VL	43
IS	3
BP	285
EP	294
PG	10
SC	Mathematics
GA	070WC
UT	ISI:000239555600002
ER

---

PT	J
AU	Zeng, XM Chen, XJ
AF	Zeng, Xiao-Ming Chen, X. J.
TI	Approximation for bounded functions and absolutely continuous functions by Beta operators
SO	COMPUTERS & MATHEMATICS WITH APPLICATIONS
LA	English
DT	Article
DE	approximation property; absolutely continuous functions; Beta operators; probabilistic methods
AB	In this paper, the pointwise approximation properties of Beta operators (B) over bar (n) are studied to the bounded functions and the absolutely continuous functions, respectively. First, we use the asymptotic form of the central limit theorem in probability theory to derive an asymptotic estimate on the rate of convergence of Beta operators (B) over tilde (n) for the bounded functions. Next, we give the optimal estimate on the first-order absolute moment of the Beta operators B-n(vertical bar t - x vertical bar, x) by direct computations. Then, we use this estimate and Bojanic-Cheng-Khan's method combining with some analysis techniques to derive an asymptotically optimal estimate on the rate of convergence of Beta operators (B) over bar (n) for the absolutely continuous functions. (c) 2006 Elsevier Ltd. All rights reserved.
C1	Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
RP	Zeng, XM, Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
EM	xmzeng@jingxian.xmu.edu.cn
CR	BOJANIC R, 1989, J MATH ANAL APPL, V141, P136 BOJANIC R, 1991, ATTI SEMIN MAT FIS, V29, P153 DIVIS Z, 1991, PUBL I MATH, V49, P104 FELLER W, 1971, INTRO PROBABILITY TH KHAN MK, 1991, PROGR APPROXIMATION, P483 NAMIAS V, 1986, AM MATH MON, V93, P25 OMEY E, 1996, THEOR PROBAB APPL, V41, P219 PYCHTABERSKA P, 2003, J APPROX THEORY, V123, P256, DOI 10.1016/S0021-9045(03)00106-0 SHIRYAYEV AN, 1984, PROBABILITY ZENG XM, 2001, J APPROX THEORY, V109, P242 ZENG XM, 2005, J MATH ANAL APPL, P1
NR	11
TC	0
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0898-1221
J9	COMPUT MATH APPL
JI	Comput. Math. Appl.
PD	MAY
PY	2006
VL	51
IS	9-10
BP	1585
EP	1592
PG	8
SC	Computer Science, Interdisciplinary Applications; Mathematics, Applied
GA	062TH
UT	ISI:000238966900020
ER

---

PT	J
AU	Downing, J Coates, E Street, J Hammond, L Rees, TJ Pepperall, J Darke, C
TI	A high-resolution polymerase chain reaction-sequence-specific primer HLA-B*27 typing set and its application in routine HLA-B27 testing
SO	GENETIC TESTING
LA	English
DT	Article
ID	ANKYLOSING-SPONDYLITIS; HLA SYSTEM; IDENTIFICATION; ANTIBODY; SUBTYPES; DISEASE; ALLELE; UPDATE
AB	We designed a set of 35 polymerase chain reaction sequence- specific primers ( PCR- SSP) in 29 SSP mixtures to assign 29 HLA- B* 27 4- digit level alleles ( B* 2701- B* 2721 and B* 2723- B* 2730). This was used in conjunction with our 41 PCR- SSP primer mixture low- resolution HLA- B typing set to fully differentiate B* 27 from all other HLA- B alleles. Successful typing set validation used 521 B* 27 samples covering 13 ( B* 2701- B* 2710 and B* 2712, B* 2717, B* 2723) alleles. The distribution of B* 27 alleles was determined in a random population of 4020 local blood donors and the use of PCR- SSP B* 27 typing in our routine flow cytometry- based HLA- B27/ B2708 typing strategy is described.
C1	Welsh Blood Serv, Welsh Transplantat & Immogenet Lab, Pontyclun CF72 9WB, Wales.
RP	Darke, C, Welsh Blood Serv, Welsh Transplantat & Immogenet Lab, Ely Valley Rd, Pontyclun CF72 9WB, Wales.
EM	chris.darke@wbs.wales.nhs.uk
CR	*UK NEQAS H I, 2001, UK NAT EXT QUAL ASS BALL EJ, 2001, JOINT BONE SPINE, V68, P378 BREWERTON DA, 1973, LANCET, V1, P904 BRODSKY FM, 1979, IMMUNOL REV, V47, P3 BROWN MA, 1996, ANN RHEUM DIS, V55, P268 COATES E, 1998, EUR J IMMUNOGENET, V25, P29 DAMATO M, 1995, DIS MARKERS, V12, P215 DARKE C, 2000, BONE MARROW TRANSPL, V25, P771 DARKE C, 2002, TISSUE ANTIGENS, V60, P400 DOWNING J, 2004, GENET TEST, V8, P301 FUSSELL H, 1994, EUR J IMMUNOGENET, V21, P23 GOOD AE, 1979, CUTIS, V24, P514 GUTTRIDGE MG, 1999, TISSUE ANTIGENS 1, V53, P383 HELMBERG W, 1998, TISSUE ANTIGENS, V51, P587 HILL G, 1991, POETRY WALES, V27, P27 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1995, CURR OPIN RHEUMATOL, V7, P263 KHAN MA, 2002, ANN INTERN MED, V136, P896 LAU M, 1994, CLIN TRANSPLANT, P467 LOPEZLARREA C, 1995, TISSUE ANTIGENS, V45, P169 MARSH SGE, 2006, TISSUE ANTIGENS, V67, P258, DOI 10.1111/j.1399-0039.2005.00545.x NASUTION AR, 1997, J RHEUMATOL, V24, P1111 OHNO S, 1977, BR J OPHTHALMOL, V61, P62 PARHAM P, 1993, TRANSPLANT P, V25, P159 PEI R, 1993, TISSUE ANTIGENS, V41, P200 PETERSDORF EW, 1999, CURR OPIN IMMUNOL, V11, P521 TOMLINSON IPM, 1995, TRENDS GENET, V11, P493 TRAPANI JA, 1983, HUM IMMUNOL, V7, P205
NR	28
TC	0
PU	MARY ANN LIEBERT INC
PI	NEW ROCHELLE
PA	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA
SN	1090-6576
J9	GENET TEST
JI	Genet. Test.
PD	JUN
PY	2006
VL	10
IS	2
BP	98
EP	103
PG	6
SC	Genetics & Heredity; Medicine, Research & Experimental
GA	058UA
UT	ISI:000238688900004
ER

---

PT	J
AU	Duman, O Orhan, C
TI	An abstract version of the Korovkin approximation theorem
SO	PUBLICATIONES MATHEMATICAE-DEBRECEN
LA	English
DT	Article
DE	statistical convergence; A-density; A-statistical convergence; positive linear operators; the Korovkin theorem
ID	POSITIVE LINEAR-OPERATORS; STATISTICAL CONVERGENCE; SUMMABILITY
AB	In this paper we consider some analogs of the Korovkin approximation theorem via A-statistical convergence. In particular we study A-statistical convergence of approximating operators defined on C(X, R), the space of all real valued continuous functions on the compact Hausdorff space X. We also discuss some of its applications.
C1	Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
RP	Duman, O, Tobb Univ Econ & Technol, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey.
EM	oduman@etu.edu.tr orhan@science.ankara.edu.tr
CR	ALTOMARE F, 1994, DEGRUYTER STUD MATH, V17 BOJANIC R, 1983, CANADIAN MATH SOC C, V3, P5 BOJANIC R, 1992, J NAT SCI MATH, V32, P5 BOOS J, 2000, CLASSICAL MODERN MET CONNOR J, 1989, CAN MATH BULL, V32, P194 CONNOR J, 1999, APPL NUM HARM ANAL, P403 DUMAN O, 2003, DEMONSTRATIO MATH, V36, P873 DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 DUMAN O, 2003, PUBL MATH-DEBRECEN, V63, P133 DUMAN O, 2004, STUD MATH, V161, P187 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1997, P AM MATH SOC, V125, P3625 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 HARDY GH, 1949, DIVERGENT SERIES KING JP, 2003, ACTA MATH HUNG, V99, P203 KOLK E, 1991, TARTU UL TOIMETISED, V928, P41, UNSP MR 93C:40003 KOLK E, 1993, ANALYSIS, V13, P77 KOROVKIN PP, 1960, LINEAR OPERATORS APP MHASKAR HN, 2000, FUNDAMENTALS APPROXI MILLER HI, 1995, T AM MATH SOC, V347, P1811 STEINHAUS H, 1951, C MATH, V2, P73
NR	23
TC	0
PU	KOSSUTH LAJOS TUDOMANYEGYETEM
PI	DEBRECEN
PA	MATEMATIKAI INTEZET NAGYERDEIKORUT, 10 DEBRECEN, HUNGARY
SN	0033-3883
J9	PUBL MATH-DEBRECEN
JI	Publ. Math.-Debr.
PD	MAY
PY	2006
VL	69
IS	1-2
BP	33
EP	46
PG	14
SC	Mathematics
GA	056VO
UT	ISI:000238553400003
ER

---

PT	J
AU	Dogru, O Duman, O
TI	Statistical approximation of Meyer-Konig and Zeller operators based on q-integers
SO	PUBLICATIONES MATHEMATICAE-DEBRECEN
LA	English
DT	Article
DE	A-statistical convergence; positive linear operators; the Bollman-Korovkin type theorem; modulus of continuity; q-integers; Lipschitz type maximal function
ID	BERNSTEIN POWER-SERIES; CONVERGENCE; SUMMABILITY
AB	In this paper, we introduce a generalization of the Meyer-Konig and Zeller operators based on q-integers and get a Bohman-Korovkin type approximation theorem of these operators via A-statistical convergence. We also compute rate of A-statistical convergence of these q-type operators by means of the modulus of continuity and Lipschitz type maximal function, respectively. The second purpose of this note is to obtain explicit formulas for the monomials (t/1-t)(v), v = 0, 1; 2 of q-type generalization of Meyer-Konig and Zeller operators.
C1	Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey. Tobb Univ Econ & Technol, Fac Arts & Sci, Dept Math, TR-06530 Ankara, Turkey.
RP	Dogru, O, Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
EM	dogru@science.ankara.edu.tr oduman@etu.edu.tr
CR	AGRATINI O, 2001, MATH INEQUAL APPL, V4, P119 ALKEMADE JAH, 1984, J APPROX THEORY, V40, P261 ANDREWS GE, 1999, SPECIAL FUNCTION BLEIMANN G, 1980, P NETHERL ACAD SCI A, V83, P255 CHENEY EW, 1964, CAN J MATH, V16, P241 DEMIRCI K, 2003, J MATH ANAL APPL, V278, P27, DOI 10.1016/S0022-247X(02)00456-0 DOCRU O, 2002, STUD U BABES BOLYAI, V47, P37 DOGRU O, 2003, STUD SCI MATH HUNG, V40, P359 DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1993, J MATH ANAL APPL, V173, P497 FRIDY JA, 1997, P AM MATH SOC, V125, P3625 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 HARDY GH, 1949, DIVERGENT SERIES KHAN MK, 1989, J APPROX THEORY, V57, P90 KOLK E, 1991, ACTA COMMENT U TARTU, V928, P41 KOLK E, 1993, ANALYSIS, V13, P77 LENZE B, 1998, P NETH AC SCI A, V91, P53 MEYERKONIG W, 1960, STUD MATH, V19, P89 MILLER HI, 1995, T AM MATH SOC, V347, P1811 PHILLIPS GM, 1996, NUMERICAL ANAL AR MI, P263 TRIF T, 2000, REV ANAL NUMER THEOR, V29, P221
NR	24
TC	1
PU	KOSSUTH LAJOS TUDOMANYEGYETEM
PI	DEBRECEN
PA	MATEMATIKAI INTEZET NAGYERDEIKORUT, 10 DEBRECEN, HUNGARY
SN	0033-3883
J9	PUBL MATH-DEBRECEN
JI	Publ. Math.-Debr.
PD	JAN
PY	2006
VL	68
IS	1-2
BP	199
EP	214
PG	16
SC	Mathematics
GA	031HE
UT	ISI:000236694500014
ER

---

PT	J
AU	Beg, I
TI	Convolution of fuzzy multifunctions and applications
SO	JOURNAL OF COMPUTATIONAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
DE	fuzzy multifunction; convolution; selector; extension; group; vector space
ID	MAPPINGS
AB	The purpose of this article is to define intersection convolution of fuzzy multifunctions defined between groups and study their properties. As application we obtained extension of linear selector fuzzy multifunction.
C1	Lahore Univ Management Sci, Ctr Adv Studies Math, Lahore 54792, Pakistan. Lahore Univ Management Sci, Dept Math, Lahore 54792, Pakistan.
RP	Beg, I, Lahore Univ Management Sci, Ctr Adv Studies Math, Lahore 54792, Pakistan.
EM	ibeg@lums.edu.pk
CR	ALBRYCHT J, 1984, FUZZY SET SYST, V12, P61 ALIPRANTIS CD, 1994, INFINITE DIMENSIONAL ARENS R, 1961, PAC J MATH, V11, P9 BALAKRISHNAN AV, 1981, APPL FUNCTIONAL ANAL BEG I, 1998, J FUZZY MATH, V6, P127 BEG I, 2000, FUZZY SET SYST, V115, P451 BERGE C, 1963, TOPOLOGICAL SPACES BUTNARIU D, 1982, FUZZY SETS SYSTEMS, V7, P191 HEILPERN S, 1981, J MATH ANAL APPL, V83, P566 KHAN MK, 1996, PROBABILITY APPL KLEIN E, 1984, THEORY CORRES INCLUD NIKODEM K, 1988, ZB RAD PRIROD MAT M, V18, P143 SMAJDOR W, 1987, SUBADDITIVE SUBQUADR, P889 STROMBERG T, 1996, DISSERTATIONES MATH, V352 TSIPORKOVAHRISTOSKOVA E, 1997, FUZZY SET SYST, V85, P93 ZIMMERMANN HJ, 1991, FUZZY SET THEORY ITS
NR	16
TC	0
PU	EUDOXUS PRESS, LLC
PI	CORDOVA
PA	1424 BEAVER TRAIL DRIVE, CORDOVA, TN 38016 USA
SN	1521-1398
J9	J COMPUT ANAL APPL
JI	J. Comput. Anal. Appl.
PD	APR
PY	2004
VL	6
IS	2
BP	125
EP	137
PG	13
SC	Computer Science, Theory & Methods; Mathematics, Applied
GA	018YH
UT	ISI:000235800200002
ER

---

PT	J
AU	Edely, OHH Mursaleen, M
TI	Tauberian theorems for statistically convergent double sequences
SO	INFORMATION SCIENCES
LA	English
DT	Article
DE	double sequence; convergence in Pringsheim's sense; summability C-11, C-10 and C-01; statistical convergence; Tauberian condition
AB	In [F. Moricz, Tauberian theorems for Cesaro summable double sequences, Studia Math. 110 (1994) 83-96], Moricz has proved some Tauberian theorems for Cesaro summable double sequences and deduced the Tauberian theorems of Landau [E. Landau, Uber die Bedeutung einiger neuerer Grenzwertsatze der Herren Hardy and Axer, Prac. Mat.-Fiz. 21 (1910) 97-177] and Hardy [G.H. Hardy, Divergent Series, Univ. Press, Oxford 1956] type. In [J.A. Fridy, M.K. Khan, Statistical extension of some classical Tauberian theorems, Proc. Amer. Math. Soc. 128 (2000) 2347-2355], Fridy and Khan have given statistical extensions of some classical Tauberian theorems. The concept of statistical convergence for double sequences has recently been introduced by Mursaleen and Edely [M. Mursaleen, Osama H. H. Edely, Statistical convergence of double sequences, J. Math. Anal. Appl. 288 (2003) 223-231] and by Moricz [F. Moricz, Statistical convergence of multiple sequences, Arch. Math. 81 (2003) 82-89] independently. In this paper we give some Tauberian theorems for statistically convergent double sequences. We have also provided some examples including an example to Problem I of Moricz [F. Moricz, Tauberian theorems for Cesaro summable double sequences, Studia Math. 110 (1994) 83-96]. (c) 2005 Published by Elsevier Inc.
C1	Aligarh Muslim Univ, Dept Math, Aligarh 202002, Uttar Pradesh, India. King Abdul Aziz Univ, Fac Sci, Dept Math, Jeddah, Saudi Arabia.
RP	Mursaleen, M, Aligarh Muslim Univ, Dept Math, Aligarh 202002, Uttar Pradesh, India.
EM	osamaedely@yahoo.com mursaleen@postmark.net
CR	CHRISTOPHER J, 1956, AM MATH MONTHLY, V63, P399 CONNOR JS, 1988, ANALYSIS, V8, P47 FAST H, 1951, C MATH, V2, P241 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 2000, P AM MATH SOC, V128, P2347 HARDY GH, 1956, DIVERGENT SERIES LANDAU E, 1910, PRAC MAT FIZ, V21, P97 MORICZ F, 1994, STUD MATH, V110, P83 MORICZ F, 2003, ARCH MATH, V81, P82, DOI 10.1007/s00013-003-0506-9 MURSALEEN M, 2003, J MATH ANAL APPL, V288, P223 PRINGSHEIM A, 1900, MATH ANN, V53, P289 SALAT T, 1980, MATH SLOVACA, V30, P139 STADTMULLER U, 1999, ANAL MATH, V25, P57
NR	13
TC	0
PU	ELSEVIER SCIENCE INC
PI	NEW YORK
PA	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN	0020-0255
J9	INFORM SCIENCES
JI	Inf. Sci.
PD	APR 6
PY	2006
VL	176
IS	7
BP	875
EP	886
PG	12
SC	Computer Science, Information Systems
GA	011KL
UT	ISI:000235266900007
ER

---

PT	J
AU	Yates, JA Stetz, LC
TI	Reiter's syndrome (reactive arthritis) and travelers' diarrhea
SO	JOURNAL OF TRAVEL MEDICINE
LA	English
DT	Article
ID	GASTROENTERITIS; EPIDEMIOLOGY; HLA-B27
AB	Reiter's syndrome [also called reactive arthritis (ReA)] is the triad of arthritis, urethritis, and conjunctivitis. Two cases of Reiter's syndrome triggered by travelers' diarrhea are presented. Health care providers should suspect ReA in travelers with joint symptoms and antecedent diarrheal disease.
C1	CIWEC Clin Travel Med Ctr, Kathmandu, Nepal. Chestnut Hill Hosp Family Practice Residency, Philadelphia, PA USA.
RP	Yates, JA, DTM&H, POB 159271, Honolulu, HI 96830 USA.
CR	ADACHI JA, 2000, J TRAVEL MED, V7, P35 AMOR B, 1998, RHEUM DIS CLIN N AM, V24, P677 BEECHAM HJ, 1997, AM J TROP MED HYG, V57, P699 CONNOR BA, 2001, EMERG INFECT DIS, V7, P453 CRON RQ, 1995, J RHEUMATOL, V22, P1962 DUPONT HL, 2005, ANN INTERN MED, V142, P805 DWORKIN MS, 2001, CLIN INFECT DIS, V33, P1010 HANNU T, 2002, RHEUMATOLOGY, V41, P312 HOGE CW, 1996, JAMA-J AM MED ASSOC, V275, P533 JIANG ZD, 2002, J INFECT DIS, V185, P497 KHAN MA, 1982, ANN INTERN MED, V96, P70 KISCHNER RA, 1995, CLIN INFECT DIS, V21, P536 SHAW RA, 1987, JAMA-J AM MED ASSOC, V258, P2734 SIEPER J, 2002, ARTHRITIS RHEUM, V46, P319 STEFFEN R, 2004, J TRAVEL MED, V11, P231 THOMSON GTD, 1995, AM J MED, V98, P13 YLIKERTTULA T, 2000, ANN RHEUM DIS, V59, P565
NR	17
TC	0
PU	B C DECKER INC
PI	HAMILTON
PA	20 HUGHSON ST SOUTH, PO BOX 620, L C D 1, HAMILTON, ONTARIO L8N 3K7, CANADA
SN	1195-1982
J9	J TRAVEL MED
JI	J. Travel Med.
PD	JAN-FEB
PY	2006
VL	13
IS	1
BP	54
EP	56
PG	3
SC	Medicine, General & Internal
GA	005GC
UT	ISI:000234809600009
ER

---

PT	J
AU	Duman, O Orhan, C
TI	Rates of A-statistical convergence of positive linear operators
SO	APPLIED MATHEMATICS LETTERS
LA	English
DT	Article
DE	A-density; A-statistical convergence; sequence of positive linear operators; weight function; weighted space; modulus of continuity; the Korovkin theorem
ID	SUMMABILITY; APPROXIMATION
AB	In this paper we study the rates of A-statistical convergence of sequences of positive linear operators mapping the weighted space C-P1 into the weighted space B-P2. (c) 2005 Elsevier Ltd. All rights reserved.
C1	Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
RP	Orhan, C, Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
EM	oduman@science.ankara.edu.tr orhan@science.ankara.edu.tr
CR	ALTOMARE F, 1994, W DEGRUYTER STUDIES, V17 CONNOR J, 1989, CAN MATH BULL, V32, P194 CONNOR J, 1996, J MATH ANAL APPL, V197, P392 DEVORE RA, 1972, LECT NOTES MATH, V293 DOGRU O, 2002, INT J COMPUT NUMER A, V1, P135 DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 DUMAN O, 2004, STUD MATH, V161, P187 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1978, CAN J MATH, V30, P808 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1997, P AM MATH SOC, V125, P3625 FRIDY JA, 2003, ACTA SCI MATH SZEGED, V69, P147 GADJIEV AD, 1976, MAT ZAMETKI, V20, P781 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 GADZIEV AD, 1974, SOV MATH DOKL, V15, P1433 HARDY GH, 1949, DIVERGENT SERIES KOLK E, 1991, ACTA COMMENT U TARTU, V928, P41 KOLK E, 1993, ANALYSIS, V13, P77 KOROVKIN PP, 1960, LINEAR OPERATORS THE MAROUF M, 1989, THESIS KENT STATE U MILLER HI, 1983, RADOVI AKAD NAUKA UM, V74, P39 MILLER HI, 1995, T AM MATH SOC, V347, P1811
NR	23
TC	1
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0893-9659
J9	APPL MATH LETT
JI	Appl. Math. Lett.
PD	DEC
PY	2005
VL	18
IS	12
BP	1339
EP	1344
PG	6
SC	Mathematics, Applied
GA	996IR
UT	ISI:000234168100004
ER

---

PT	J
AU	Erkus, E Duman, O
TI	A-statistical extension of the Korovkin type approximation theorem
SO	PROCEEDINGS OF THE INDIAN ACADEMY OF SCIENCES-MATHEMATICAL SCIENCES
LA	English
DT	Article
DE	A-statistical convergence; positive linear operator; Korovkin theorem
ID	CONVERGENCE; OPERATORS
AB	In this paper, using the concept of A-statistical convergence which is a regular (non-matrix) summability method, we obtain a general Korovkin type approximation theorem which concerns the problem of approximating a function f by means of a sequence {L(n)f} of positive linear operators.
C1	Canakkale Onsekiz Mart Univ, Fac Sci & Arts, Dept Math, Canakkale 17020, Turkey. TOBB Univ Econ & Technol, Dept Math, Fac Arts & Sci, TR-06530 Ankara, Turkey.
RP	Erkus, E, Canakkale Onsekiz Mart Univ, Fac Sci & Arts, Dept Math, Terzioglu Kampusu, Canakkale 17020, Turkey.
EM	erkus@comu.edu.tr oduman@etu.edu.tr
CR	ALTOMARE F, 1994, DEGRUYTER STUD MATH, V17 BLEIMANN G, 1980, INDAG MATH, V42, P255 BOJANIC R, 1992, J NAT SCI MATH, V32, P5 BOOS J, 2000, CLASSICAL MODERN MET CAKAR O, 1999, T ACAD SCI AZER PTMS, V19, P21 CHENEY EW, 1964, CAN J MATH, V16, P241 DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 KHAN MK, 1998, J APPROX THEORY, V92, P22 KOLK E, 1991, TARTU UL TOIMETISED, V928, P41, UNSP MR 93C:40003 KOLK E, 1993, ANALYSIS, V13, P77 KOROVKIN PP, 1960, LINEAR OPERATORS APP MILLER HI, 1995, T AM MATH SOC, V347, P1811 STEINHAUS H, 1951, C MATH, V2, P73
NR	17
TC	1
PU	INDIAN ACADEMY SCIENCES
PI	BANGALORE
PA	C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005, BANGALORE 560 080, INDIA
SN	0253-4142
J9	PROC INDIAN ACAD SCI-MATH SCI
JI	Proc. Indian Acad. Sci.-Math. Sci.
PD	NOV
PY	2005
VL	115
IS	4
BP	499
EP	508
PG	10
SC	Mathematics
GA	990PE
UT	ISI:000233754900014
ER

---

PT	J
AU	Brunner, F Kunz, A Weber, U Kissling, R
TI	Ankylosing spondylitis and heart abnormalities: do cardiac conduction disorders, valve regurgitation and diastolic dysfunction occur more often in male patients with diagnosed ankylosing spondylitis for over 15 years than in the normal population?
SO	CLINICAL RHEUMATOLOGY
LA	English
DT	Article
DE	ankylosing spondylitis; conduction disorder; diastolic dysfunction; heart affection; valve regurgitation
ID	PHYSIOLOGICAL VALVULAR REGURGITATION; STRUCTURALLY NORMAL HEARTS; COLOR-DOPPLER; AORTIC REGURGITATION; PREVALENCE; DISEASE; ECHOCARDIOGRAPHY; MANIFESTATIONS; ARTHRITIS; INDEXES
AB	The objective of this study was to determine the rate of selected cardiac pathologies (conduction disorders, valve regurgitation and diastolic dysfunction) in patients with long-standing ankylosing spondylitis (AS) and compare the results with the prevalence in the normal population. A rheumatologic (structured questionnaire interview) and cardiac evaluation (resting electrocardiography and echocardiography) was performed in 100 male subjects with AS and a disease duration of more than 15 years. The rates for conduction disorders, aortic and mitral valve regurgitation and diastolic dysfunction were compared with the corresponding results in the literature among the normal population. In patients with long-standing AS there was no increased rate for valve regurgitation (mitral and aortic valve) and for arrhythmia. Diastolic dysfunction occurred more often in patients with long-standing AS. However, this might be caused by the presence of other cardiovascular risk factors such as age and hypertension. According to these results, a cardiologic evaluation with echocardiography should not be recommended routinely in patients with long-standing AS. To confirm these results, a large prospective study with patients with long-standing AS and with a matched control group should be performed in the future.
C1	Balgrist Univ Hosp, Dept Phys Med & Rheumatol, CH-8008 Zurich, Switzerland.
RP	Brunner, F, Balgrist Univ Hosp, Dept Phys Med & Rheumatol, Forchstr 340, CH-8008 Zurich, Switzerland.
EM	florian.brunner@balgrist.ch
CR	BACHMANN F, 1976, MED WELT, V27, P2149 BAGGENSTOSS AH, 1941, ARCH INTERN MED, V67, P241 BERGER M, 1989, J AM COLL CARDIOL, V13, P1540 BERGFELDT L, 1982, ACTA MED SCAND, V212, P217 BERGFELDT L, 1997, ANN INTERN MED 1, V127, P621 BERNSTEIN L, 1951, RHEUMATISM, V7, P18 BIAVA G, 1997, CORONARY ARTERY DIS, V8, P559 BLACK HR, 1997, ARCH INTERN MED, V157, P2413 BRADY A, 2003, ANN M BRIT SOC RHEUM BREWERTON DA, 1987, LANCET, V1, P995 CHOONG CY, 1989, AM HEART J, V117, P636 CLARK WS, 1957, AM J MED, V22, P580 CROWLEY JJ, 1993, AM J CARDIOL, V71, P1337 DEBACQUER D, 2000, HEART, V84, P625 EDNER M, 2000, EUR J ECHOCARDIOGR, V1, P87 GOULD BA, 1992, ANN RHEUM DIS, V51, P227 GRAHAM DC, 1958, B RHEUM DIS, V9, P171 JOBIC Y, 1993, BRIT HEART J, V69, P109 KHAN MA, 1981, J RHEUMATOL, V8, P86 KHAN MA, 2003, RHEUMATOLOGY, P1161 KINSELLA TD, 1966, CAN MED ASSOC J, V95, P1 KLEIN AL, 1990, J AM SOC ECHOCARDIOG, V3, P54 KREGER BE, 1989, AM HEART J, V117, P903 KRUEGER K, 1981, HYPERTROPHIC NONOBST LAUTERMANN D, 2002, CLIN EXP RHEUMAT S28, V20, S11 LEHTINEN K, 1983, SCAND J RHEUMATOL, V12, P5 LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174 LONATI L, 1992, CARDIOLOGY, V81, P365 MACCHI C, 1994, ANN ANAT, V176, P81 MENOTTI A, 1997, G ITAL CARDIOL, V27, P40 MIRVIS MGL, 2001, HEART DIS, P82 MORLEY K, 1982, LEFT VENTRICULAR FUN MYERBURG R, 2001, HEART DIS, P815 OH JK, 1999, ECHO MANUAL, P45 QAIYUMI S, 1985, ARCH INTERN MED, V145, P822 RIBEIRO P, 1984, EUR HEART J, V5, P419 ROLDAN CA, 1998, J AM COLL CARDIOL, V32, P1397 SINGH JP, 1999, AM J CARDIOL, V83, P897 SPIRITO P, 1988, BRIT HEART J, V59, P672 SUKENIK S, 1987, CLIN RHEUMATOL, V6, P588 SUTER L, 1962, CARDIOLOGIA, V41, P15 TAKKUNEN J, 1970, ANN CLIN RES, V2, P106 WILKENSHOFF UM, 2001, J AM SOC ECHOCARDIOG, V14, P959 YILDIRIR A, 2000, RHEUMATOLOGY, V39, P875
NR	44
TC	1
PU	SPRINGER
PI	NEW YORK
PA	233 SPRING STREET, NEW YORK, NY 10013 USA
SN	0770-3198
J9	CLIN RHEUMATOL
JI	Clin. Rheumatol.
PD	FEB
PY	2006
VL	25
IS	1
BP	24
EP	29
PG	6
SC	Rheumatology
GA	991BP
UT	ISI:000233787500005
ER

---

PT	J
AU	Angles, JM Famula, TR Pedersen, NC
TI	Uveodermatologic (VKH-like) syndrome in American Akita dogs is associated with an increased frequency of DQA1*00201
SO	TISSUE ANTIGENS
LA	English
DT	Article
DE	canine; DLA-DQA1; DLA-DQB1; DLA-DRB1; uveodermatologic syndrome; VKH-like
ID	KOYANAGI-HARADA-DISEASE; MAJOR HISTOCOMPATIBILITY COMPLEX; DLA NOMENCLATURE COMMITTEE/; ACQUIRED MYASTHENIA-GRAVIS; CANINE PEMPHIGUS-VULGARIS; LINKAGE DISEQUILIBRIUM; MOLECULAR ANALYSIS; DOMESTIC DOG; JAPANESE AKITA; HLA ANTIGENS
AB	The Akita breed of dog is affected by a number of distinct immune-mediated diseases, including thyroiditis, sebaceous adenitis, pemphigus foliaceus, uveitis, polyarthritis, myasthenia gravis, and uveodermatologic (UV) syndrome. UV syndrome is manifested by progressive uveitis and depigmenting dermatitis that closely resembles the human Vogt - Koyanagi - Harada syndrome. This study examined the allelic diversity of the three DLA class II loci (DRB1, DQA1, and DQB1) in the American Akita dog, and the relationship of specific DLA class II alleles to the UV. Low allelic variation was demonstrated within genes of DLA class II. American Akita dogs possessed six of the reported 16 DQA1 alleles, but only eight of 61 reported alleles in DRB1 and nine of 47 reported alleles in DQB1. Almost one-half of American Akita dogs were homozygous for a single allele at DQA1 and up to a quarter at DRB1 and DQB1. DLA-DQA1*00201 was associated with a significantly higher relative risk (RR = 15.3) or odds ratio (OR = 15.99) for UV syndrome than other DLA class II alleles. No significant association was noted with haplotypes of DRB1, DQB1, and DQA1 alleles; DRB1*03201-DQA1*00201 trended toward significance. This study confirmed loss of DLA genetic diversity in the American Akita dog in common with other pure breeds of dog and suggested a role for certain DLA class II gene alleles in the pathogenesis of UV.
C1	Univ Calif Davis, Koret Ctr Vet Genet, Davis, CA 95616 USA. Univ Calif Davis, Ctr Compan Anim Hlth, Davis, CA 95616 USA. Univ Calif Davis, Sch Vet Med, Dept Anim Sci, Davis, CA 95616 USA.
RP	Pedersen, NC, Univ Calif Davis, Koret Ctr Vet Genet, 1 Shields Dr, Davis, CA 95616 USA.
EM	ncpedersen@ucdavis.edu
CR	ALAEZ C, 1999, HUM IMMUNOL, V60, P875 ALTMAN DG, 1992, PRACTICAL STAT MED R APANIUS V, 1997, CRIT REV IMMUNOL, V17, P179 ARELLANESGARCIA L, 1998, OCUL IMMUNOL INFLAMM, V6, P93 ASAKURA S, 1977, JPN J VET MED, V673, P445 BARROWS PSM, 1991, BRAZ J VET RES ANIM, V28, P75 BLAND M, 1996, INTRO MED STAT BUSSANICH MN, 1982, J AM ANIM HOSP ASSOC, V18, P131 CARTER WJ, 2005, VET OPHTHALMOL, V8, P17 CHAN C, 1988, AM J OPHTHALMOL, V105, P607 CLARK AG, 1990, MOL BIOL EVOL, V7, P111 COTTRELL BD, 1987, J SMALL ANIM PRACT, V28, P517 DEAN RR, 1989, HUM IMMUNOL, V25, P27 DEBENHAM SL, 2005, GENOMICS, V85, P48, DOI 10.1016/j.ygeno.2004.09.009 DORAK MT, STAT ANAL HLA DIS AS DOUGHERTY SA, 1991, J AM VET MED ASSOC, V198, P849 EDWARDS JH, 1974, J IMMUNOGENET, V1, P249 GOLDBERG AC, 1998, HUM IMMUNOL, V59, P183 HALDANE JBS, 1956, ANN HUM GENET, V20, P309 HYUN CB, 2003, MAMM GENOME, V14, P640, DOI 10.1007/s00335-003-3006-0 IHRKE PJ, 1985, J AM VET MED ASSOC, V186, P59 IRION DN, 2003, J HERED, V94, P81, DOI 10.1093/jhered/esg004 ISLAM SMM, 1994, INVEST OPHTH VIS SCI, V35, P3890 IZAKS GJ, 2000, EUR J IMMUNOGENET, V27, P87 JACKSON HA, 2004, VET DERMATOL, V15, P230 JIMENEZ M, 1988, P NATL ACAD SCI USA, V85, P3830 KENNEDY LJ, 2001, ANIM GENET, V32, P193 KENNEDY LJ, 2001, TISSUE ANTIGENS, V58, P55 KENNEDY LJ, 2002, TISSUE ANTIGENS, V59, P194 KERN TJ, 1985, J AM VET MED ASSOC, V187, P408 KHAN MA, 1982, ANN INTERN MED, V96, P70 KIM MH, 2000, AM J OPHTHALMOL, V129, P173 KOBAYASHI H, 1998, IMMUNOGENETICS, V47, P398 KUHL KA, 1994, VET PATHOL, V31, P19 LIN L, 1999, CELL, V98, P365 LINDLEY DM, 1990, VET PATHOL, V27, P294 LOU XY, 2003, MAMM GENOME, V14, P555, DOI 10.1007/s00335-003-2272-1 MORGAN RV, 1989, COMP CONT EDUC PRACT, V11, P1211 MURPHY CJ, 1991, J AM ANIM HOSP ASSOC, V27, P399 NISHIFUJI K, 2003, J DERMATOL SCI, V32, P181, DOI 10.1016/S0923-1811(03)00095-1 NOROSE K, 1996, BRIT J OPHTHALMOL, V80, P1002 OBERBAUER AM, 2003, VET RES COMMUN, V27, P27 OLIVRY T, 2003, EXP DERMATOL, V12, P198 OLLIER WER, 2001, IMMUNOGENETICS, V53, P669 PARKER HG, 2004, SCIENCE, V304, P1160 PEDERSEN NC, 1999, VET IMMUNOL IMMUNOP, V69, P251 PIVETTIPEZZI P, 1996, AM J OPHTHALMOL, V122, P889 QUINNELL RJ, 2003, IMMUNOGENETICS, V55, P23, DOI 10.1007/s00251-003-0545-1 READ RW, 2001, AM J OPHTHALMOL, V131, P647 REICHLER IM, 2001, VET DERMATOL, V12, P243 REUSCH C, 1994, TIERARZTL PRAX, V22, P398 RHODEN NC, 2002, DOGS MYTH HIST RICHARDS B, 1993, HUM MOL GENET, V2, P159 RIDDINGTON L, 1996, AUST NZ J OPHTHALMOL, V24, P147 ROMATOWSKI J, 1985, J AM ANIM HOSP ASSOC, V21, P777 SAKAMOTO T, 1991, ARCH OPHTHALMOL-CHIC, V109, P1270 SHELTON GD, 1997, J AM VET MED ASSOC, V211, P1428 SHELTON GD, 1998, ANN NY ACAD SCI, V841, P587 SHELTON GD, 1999, VET IMMUNOL IMMUNOP, V69, P239 SHELTON GD, 2001, VET IMMUNOL IMMUNOP, V78, P97 SHINDO Y, 1994, BRIT J OPHTHALMOL, V78, P223 SHINDO Y, 1994, HUM IMMUNOL, V39, P169 SHINDO Y, 1996, TISSUE ANTIGENS, V47, P344 SUGITA S, 1996, INT IMMUNOL, V8, P799 SUTTER NB, 2004, GENOME RES, V14, P2388, DOI 10.1101/gr.3147604 SUTTER NB, 2004, NAT REV GENET, V5, P900, DOI 10.1038/nrg1492 SVEJGAARD A, 1994, TISSUE ANTIGENS, V43, P18 USAMI H, 1988, JAP J VET SCI, V51, P215 WAGNER JL, 1996, TISSUE ANTIGENS, V48, P199 WAGNER JL, 1996, TISSUE ANTIGENS, V48, P554 WAGNER JL, 1998, TISSUE ANTIGENS, V52, P242 WAGNER JL, 2000, TISSUE ANTIGENS, V56, P223 WEBB AA, 2002, J VET INTERN MED, V16, P269 YAMAKI K, 2005, EXP EYE RES, V80, P273, DOI 10.1016/j.exer.2004.09.010 ZAROUR HM, 2000, P NATL ACAD SCI USA, V97, P400 ZAVROS NS, 2001, AUST VET PRACT, V31, P27 ZHAO M, 1991, ARCH OPHTHALMOL-CHIC, V109, P368
NR	77
TC	0
PU	BLACKWELL PUBLISHING
PI	OXFORD
PA	9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN	0001-2815
J9	TISSUE ANTIGEN
JI	Tissue Antigens
PD	DEC
PY	2005
VL	66
IS	6
BP	656
EP	665
PG	10
SC	Cell Biology; Immunology; Pathology
GA	983AC
UT	ISI:000233202500004
ER

---

PT	J
AU	Teran, P
TI	A reduction principle for obtaining Tauberian theorems for statistical convergence in metric spaces
SO	BULLETIN OF THE BELGIAN MATHEMATICAL SOCIETY-SIMON STEVIN
LA	English
DT	Article
DE	statistical convergence; Tauberian theorem; summability; distance function
AB	We show a general method to translate Tauberian theorems for summability methods in R into Tauberian theorems for the corresponding forms of statistical convergence in metric spaces. The main tools (distance functions and the Hausdorff metric) come from set-valued analysis.
C1	Univ Zaragoza, Fac CC Econ & Empresariales, Dept Metodos Estadist, Zaragoza 50005, Spain.
RP	Teran, P, Univ Zaragoza, Fac CC Econ & Empresariales, Dept Metodos Estadist, Gran Via 2, Zaragoza 50005, Spain.
EM	teran@unizar.es
CR	AUBIN JP, 1990, SYSTEMS CONTROL FDN, V2 BEER G, 1993, MATH APPL, V268 BINGHAM NH, 1981, ANN PROBAB, V9, P221 CONNOR J, 2000, J MATH ANAL APPL, V244, P251 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1998, ANALYSIS, V18, P145 FRIDY JA, 1998, J MATH ANAL APPL, V228, P73 FRIDY JA, 2000, P AM MATH SOC, V128, P2347 KIESEL R, 1997, ELECT COMMUN PROBAB, V2, P27 KIESEL R, 2000, J MATH ANAL APPL, V251, P929 MADDOX IJ, 1988, MATH P CAMBRIDGE PHI, V104, P141
NR	11
TC	0
PU	BELGIAN MATHEMATICAL SOC TRIOMPHE
PI	BRUSSELS
PA	CP 218,01 BOULEVARD TRIOMPE, B 1050 BRUSSELS, BELGIUM
SN	1370-1444
J9	BULL BELG MATH SOC-SIMON STEV
JI	Bull. Belg. Math. Soc.-Simon Steven
PD	APR-JUN
PY	2005
VL	12
IS	2
BP	295
EP	299
PG	5
SC	Mathematics
GA	981XI
UT	ISI:000233120900010
ER

---

PT	J
AU	Altin, A Dogru, O Tasdelen, F
TI	The generalization of Meyer-Konig and Zeller operators by generating functions
SO	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
DE	positive linear operators; Korovkin theorem; Meyer-Konig and zeller operators; modified Lipschitz class; K-functional of Peetre; modulus of continuity; Riccati differential equation
ID	BERNSTEIN POWER-SERIES
AB	In this paper, theorems are proved concerned with some approximation properties of generating functions type Meyer-Konig and Zeller operators with the help of a Korovkin type theorem. Secondly, we compute the rates of convergence of these operators by means of the modulus of continuity, Peetre's K-functional and the elements of the modified Lipschitz class. Also we introduce the rth order generalization of these operators and we obtain approximation properties of them. In the last part, we give some applications to the differential equations. (c) 2005 Elsevier Inc. All rights reserved.
C1	Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
RP	Dogru, O, Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
EM	altin@science.ankara.edu.tr dogru@science.ankara.edu.tr tasdelen@science.ankara.edu.tr
CR	ABEL U, 1995, J APPROX THEORY, V82, P352 AGRATINI O, 2001, MATH INEQUAL APPL, P119 ALKEMADE JAH, 1984, J APPROX THEORY, V40, P261 BECKER M, 1978, MATH Z, V160, P195 BLEIMANN G, 1980, INDAG MATH, V42, P255 CHENEY EW, 1964, CAN J MATH, V16, P241 DITZIAN Z, 1987, SPRINGER SER COMPUT, V9 DOGRU O, 1998, MATH BALKANICA, V12, P359 DOGRU O, 2002, STUD U BABES BOLYAI, V47, P37 GADJIEV AD, 1999, T ACAD SI AZERB PTMS, V19, P21 KHAN MK, 1989, J APPROX THEORY, V57, P90 KIROV GH, 1960, LINEAR OPERATORS APP KIROV GH, 1992, APPROXIMATION QUASIS KIROV GH, 1993, MATH BALKANICA, V7, P149, UNSP MR 95I:41048 LENZE B, 1990, APPROX TH KECSKEMET, V58, P469 LORENTZ GG, 1953, BERNSTEIN POLYNOMIAL LUPAS A, 1970, AEQUATIONES MATH, V5, P19 MAY CP, 1976, CAN J MATH, V28, P1224 MEYERKONIG W, 1960, STUD MATH, V19, P89 MULLER MW, 1967, FOLGE GAMMAOPERATORE SIKKEMA PC, 1970, INDAGATIONES MATH, V32, P428 VOLKOV YI, 1978, MAT ZAMETKI, V23, P363 WOLFRAM S, 1999, MATHEMATICA, V4
NR	23
TC	1
PU	ACADEMIC PRESS INC ELSEVIER SCIENCE
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0022-247X
J9	J MATH ANAL APPL
JI	J. Math. Anal. Appl.
PD	DEC 1
PY	2005
VL	312
IS	1
BP	181
EP	194
PG	14
SC	Mathematics, Applied; Mathematics
GA	979QV
UT	ISI:000232960800015
ER

---

PT	J
AU	Pincus, T Sokka, T
TI	Complexities in the quantitative assessment of patients with rheumatic diseases in clinical trials and clinical care
SO	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
LA	English
DT	Review
DE	indices; activity; damage; measures
AB	Quantitative measurement has led to major advances in the diagnosis, prognosis and management chronic diseases. Quantitative measures in rheumatic diseases differ from measures in many chronic diseases in several respects. There is no single "gold standard, " such as blood pressure or cholesterol, in the diagnosis, management, and prognosis of any rheumatic disease. Laboratory tests are limited; for example, in rheumatoid arthritis > 40% of Patients or more have a normal erythrocyte sedimentation rate (ESR). Formal joint counts have poor reliability and are not performed at most visits of most patients. Radiographs are rarely read quantitatively, except in formal clinical trials. The optimal quantitative measures to monitor status and assess long-term prognosis are often derived firom patient self-report questionnaires. Quantitative measures may reflect disease activity e.g., swollen joint counts or C-reactive protein (CRP), long-term damage, e.g., radiographic damage, or poor outcomes, e.g., work disability and premature death. Disease activity measures used in clinical trials are primarily surrogates for long-term outcomes. As there is no single "gold standard" measure, indices of multiple measures are used in patient assessment. Indices used in rheumatoid arthritis assess primarily disease activity but separate indices have been developed to assess disease activity versus damage in patients with ankylosing spondylitis, systemic lupus erythematosus, and vasculitis.
C1	Vanderbilt Univ, Med Ctr, Div Rheumatol & Immunol, Dept Med, Nashville, TN USA. Jyvaskyla Cent Hosp, Dept Rheumatol, Jyvaskyla, Finland.
RP	Pincus, T, Vanderbilt Univ, Sch Med, Div Rheumatol & Immunol, 203 Oxford House,Box 5, Nashville, TN 37232 USA.
EM	t.pincus@vanderbilt.edu
CR	ALETAHA D, 2005, CLIN EXP RHEUMAT S39, V23, S100 BACON PA, 1995, CLIN EXP RHEUMATOL, V13, P275 BARRETT EM, 2000, RHEUMATOLOGY, V39, P1403 BELLAMY N, 1988, J RHEUMATOL, V15, P1833 BELLAMY N, 1989, SEMIN ARTHRITIS RHEU, V18, P14 BELLAMY N, 2005, CLIN EXP RHEUMAT S39, V23, S148 BENCIVELLI W, 1992, CLIN EXP RHEUMATOL, V10, P549 BENNETT R, 2005, CLIN EXP RHEUMAT S39, V23, S154 BROWN AK, 2004, CLIN EXP RHEUMAT S35, V22, S18 BRUCE B, 2005, CLIN EXP RHEUMAT S39, V23, S14 BUCHANAN WW, 1982, J RHEUMATOL, V9, P653 BURCKHARDT CS, 1991, J RHEUMATOL, V18, P728 BURCKHARDT CS, 1993, J RHEUMATOL, V20, P475 CALIN A, 1994, J RHEUMATOL, V21, P2281 CALIN A, 1999, J RHEUMATOL, V26, P988 CALIN A, 1999, RHEUMATOLOGY, V38, P878 CALLAHAN LF, 1989, ARTHRIT CARE RES, V2, P122 CALLAHAN LF, 1992, J CLIN EPIDEMIOL, V45, P127 CALLAHAN LF, 1997, ARTHRIT CARE RES, V10, P381 CARRUTHERS D, 2001, BEST PRACT RES CL RH, V15, P225 CLEGG DO, 1996, ARTHRITIS RHEUM, V39, P2004 CREEMERS MCW, 2005, ANN RHEUM DIS, V64, P127, DOI 10.1136/ard.2004.020503 CUSH JJ, 2001, PRINCIPLES INTERNAL, P1979 DOUGADOS M, 1988, J RHEUMATOL, V15, P302 EGSMOSE C, 1995, J RHEUMATOL, V22, P2208 EMERY P, 1995, ANN RHEUM DIS, V54, P944 EXLEY AR, 1997, ARTHRITIS RHEUM, V40, P371 FELSON DT, 1993, ARTHRITIS RHEUM, V36, P729 FEX E, 1996, BRIT J RHEUMATOL, V35, P1106 FEX E, 1998, J RHEUMATOL, V25, P44 FLEISCHER AB, 1996, J INVEST DERMATOL, V107, P26 FRANSEN J, 2005, CLIN EXP RHEUMAT S39, V23, S93 FRIES JF, 1980, ARTHRITIS RHEUM, V23, P137 FRIES JF, 2005, CLIN EXP RHEUMAT S39, V23, S53 GLADMAN DD, 1997, ARTHRITIS RHEUM, V40, P809 GOLDSMITH CH, 1993, J RHEUMATOL, V20, P575 GOODSON NJ, 2002, ARTHRITIS RHEUM, V46, P2010, DOI 10.1002/art.10419 GRAUDAL N, 2000, J RHEUMATOL, V27, P47 HAWKER G, 1993, J RHEUMATOL, V20, P657 HAWLEY DJ, 1992, ARTHRIT CARE RES, V5, P130 HAY EM, 1993, Q J MED, V86, P447 HUSKISSON EC, 1983, PAIN MEASUREMENT ASS, P33 JENKINSON TR, 1994, J RHEUMATOL, V21, P1694 KAVANAUGH A, 2005, CLIN EXP RHEUMAT S39, V23, S142 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 2000, J RHEUMATOL, V27, P1110 KRISHNAN E, 2004, ARTHRITIS RHEUM, V50, P953, DOI 10.1002/art.20048 LAM GKW, 2005, CLIN EXP RHEUMAT S39, V23, S120 LANDEWE R, 2005, CLIN EXP RHEUMAT S39, V23, S63 LARSEN A, 1974, THESIS U HELSINKI HE LARSEN A, 1977, ACTA RADIOL DIAGN, V18, P481 LARSEN A, 1995, J RHEUMATOL, V22, P1974 LEIGH JP, 1991, J RHEUMATOL, V18, P1307 LEIRISALOREPO M, 1999, ARTHRITIS RHEUM S, V42, S130 LICHTENSTEIN MJ, 1988, J GEN INTERN MED, V3, P435 LUBECK DP, 1986, ARTHRITIS RHEUM, V29, P488 LUQMANI RA, 1994, Q J MED, V87, P671 MEENAN RF, 1978, ARTHRITIS RHEUM, V21, P827 MEENAN RF, 1980, ARTHRITIS RHEUM, V23, P146 MOSCA M, 2000, LUPUS, V9, P445 MULHERIN D, 1996, BRIT J RHEUMATOL, V35, P1263 PETRI M, 1992, J RHEUMATOL, V19, P53 PINCUS T, 1983, ARTHRITIS RHEUM, V26, P1346 PINCUS T, 1984, ARTHRITIS RHEUM, V27, P864 PINCUS T, 1987, J RHEUMATOL, V14, P240 PINCUS T, 1992, J RHEUMATOL, V19, P1051 PINCUS T, 1993, BRIT J RHEUMATOL, V32, P28 PINCUS T, 1993, PRIMARY CARE, V20, P795 PINCUS T, 1993, RHEUM DIS CLIN N AM, V19, P123 PINCUS T, 1994, ANN INTERN MED, V120, P26 PINCUS T, 1994, SCAND J RHEUMAT S100, V23, P21 PINCUS T, 1995, BRIT J RHEUMATOL, V34, P196 PINCUS T, 1997, RHEUMATOLOGY PINCUS T, 1999, ARTHRITIS RHEUM, V42, P2220 PINCUS T, 2002, CLIN EXP RHEUMAT S27, V20, S42 PINCUS T, 2003, ARTHRITIS RHEUM, V48, P625, DOI 10.1002/art.10824 PINCUS T, 2005, ARTHRITIS RHEUM, V52, P1031, DOI 10.1002/art.20995 PINCUS T, 2005, CLIN EXP RHEUMAT S39, V23, S109 PINCUS T, 2005, CLIN EXP RHEUMAT S39, V23, S19 PINCUS T, 2005, CLIN EXP RHEUMAT S39, V23, S85 PINCUS T, 2005, J RHEUMATOL, V32, P1432 PINCUS T, 2005, J RHEUMATOL, V32, P575 POLLARD L, 2005, CLIN EXP RHEUMAT S39, V23, S43 PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44 RAU R, 1998, J RHEUMATOL, V25, P2094 SALAFFI F, 2005, CLIN EXP RHEUMAT S39, V23, S31 SCOTT DL, 1984, ANN RHEUM DIS, V43, P8 SEO P, 2005, ARTHRITIS RHEUM, V52, P2168, DOI 10.1002/art.21137 SHARP JT, 1971, ARTHRITIS RHEUM, V14, P706 SHARP JT, 1989, J RHEUMATOL, V16, P568 SHARP JT, 1991, ARTHRITIS RHEUM, V34, P660 SHARP JT, 1995, J RHEUMATOL, V22, P1787 SOKKA T, 1999, J RHEUMATOL, V26, P1681 SOKKA T, 2003, J RHEUMATOL, V30, P1138 SOKKA T, 2004, ANN RHEUM DIS, V63, P494, DOI 10.1136/ard.2003.009530 SOKKA T, 2005, CLIN EXP RHEUMAT S39, V23, S58 SOKKA T, 2005, CLIN EXP RHEUMAT S39, V23, S77 STEINBROCKER O, 1949, JAMA-J AM MED ASSOC, V140, P659 STONE JH, 2001, ARTHRITIS RHEUM, V44, P912 SWAAK AJG, 2001, LUPUS, V10, P51 TUGWELL P, 1993, J RHEUMATOL, V20, P527 VANDERHEIJDE D, 1999, J RHEUMATOL, V26, P743 VANDERHEIJDE DMFM, 1993, J RHEUMATOL, V20, P579 VANRIEL PLC, 1994, BR J RHEUMATOL, V31, P793 WARE JE, 1992, MED CARE, V30, P473 WEINBLATT ME, 1996, ANN INTERN MED, V124, P773 WELSING PMJ, 2001, ARTHRITIS RHEUM, V44, P2009 WHITINGOKEEFE QE, 1999, ARTHRITIS RHEUM, V42, P2365 WOLFE F, 1991, J RHEUMATOL, V18, P1298 WOLFE F, 1994, ARTHRITIS RHEUM, V37, P481 WOLFE F, 1994, J RHEUMATOL, V21, P1227 WOLFE F, 1998, J RHEUMATOL, V25, P2108 WOLFE F, 2003, ARTHRIT RHEUM-ARTHR, V49, P59, DOI 10.1002/art.10904 WOLFE F, 2004, ARTHRITIS RHEUM, V50, P3296 WOLFE F, 2005, CLIN EXP RHEUMAT S39, V23, S29 ZOCHLING J, 2005, CLIN EXP RHEUMAT S39, V23, S133
NR	116
TC	16
PU	CLINICAL & EXPER RHEUMATOLOGY
PI	PISA
PA	VIA SANTA MARIA 31, 56126 PISA, ITALY
SN	0392-856X
J9	CLIN EXP RHEUMATOL
JI	Clin. Exp. Rheumatol.
PD	SEP-OCT
PY	2005
VL	23
IS	5
SU	Suppl. 39
BP	S1
EP	S9
PG	9
SC	Rheumatology
GA	980KN
UT	ISI:000233017500001
ER

---

PT	J
AU	Zeng, XM
TI	Approximation properties of Gamma operators
SO	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
DE	approximation properties; locally bounded functions; absolutely continuous functions; gamma operators; probabilistic methods
ID	BOUNDED VARIATION; CONVERGENCE; SERIES
AB	In this paper the approximation properties of Gamma operators G(n) are studied to the locally bounded functions and the absolutely continuous functions, respectively. Firstly, in Section 2 of the paper a quantitative form of the central limit theorem in probability theory is used to derive an asymptotic formula on approximation of Gamma operators G(n) for sign function. And then, this asymptotic formula combining with a metric form Omega(x)(f,lambda) is used to derive an asymptotic estimate on the rate of convergence of Gamma operators G(n) for the locally bounded functions. Next, in Section 3 of the paper the optimal estimate on the first order absolute moment of the Gamma operators G (vertical bar t-x vertical bar, x) is obtained by direct computations. And then, this estimate and Bojanic-Khan-Cheng's method combining with analysis techniques are used to derive an asymptotically optimal estimate on the rate of convergence of Gamma operators G(n) for the absolutely continuous functions. (c) 2005 Elsevier Inc. All rights reserved.
C1	Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
RP	Zeng, XM, Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
EM	xmzeng@jingxian.xmu.edu.cn
CR	BOJANIC R, 1991, ATTI SEMIN MAT FIS, V29, P153 FELLER W, 1971, INTRO PROBABILITY TH GUO SS, 1989, J APPROX THEORY, V58, P90 KHAN MK, 1989, J APPROX THEORY, V57, P90 KHAN MK, 2002, REND CIRC MAT PALE S, V68, P539 NAMIAS V, 1986, AM MATH MON, V93, P25 OMEY E, 1996, THEOR PROBAB APPL, V41, P219 PYCHTABERSKA P, 2003, J APPROX THEORY, V123, P256, DOI 10.1016/S0021-9045(03)00106-0 SHIRYAYEV AN, 1984, PROBABILITY SRIVASTAVA HM, 2003, MATH COMPUT MODEL, V37, P1307 ZENG XM, 1998, J APPROX THEORY, V95, P369 ZENG XM, 2001, J APPROX THEORY, V109, P242
NR	12
TC	2
PU	ACADEMIC PRESS INC ELSEVIER SCIENCE
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0022-247X
J9	J MATH ANAL APPL
JI	J. Math. Anal. Appl.
PD	NOV 15
PY	2005
VL	311
IS	2
BP	389
EP	401
PG	13
SC	Mathematics, Applied; Mathematics
GA	970XO
UT	ISI:000232345900002
ER

---

PT	J
AU	Gupta, V Ispir, N
TI	On the Bezier variant of generalized Kantorovich type Balazs operators
SO	APPLIED MATHEMATICS LETTERS
LA	English
DT	Article
DE	Balazs operators; rate of convergence; bounded variation; total variation; Bezier basis
ID	BOUNDED VARIATION; RATIONAL FUNCTIONS; CONVERGENCE; APPROXIMATION
AB	In the present work we define the Bezier variant of the generalized Balazs-Kantorovich operators. The special cases of our operators reduce to some well known operators. We establish the rate of convergence for functions of bounded variation for the generalized operators. (c) 2005 Elsevier Ltd. All rights reserved.
C1	Gazi Univ, Dept Math, Sci & Arts Fac, TR-06500 Ankara, Turkey. Netaji Subhas Inst Technol, Sch Appl Sci, New Delhi 110045, India.
RP	Ispir, N, Gazi Univ, Dept Math, Sci & Arts Fac, TR-06500 Ankara, Turkey.
EM	vijay@nsit.ac.in nispir@gazi.edu.tr
CR	AGRATINI O, 2001, MATH NOTES MISKOLE, V2, P3 ANIOL G, 1999, FASCICULI MATH, V29, P5 BALAZS C, 1982, ACTA MATH ACAD SCI H, V40, P331 BALAZS K, 1975, ACTA MATH ACAD SCI H, V26, P123 BOJANIC R, 1992, J NAT SCI MATH, V32, P5 CHENG F, 1983, J APPROX THEORY, V39, P259 GUO SS, 1989, J APPROX THEORY, V58, P90 ISPIR N, 2003, INTJ COMPUT NUM ANAL, V4, P297 KHAN MK, 2002, REND CIRC MAT PALE S, V68, P539 TABERSKA PP, 1991, ANN SOC MATH POL COM, V31, P147 ZENG XM, 1998, J APPROX THEORY, V95, P369 ZENG XM, 1998, J MATH ANAL APPL, V219, P364 ZENG XM, 1998, J MATH ANAL APPL, V226, P309 ZENG XM, 2001, J INEQUAL APPL, V6, P563
NR	14
TC	1
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0893-9659
J9	APPL MATH LETT
JI	Appl. Math. Lett.
PD	SEP
PY	2005
VL	18
IS	9
BP	1053
EP	1061
PG	9
SC	Mathematics, Applied
GA	957YJ
UT	ISI:000231409100013
ER

---

PT	J
AU	Srivastava, HM Gupta, V
TI	Rate of convergence for the Bezier variant of the Bleimann-Butzer-Hahn operators
SO	APPLIED MATHEMATICS LETTERS
LA	English
DT	Article
DE	positive linear operators; Bleimann-Butzer-Hahn operators; probability theory; random variables; binomial distribution; rate of convergence; functions of bounded variation; basis functions; Lebesgue-Stieltjes integral; total variation; stirling numbers of the second kind; decomposition technique
AB	In the present paper, the authors make use of some results in probability theory with a view to estimating the rate of convergence for the Bezier variant of the Bleimann-Butzer-Hahn operators for functions of bounded variation. (c) 2005 Elsevier Ltd. All rights reserved.
C1	Univ Victoria, Dept Math & Stat, Victoria, BC V8W 3P4, Canada. Netaj Subhas Inst Technol, Sch Appl Sci, New Delhi 110045, India.
RP	Srivastava, HM, Univ Victoria, Dept Math & Stat, Victoria, BC V8W 3P4, Canada.
EM	harimsri@math.uvic.ca vijay@nsit.ac.in
CR	ABEL U, 1999, J APPROX THEORY, V97, P181 ABEL U, 2000, E J APPROX, V6, P349 BLEIMANN G, 1980, INDAG MATH, V42, P255 BOJANIC R, 1981, J APPROX THEORY, V31, P67 KHAN MK, 1991, PROGR APPROXIMATION, P483 KHAN MK, 1991, PROGR APPROXIMATION, P483 KHAN RA, 1988, J APPROX THEORY, V53, P295 SRIVASTAVA HM, 2003, MATH COMPUT MODEL, V37, P1307 VECCHIA BD, 1991, PROGR APPROXIMATION, P177 ZENG XM, 1998, J MATH ANAL APPL, V219, P364
NR	10
TC	2
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0893-9659
J9	APPL MATH LETT
JI	Appl. Math. Lett.
PD	AUG
PY	2005
VL	18
IS	8
BP	849
EP	857
PG	9
SC	Mathematics, Applied
GA	947YL
UT	ISI:000230683100002
ER

---

PT	J
AU	Ozarslan, MA Duman, O Dogru, O
TI	Rates of A-statistical convergence of approximating operators
SO	CALCOLO
LA	English
DT	Article
ID	BERNSTEIN POWER-SERIES; SUMMABILITY
AB	Using the concepts of rates of statistical convergence we investigate approximation properties of positive linear operators defined on the space C[0,b], 0 < b < 1, which includes many well-known operators in approximation theory. We also use the modulus of continuity and Lipschitz functions.
C1	Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey. TOBB Univ Econ & Technol, Fac Arts & Sci, Dept Math, Ankara, Turkey.
RP	Ozarslan, MA, Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
CR	ALTOMARE F, 1994, KOROVKIN TYPE APPROX BLEIMANN G, 1980, INDAG MATH, V42, P255 BOJANIC R, 1983, CANADIAN MATH SOC C, V3, P5 BOJANIC R, 1992, J NAT SCI MATH, V32, P5 CHENEY EW, 1964, CAN J MATH, V16, P241 CHENEY EW, 1998, INTRO APPROXIMATION DEVORE RA, 1972, LECT NOTES MATH, V293 DOGRU O, 2003, STUD SCI MATH HUNG, V40, P359 DOGRU O, 2004, STUD SCI MATH HUNG, V41, P415 DUMAN O, 2003, MATH INEQUAL APPL, V6, P689 DUMAN O, 2004, STUD MATH, V161, P187 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1978, CAN J MATH, V30, P808 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 2003, ACTA SCI MATH SZEGED, V69, P147 HARDY GH, 1949, DIVERGENT SERIES KHAN MK, 1989, J APPROX THEORY, V57, P90 KOLK E, 1993, ANALYSIS, V13, P77 KOROVKIN PP, 1960, LINEAR OPERATORS APP KUTTNER B, 1944, J LOND MATH SOC, V19, P153 MEYERKONIG W, 1960, STUD MATH, V19, P89 MILLER HI, 1983, AKAD NAUKA UMJET BOS, P39 MILLER HI, 1995, T AM MATH SOC, V347, P1811 STEINHAUS H, 1951, C MATH, V2, P73 SZASZ O, 1950, T AM MATH SOC, V69, P440
NR	26
TC	0
PU	SPRINGER
PI	NEW YORK
PA	233 SPRING STREET, NEW YORK, NY 10013 USA
SN	0008-0624
J9	CALCOLO
JI	Calcolo
PD	JUL
PY	2005
VL	42
IS	2
BP	93
EP	104
PG	12
SC	Mathematics
GA	940KB
UT	ISI:000230142300003
ER

---

PT	J
AU	Agratini, O
TI	On the rate of convergence of some integral operators for functions of bounded variation
SO	STUDIA SCIENTIARUM MATHEMATICARUM HUNGARICA
LA	English
DT	Article
DE	approximation process; function with bounded variation; Kantorovich-type operators; rate of convergence
ID	BERNSTEIN POLYNOMIALS; MEYER-KONIG; SERIES
AB	In the present paper we define a general class B-n,B-alpha, alpha >= 1, of Durrmeyer-Bezier type of linear positive operators. Our main aim is to estimate the rate of pointwise convergence for functions f at those points x at which the one-sided limits f(x+) and f(x-) exist. As regards these functions defined on an interval J certain conditions are required. We discuss two distinct cases: Int (J) = (0, infinity) and Int (J) = (0, 1).
C1	Univ Babes Bolyai, Fac Math & Comp Sci, R-3400 Cluj Napoca, Romania.
RP	Agratini, O, Univ Babes Bolyai, Fac Math & Comp Sci, Str Kogalniceanu,1, R-3400 Cluj Napoca, Romania.
EM	agratini@math.ubbcluj.ro
CR	ANIOL G, 1994, DEMONSTRATIO MATH, V27, P367 ANIOL G, 1999, FASCICULI MATH, V29, P5 BASTIEN G, 2002, CAN J MATH, V54, P5 BASTIEN G, 2002, CAN J MATH, V54, P916 BOJANIC R, 1981, J APPROX THEORY, V31, P67 BOJANIC R, 1991, ATT SEM MAT U MOD, V39, P495 CHENG F, 1983, J APPROX THEORY, V39, P259 DERRIENNIC MM, 1981, J APPROX THEORY, V31, P325 GUO SS, 1989, J APPROX THEORY, V56, P245 GUPTA S, 1997, SCHIZOPHR RES, V23, P1 GUPTA V, 1997, SOOCHOW J MATH, V23, P115 GUPTA V, 1998, KUUNGPOOK MATH J, V38, P283 GUPTA V, 1999, J MATH ANAL APPL, V233, P476 GUPTA V, 2002, NONLINEAR FUNCT ANAL, V7, P481 GUPTA V, 2003, ANAL THEORY APPL, V19, P1 GUPTA V, 2003, ANAL THEORY APPL, V19, P81 HEILMANNM, 1989, NUMERICAL FUNCTIONAL, V10, P127 KHAN MK, 1989, J APPROX THEORY, V57, P90 SAHAI A, 1993, BEOGRAD, V53, P73 ZENG XM, 1998, J MATH ANAL APPL, V219, P364 ZENG XM, 2000, J APPROX THEORY, V102, P1
NR	21
TC	0
PU	AKADEMIAI KIADO
PI	BUDAPEST
PA	PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN	0081-6906
J9	STUD SCI MATH HUNG
JI	Stud. Sci. Math. Hung.
PY	2005
VL	42
IS	2
BP	235
EP	252
PG	18
SC	Mathematics
GA	937AF
UT	ISI:000229896200009
ER

---

PT	J
AU	Zeng, XM Piriou, A
TI	Rate of pointwise approximation for locally bounded functions by Szasz operators
SO	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
ID	BERNSTEIN POLYNOMIALS; CONVERGENCE
AB	In this paper the asymptotic behavior of Szasz operators for locally bounded functions f is studied at points x where f (x +) and f (x -) exist. An asymptotic estimate of this type approximation is obtained by using some techniques and results of probability theory. The estimate essentially is the best possible for continuous points of f. (c) 2004 Elsevier Inc. All rights reserved.
C1	Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China. Univ Nice Sophia Antopolis, Math Lab, URA 168, CNRS, F-06108 Nice, France.
RP	Zeng, XM, Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
EM	xmzeng@jingxian.xmu.edu.cn
CR	BOJANIC R, 1989, J MATH ANAL APPL, V141, P136 CHENG F, 1983, J APPROX THEORY, V39, P259 CHENG F, 1984, J APPROX THEORY, V40, P226 FELLER W, 1971, INTRO PROBABILITY TH GUO SS, 1989, J APPROX THEORY, V58, P90 LOEVE M, 1977, PROBABILITY THEORY SZASZ O, 1950, J RES NAT BUR STANDA, V45, P239 ZENG XM, 1998, J MATH ANAL APPL, V226, P309 ZENG XM, 2001, J APPROX THEORY, V109, P242
NR	9
TC	0
PU	ACADEMIC PRESS INC ELSEVIER SCIENCE
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0022-247X
J9	J MATH ANAL APPL
JI	J. Math. Anal. Appl.
PD	JUL 15
PY	2005
VL	307
IS	2
BP	433
EP	443
PG	11
SC	Mathematics, Applied; Mathematics
GA	934RA
UT	ISI:000229724700004
ER

---

PT	J
AU	Abel, U Gupta, V Mohapatra, RN
TI	Local approximation by Beta operators
SO	NONLINEAR ANALYSIS-THEORY METHODS & APPLICATIONS
LA	English
DT	Article
DE	approximation by positive operators; rate of convergence; degree of approximation; functions of bounded variation; total variation; asymptotic expansions
AB	The present paper deals with the Beta approximation operators. We obtain an estimate on the rate of convergence for functions of bounded variation by means of the decomposition technique. Furthermore we derive the complete asymptotic expansion of the sequence ((L(n)f)(x))(∞)(n=1) for smooth functions as n tends to infinity. © 2005 Elsevier Ltd. All rights reserved.
C1	Univ Cent Florida, Dept Math, Orlando, FL 32816 USA. Univ Appl Sci, Fachhsch Giessen Friedberg, Fachbereich MND, D-61169 Friedberg, Germany. Sch Appl Sci, Netaji Subhas Inst Technol, New Delhi 110045, India.
RP	Abel, U, Univ Cent Florida, Dept Math, Orlando, FL 32816 USA.
EM	Ulrich.Abel@mnd.fh-friedberg.de vijay@nsit.ac.in ramm@mail.ucf.edu
CR	ABEL U, 1997, J MATH ANAL APPL, V208, P109 DOETSCH G, 1972, HDB LAPLACE TRANSFOR, V2 JORDAN C, 1965, CALCULUS FINITE DIFF KHAN MK, 1991, PROGR APPROXIMATION, P483 KHAN MK, 2002, REND CIRC MAT PALE S, V68, P539 LUPAS A, 1972, THESIS U STUTTGART SIKKEMA PC, 1970, INDAG MATH, V32, P327 SIKKEMA PC, 1970, INDAGATIONES MATH, V32, P428
NR	8
TC	0
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0362-546X
J9	NONLINEAR ANAL-THEOR METH APP
JI	Nonlinear Anal.-Theory Methods Appl.
PD	JUL 1
PY	2005
VL	62
IS	1
BP	41
EP	52
PG	12
SC	Mathematics, Applied; Mathematics
GA	932AV
UT	ISI:000229527500003
ER

---

PT	J
AU	Sieper, J Rudwaleit, M
TI	Early referral recommendations for ankylosing spondylitis (including pre-radiographic and radiographic forms) in primary care
SO	ANNALS OF THE RHEUMATIC DISEASES
LA	English
DT	Review
ID	NECROSIS-FACTOR-ALPHA; LOW-BACK-PAIN; DIAGNOSTIC-CRITERIA; CONTROLLED-TRIAL; DOUBLE-BLIND; HLA-B27; SPONDYLARTHROPATHY; INFLIXIMAB; PLACEBO; CLASSIFICATION
AB	An earlier diagnosis of ankylosing spondylitis ( AS) is required because there is still a 5 - 7 year delay between first symptoms and diagnosis, and new effective treatments are available for active disease. Primary care physicians need easy to apply parameters to help them identify patients with suspected AS for onward referral. The best measures found were inflammatory back pain and HLA-B27 positivity.
C1	Univ Med Berlin, Charite, Dept Med 1, D-12200 Berlin, Germany.
RP	Sieper, J, Univ Med Berlin, Charite, Dept Med 1, Hindenburgdamm 30,Campus Benjamin Franklin Charit, D-12200 Berlin, Germany.
EM	joachim.sieper@charite.de
CR	ALLALI F, 2003, ANN RHEUM DIS, V62, P347 AMOR B, 1994, J RHEUMATOL, V21, P1883 AMOR B, 1995, REV RHUM, V62, P10 BRANDT J, 2003, ARTHRITIS RHEUM, V48, P1667 BRAUN J, 1994, ARTHRITIS RHEUM, V37, P1039 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 2002, LANCET, V359, P1187 BRAUN J, 2003, ARTHRITIS RHEUM, V48, P1126, DOI 10.1002/art.10883 CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613 DAVIS JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325 DEYO RA, 2001, NEW ENGL J MED, V344, P363 DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218 DOUGADOS M, 2001, ARTHRITIS RHEUM, V44, P180 DOUGADOS M, 2002, ANN RHEUM DIS S3, V61, P40 EMERY P, 2002, ANN RHEUM DIS, V61, P290 FELDTKELLER E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4 GRAN JT, 1985, ANN RHEUM DIS, V44, P359 GRAN JT, 2000, CLIN RHEUMATOL, V19, P450 HAIBEL H, 2005, ANN RHEUM DIS, V64, P124, DOI 10.1136/ard.2003.019174 JAJIC I, 1979, ACTA ORTHOP SCAND, V50, P411 KHAN MA, 1982, ANN INTERN MED, V96, P70 MAOU W, 1988, J RHEUMATOL, V15, P1109 RUDWALEIT M, 2004, ANN RHEUM DIS, V63, P535, DOI 10.1136/ard.2003.011247 RUDWALEIT M, 2004, ANN RHEUM DIS, V63, P665, DOI 10.1136/ard.2003.016386 SANDSTROM J, 1984, SCAND J REHABIL MED, V16, P27 UNDERWOOD MR, 1995, BRIT J RHEUMATOL, V34, P1074 VANDENBOSCH F, 2002, ARTHRITIS RHEUM, V46, P755 VANDERHEIJDE DMF, 2003, ARTHRITIS RHEUM S, V48, S175 VANDERHEIJDE DMFM, 2004, ANN RHEUM DIS S1, V63, P98 VANDERLINDEN S, 1983, BRIT J RHEUMATOL, V22, P18 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDERLINDEN S, 1998, RHEUM DIS CLIN N AM, V24, P663 VANTUBERGEN A, 2003, ANN RHEUM DIS, V62, P519
NR	33
TC	18
PU	B M J PUBLISHING GROUP
PI	LONDON
PA	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN	0003-4967
J9	ANN RHEUM DIS
JI	Ann. Rheum. Dis.
PD	MAY
PY	2005
VL	64
IS	5
BP	659
EP	663
PG	5
SC	Rheumatology
GA	917GM
UT	ISI:000228444500002
ER

---

PT	J
AU	Peters, MJ van der Horst-Bruinsma, IE Dijkmans, BA Nurmohamed, MT
TI	Cardiovascular risk profile of patients with spondylarthropathies, particularly ankylosing spondylitis and psoriatic arthritis
SO	SEMINARS IN ARTHRITIS AND RHEUMATISM
LA	English
DT	Review
DE	ankylosing spondylitis; psoriatic arthritis; cardiovascular disease
ID	C-REACTIVE-PROTEIN; ERYTHROCYTE SEDIMENTATION-RATE; HLA-B27 ASSOCIATED DISEASE; APPARENTLY HEALTHY-MEN; MITRAL-VALVE PROLAPSE; ACUTE-PHASE PROTEINS; RHEUMATOID-ARTHRITIS; SERUM IMMUNOGLOBULINS; AORTIC REGURGITATION; CONDUCTION SYSTEM
AB	OBJECTIVE To evaluate the cardiovascular risk profile of spondylarthropathy patients, particularly ankylosing spondylitis and psoriatic arthritis. METHODS A Pubmed literature search was performed to collect English-language articles for this clinically orientated review. Studies were selected if they included (cardiovascular) mortality and morbidity and/or data about cardiovascular risk factors in spondylarthropathies. RESULTS Ankylosing spondylitis as well as psoriatic arthritis appear to be associated with an increased cardiovascular mortality and morbidity. Several factors, ie, smoking, altered lipid profile, hypertension, increased fibrinogen level, enhanced number of platelets, and hypercoagulability might explain the enhanced cardiovascular risk. Moreover, a decline in physical activity, the presence of HLA-B27, and inflammation may play a role. Finally, undertreatment of cardiovascular morbidity also may contribute to the higher cardiovascular risk. CONCLUSIONS The available data indicate an increased cardiovascular risk in spondylarthropathy patients, particularly those with ankylosing spondylitis and psoriatic arthritis. RELEVANCE Rheumatologists should be aware of the enhanced cardiovascular risk in patients with ankylosing spondylitis and psoriatic arthritis. If modifiable cardiovascular risk factors are identified, treatment could ultimately result in a lower cardiovascular morbidity and mortality.
C1	VU Univ, Med Ctr, Dept Rheumatol, Amsterdam, Netherlands. VU Univ, Med Ctr, Dept Internal Med, Jan Breemen Inst,Slotervaart Hosp, Amsterdam, Netherlands.
RP	Nurmohamed, MT, VU Univ, Med Ctr, Dept Rheumatol, Room 4A40,POB 7057, Amsterdam, Netherlands.
EM	m.nurmohamed@janvanbreemen.nl
CR	ALVES MG, 1988, ANGIOLOGY, V39, P567 ARNEU FC, 1992, CURR OPIN RHEUMATOL, V4, P460 AVERNS HL, 1996, SCAND J RHEUMATOL, V25, P138 BERGFELDT L, 1982, AM J MED, V73, P187 BERGFELDT L, 1983, AM J MED, V75, P210 BERGFELDT L, 1983, TISSUE ANTIGENS, V21, P385 BERGFELDT L, 1988, AM J MED, V85, P12 BERGFELDT L, 1991, BRIT HEART J, V65, P184 BERGFELDT L, 1997, ANN INTERN MED 1, V127, P621 BREWERTON DA, 1987, LANCET, V1, P995 BRUNZELL JD, 1999, AM J MED, V107, S16 CALLAHAN LF, 1995, ARTHRIT CARE RES, V8, P229 CALLE EE, 1999, NEW ENGL J MED, V341, P1097 CARTER ET, 1979, ARTHRITIS RHEUM, V22, P365 CHOI HK, 2002, LANCET, V359, P1173 DORAN MF, 2003, J RHEUMATOL, V30, P316 DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218 ERNST E, 1993, ANN INTERN MED, V118, P956 FORD ES, 2002, EPIDEMIOLOGY, V13, P561, DOI 10.1097/01.EDE.0000023965.92535.C0 FUKUHARA K, 1998, BRIT J DERMATOL, V138, P329 GLADMAN DD, 1998, ARTHRITIS RHEUM, V41, P1103 GOULD BA, 1992, ANN RHEUM DIS, V51, P227 HELLIWELL PS, 1991, ANN RHEUM DIS, V50, P362 JONES SM, 2000, ANN RHEUM DIS, V59, P904 JOVEN J, 1984, ARTHRITIS RHEUM, V27, P1199 KAPROVE RE, 1980, ARTHRITIS RHEUM, V23, P57 KHAN MA, 1981, J RHEUMATOL, V8, P86 KHAN MA, 1990, SEMIN ARTHRITIS RHEU, V20, P107 KHAN MA, 2002, ANN INTERN MED, V136, P896 KINOSIAN B, 1994, ANN INTERN MED, V121, P641 KULLO IJ, 2000, MAYO CLIN PROC, V75, P369 LAURENT MR, 1981, ANN RHEUM DIS, V40, P66 LAURENT MR, 1983, ANN RHEUM DIS, V42, P524 LAZAREVIC MB, 1992, SEMIN ARTHRITIS RHEU, V22, P172 LEHTINEN K, 1980, SCAND J RHEUMATOL, V9, P145 LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174 MASI AT, 1999, ARTHRITIS RHEUM S, V42, S300 MASI AT, 2000, ARTHRITIS RHEUM S, V43, S102 MAYER EL, 1996, J AM COLL CARDIOL, V27, P517 MORROW DA, 2000, MED CLIN N AM, V84, P149 MOYA JL, 1987, ARCH INTERN MED, V147, P992 MUNA WF, 1980, JAMA-J AM MED ASSOC, V244, P363 NAGYHEGYI G, 1988, CLIN EXP RHEUMATOL, V6, P17 ONEILL TW, 1992, ANN RHEUM DIS, V51, P652 ONEILL TW, 1992, ANN RHEUM DIS, V51, P705 PEARSON TA, 2002, CIRCULATION, V106, P388 PEETERS AJ, 1991, ANN RHEUM DIS, V50, P348 PINES A, 1986, ARCH INTERN MED, V146, P1371 PRASAD A, 2002, CIRCULATION, V106, P184 QAIYUMI S, 1985, ARCH INTERN MED, V145, P822 RADFORD EP, 1977, NEW ENGL J MED, V297, P572 REDELMEIER DA, 1998, NEW ENGL J MED, V338, P1516 REED WB, 1961, ARCH DERMATOL, V83, P41 RIBEIRO P, 1984, EUR HEART J, V5, P419 RIDKER PM, 1997, NEW ENGL J MED, V336, P973 RIDKER PM, 1998, CIRCULATION, V98, P731 RIDKER PM, 1998, J INVEST MED, V46, P391 RIDKER PM, 2000, NEW ENGL J MED, V342, P836 ROBERTS MET, 1976, ANN RHEUM DIS, V35, P206 ROSSNER S, 1978, ATHEROSCLEROSIS, V31, P93 RUOF J, 1999, J RHEUMATOL, V26, P966 SHBEEB M, 2000, J RHEUMATOL, V27, P1247 SLOT O, 2001, SCAND J RHEUMATOL, V30, P305 SMITH PG, 1982, BRIT MED J, V284, P449 SPOORENBERG A, 1999, J RHEUMATOL, V26, P980 SUKENIK S, 1987, CLIN RHEUMATOL, V6, P588 SUN JP, 1992, INT J CARDIOL, V37, P65 THAULOW E, 1991, CIRCULATION, V84, P613 VALENTINI G, 1978, Z RHEUMATOL, V37, P233 VANDOORNUM S, 2002, ARTHRITIS RHEUM, V46, P862 WARD MM, 2002, J RHEUMATOL, V29, P1420 WELCH GN, 1998, NEW ENGL J MED, V338, P1042 WONG K, 1997, ARTHRITIS RHEUM, V40, P1868 YILDIRIR A, 2002, CLIN RHEUMATOL, V21, P129 YOUSSEF W, 1990, CURR OPIN RHEUMATOL, V2, P582 ZHANG YX, 1999, ATHEROSCLEROSIS, V145, P375
NR	76
TC	26
PU	W B SAUNDERS CO
PI	PHILADELPHIA
PA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA
SN	0049-0172
J9	SEMIN ARTHRITIS RHEUM
JI	Semin. Arthritis Rheum.
PD	DEC
PY	2004
VL	34
IS	3
BP	585
EP	592
PG	8
SC	Rheumatology
GA	885XM
UT	ISI:000226190600004
ER

---

PT	J
AU	Moricz, F Orhan, C
TI	Tauberian conditions under which statistical convergence follows from statistical summability by weighted means
SO	STUDIA SCIENTIARUM MATHEMATICARUM HUNGARICA
LA	English
DT	Article
DE	statistical convergence; statistical summability (N,p); statistical limit inferior; statistical limit superior; one-sided and two-sided Tauberian conditions; slow decrease; slow oscillation
AB	The first named author has recently proved necessary and sufficient Tauberian conditions under which statistical convergence (introduced by H. Fast in 1951) follows from statistical summability (C, 1). The aim of the present paper is to generalize these results to a large class of summability methods (N,p) by weighted means. Let p = (P-k : k = 0, 1, 2....) be a sequence of nonnegative numbers such that p(0) > 0 and P-n := Sigma(k=0)(n)Pk --> infinity as n --> infinity. Let (x(k)) be a sequence of real or complex numbers and set t(n) := P-n(-1) Sigma(k)(n=0) p(k)x(k) for n = 0, 1, 2..... We present necessary and sufficient conditions under which the existence of the limit St-lim x(k) = L follows from that of st-lim tn = L, where L is a finite number. If (x(k)) is a sequence of real numbers, then these are one-sided Tauberian conditions. If (x(k)) is a sequence of complex numbers, then these are two-sided Tauberian conditions.
C1	Univ Szeged, Bolyai Inst, H-6720 Szeged, Hungary. Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
RP	Moricz, F, Univ Szeged, Bolyai Inst, Aradi Vertanuk Tere 1, H-6720 Szeged, Hungary.
EM	moricz@math.u-szeged.hu orhan@science.ankara.edu.tr
CR	FAST H, 1951, C MATH, V2, P241 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1997, P AM MATH SOC, V125, P3625 FRIDY JA, 2000, P AM MATH SOC, V128, P2347 HARDY GH, 1910, P LOND MATH SOC, V8, P310 KOLK E, 1993, ANALYSIS, V13, P77 LANDAU E, 1910, PRAC MAT FIZ, V21, P97 MORICZ F, 2002, J MATH ANAL APPL, V275, P277 MORICZ F, 2004, ACTA MATH HUNG, V102, P279, UNSP MR 2040109 SALAT T, 1980, MATH SLOVACA, V30, P139 SCHMIDT R, 1925, MATH Z, V22, P89 SCHOENBERG IJ, 1959, AM MATH MONTHLY, V66, P361
NR	12
TC	0
PU	AKADEMIAI KIADO
PI	BUDAPEST
PA	PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN	0081-6906
J9	STUD SCI MATH HUNG
JI	Stud. Sci. Math. Hung.
PY	2004
VL	41
IS	4
BP	391
EP	403
PG	13
SC	Mathematics
GA	869IV
UT	ISI:000224977500003
ER

---

PT	J
AU	Dogru, O Ozarslan, MA Tasdelen, F
TI	On positive operators involving a certain class of generating functions
SO	STUDIA SCIENTIARUM MATHEMATICARUM HUNGARICA
LA	English
DT	Article
DE	positive linear operators; the Korovkin theorem; the Meyer-Konig and Zeller operators; Lipschitz class; K-functional of Peetre; modulus of continuity
ID	BERNSTEIN POWER-SERIES
AB	In this paper we introduced the general sequence of linear positive operators via generating functions. Approximation properties of these operators are obtained with the help of the Korovkin Theorem. The order of convergence of these operators computed by means of modulus of continuity Peetre's K-functional and the elements of the usual Lipschitz class. Also we introduce the r-th order generalization of these operators and we evaluate this generalization by the operators defined in this paper. Finally we give some applications to differential equations.
C1	Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
RP	Dogru, O, Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
EM	dogru@science.ankara.edu.tr ozarslan@science.ankara.edu.tr tasdelen@science.ankara.edu.tr
CR	ALKEMADE JAH, 1984, J APPROX THEORY, V40, P261 BLEIMANN G, 1980, NEDERL AKAD WETENSCH, V42, P255 CHENEY EW, 1964, CAN J MATH, V16, P241 DOGRU O, 1998, MATH BALKANICA, V12, P359 DOGRU O, 2002, INT MATH J, V2, P889 KHAN MK, 1989, J APPROX THEORY, V57, P90 KIROV GH, 1992, I PHYS PUBLUNSP MR 93F:41001 KIROV GH, 1993, MATH BALKANICA, V7, P149, UNSP MR 95I:41048 MAY CP, 1976, CAN J MATH, V28, P1224 MEYERKONIG W, 1960, STUD MATH, V19, P89 SZASZ O, 1950, J RES NAT GUR STAND, V445, P239, UNSP MR 13 648C VOLKOV YI, 1978, MAT ZAMETKI, V23, P363
NR	12
TC	4
PU	AKADEMIAI KIADO
PI	BUDAPEST
PA	PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN	0081-6906
J9	STUD SCI MATH HUNG
JI	Stud. Sci. Math. Hung.
PY	2004
VL	41
IS	4
BP	415
EP	429
PG	15
SC	Mathematics
GA	869IV
UT	ISI:000224977500005
ER

---

PT	J
AU	Wendling, D Toussirot, E
TI	Anti-TNF-alpha therapy in ankylosing spondylitis
SO	EXPERT OPINION ON PHARMACOTHERAPY
LA	English
DT	Review
DE	ankylosing spondylitis; anti-TNF-alpha agents; treatment
ID	NECROSIS-FACTOR-ALPHA; CHIMERIC MONOCLONAL-ANTIBODY; PLACEBO-CONTROLLED TRIAL; BONE-MINERAL DENSITY; PSORIATIC-ARTHRITIS; DOUBLE-BLIND; OPEN-LABEL; FOLLOW-UP; INFLIXIMAB TREATMENT; DISEASE-ACTIVITY
AB	Ankylosing spondylitis (AS) is a frequent disease leading to functional impairment and socioeconomic burden. Anti-TNF-alpha therapy has brought new perspectives in this condition. Two agents are currently used in the treatment of AS and spondyloarthropathies - infliximab (a chimeric monoclonal antibody) and etanercept (a soluble p75 TNF-receptor). Open-label studies have shown the feasibility and efficacy of these drugs. Controlled studies have confirmed the latter, at least in the short-term (1 year). Improvement in several clinical parameters, function, quality of life, biological parameters and magentic resonance imaging acute inflammation, have been observed. Due to these favourable results, anti-TNF have been approved for the treatment of AS. However, there are some safety concerns, essentially involving infection. Consensus guidelines for the use of anti-TNF in AS are available and assessment is based on validated tools. However, some questions still remain unanswered, such as the long-term efficacy and safety of anti-TNF, the possibility of structural benefit and the cost-effectiveness. Despite these concerns, Anti-TNF represents a major therapeutic advancement in the treatment of AS.
C1	Univ Teaching, Hosp Minjoz, Dept Rheumatol, F-25030 Besancon, France.
RP	Wendling, D, Univ Teaching, Hosp Minjoz, Dept Rheumatol, Blvd Fleming, F-25030 Besancon, France.
EM	daniel.wendling@ufc-chu.univ-fcomte.fr
CR	ALLALI F, 2003, ANN RHEUM DIS, V62, P347 AMOR B, 1994, J RHEUMATOL, V21, P1884 ANDERSON JJ, 2001, ARTHRITIS RHEUM, V44, P1876 ANTONI C, 2003, ARTHRITIS RHEUM S, V48, S265 BAETEN D, 2001, ANN RHEUM DIS, V60, P750 BAETEN D, 2001, ARTHRITIS RHEUM, V44, P186 BAETEN D, 2003, ANN RHEUM DIS, V62, P829 BARKHAM N, 2003, ARTHRITIS RHEUM S, V48, S175 BOEGER CA, 2001, ANN RHEUM DIS, V60, P1159 BOKAREWA M, 2003, ANN RHEUM DIS, V62, P783 BOONEN A, 2001, ANN RHEUM DIS, V60, P353 BOONEN A, 2002, CLIN EXP RHEUMAT S28, V20, S23 BRANDT J, 2000, ARTHRITIS RHEUM, V43, P1346 BRANDT J, 2001, ARTHRITIS RHEUM, V44, P2936 BRANDT J, 2002, J RHEUMATOL, V29, P118 BRANDT J, 2003, ARTHRITIS RHEUM, V48, P1667 BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 2002, LANCET, V359, P1187 BRAUN J, 2003, ANN RHEUM DIS, V62, P817 BRAUN J, 2003, ARTHRITIS RHEUM, V48, P1126, DOI 10.1002/art.10883 BRAUN J, 2003, ARTHRITIS RHEUM, V48, P2224, DOI 10.1002/art.11104 BRAUN J, 2003, EXPERT OPIN INV DRUG, V12, P1097 BREBAN M, 2002, RHEUMATOLOGY, V41, P1280 COLLANTESESTEVEZ E, 2003, ANN RHEUM DIS, V62, P1239, DOI 10.1136/ard.2002.004879 DAGOSTINO MA, 2002, ARTHRITIS RHEUM, V46, P840 DAVIS JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325 GORMAN J, 2002, NEW ENGL J MED, V346, P385 GRAN JT, 1985, ANN RHEUM DIS, V44, P359 GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927 GUILLEMIN F, 2002, REV RHUM, V69, P1014 HADI A, 2002, RHEUMATOLOGY, V41, P114 KELLER C, 2003, ANN RHEUM DIS, V62, P1128, DOI 10.1136/ard.2003.011023 KHAN MA, 1981, J RHEUMATOL, V8, P86 KRUITHOF E, 2002, ANN RHEUM DIS, V61, P207 MAKSYMOWYCH WP, 2002, ARTHRITIS RHEUM, V46, P766 MAKSYMOWYCH WP, 2002, J RHEUMATOL, V29, P959 MAKSYMOWYCH WP, 2003, J RHEUMATOL, V30, P1356 MARZOORTEGA H, 2003, ANN RHEUM DIS, V62, P1020 MEASE PJ, 2000, LANCET, V356, P385 ONIANKITAN O, 2002, REV RHUM, V69, P1025 RUDWALEIT M, 2004, ANN RHEUM DIS, V63, P665, DOI 10.1136/ard.2003.016386 SALMON D, 2002, JOINT BONE SPINE, V69, P170 SALVARANI C, 2003, ARTHRIT RHEUM-ARTHR, V49, P541, DOI 10.1002/art.11201 SIEPER J, 2002, ANN RHEUM DIS S3, V61, P8 STONE M, 2001, J RHEUMATOL, V28, P1605 STONE MA, 2004, ANN RHEUM DIS, V63, P84, DOI 10.1136/ard.2003.006916 TEMEKONIDIS TI, 2003, ANN RHEUM DIS, V62, P1218, DOI 10.1136/ard.2003.014258 TOUSSIROT E, 1998, DRUGS, V56, P225 TOUSSIROT E, 2004, EXPERT OPIN PHARMACO, V5, P581 VANDENBOSCH F, 2000, ANN RHEUM DIS, V59, P428 VANDENBOSCH F, 2000, LANCET, V356, P1821 VANDENBOSCH F, 2002, ARTHRITIS RHEUM, V46, P755 VANDERHEIJDE D, 1997, J RHEUMATOL, V24, P2225 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANTUBERGEN A, 2001, ARTHRIT RHEUM-ARTHR, V45, P430 VANVOLLENHOVEN R, 2003, ANN RHEUM DIS, V62, P1195, DOI 10.1136/ard.2003.009589 WANDERS A, 2003, ARTHRITIS RHEUM S, V48, S233 WARD MM, 2002, J RHEUMATOL, V16, P691 WENDLING D, 2003, JOINT BONE SPINE, V70, P401, DOI 10.1016/S1297-319X(03)00117-9 ZOU J, 2003, ANN RHEUM DIS, V62, P561 ZOU JX, 2003, ARTHRITIS RHEUM, V48, P780, DOI 10.1002/art.10847
NR	62
TC	12
PU	ASHLEY PUBLICATIONS LTD
PI	LONDON
PA	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND
SN	1465-6566
J9	EXPERT OPIN PHARMACOTHER
JI	Expert Opin. Pharmacother.
PD	JUL
PY	2004
VL	5
IS	7
BP	1497
EP	1507
PG	11
SC	Pharmacology & Pharmacy
GA	839XO
UT	ISI:000222818500005
ER

---

PT	J
AU	Duman, O Orhan, C
TI	mu-statistically convergent function sequences
SO	CZECHOSLOVAK MATHEMATICAL JOURNAL
LA	English
DT	Article
DE	pointwise and uniform convergence; p-statistical convergence; convergence in mu-density; finitely additive measure; additive property for null sets
ID	SUMMABILITY
AB	In the present paper we are concerned with convergence in mu-density and mu-statistical convergence of sequences of functions defined on a subset D of real numbers, where A is a finitely additive measure. Particularly, we introduce the concepts of mu-statistical uniform convergence and mu-statistical pointwise convergence, and observe that mu-statistical uniform convergence inherits the basic properties of uniform convergence.
C1	Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
RP	Duman, O, Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
EM	oduman@science.ankara.edu.tr orhan@science.ankara.edu.tr
CR	BARTLE RG, 1964, ELEMENTS REAL ANAL CONNOR J, 1990, ANALYSIS, V10, P373 CONNOR J, 1992, P AM MATH SOC, V115, P319 CONNOR J, 1993, PAC J MATH, V157, P201 CONNOR J, 1996, J MATH ANAL APPL, V197, P393 CONNOR J, 1999, TOPOLOGICAL FUNCTION, P403 CONNOR J, 2000, J MATH ANAL APPL, V244, P251 CONNOR JS, 1988, ANALYSIS, V8, P47 DEMIRCI K, 1999, J MATH ANAL APPL, V235, P122 FAST H, 1951, C MATH, V2, P241 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1993, J MATH ANAL APPL, V173, P497 FRIDY JA, 1993, PAC J MATH, V160, P43 FRIDY JA, 1998, J MATH ANAL APPL, V228, P73 KOLK E, 1999, J MATH ANAL APPL, V238, P599 MADDOX IJ, 1988, MATH P CAMBRIDGE PHI, V104, P141 MILLER HI, 1995, T AM MATH SOC, V347, P1811 SALAT T, 1980, MATH SLOVACA, V30, P139 STEINHAUS H, 1951, C MATH, V2, P73 WILCZYNSKI W, 2000, REAL ANAL EXCHANGE, V25, P49 ZYGMUND A, 1979, TRIGONOMETRIC SERIES
NR	21
TC	0
PU	CZECHOSLOVAK MATHEMATICAL JOURNAL
PI	PRAGUE 1
PA	ZITNA 25, PRAGUE 1 115 67, CZECH REPUBLIC
SN	0011-4642
J9	CZECH MATH J
JI	Czech. Math. J.
PY	2004
VL	54
IS	2
BP	413
EP	422
PG	10
SC	Mathematics
GA	839WZ
UT	ISI:000222816900014
ER

---

PT	J
AU	Braun, J
TI	Epidemiology and prognosis of ankylosing spondylitis
SO	RADIOLOGE
LA	German
DT	Article
DE	spondyloarthritides; prognosis of ankylosing spondylitis; acute and chronic spinal changes; sacroiliac joints; magnetic resonance imaging
ID	CORTICOSTEROID INJECTION; SACROILIAC JOINT; FOLLOW-UP; RHEUMATOID-ARTHRITIS; COMPUTED-TOMOGRAPHY; ZYGAPOPHYSEAL JOINT; PREDICTIVE FACTORS; DISEASE; SPONDYLOARTHROPATHY; SPONDYLARTHROPATHY
AB	The spondyloarthritides (SpA) comprise ankylosing spondylitis (AS), psoriatic SpA (PsSpA), reactive SpA (ReSpA) arthritis associated with chronic inflammatory bowel disease (SpAIBD) and undifferentiated SpA (uSpA). There are characteristic clinical features of SpA: inflammatory back pain (IBP), asymmetric peripheral arthritis, enthesitis, anterior uveitis, positive family history and others. The SpA, mainly AS, are strongly associated with HLA B27. AS is the most frequent and potentially most severe subtype, next to PsSpA. The prevalence of all SpA is rather high and not much different from rheumatoid arthritis (RA) and AS patients carry a burden of disease similar to RA patients. The prognosis of AS has not been extensively studied but some factors have been identified. There is a clear role for imaging modalities in the diagnosis of AS. Changes in the sacroiliac joint as detected by radiography still constitute the basis for the diagnosis of AS (New York criteria 1984). A diagnosis of sacroilitis as made by magnetic resonance imaging (MRI) provides more objective evidence to a diagnosis,of IBP arguing in favour of SpA which is defined on the basis of the ESSG criteria 1991 mainly on a clinical basis. Radiographic spinal changes such as syndesmophytes are important for the staging and outcome of AS. MR based assessment of spinal changes in are now being increasingly used to assess disease activity of AS patients. The presence of spinal radiographic changes at time of presentation was found to be the best predictor of further deterioration using the score 'modified SASS' in a recent study. Other clinical features such as hip arthritis, early onset of disease, dactylitis, oligoarthritis, limitation of spinal mobility negative prognostic value.
C1	St Josefs Hosp, Rheumazentrum Ruhrgebiet, D-44652 Herne, Germany.
RP	Braun, J, St Josefs Hosp, Rheumazentrum Ruhrgebiet, Landgrafenstr 15, D-44652 Herne, Germany.
EM	braun@rheumazentrum-ruhrgebiet.de
CR	AMOR B, 1994, J RHEUMATOL, V21, P1883 ANDERSON JJ, 2001, ARTHRITIS RHEUM, V44, P1878 AUFDERMAUR M, 1989, ANN RHEUM DIS, V48, P628 AVERNS HL, 1996, BRIT J RHEUMATOL, V35, P373 BLUM U, 1996, J RHEUMATOL, V23, P2107 BOLLOW M, 2000, ANN RHEUM DIS, V59, P135 BOONEN A, 2001, ANN RHEUM DIS, V60, P353 BRANDT J, 1999, RHEUMATOLOGY, V38, P831 BRANDT J, 2000, ARTHRITIS RHEUM, V43, P1346 BRAUN J, 1994, ARTHRITIS RHEUM, V37, P1039 BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499 BRAUN J, 1996, CURR OPIN RHEUMATOL, V8, P275 BRAUN J, 1996, J RHEUMATOL, V23, P659 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 1998, RHEUM DIS CLIN N AM, V24, P697 BRAUN J, 2001, Z RHEUMATOL, V60, P74 BRAUN J, 2002, ANN RHEUM DIS S3, V61, P19 BRAUN J, 2002, ARTHRITIS RES, V4, P307 BRAUN J, 2002, BEST PRACT RES CL RH, V16, P573, DOI 10.1053/berh.2002.0250 BRAUN J, 2002, CLIN EXP RHEUMAT S28, V20, S16 BRAUN J, 2002, LANCET, V359, P1187 BRAUN J, 2003, ARTHRITIS RHEUM, V48, P1126, DOI 10.1002/art.10883 BROPHY S, 2001, J RHEUMATOL, V28, P2283 BROPHY S, 2002, J RHEUMATOL, V29, P1236 CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186 CLAUDEPIERRE P, 1995, BRIT J RHEUMATOL, V34, P1139 COOPER C, 1994, J RHEUMATOL, V21, P1877 DAGOSTINO MA, 2003, ARTHRITIS RHEUM, V48, P523, DOI 10.1002/art.10812 DAVIS JC, 2003, ARTHRITIS RHEUM, V48, P3230, DOI 10.1002/art.11325 DEVLAM K, 1999, J RHEUMATOL, V26, P1738 DEVLAM K, 2000, J RHEUMATOL, V27, P1732 DIHLMANN W, 1979, SKELETAL RADIOL, V4, P179 DONNELLY S, 1994, ANN RHEUM DIS, V53, P117 DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218 EDMUNDS L, 1991, J RHEUMATOL, V18, P696 ELMAGHRAOUI A, 1999, J RHEUMATOL, V26, P2205 ELSAGHIR H, 2001, CLIN EXP RHEUMAT S28, V20, S101 FELDTKELLER E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4 FRANCOIS RJ, 2000, ARTHRITIS RHEUM, V43, P2011 GARRETT S, 1994, J RHEUMATOL, V21, P2286 GARRETT S, 1994, J RHEUMATOL, V21, P2286 GEUSENS P, 2001, J RHEUMATOL, V28, P1856 GINSBURG WW, 1983, MAYO CLIN P, V58, P2593 GRAHAM B, 1989, SPINE, V14, P803 GRAN JT, 1985, ANN RHEUM DIS, V44, P359 GRAN JT, 1997, BRIT J RHEUMATOL, V36, P766 GRATACOS J, 1997, J RHEUMATOL, V24, P912 GRATACOS J, 1999, ARTHRITIS RHEUM, V42, P2319 HAMERSMA J, 2001, ARTHRITIS RHEUM, V44, P1396 JAYSON MIV, 2003, ARTHRITIS RHEUM, V48, P612, DOI 10.1002/art.10875 JENKINSON TR, 1994, J RHEUMATOL, V21, P1694 KABASAKAL Y, 1996, BRIT J RHEUMATOL, V35, P660 KHAN MA, 1981, J RHEUMATOL, V8, P86 KHAN MA, 1985, ARTHRITIS RHEUM, V28, P40 LAUTERMANN D, 2002, CLIN EXP RHEUMAT S28, V20, S11 LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174 MACKAY K, 1998, ARTHRITIS RHEUM, V41, P2263 MARZOORTEGA H, 2001, ARTHRITIS RHEUM, V44, P2112 MAU W, 1988, J RHEUMATOL, V15, P1109 MAUGARS Y, 1992, ARTHRITIS RHEUM, V35, P564 MAUGARS Y, 1996, BRIT J RHEUMATOL, V35, P767 MCGONAGLE D, 1998, ARTHRITIS RHEUM, V41, P694 MCGONAGLE D, 2002, ARTHRITIS RHEUM, V46, P489 MUCHE B, 2003, ARTHRITIS RHEUM, V48, P1374, DOI 10.1002/art.10934 NEKOLLA EA, 2000, RADIAT RES, V153, P93 OBERMAYERPIETSCH BM, 2003, OSTEOPOROSIS INT, V14, P995, DOI 10.1007/s00198-003-1501-5 OOSTVEEN J, 1999, J RHEUMATOL, V26, P1953 PEREIRA PL, 2000, AM J ROENTGENOL, V175, P265 SARAUX A, 1999, J RHEUMATOL, V26, P2622 SPOORENBERG A, 1999, J RHEUMATOL, V26, P997 SWEENEY S, 2001, J RHEUMATOL, V28, P1862 VANDERHEIJDE D, 1997, J RHEUMATOL, V24, P2225 VANDERHEIJDE DMF, 2003, ARTHRITIS RHEUM S, V48, S175 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDERLINDEN SM, 1984, ARTHRITIS RHEUM, V27, P241 WANDERS A, 2003, ARTHRITIS RHEUM S, V48, S233 WARD MM, 1999, ARTHRIT CARE RES, V12, P247 WEISS HA, 1995, RADIAT RES, V142, P1 WILL R, 1989, LANCET, V2, P1483 WILL R, 2000, J RHEUMATOL, V27, P177 YU W, 1998, SKELETAL RADIOL, V27, P311 ZINK A, 2000, J RHEUMATOL, V27, P613 ZINK A, 2001, ANN RHEUM DIS, V60, P199
NR	83
TC	0
PU	SPRINGER-VERLAG
PI	NEW YORK
PA	175 FIFTH AVE, NEW YORK, NY 10010 USA
SN	0033-832X
J9	RADIOLOGE
JI	Radiologe
PD	MAR
PY	2004
VL	44
IS	3
BP	209
EP	+
PG	7
SC	Radiology, Nuclear Medicine & Medical Imaging
GA	812LI
UT	ISI:000220840600001
ER

---

PT	J
AU	Barkham, N Marzo-Ortega, H McGonagle, D Emery, P
TI	How to diagnose axial spondyloarthropathy early
SO	ANNALS OF THE RHEUMATIC DISEASES
LA	English
DT	Article
ID	ANKYLOSING-SPONDYLITIS
C1	Univ Leeds, Gen Infirm, Acad Unit Musculoskeletal Dis, Leeds LS1 3EX, W Yorkshire, England.
RP	Emery, P, Univ Leeds, Gen Infirm, Acad Unit Musculoskeletal Dis, 1st Floor,Great George St, Leeds LS1 3EX, W Yorkshire, England.
EM	p.emery@leeds.ac.uk
CR	BARKHAM N, 2003, ACR ABSTR BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 2003, ARTHRITIS RHEUM, V48, P1126, DOI 10.1002/art.10883 CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613 CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186 GRAN JT, 1997, BRIT J RHEUMATOL, V36, P766 KHAN MA, 1981, J RHEUMATOL, V8, P86 LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174 MAKSYMOWYCH WP, 2002, ARTHRITIS RHEUM, V46, P766 MARZOORTEGA H, 2001, ARTHRITIS RHEUM, V44, P2112 MARZOORTEGA H, 2002, ARTHRITIS RHEUM S, V46, S428 MARZOORTEGA H, 2002, J RHEUMATOL, V29, P1583 OOSTVEEN J, 1999, J RHEUMATOL, V26, P1953 QUINN M, 2002, ARTHRITIS RHEUM S, P3416 RUDWALEIT M, 2004, ANN RHEUM DIS, V63, P535, DOI 10.1136/ard.2003.011247 SIEPER J, 2002, ANN RHEUM DIS S3, V61, P1 SPOORENBERG A, 1999, J RHEUMATOL, V26, P980
NR	17
TC	2
PU	B M J PUBLISHING GROUP
PI	LONDON
PA	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN	0003-4967
J9	ANN RHEUM DIS
JI	Ann. Rheum. Dis.
PD	MAY 1
PY	2004
VL	63
IS	5
BP	471
EP	472
PG	2
SC	Rheumatology
GA	812AY
UT	ISI:000220813600001
ER

---

PT	J
AU	Rudwaleit, M van der Heijde, D Khan, MA Braun, J Sieper, J
TI	How to diagnose axial spondyloarthritis early
SO	ANNALS OF THE RHEUMATIC DISEASES
LA	English
DT	Article
ID	SPONDYLARTHROPATHY-STUDY-GROUP; INFLAMMATORY BACK-PAIN; PRELIMINARY CLASSIFICATION CRITERIA; NECROSIS-FACTOR-ALPHA; C-REACTIVE PROTEIN; 10-YEAR FOLLOW-UP; NEW-YORK CRITERIA; ANKYLOSING-SPONDYLITIS; CLINICAL HISTORY; SCREENING-TEST
AB	Background: Chronic low back pain (LBP), the leading symptom of ankylosing spondylitis (AS) and undifferentiated axial spondyloarthritis (SpA), precedes the development of radiographic sacroiliitis, sometimes by many years. Objective: To assign disease probabilities and to develop an algorithm to help in the early diagnosis of axial SpA. Methods: Axial SpA comprises AS and undifferentiated SpA with predominant axial involvement. Clinical features include inflammatory back pain (IBP), alternating buttock pain, enthesitis, arthritis, dactylitis, acute anterior uveitis, a positive family history, psoriasis, inflammatory bowel disease, and good response to NSAIDs. Associated laboratory findings include raised acute phase reactions, HLA-B27 association, and abnormalities on skeletal imaging. Sensitivities, specificities, and likelihood ratios (LRs) of these parameters were determined from published studies. A 5% prevalence of axial SpA among patients with chronic LBP was used. The probability of the presence of axial SpA, depending on the presence or absence of the above clinical features of SpA, was determined. A probability of greater than or equal to 90% was used to make a diagnosis of axial SpA. Results: The presence of inflammatory back pain features increased the probability of axial SpA from the background 5% prevalence to 14%. The presence of 2 - 3 SpA features was necessary to increase the probability of axial SpA to 90%. The highest LRs were obtained for HLA-B27 and MRI. Diagnostic algorithms to be used in daily practice were suggested. Conclusions: This approach can help clinicians to diagnose with a high degree of confidence axial SpA at an early stage in patients with IBP who lack radiographic sacroiliitis.
C1	Med Klin 1, Dept Med 1, D-12200 Berlin, Germany. Maastricht Univ, Res Inst Caphri, Maastricht, Netherlands. Case Western Reserve Univ, Metrohlth Med Ctr, Cleveland, OH USA. Rheumazentrum Ruhrgebiet, Herne, Germany.
RP	Rudwaleit, M, Med Klin 1, Dept Med 1, Charite Campus Benjamin Franklin,Hindenburgdamm 3, D-12200 Berlin, Germany.
EM	martin.rudwaleit@charite.de
CR	AMOR B, 1990, REV RHUM MAL OSTEO, V57, P85 AMOR B, 1991, ANN MED INTERNE, V142, P85 AMOR B, 1995, REV RHUM, V62, P10 AMOR B, 2000, JOINT BONE SPINE, V67, P502 BADDOURA R, 1997, REV RHUM, V64, P459 BARON M, 1989, J RHEUMATOL, V16, P631 BLUM U, 1996, J RHEUMATOL, V23, P2107 BOLLOW M, 1995, RADIOLOGY, V194, P529 BOYER GS, 1993, ARTHRITIS RHEUM, V36, P534 BRANDT J, 1999, RHEUMATOLOGY, V38, P831 BRAUN J, 1994, ARTHRITIS RHEUM, V37, P1039 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 2002, ANN RHEUM DIS S3, V61, P51 BRAUN J, 2002, LANCET, V359, P1187 BREWERTON DA, 1973, LANCET, V1, P904 BROPHY S, 2001, J RHEUMATOL, V28, P2283 CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613 CALIN A, 1980, SPINE, V5, P201 COLLANTES E, 2000, JOINT BONE SPINE, V67, P516 COLLANTESESTEVEZ E, 1995, J RHEUMATOL, V22, P246 CURY SE, 1997, CLIN EXP RHEUMATOL, V15, P79 DEYO RA, 2001, NEW ENGL J MED, V344, P363 DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218 DOUGADOS M, 1995, BRIT J RHEUMATOL, V34, P301 DOUGADOS M, 1999, J RHEUMATOL, V26, P971 FELDTKELLER E, 2003, RHEUMATOL INT, V23, P61, DOI 10.1007/s00296-002-0237-4 FRIES JF, 1994, ARTHRITIS RHEUM, V37, P454 GOEITHE HS, 1985, BRIT J RHEUMATOL, V24, P242 GORMAN JD, 2002, NEW ENGL J MED, V346, P1349 GRAN JT, 1985, ANN RHEUM DIS, V44, P359 GRAN JT, 1985, CLIN RHEUMATOL, V4, P161 GRAN JT, 1995, J MED GENET, V32, P497 GRAN JT, 2000, CLIN RHEUMATOL, V19, P450 GRINER PF, 1981, ANN INTERN MED 2, V94, P553 HANLY JG, 1994, J RHEUMATOL, V21, P2088 HAWKINS BR, 1981, ARTHRITIS RHEUM, V24, P743 HUKUDA S, 2001, J RHEUMATOL, V28, P554 HUNDER GG, 1998, ANN INTERN MED, V129, P417 KHAN MA, 1980, ARCH INTERN MED, V140, P177 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 2000, J RHEUMATOL, V27, P1110 KHAN MA, 2002, ANN INTERN MED, V136, P896 KHAN MA, 2002, ANN RHEUM DIS S3, V61, P3 MAU W, 1988, J RHEUMATOL, V15, P1109 MAU W, 1990, Z RHEUMATOL, V49, P82 MIRON SD, 1983, CLIN RHEUMATOL, V2, P407 PAUKER SG, 1987, NEW ENGL J MED, V316, P250 PUHAKKA KB, 2003, ACTA RADIOL, V44, P218 RUDWALEIT M, 2002, ANN RHEUM DIS S1, V61, P57 SACKETT DL, 1991, CLIN EPIDEMIOLOGY BA, P69 SADOWSKAWROBLEW.M, 1983, CLIN RHEUMATOL, V2, P37 SARAUX A, 1999, J RHEUMATOL, V26, P2622 SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704 SIEPER J, 2002, ARTHRITIS RHEUM, V46, P319 SPOORENBERG A, 1999, J RHEUMATOL, V26, P980 THE HSG, 1985, SKELETAL RADIOL, V14, P243 UNDERWOOD MR, 1995, BRIT J RHEUMATOL, V34, P1074 VANDENBOSCH F, 2002, ARTHRITIS RHEUM, V46, P755 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDERLINDEN SM, 1988, SCAND J RHEUMATOL, V17, P475
NR	60
TC	62
PU	B M J PUBLISHING GROUP
PI	LONDON
PA	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN	0003-4967
J9	ANN RHEUM DIS
JI	Ann. Rheum. Dis.
PD	MAY 1
PY	2004
VL	63
IS	5
BP	535
EP	543
PG	9
SC	Rheumatology
GA	812AY
UT	ISI:000220813600012
ER

---

PT	J
AU	Kiratiseavee, S Brent, LH
TI	Spondyloarthropathies: Using presentation to make the diagnosis
SO	CLEVELAND CLINIC JOURNAL OF MEDICINE
LA	English
DT	Review
ID	INFLAMMATORY-BOWEL-DISEASE; ANKYLOSING-SPONDYLITIS; PSORIATIC-ARTHRITIS; REITERS-SYNDROME; UNDIFFERENTIATED SPONDYLOARTHROPATHIES; REACTIVE ARTHRITIS; CLINICAL-FEATURES; TRANSGENIC RATS; SULFASALAZINE; METHOTREXATE
AB	Diagnosing the spondyloarthropathies-chronic inflammatory diseases of the spine and peripheral joints that share several distinctive features-is challenging and depends on careful evaluation of the history, physical examination, and radiographs. The recent use of tumor necrosis factor inhibitors is exciting and may represent true disease-modifying drugs for these conditions.
C1	Einstein Arthrit Ctr, Dept Med, Philadelphia, PA 19141 USA.
RP	Brent, LH, Einstein Arthrit Ctr, Dept Med, 5501 Old York Rd,Korman 103, Philadelphia, PA 19141 USA.
EM	brentlh@hotmail.com
CR	AMOR B, 1998, RHEUM DIS CLIN N AM, V24, P677 BIASI D, 2000, CLIN RHEUMATOL, V19, P114 BOYER GS, 1990, J RHEUMATOL, V17, P489 BRANDT J, 2000, ARTHRITIS RHEUM, V43, P1346 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 CALIN A, 1986, MED CLIN N AM, V70, P323 CLEGG DO, 1996, ARTHRITIS RHEUM, V39, P2004 CLEGG DO, 1996, ARTHRITIS RHEUM, V39, P2021 CLEGG DO, 1999, ARTHRITIS RHEUM, V42, P2325 COLLANTESESTEVEZ E, 1995, J RHEUMATOL, V22, P246 CUCHACOVICH R, 2002, J RHEUMATOL, V29, P1426 CUELLAR ML, 1997, RHEUM DIS CLIN N AM, V23, P797 DEER T, 1991, SOUTH MED J, V84, P799 DEKEYSER F, 1998, RHEUM DIS CLIN N AM, V24, P785 DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218 DOUGADOS M, 1992, ANN RHEUM DIS, V51, P955 DOUGADOS M, 1995, ARTHRITIS RHEUM GLADMAN DD, 1998, J RHEUMATOL, V25, P730 GLADMAN DD, 2001, KELLYS TXB RHEUMATOL, P1071 HAMMER RE, 1990, CELL, V63, P1099 JONES SM, 1994, BRIT J RHEUMATOL, V33, P834 KHAN MA, 1982, ANN INTERN MED, V96, P70 MARSAL S, 1999, RHEUMATOLOGY, V38, P332 MARSHALL RW, 2001, SCAND J RHEUMATOL, V30, P313 MEASE PJ, 2000, LANCET, V356, P385 OLIVIERI I, 2001, CURR OPIN RHEUMATOL, V13, P280 ORCHARD TR, 1998, GUT, V42, P387 QUEIRO R, 2002, SEMIN ARTHRITIS RHEU, V31, P264 REITER H, 1916, DEUT MED WOCHENSCH 2, V42, P1535 REZAIAN MM, 2000, ANN RHEUM DIS S1, V59, P199 REZAIAN MM, 2001, ARTHRITIS RHEUM S, V44, P593 SAMPAIOBARROS PD, 2000, SCAND J RHEUMATOL, V29, P160 SIEPER J, 1995, ARTHRITIS RHEUM, V38, P1547 SMALE S, 2001, ARTHRITIS RHEUM, V44, P2728 TAUROG JD, 1994, J EXP MED, V180, P2359 THOMSON GTD, 2000, J RHEUMATOL, V27, P714 TORREALONSO JC, 1991, BR J RHEUMATOL, V30, P245 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDERLINDEN S, 2001, KELLEYS TXB RHEUMATO, P1039 WILKINS RF, 1981, ARTHRITIS RHEUM, V24, P844 WOLLHEIM FA, 2001, KELLEYS TXB RHEUMATO, P1081 ZEIDLER H, 1987, SCAND J RHEUMATOL S, V65, P54 ZEIDLER H, 1992, RHEUM DIS CLIN N AM, V18, P187
NR	43
TC	0
PU	CLEVELAND CLINIC
PI	CLEVELAND
PA	9500 EUCLID AVE, CLEVELAND, OH 44106 USA
SN	0891-1150
J9	CLEVELAND CLIN J MED
JI	Clevel. Clin. J. Med.
PD	MAR
PY	2004
VL	71
IS	3
BP	184
EP	+
PG	20
SC	Medicine, General & Internal
GA	802GH
UT	ISI:000220151500003
ER

---

PT	J
AU	Sheehan, NJ
TI	The ramifications of HLA-B27
SO	JOURNAL OF THE ROYAL SOCIETY OF MEDICINE
LA	English
DT	Review
ID	ACUTE ANTERIOR UVEITIS; ANKYLOSING-SPONDYLITIS; REACTIVE ARTHRITIS; CHLAMYDIA-TRACHOMATIS; ASBESTOS WORKERS; PSORIATIC-ARTHRITIS; SUSCEPTIBILITY LOCI; PULMONARY FIBROSIS; REITERS DISEASE; SYNOVIAL-FLUID
C1	Edith Cavell Hosp, Dept Rheumatol, Peterborough PE3 9GZ, England.
RP	Sheehan, NJ, Edith Cavell Hosp, Dept Rheumatol, Bretton Gate, Peterborough PE3 9GZ, England.
EM	njsheehan@doctors.org.uk
CR	AMOR B, 1990, REV RHUM MAL OSTEO, V57, P85 AU WY, 2001, BRIT J HAEMATOL, V115, P320 BAS S, 2003, RHEUMATOLOGY, V42, P461, DOI 10.1093/rheumatology/keg163 BERGFELDT L, 1997, ANN INTERN MED 1, V127, P621 BOWNESS P, 2000, HLA HLTH DIS, P187 BOWNESS P, 2002, RHEUMATOLOGY, V41, P857 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BREWERTON DA, 1973, LANCET, V1, P904 BROPHY S, 2001, RHEUMATOLOGY S1, V40, A48 BROWN MA, 1997, ARTHRITIS RHEUM, V40, P1823 BROWN MA, 1998, ARTHRITIS RHEUM, V41, P588 CAULI A, 2002, RHEUMATOLOGY, V41, P1375 EBRINGER RW, 1978, ANN RHEUM DIS, V37, P146 EVANS CC, 1977, BRIT MED J, V1, P603 FELDMAN M, 1986, AM J MED SCI, V291, P56 FRIEDMANN A, 2000, HLA HLTH DIS, P365 GOULDER PJR, 1997, NAT MED, V3, P212 HAMMER RE, 1990, CELL, V63, P1099 HILLERDAL G, 1983, LANCET, V2, P1195 HORSLEVPETERSEN K, 1984, LANCET, V1, P104 HOYLE E, 2000, ARTHRITIS RHEUM, V43, P1353 HUUSKONEN MS, 1979, BR J DIS CHEST, V73, P253 JARAQUEMADA D, 1986, ANN RHEUM DIS, V45, P627 KEAT A, 1987, LANCET, V1, P72 KEAT AC, 1978, BRIT MED J, V1, P605 KHAN A, 1998, SPONDYLOARTHRITIDES, P17 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 2002, BEST PRACT RES CL RH, V16, P675, DOI 10.1053/BERH.2002.0243 LAHESMAARANTALA R, 1987, ANN RHEUM DIS, V46, P510 LAU CS, 1998, RHEUM DIS CLIN N AM, V24, P753 LAVAL SH, 2000, RHEUMATOLOGY S, V39, A115 LAVAL SH, 2001, AM J HUM GENET, V68, P918 LEIRISALO M, 1982, ARTHRITIS RHEUM, V25, P249 LEIRISALOREPO M, 1997, ANN RHEUM DIS, V56, P516 LINSSEN A, 1991, INVEST OPHTH VIS SCI, V32, P2568 MERCHANT JA, 1975, BRIT MED J, V1, P189 MOLL JMH, 1974, MEDICINE, V53, P343 MORRIS AS, 1995, ARTHRITIS RHEUM, V38, P251 NJOBVU P, 1998, J RHEUMATOL, V25, P1553 OLIVIERI I, 1987, ANN RHEUM DIS, V46, P626 OLLIER W, 1994, ARTHRITIS RHEUM S, V37, A1017 PULIDO JS, 2000, HLA HLTH DIS, P279 QUEIRO R, 2001, RHEUMATOLOGY S1, V40, A128 RAHMAN P, 1999, ARTHRITIS RHEUM, V42, P822 ROSENBAUM JT, 1992, RHEUM DIS CLIN N AM, V18, P143 SAARINEN M, 2002, RHEUMATOLOGY, V41, P651 SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704 VANDERLINDEN SM, 1984, ARTHRITIS RHEUM, V27, P241 WILLIAMSON L, 2002, RHEUMATOLOGY S1, V41, A315 YAZICI H, 1998, OXFORD TXB RHEUMATOL, P1394
NR	50
TC	4
PU	ROYAL SOC MEDICINE PRESS LTD
PI	LONDON
PA	1 WIMPOLE STREET, LONDON W1G 0AE, ENGLAND
SN	0141-0768
J9	J ROY SOC MED
JI	J. R. Soc. Med.
PD	JAN
PY	2004
VL	97
IS	1
BP	10
EP	14
PG	5
SC	Medicine, General & Internal
GA	767DW
UT	ISI:000188425800004
ER

---

PT	J
AU	Harrison, MJ
TI	Young women with chronic disease: A female perspective on the impact and management of rheumatoid arthritis
SO	ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH
LA	English
DT	Article
ID	QUALITY-OF-LIFE; FUNCTIONAL DISABILITY; DEPRESSIVE SYMPTOMS; ORAL-CONTRACEPTIVES; CONTROLLED-TRIAL; DRUG-THERAPY; METHOTREXATE; PREVALENCE; PLACEBO; GENDER
C1	Cornell Univ, Div Rheumatol, Dept Med, Hosp Special Surg, New York, NY 10021 USA.
RP	Harrison, MJ, Cornell Univ, Div Rheumatol, Dept Med, Hosp Special Surg, 535 E 70th St, New York, NY 10021 USA.
CR	*AM AUT REL DIS AS, 2001, AUT DIS WOM FACTS *AV PHARM, 2002, AR PACK INS *IMM CORP, 1997, METH PACK INS *ROYAL COLL GEN PR, 1978, LANCET, V1, P569 ABRAIDOLANZA AF, 1997, AM J COMMUN PSYCHOL, V25, P601 AFFLECK G, 1999, PAIN, V83, P601 ALLAIRE SH, 1991, ARTHRITIS RHEUM, V34, P669 ANDERSON JJ, 2000, ARTHRITIS RHEUM, V43, P22 ANDERSON ST, 1996, SEMIN ARTHRITIS RHEU, V25, P291 ARCHENHOLTZ B, 1999, QUAL LIFE RES, V8, P411 BELGHOMARI H, 1999, J RHEUMATOL, V26, P2534 BERKANOVIC E, 1996, ARTHRIT CARE RES, V9, P457 BUCHI S, 1998, J RHEUMATOL, V25, P869 CARETTE S, 1989, J RHEUMATOL, V16, P911 CASH JM, 1994, NEW ENGL J MED, V330, P1368 DALTROY LH, 1999, SOC SCI MED, V48, P1549 DEIGHTON CM, 1992, ANN RHEUM DIS, V51, P473 DOWDY SW, 1996, ARTHRIT CARE RES, V9, P449 ESCALANTE A, 1999, ARTHRITIS RHEUM, V42, P1712 FIFIELD J, 1991, SOC SCI MED, V33, P579 FINCK B, 1999, ARTHRITIS RHEUM S, V42, P117 FOX RI, 1997, NOVEL THERAPEUTIC AG, P257 FUCHS HA, 1989, J RHEUMATOL, V16, P585 FYRAND L, 2000, SCAND J RHEUMATOL, V29, P37 GABRIEL SE, 1999, ARTHRITIS RHEUM, V42, P415 GOLDRING SR, 2000, JAMA-J AM MED ASSOC, V283, P524 GONZALEZESCRIBANO MF, 1999, HUM IMMUNOL, V60, P1259 GOODENOW C, 1990, HEALTH PSYCHOL, V9, P266 GROSSMAN JM, 1997, J WOMENS HEALTH, V6, P627 HARRIS ED, 1990, NEW ENGL J MED, V322, P1277 HAZES JMW, 1990, ARTHRITIS RHEUM, V33, P1770 HEIMER H, 1999, ENVIRON HEALTH PERSP, V107, A504 HERNANDEZAVILA M, 1990, ARTHRITIS RHEUM, V33, P947 HOCHBERG MC, 1999, SCAND J RHEUMATOL S, V112, P3 HUYSER BA, 1999, RHEUM DIS CLIN N AM, V25, P105 JORDAN MS, 1998, ARTHRIT CARE RES, V11, P80 KAIPIAINENSEPPANEN O, 1996, CLIN EXP RHEUMATOL, V14, P537 KATZ PP, 1993, J RHEUMATOL, V20, P790 KATZ PP, 1996, ARTHRIT CARE RES, V9, P441 KHAN MA, 1988, TISSUE ANTIGENS, V31, P254 KOUMANTAKI Y, 1997, J RHEUMATOL, V24, P1522 KVIEN TK, 1997, SCAND J RHEUMATOL, V26, P412 KWOH CK, 1996, ARTHRITIS RHEUM, V39, P713 LAWRENCE RC, 1998, ARTHRITIS RHEUM, V41, P778 LINOS A, 1983, LANCET, V1, P1299 LIPSKY P, 1999, ARTHRITIS RHEUM S, V42, P401 LIPSKY P, 2000, ARTHRITIS RHEUM S, V43, S269 MACGREGOR AJ, 2000, ARTHRITIS RHEUM, V43, P30 MACLEAN CH, 2000, JAMA-J AM MED ASSOC, V284, P984 MAINI R, 1999, LANCET, V354, P1932 MATHIAS SD, 2000, CLIN THER, V22, P128 MATTEY DL, 1999, ARTHRITIS RHEUM, V42, P2698 MCQUEEN FM, 1999, ANN RHEUM DIS, V58, P156 MORELAND LW, 1999, ANN INTERN MED, V130, P478 NICHOL MB, 1999, PHARMACOECONOMICS 1, V16, P433 OSTENSEN M, 2000, J RHEUMATOL, V27, P1872 PETERFY C, 1999, ARTHRITIS RHEUM S, V42, S241 REISINE S, 1995, WOMEN HEALTH, V22, P25 REISINE ST, 1987, SOC SCI MED, V25, P89 SHARP JT, 2000, ARTHRITIS RHEUM, V43, P495 SIMMS RW, 1996, ARTHRITIS RHEUM, V39, P723 SIMONSSON M, 1999, SCAND J RHEUMATOL, V28, P340 SMOLEN JS, 1999, LANCET, V353, P259 SPECTOR TD, 1990, ARTHRITIS RHEUM, V33, P782 STAR VL, 1996, J RHEUMATOL, V23, P1862 STRAND V, 1999, ARTHRITIS RHEUM, V42, P1870 VANDENBROUCKE JP, 1982, LANCET, V2, P839 VANDENBROUCKE JP, 1986, JAMA-J AM MED ASSOC, V255, P1299 WEYAND CM, 1998, ARTHRITIS RHEUM, V41, P817 WOLFE F, 1991, J RHEUMATOL, V18, P1290 WOLFE F, 1991, J RHEUMATOL, V18, P1298 WOLFE F, 1997, J RHEUMATOL, V24, P990 YOUNG A, 2000, RHEUMATOLOGY, V39, P603 ZAPHIROPOULOS G, 1974, ANN RHEUM DIS, V33, P132
NR	74
TC	2
PU	WILEY-LISS
PI	NEW YORK
PA	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN	0004-3591
J9	ARTHRITIS RHEUM-ARTHR CARE RE
JI	Arthritis Rheum-Arthritis Care Res.
PD	DEC 15
PY	2003
VL	49
IS	6
BP	846
EP	852
PG	7
SC	Rheumatology
GA	753LK
UT	ISI:000187232700016
ER

---

PT	J
AU	Temekonidis, TI Alamanos, Y Nikas, SN Bougias, DV Georgiadis, AN Voulgari, PV Drosos, AA
TI	Infliximab therapy in patients with ankylosing spondylitis: an open label 12 month study
SO	ANNALS OF THE RHEUMATIC DISEASES
LA	English
DT	Article
ID	CHIMERIC MONOCLONAL-ANTIBODY; FACTOR-ALPHA INFLIXIMAB; SPONDYLOARTHROPATHY; SPONDYLARTHROPATHY; INFUSIONS; EFFICACY; INDEX
AB	Objective: To evaluate the efficacy and safety of long term infliximab therapy in patients with severe refractory ankylosing spondylitis (AS). Patients and methods: Twenty five patients (24 male, 1 female; mean (SD) age 36.0 (10.5); disease duration 13.8 (8.5) years) with AS fulfilling the modified New York criteria for AS were investigated. Twenty two (88%) patients were HLA-B27 positive. All patients had active axial disease (Bath Ankylosing Spondylitis Disease Activity Index (BASDAI) greater than or equal to30/100) and C reactive protein (CRP) greater than or equal to10 mg/l, despite adequate treatment. Intravenous infliximab (5 mg/kg) was given at weeks 0, 2, 6, and every eight weeks thereafter for 12 months. The primary end point was the reduction of the patient's global assessment of pain (GAP) by >20% on a 100 mm visual analogue scale. Results: GAP was reduced by >20% in 23 (92%) patients, by 50% in 21 (84%) patients, and by 70% in 13 (52%). The change in BASDAI and CRP from baseline was statistically significant. The treatment was well tolerated with minimal side effects. One patient dropped out owing to inefficacy and one stopped treatment owing to an allergic reaction. Conclusion: This longer length study confirms the efficacy of infliximab and the good safety profile in patients with AS.
C1	Univ Ioannina, Sch Med, Dept Internal Med, Div Rheumatol, GR-45110 Ioannina, Greece. Univ Ioannina, Sch Med, Dept Hyg & Epidemiol, GR-45110 Ioannina, Greece.
RP	Drosos, AA, Univ Ioannina, Sch Med, Dept Internal Med, Div Rheumatol, GR-45110 Ioannina, Greece.
CR	ANDERSON JJ, 2001, ARTHRITIS RHEUM, V44, P1876 BRANDT J, 2000, ARTHRITIS RHEUM, V43, P1346 BRAUN J, 2002, LANCET, V359, P1187 BREBAN M, 2002, RHEUMATOLOGY, V41, P1280 CALIN A, 1994, J RHEUMATOL, V21, P2281 DERYCKE L, 2003, ARTHRITIS RHEUM, V48, P1015, DOI 10.1002/art.10876 GARRETT S, 1994, J RHEUMATOL, V21, P2286 KHAN MA, 1981, J RHEUMATOL, V8, P86 KHAN MA, 2002, ANN INTERN MED, V136, P896 KRUITHOF E, 2002, ANN RHEUM DIS, V61, P207 LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174 MAKSYMOWYCH WP, 2002, J RHEUMATOL, V29, P959 SCALAPINO KJ, 2003, CLIN EXP MED, V2, P159 STONE M, 2001, J RHEUMATOL, V28, P1605 VANDENBOSCH F, 2000, ANN RHEUM DIS, V59, P428 VANDENBOSCH F, 2002, ARTHRITIS RHEUM, V46, P755 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361
NR	17
TC	32
PU	B M J PUBLISHING GROUP
PI	LONDON
PA	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN	0003-4967
J9	ANN RHEUM DIS
JI	Ann. Rheum. Dis.
PD	DEC 1
PY	2003
VL	62
IS	12
BP	1218
EP	1220
PG	3
SC	Rheumatology
GA	746KH
UT	ISI:000186745200018
ER

---

PT	J
AU	Boonen, A van Tubergen, A van der Linden, S
TI	Insurance problems among patients with ankylosing spondylitis
SO	ANNALS OF THE RHEUMATIC DISEASES
LA	English
DT	Article
ID	3 EUROPEAN COUNTRIES; COSTS; EPIDEMIOLOGY; DISABILITY; MINNESOTA; ROCHESTER
C1	Univ Hosp Maastricht, Dept Internal Med, Div Rheumatol, NL-6202 AZ Maastricht, Netherlands.
RP	Boonen, A, Univ Hosp Maastricht, Dept Internal Med, Div Rheumatol, POB 5800, NL-6202 AZ Maastricht, Netherlands.
CR	BOONEN A, 2002, ANN RHEUM DIS, V61, P429 BOONEN A, 2003, ANN RHEUM DIS, V62, P732 CARBONE LD, 1992, ARTHRITIS RHEUM, V35, P1476 CARTER ET, 1979, ARTHRITIS RHEUM, V22, P365 KHAN MA, 1981, J RHEUMATOL, V8, P86 LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174 WARD MM, 2001, J RHEUMATOL, V28, P315 WARD MM, 2002, ARTHRITIS RHEUM, V46, P223
NR	8
TC	0
PU	B M J PUBLISHING GROUP
PI	LONDON
PA	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN	0003-4967
J9	ANN RHEUM DIS
JI	Ann. Rheum. Dis.
PD	DEC 1
PY	2003
VL	62
IS	12
BP	1242
EP	1243
PG	2
SC	Rheumatology
GA	746KH
UT	ISI:000186745200027
ER

---

PT	J
AU	Dogru, O Duman, O Orhan, C
TI	Statistical approximation by generalized Meyer-Konig and Zeller type operators
SO	STUDIA SCIENTIARUM MATHEMATICARUM HUNGARICA
LA	English
DT	Article
DE	A-statistical convergence; positive linear operators; the Korovkin type theorem; the Meyer-Konig and Zeller operators; Peetre's K-functional
ID	STRONG CONVERSE INEQUALITY; BERNSTEIN POWER-SERIES; CONVERGENCE
AB	In the present paper, we study a Kantorovich type generalization of Agratini's operators. Using A-statistical convergence, we will give the approximation properties of Agratini's operators and their Kantorovich type generalizations. We also give the rates of A-statistical convergence of these operators.
C1	Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
RP	Dogru, O, Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
CR	AGRATINI O, 2001, MATH INEQUAL APPL, V4, P119 BLEIMANN G, 1980, INDAG MATH, V42, P255 CHEN W, 1993, J APPROX THEORY, V75, P25 CHEN W, 1994, CONSTR APPROX, V10, P95 CHENEY EW, 1964, CAN J MATH, V16, P241 DITZIAN Z, 1996, P AM MATH SOC, V124, P1773 DOGRU O, 1998, MATH BALKANICA, V12, P359 DOGRU O, 2001, GLASNIK MATH, V36, P311 DUMAN O, IN PRESS MATH INEQ A FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1991, ANALYSIS, V11, P59 FRIDY JA, 1997, P AM MATH SOC, V125, P3625 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 HARDY GH, 1949, DIVERGENT SERIES JIHUA X, 1991, PROGR APPROXIMATION, P899 KHAN MK, 1989, J APPROX THEORY, V57, P90 KOLK E, 1993, ANALYSIS, V13, P77 LUPAS A, 1970, AEQUATIONES MATH, V5, P19 MEYERKONIG W, 1960, STUD MATH, V19, P89 MILLER HI, 1995, T AM MATH SOC, V347, P1811 MULLER MW, 1978, STUD MATH, V63, P81 TOTIK V, 1983, MATH Z, V182, P425
NR	24
TC	3
PU	AKADEMIAI KIADO
PI	BUDAPEST
PA	PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN	0081-6906
J9	STUD SCI MATH HUNG
JI	Stud. Sci. Math. Hung.
PY	2003
VL	40
IS	3
BP	359
EP	371
PG	13
SC	Mathematics
GA	742BP
UT	ISI:000186495600009
ER

---

PT	J
AU	Duman, O Khan, MK Orhan, C
TI	A-statistical convergence of approximating operators
SO	MATHEMATICAL INEQUALITIES & APPLICATIONS
LA	English
DT	Article
DE	A-statistical convergence; sequence of positive linear operators; the Korovkin theorem
ID	SUMMABILITY
AB	In this paper we provide various approximation results concerning the classical Korovkin theorem via A -statistical convergence. We also study the rates of A -statistical convergence of approximating positive linear operators and give some examples.
C1	Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey. Kent State Univ, Dept Math Sci, Kent, OH 44242 USA.
RP	Duman, O, Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
CR	ALTOMARE F, 1994, KOROVKIN TYPE APPROX BOJANIC R, 1983, CANADIAN MATH SOC C, V3, P5 BOJANIC R, 1992, J NAT SCI MATH, V32, P5 CONNOR J, 1989, CAN MATH BULL, V32, P194 DEVORE RA, 1972, LECT NOTES MATH, V293 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, IN PRESS ACTA SCI MA FRIDY JA, 1978, CAN J MATH, V30, P808 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1991, ANALYSIS, V11, P59 GADJIEV AD, 2002, ROCKY MOUNTAIN J MAT, V32, P1 GADZIEV AD, 1974, SOV MATH DOKL, V15, P1433 HARDY GH, 1949, DIVERGENT SERIES KHAN MK, 1998, J APPROX THEORY, V92, P22 KOLK E, 1993, ANALYSIS, V13, P77 KOROVKIN PP, 1960, LINEAR OPERATORS APP KUTTNER B, 1944, J LOND MATH SOC, V19, P153 MAROUF M, 1989, THESIS KENT STATE U MILLER HI, 1983, RADOVI AKAD NAUKA UM, V74, P39 MILLER HI, 1995, T AM MATH SOC, V347, P1811 SZASZ O, 1950, ACTA SCIENTIARUM M B, V12, P107 SZASZ O, 1950, T AM MATH SOC, V69, P440
NR	23
TC	11
PU	ELEMENT
PI	ZAGREB
PA	R AUSTRIJE 11, 10000 ZAGREB, CROATIA
SN	1331-4343
J9	MATH INEQUAL APPL
JI	Math. Inequal. Appl.
PD	OCT
PY	2003
VL	6
IS	4
BP	689
EP	699
PG	11
SC	Mathematics
GA	736GN
UT	ISI:000186163200010
ER

---

PT	J
AU	Moricz, F
TI	Tauberian theorems for double sequences that are statistically summable (C, 1, 1)
SO	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
DE	double sequence; convergence in Pringsheim's sense; statistical convergence; statistical summability (C, 1, 1); one-sided and two-sided Tauberian conditions; slow decrease; condition of Landau type; slow oscillation; condition of Hardy type
AB	Let (x(jk): j, k = 0, 1, 2, . . .) be a double sequence of real or complex numbers, and set sigma(mn) := (m + 1)(-1)(n + 1)-1 Sigma(j=0)(m)Sigma(k=0)(n)x(jk) for m, n = 0, 1, 2, . . . We give necessary and sufficient conditions, under which st-lim sigma(mn) = xi implies st-lim x(jk) = xi, where xi is a finite number. These Tauberian conditions are one-sided when the x(jk) are real numbers, and they are two-sided when the x(jk) are complex numbers. In particular, these Tauberian conditions are clearly satisfied if (x(jk)) is statistically slowly decreasing in the case of real sequences or if (x(jk)) is statistically slowly oscillating in the case of complex sequences. (C) 2003 Elsevier Inc. All rights reserved.
C1	Univ Szeged, Bolyai Inst, H-6720 Szeged, Hungary.
RP	Moricz, F, Univ Szeged, Bolyai Inst, Aradi Vertanuk Tere 1, H-6720 Szeged, Hungary.
CR	CONNOR JS, 1988, ANALYSIS, V8, P47 FAST H, 1951, C MATH, V2, P241 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 2000, P AM MATH SOC, V128, P2347 HARDY GH, 1910, P LOND MATH SOC, V8, P310 LANDAU E, 1910, PRAC MAT FIZ, V21, P97 MORICZ F, 2002, J MATH ANAL APPL, V275, P277 MORICZ F, 2003, IN PRESS ARCH MATH B, V80 SCHMIDT R, 1925, MATH Z, V22, P89 SCHOENBERG IJ, 1959, AM MATH MONTHLY, V66, P361
NR	10
TC	1
PU	ACADEMIC PRESS INC ELSEVIER SCIENCE
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0022-247X
J9	J MATH ANAL APPL
JI	J. Math. Anal. Appl.
PD	OCT 1
PY	2003
VL	286
IS	1
BP	340
EP	350
PG	11
SC	Mathematics, Applied; Mathematics
GA	729MM
UT	ISI:000185777500028
ER

---

PT	S
AU	Wu, YJ Pan, G Wu, ZH
TI	Face authentication based on multiple profiles extracted from range data
SO	AUDIO-AND VIDEO-BASED BIOMETRIC PERSON AUTHENTICATION, PROCEEDINGS
SE	LECTURE NOTES IN COMPUTER SCIENCE
LA	English
DT	Article
ID	RECOGNITION
AB	In this paper we address face authentication based on profiles extracted from range data. Three kinds of profiles are defined, then extracted, and are combined to classify. For obtaining central profile, a novel robust symmetry plane detection method is proposed. A global profile matching approach based on the partial Hausdorff metric is presented to align and compare profiles, without detection of fiducial points that is often unreliable. To utilize more information in range data, we extract nose-crossing profile and forehead-crossing profile,more than only central profile. The experiments are carried out on a low-quality database with 180 pieces of range data of 30 individuals acquired by structured light system. Based on the experimental results, we observe that the presented scheme can cope with limited quality of facial range data.
C1	Zhejiang Univ, Dept Comp Sci & Engn, Hangzhou 310027, Peoples R China.
RP	Wu, YJ, Zhejiang Univ, Dept Comp Sci & Engn, Hangzhou 310027, Peoples R China.
CR	BEUMIER C, 2000, IMAGE VISION COMPUT, V18, P315 CARTOUX JY, 1989, WORKSH INT 3D SCEN N, P194 GAO YS, 2002, PATTERN RECOGN, V35, P353 GOFFE WL, 1994, J ECONOMETRICS, V60, P65 HARMON LD, 1981, PATTERN RECOGN, V13, P97 HARMON LD, 1997, COMPUT GRAPHICS IMAG, V6 HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850 MCKAY ND, 1992, METHOD REGISTRATION, V14, P239 RUSINKIEWICZ S, 2002, SIGGRAPH 2002 P, P438 WU CJ, 1990, PATTERN RECOGN, V23, P255 YU K, 1996, P IEEE INT C IM PROC, V3, P491
NR	11
TC	4
PU	SPRINGER-VERLAG BERLIN
PI	BERLIN
PA	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN	0302-9743
J9	LECT NOTE COMPUT SCI
PY	2003
VL	2688
BP	515
EP	522
PG	8
SC	Computer Science, Theory & Methods
GA	BX31Z
UT	ISI:000184940200061
ER

---

PT	J
AU	Demirci, K Khan, MK Orhan, C
TI	Subspaces of A-statistically convergent sequences
SO	STUDIA SCIENTIARUM MATHEMATICARUM HUNGARICA
LA	English
DT	Article
DE	statistically convergent sequence; FK-topology; multipliers
ID	SUMMABILITY; THEOREMS
AB	Let A be a nonnegative regular summability method. In this paper we deal with various subspaces of A-statistically convergent sequences by using the rate of convergence concept. We show, under certain conditions, that these subspaces cannot be endowed with a locally convex FK-topology. We also describe multipliers for bounded A-statistically convergent and bounded A-statistically null sequences with the appropriate rate and provide a Steinhaus type result.
C1	Kirikkale Univ, Fen Fak, Matemat Bolumu, TR-71450 Yahsihan, Kirikkale, Turkey. Kent State Univ, Dept Math Sci, Kent, OH 44242 USA. Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
RP	Demirci, K, Kirikkale Univ, Fen Fak, Matemat Bolumu, TR-71450 Yahsihan, Kirikkale, Turkey.
CR	BENNETT G, 1973, PAC J MATH, V46, P17 BENNETT G, 1996, MAM AM MATH SOC, V120 BOOS J, 2000, OXFORD MATH MONOGRAP CONNOR J, 1989, CAN MATH BULL, V32, P194 CONNOR J, 1996, J MATH ANAL APPL, V197, P392 CONNOR J, 2002, ANALYSIS, V22, P321 DEMIRCI K, 1999, J MATH ANAL APPL, V235, P122 DUMAN O, UNPUB A STAT CONVERG FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1991, ANALYSIS, V11, P59 FRIDY JA, 1997, P AM MATH SOC, V125, P3625 FRIDY JA, 1998, J MATH ANAL APPL, V228, P73 GROSSEERDMANN KG, 1998, LECT NOTES MATH, V1679 HARDY GH, 1949, DIVERGENT SERIES KLINE J, 1995, INT J MATH MATH SCI, V18, P825 KOLK E, 1993, ANALYSIS, V13, P77 LORENTZ GG, 1948, ACTA MATH, V80, P167 LORENTZ GG, 1949, CAN J MATH, V1, P305 MADDOX IJ, 1974, P AM MATH SOC, V45, P209 MILLER HI, 1995, T AM MATH SOC, V347, P1811 MILLER HI, 2001, ACTA MATH HUNG, V93, P135 SALAT T, 1980, MATH SLOVACA, V30, P139 WILANSKY A, 1984, N HOLLAND MATH STUDI, V85
NR	25
TC	0
PU	AKADEMIAI KIADO
PI	BUDAPEST
PA	PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN	0081-6906
J9	STUD SCI MATH HUNG
JI	Stud. Sci. Math. Hung.
PY	2003
VL	40
IS	1-2
BP	183
EP	190
PG	8
SC	Mathematics
GA	708RE
UT	ISI:000184581800015
ER

---

PT	J
AU	Pych-Taberska, P
TI	Some properties of the Bezier-Kantorovich type operators
SO	JOURNAL OF APPROXIMATION THEORY
LA	English
DT	Article
DE	discrete Feller operator; Kantorovich and Bezier type operator; rate of pointwise convergence; modulus of variation; pth power variation
ID	BOUNDED VARIATION FUNCTIONS; CONVERGENCE
AB	The aim of this paper is to present estimates for the rate of pointwise convergence of the Bezier-Kantorovich modification of the discrete Feller operators in some classes of measurable functions bounded on an interval I, in particular, for functions of bounded pth power variation on I. Our theorems generalize and extend the recent results of Zeng and Piriou (J. Approx. Theory 95(1998) 369; 104(2000) 330) for the kantorovichians of the Bernstein-Bezier operators in the class of functions of bounded variation in the Jordan sense on [0, 1]. (C) 2003 Elsevier Inc. All rights reserved.
C1	Adam Mickiewicz Univ Poznan, Fac Math & Comp Sci, PL-61614 Poznan, Poland.
RP	Pych-Taberska, P, Adam Mickiewicz Univ Poznan, Fac Math & Comp Sci, Umultowska 87, PL-61614 Poznan, Poland.
CR	CHANTURIYA ZA, 1974, DOKL AKAD NAUK SSSR, V214, P63 FELLER W, 1966, INTRO PROBABILITY TH, V2 GUO SS, 1989, J APPROX THEORY, V58, P90 HEILMANN M, 1989, APPROX THEORY APPL, V5, P105 LAGRANGE MR, 1965, ANN SCI ECOLE NORM S, V3, P101 PYCHTABERSKA P, 1991, ANN SOC MATH POLON 1, V31, P147 PYCHTABERSKA P, 2000, FUNCT APPROX COMMENT, V28, P201 ZENG XM, 1998, J APPROX THEORY, V95, P369 ZENG XM, 2000, J APPROX THEORY, V104, P330
NR	9
TC	4
PU	ACADEMIC PRESS INC ELSEVIER SCIENCE
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0021-9045
J9	J APPROX THEOR
JI	J. Approx. Theory
PD	AUG
PY	2003
VL	123
IS	2
BP	256
EP	269
PG	14
SC	Mathematics
GA	705CQ
UT	ISI:000184378800007
ER

---

PT	J
AU	Fridy, JA Khan, MK
TI	Statistical gap Tauberian theorems in metric spaces
SO	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
DE	central limit theorem; circle methods; convolution methods; random walk methods; Hausdorff methods; statistical convergence
ID	INTEGRALS
AB	By using the concept of statistical convergence we present statistical Tauberian theorems of gap type for the Cesaro, Euler-Borel family and the Hausdorff families applicable in arbitrary metric spaces. In contrast to the classical gap Tauberian theorems, we show that such theorems exist in the statistical sense for the convolution methods which include the Taylor and the Borel matrix methods. We further provide statistical analogs of the gap Tauberian theorems for the Hausdorff methods and provide an explanation as to how the Tauberian rates over the gaps may differ from those of the classical Tauberian theorems. (C) 2003 Elsevier Inc. All rights reserved.
C1	Kent State Univ, Dept Math Sci, Kent, OH 44242 USA.
RP	Khan, MK, Kent State Univ, Dept Math Sci, Kent, OH 44242 USA.
CR	BINGHAM NH, 1981, ANN PROBAB, V9, P221 BINGHAM NH, 1984, J LOND MATH SOC, V30, P281 BINGHAM NH, 1988, MATHEMATIKA, V35, P216 BOOS J, 2000, CLASSICAL MODERN MET ERDOS P, 1956, ACTA MATH ACAD SCI H, V7, P265 FAST H, 1951, C MATH, V2, P241 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1991, ANALYSIS, V11, P59 FRIDY JA, 1998, ANALYSIS, V18, P145 FRIDY JA, 1998, J MATH ANAL APPL, V228, P73 FRIDY JA, 2000, P AM MATH SOC, V128, P2347 GAIER D, 1965, MATH Z, V88, P410 GAIER D, 1966, SIAM J NUMER ANAL, V31, P248 HARDY GH, 1910, P LOND MATH SOC, V8, P310 HARDY GH, 1910, REND CIRC MAT PALERM, V41, P36 HARDY GH, 1914, P LOND MATH SOC, V13, P174 HARDY GH, 1926, P LOND MATH SOC, V25, P219 HARDY GH, 1949, DIVERGENT SERIES IMGHAM AE, 1969, NUMBER THEORY ANAL, P121 JAKIMOVSKI A, 1959, MICH MATH J, V6, P277 KARAMATA J, 1935, MATH CLUJ, V9, P164 KNOPP K, 1923, MATH Z, V18, P125 LANDAU E, 1910, PRAC MAT FIZ, V21, P97 LANDAU E, 1986, DARSTELLUNG BEGRUNDU LEVINSON N, 1940, AM MATH SOC C PUBL LITTLEWOOD JE, 1910, P LOND MATH SOC, V9, P434 LORENTZ GG, 1949, CAN J MATH, V1, P305 LORENTZ GG, 1951, CAN J MATH, V3, P236 MEYERKONIG W, 1956, MATH Z, V66, P203 MEYERKONIG W, 1958, C THEORIE SUITES, P32 MEYERKONIG W, 1960, P AM MATH SOC, V11, P307 PETERSON GE, 1972, J LOND MATH SOC, V4, P493 PETERSON GE, 1972, J LOND MATH SOC, V5, P182 POWELL RE, 1972, SUMMABILITY THEORY A SCHMAAL A, 1976, THEOREM MATH Z, V150, P75 SCHMIDT R, 1925, MATH Z, V22, P89 SONNENSCHEIN J, 1949, B ACAD ROY BELGIQUE, V35, P594 TURAN P, 1984, NEW METHOD ANAL ITS ZYGMUND A, 1959, TRIGONOMETRIE SERIES
NR	39
TC	0
PU	ACADEMIC PRESS INC ELSEVIER SCIENCE
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0022-247X
J9	J MATH ANAL APPL
JI	J. Math. Anal. Appl.
PD	JUN 15
PY	2003
VL	282
IS	2
BP	744
EP	755
PG	12
SC	Mathematics, Applied; Mathematics
GA	701YQ
UT	ISI:000184196900023
ER

---

PT	J
AU	Toussirot, E Wendling, D
TI	Recent progress in ankylosing spondylitis treatment
SO	EXPERT OPINION ON PHARMACOTHERAPY
LA	English
DT	Review
DE	ankylosing spondylitis; anti-TNF-alpha; pamidronate; treatment
ID	NECROSIS-FACTOR-ALPHA; NONSTEROIDAL ANTIINFLAMMATORY DRUG; CHIMERIC MONOCLONAL-ANTIBODY; RHEUMATOID-ARTHRITIS; DOUBLE-BLIND; DISEASE-ACTIVITY; TNF-ALPHA; SERONEGATIVE SPONDYLARTHROPATHIES; INFLIXIMAB; EFFICACY
AB	Ankylosing spondylitis (AS) is a systemic inflammatory rheumatic disease responsible for back pain, stiffness and loss of functional capacity. The therapeutic management of AS includes regular physical exercise together with the use of NSAIDs. Second-line treatments, such as sulfasalazine, are required in cases of NSAID-refractory AS. Some patients have severe and inadequately controlled disease, explaining the need for the development of new treatments. This therapeutic development in AS involves the assessment of new NSAIDs, namely COX-2 selective agents and new second-line treatments, such as methotrexate (MTX), pamidronate and anti-TNF-alpha agents. Controlled studies are lacking for MTX Pamidronate showed to be effective in NSAID refractory AS patients in open and controlled trials. Anti-TNF-alpha agents (infliximab and etanercept) gave promising results with dramatic improvement of AS symptoms in open and preliminary controlled trials, but further studies are required to evaluate the real long-term effects and tolerability of these drugs.
C1	Univ Besancon, Hop Jean Minjoz, Dept Rheumatol, F-25030 Besancon, France.
RP	Toussirot, E, Univ Besancon, Hop Jean Minjoz, Dept Rheumatol, Bd Fleming, F-25030 Besancon, France.
CR	1999, DRUGS RES DEV, V1, P258 ALLEN RL, 1999, J IMMUNOL, V162, P5045 ALTAN L, 2001, SCAND J RHEUMATOL, V30, P255 AMOR B, 1994, J RHEUMATOL, V21, P1883 ANDERSON JJ, 2001, ARTHRITIS RHEUM, V44, P1876 BAETEN D, 2000, ANN RHEUM DIS, V59, P945 BAETEN D, 2001, ANN RHEUM DIS, V60, P750 BAETEN D, 2001, ARTHRITIS RHEUM, V44, P186 BALL EJ, 2001, JOINT BONE SPINE, V68, P378 BIASI D, 2000, CLIN RHEUMATOL, V19, P114 BOONEN A, 2001, ANN RHEUM DIS, V60, P353 BOSIFERRAZ M, 1990, J RHEUMATOL, V17, P1782 BRANDT J, 2000, ARTHRITIS RHEUM, V43, P1346 BRANDT J, 2002, ANN RHEUM DIS S1, V61, P292 BRAUN J, 1994, ARTHRITIS RHEUM, V37, P1039 BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 2001, CURR OPIN RHEUMATOL, V13, P245 BRAUN J, 2002, LANCET, V359, P1187 BREBAN M, 1999, ARTHRITIS RHEUM, V42, P580 BROWN MA, 1997, ARTHRITIS RHEUM, V40, P1823 CALIN A, 1988, J RHEUMATOL, V15, P1234 CALIN A, 1990, J RHEUMATOL, V17, P801 CALIN A, 1994, J RHEUMATOL, V21, P2281 CALIN A, 1998, SPONDYLARTHRITIDES, P1 CLEGG DO, 1999, ARTHRITIS RHEUM, V42, P2325 CREEMERS MCW, 1994, SEMIN ARTHRITIS RHEU, V24, P71 CREEMERS MCW, 1995, J RHEUMATOL, V22, P1104 DAGOSTINO MA, 2002, ARTHRITIS RHEUM, V46, P840 DOUGADOS M, 1995, ARTHRITIS RHEUM, V38, P618 DOUGADOS M, 1999, RHEUMATOLOGY, V38, P235 DOUGADOS M, 2001, ARTHRITIS RHEUM, V44, P180 DUNN CJ, 1993, J PHARMACOL EXP THER, V266, P1691 GARRETT S, 1994, J RHEUMATOL, V21, P2286 GORMAN JD, 2002, NEW ENGL J MED, V346, P1349 GRAN JT, 1992, DRUGS, V44, P585 GRAN JT, 1997, BRIT J RHEUMATOL, V36, P766 GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927 HUANG F, 2002, ARTHRIT RHEUM-ARTHR, V47, P249 KHAN MA, 1981, J RHEUMATOL, V8, P86 KRUITHOF E, 2002, ANN RHEUM DIS, V61, P207 KRUITHOF E, 2002, ANN RHEUM DIS, V61, P470 LALOUX L, 2001, ANN RHEUM DIS, V60, P316 LAURENT R, 1990, BAILLIERE CLIN RHEUM, V4, P387 LITTLE H, 1988, J RHEUMATOL, V15, P1179 MAKSYMOWYCH WP, 1998, J RHEUMATOL, V25, P714 MAKSYMOWYCH WP, 2001, J RHEUMATOL, V28, P144 MAKSYMOWYCH WP, 2002, ARTHRITIS RHEUM, V46, P766 MAKSYMOWYCH WP, 2002, J RHEUMATOL, V29, P959 MARKHAM A, 2000, DRUGS, V59, P1341 MARZOORTEGA H, 2001, ARTHRITIS RHEUM, V44, P2112 MAUGARS Y, 1996, BRIT J RHEUMATOL, V35, P767 MEASE PJ, 2000, LANCET, V356, P385 MIELANTS H, 1985, J RHEUMATOL, V12, P287 ROUSSOU E, 1997, J RHEUMATOL, V24, P908 SAMPAIOBARROS PD, 2000, SCAND J RHEUMATOL, V29, P160 SANDBORN WJ, 1999, INFLAMM BOWEL DIS, V5, P119 SARAUX A, 1999, J RHEUMATOL, V26, P2622 SIEPER J, 2001, ANN RHEUM DIS S3, V60, P58 STONE M, 2001, J RHEUMATOL, V28, P1605 TOUSSIROT E, 1998, DRUGS, V56, P225 TOUSSIROT E, 2000, CLIN EXP RHEUMAT S21, V18, S16 VANDENBOSCH F, 2000, ANN RHEUM DIS, V59, P428 VANDENBOSCH F, 2002, ARTHRITIS RHEUM, V46, P755 VANDENBOSCH, 2001, ANN RHEUM DIS S3, V60, P33 VANDERLINDEN S, 1998, RHEUM DIS CLIN N AM, V24, P663 VANTUBERGEN A, 2001, ARTHRITIS RHEUM, V45, P403 WOLLHEIM FA, 1993, TXB RHEUMATOLOGY, P943
NR	68
TC	4
PU	ASHLEY PUBLICATIONS LTD
PI	LONDON
PA	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND
SN	1465-6566
J9	EXPERT OPIN PHARMACOTHER
JI	Expert Opin. Pharmacother.
PD	JAN
PY	2003
VL	4
IS	1
BP	1
EP	12
PG	12
SC	Pharmacology & Pharmacy
GA	694BV
UT	ISI:000183754700001
ER

---

PT	J
AU	Demirci, K Khan, MK Orhan, C
TI	Strong and A-statistical comparisons for sequences
SO	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
ID	CONVERGENCE; SUMMABILITY; THEOREMS
AB	Let T and A be two nonnegative regular summability matrices and W(T, p) boolean AND l(infinity) and c(A) (b) denote the spaces of all bounded strongly T-summable sequences with index p > 0, and bounded summability domain of A, respectively. In this paper we show, among other things, that chi(N) is a multiplier from W (T, p) boolean AND l(infinity) into c(A) (b) if and only if any subset K of positive integers that has T-density zero implies that K has A-density zero. These results are used to characterize the A-statistical comparisons for both bounded as well as arbitrary sequences. Using the concept of A-statistical Tauberian rate, we also show that chi(N) is not a multiplier from W (T, p) boolean AND l(infinity) into c(A) (b) that leads to a Steinhaus type result. (C) 2003 Elsevier Science (USA). All rights reserved.
C1	Ankara Univ, Dept Math, Fac Sci, TR-06100 Ankara, Turkey. Kirikkale Univ, Dept Math, Fac Sci Arts, TR-71450 Kirikkale, Turkey. Kent State Univ, Dept Math Sci, Kent, OH 44242 USA.
RP	Orhan, C, Ankara Univ, Dept Math, Fac Sci, TR-06100 Ankara, Turkey.
CR	CONNOR J, 1989, CAN MATH BULL, V32, P194 CONNOR J, 1993, PAC J MATH, V157, P201 CONNOR J, 1996, J MATH ANAL APPL, V197, P392 CONNOR J, 2000, J MATH ANAL APPL, V224, P251 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1991, ANALYSIS, V11, P59 FRIDY JA, 1993, J MATH ANAL APPL, V173, P497 FRIDY JA, 1998, ANALYSIS, V18, P145 FRIDY JA, 1998, J MATH ANAL APPL, V228, P73 GADJIEV AD, 2002, ROCKY MT J MATH, V32, P129 HARDY GH, 1949, DIVERGENT SERIES KOLK A, 1993, ANALYSIS, V13, P77 LORENTZ GG, 1949, CAN J MATH, V1, P305 MADDOX IJ, 1974, P AM MATH SOC, V45, P209 MILLER HI, 1995, T AM MATH SOC, V347, P1881 MILLER HI, 2001, ACTA MATH HUNG, V93, P149 SALAT T, 1980, MATH SLOVACA, V30, P139 STEINHAUS H, 1951, C MATH, V2, P73 ZYGMUND A, 1979, TRIGONOMETRIC SERIES
NR	21
TC	1
PU	ACADEMIC PRESS INC ELSEVIER SCIENCE
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0022-247X
J9	J MATH ANAL APPL
JI	J. Math. Anal. Appl.
PD	FEB 1
PY	2003
VL	278
IS	1
BP	27
EP	33
PG	7
SC	Mathematics, Applied; Mathematics
GA	663TK
UT	ISI:000182021800003
ER

---

PT	J
AU	Scalapino, KJ Davis, JC
TI	The treatment of ankylosing spondylitis
SO	CLINICAL AND EXPERIMENTAL MEDICINE
LA	English
DT	Review
DE	ankylosing spondylitis; medical therapies; NSAIDS; physical therapy; sulfasalazine; pamidronate; thalidomide; methotrexate; biologic agents; TNF
ID	NECROSIS-FACTOR-ALPHA; NONSTEROIDAL ANTIINFLAMMATORY DRUG; METHYLPREDNISOLONE PULSE THERAPY; CHIMERIC MONOCLONAL-ANTIBODY; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; SERUM LEVELS; TNF-ALPHA; IN-VITRO
AB	Ankylosing spondylitis is an inflammatory disorder affecting the axial skeleton and periphery. Symptoms can often be debilitating. Current therapy for the disease include physical therapy, non-steroidal anti-inflammatory drugs (NSAIDS, anti-rheumatic disease modifying drugs (DMARDS), and the newly developed biologic agents targeting tumor necrosis factor alpha (TNF-alpha). This paper will provide a comprehensive review of these treatments which focusing on evidence based medicine for the daily clinical practice of rheumatology.
C1	Univ Calif San Francisco, Div Rheumatol, San Francisco, CA 94143 USA.
RP	Davis, JC, Univ Calif San Francisco, Div Rheumatol, 533 Parnassus Ave,Box 0633,Room U383, San Francisco, CA 94143 USA.
CR	BAETEN D, 2001, ARTHRITIS RHEUM, V44, P186 BRANDT J, 2000, ARTHRITIS RHEUM, V43, P1346 BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499 BRAUN J, 2002, LANCET, V359, P1187 BREBAN M, 1999, ARTHRITIS RHEUM, V42, P580 CALABRESE L, 2000, AM J MED, V108, P487 CALIN A, 1993, J RHEUMATOL, V290, P991 CANETE JD, 1997, BRIT J RHEUMATOL, V36, P38 CLEGG DO, 1996, ARTHRITIS RHEUM, V39, P2004 COLLANTES EE, 2002, INT WORKSH NEW TREAT CREEMERS MCW, 1995, J RHEUMATOL, V22, P1104 CRONSTEIN BN, 1997, RHEUM DIS CLIN N AM, V23, P739 DOUGADOS M, 1986, BRIT MED J, V293, P911 DOUGADOS M, 1993, REV RHUM, V60, P80 DOUGADOS M, 1995, ARTHRITIS RHEUM, V38, P618 DOUGADOS M, 2001, ARTHRITIS RHEUM, V44, P180 FERRAZ MB, 1990, J RHEUMATOL, V17, P1482 GORMAN JD, 2002, NEW ENGL J MED, V346, P1349 GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927 GRATACOS J, 1999, ARTHRITIS RHEUM, V42, P2319 GROM AA, 1996, ARTHRITIS RHEUM, V39, P1703 HUANG F, 2002, ARTHRIT RHEUM-ARTHR, V47, P249 JONES SD, 1996, J RHEUMATOL, V23, P487 KHAN MA, 1981, J RHEUMATOL, V8, P86 KOH WH, 1997, J RHEUMATOL, V24, P2158 LANGE U, 2001, OSTEOPOROSIS INT, V12, P1031 LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174 LUCKMAN SP, 1998, J BONE MINER RES, V13, P581 MAKSYMOWYCH WP, 1998, J RHEUMATOL, V25, P714 MAKSYMOWYCH WP, 2002, ARTHRITIS RHEUM, V46, P766 MARZOORTEGA H, 2001, ARTHRITIS RHEUM, V44, P2112 MAUGARS Y, 1996, BRIT J RHEUMATOL, V35, P767 MINTZ G, 1981, ARTHRITIS RHEUM, V24, P734 MITRA D, 2000, RHEUMATOLOGY, V39, P85 NISSILA M, 1988, ARTHRITIS RHEUM, V31, P1111 ORY P, 2002, ARTHRITIS RHEUM S, V46, S196 PENNANEN N, 1995, PHARMACEUT RES, V12, P916 PETERS ND, 1992, SCAND J RHEUMATOL, V21, P134 ROYCHAUDHRY B, 2001, RHEUMATOLOGY S1, V40, P43 SANSONI P, 1995, J BONE MINER RES, V10, P1719 SHARP JT, 1985, ARTHRITIS RHEUM, V28, P1326 STONE M, 2001, J RHEUMATOL, V28, P1605 TAGGART A, 1996, ARTHRITIS RHEUM, V39, P1400 TANFIELD M, 1978, LANCET, V1, P944 TOUSSIROT E, 1994, RHEUMATOL INT, V13, P175 VANDENBOSCH F, 2000, ANN RHEUM DIS, V59, P428 VANDENBOSCH F, 2002, ARTHRITIS RHEUM, V46, P755 ZINK A, 2000, J RHEUMATOL, V27, P613
NR	48
TC	7
PU	SPRINGER-VERLAG
PI	NEW YORK
PA	175 FIFTH AVE, NEW YORK, NY 10010 USA
SN	1591-8890
J9	CLIN EXP MED
JI	Clin. Exper. Med.
PD	FEB
PY	2003
VL	2
IS	4
BP	159
EP	165
PG	7
SC	Medicine, Research & Experimental
GA	655AX
UT	ISI:000181530100001
ER

---

PT	J
AU	Braun, J Sieper, J
TI	Overview of the use of the anti-TNF agent infliximab in chronic inflammatory diseases
SO	EXPERT OPINION ON BIOLOGICAL THERAPY
LA	English
DT	Review
DE	anti-TNF-alpha therapy; infliximab; monoclonal antibodies
ID	NECROSIS-FACTOR-ALPHA; CHIMERIC MONOCLONAL-ANTIBODY; ACTIVE ANKYLOSING-SPONDYLITIS; GIANT-CELL ARTERITIS; IN-VIVO BLOCKADE; CROHNS-DISEASE; RHEUMATOID-ARTHRITIS; OPEN-LABEL; PYODERMA-GANGRENOSUM; CLINICAL-EXPERIENCE
AB	Anti-inflammatory therapy with monoclonal antibodies (mAbs) directed against tumour necrosis factor (TNF)-alpha has emerged as a major advancement in the treatment of various immune mediated diseases such as rheumatoid arthritis, ankylosing spondylitis, psoriatic arthritis and Crohn's disease. TNF-alpha seems to play a major pathogenic role in these chronic immune-mediated inflammatory diseases. Infliximab (Remicade((R)), Centocor, Inc., Malvern, PA, USA), a chimaeric mAb, binds to soluble and membrane bound TNF-alpha, but not to TNF-beta. Infliximab is able to effectively regulate and mediate inflammatory processes involved in a number of different disease states. Many clinical trials in these diseases have demonstrated that biological therapy with mAbs directed against TNF-alpha is effective and relatively safe.
C1	Rheumazentrum Ruhrgebiet, D-44652 Herne, Germany. Free Univ Berlin, Klinikum Benjamin Franklin, Dept Rheumatol & Gastroenterol, D-12200 Berlin, Germany. Free Univ Berlin, Klinikum Benjamin Franklin, Dept Rheumatol, D-12200 Berlin, Germany.
RP	Braun, J, Rheumazentrum Ruhrgebiet, Landgrafenstr 15, D-44652 Herne, Germany.
CR	2002, PHYSICIANS DESK REFE ACHKAR JP, 2002, AM J GASTROENTEROL S, V97, S261 AIRO P, 2002, RHEUMATOLOGY, V41, P347 ANDERSON JJ, 2001, ARTHRITIS RHEUM, V44, P1876 ANKER SD, 2002, INT J CARDIOL, V86, P123 ANTONI A, 2002, ARTHRITIS RHEUM S, V46, S381 ANTONI CE, 2001, ANN RHEUM DIS S1, V60, P170 ANTONI CE, 2001, ARTHRITIS RHEUM S, V44, S152 ANTONI CE, 2001, ARTHRITIS RHEUM S, V44, S84 ARNOTT IDR, 2001, ALIMENT PHARM THERAP, V15, P1639 ASAKURA H, 2001, J GASTROEN HEPATOL, V16, P763 BAERT FJ, 1999, GASTROENTEROLOGY, V116, P22 BAETEN D, 2001, ARTHRITIS RHEUM, V44, P186 BATRES LA, 2002, J PEDIATR GASTR NUTR, V34, P558 BAUGHMAN RP, 2001, SARCOIDOSIS VASC DIF, V18, P70 BOEGER CA, 2001, ANN RHEUM DIS, V60, P1159 BOH E, 2002, P WORLD C DERM PAR F, P1649 BOKI KA, 2002, ANN RHEUM DIS S1, V61, P308 BOLCE RJ, 2001, ARTHRITIS RHEUM S, V44, S121 BRANDT J, 2000, ARTHRITIS RHEUM, V43, P1346 BRANDT J, 2004, ARTHRITIS RHEUM, V46, S429 BRAUN J, UNPUB LONG TERM EFFI BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499 BRAUN J, 1996, ANN RHEUM DIS, V55, P76 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 2000, ANN RHEUM DIS S1, V59, P85 BRAUN J, 2002, ANN RHEUM DIS S3, V61, P19 BRAUN J, 2002, ARTHRITIS RES, V4, P307 BRAUN J, 2002, ARTHRITIS RHEUM S, V46, S426 BRAUN J, 2002, ARTHRITIS RHEUM, V46, P2822, DOI 10.1002/art.10470 BRAUN J, 2002, CLIN EXP RHEUMAT S28, V20, S16 BRAUN J, 2002, LANCET, V359, P1187 BRAY VJ, 2001, ARTHRITIS RHEUM S, V46, S121 BREBAN MA, 2001, ARTHRITIS RHEUM S, V44, A222 BRESCIA AC, 2002, ARTHRITIS RHEUM S, V46, S313 BROWN MA, 2000, ANN RHEUM DIS, V59, P883 BROWN MA, 2002, CURR OPIN RHEUMATOL, V14, P354 BROWN SL, 2002, ARTHRITIS RHEUM, V46, P3151, DOI 10.1002/art.10679 CALIN A, 1994, J RHEUMATOL, V21, P2281 CANTINI F, 2001, ARTHRITIS RHEUM, V44, P2933 CHARLES PJ, 2000, ARTHRITIS RHEUM, V43, P2383 CHATUVREDI VP, 2002, ARTHRITIS RHEUM, V46, B12 CHAUDHARI U, 2001, LANCET, V357, P1842 CHEROUVIM EP, 2002, ANN RHEUM DIS S1, V61, P308 CHEY WY, 2001, AM J GASTROENTEROL, V96, S288 CLEGG DO, 1996, ARTHRITIS RHEUM, V39, P2013 COHEN RD, 2000, AM J GASTROENTEROL, V95, P3469 COHEN SA, 2002, AM J GASTROENTEROL S, V97, S257 COLOMBEL JF, 2002, GASTROENTEROLOGY S1, V122, A613 CRANDALL WV, 2003, ALIMENT PHARM THERAP, V17, P75, DOI 10.1046/j.0269-2813.2003.01411.x DAGOSTINO MA, 2002, ARTHRITIS RHEUM, V46, P840 DHAENS G, 1999, GASTROENTEROLOGY, V116, P1029 DROSOU A, 2002, P WORLD C DERM PAR F DUREZ P, 2002, ANN RHEUM DIS S1, V61, P201 EHRESMANN GR, 2002, ARTHRITIS RHEUM S, V46, S160 ELLIOTT MJ, 1993, ARTHRITIS RHEUM, V36, P1681 ELLIOTT MJ, 1994, LANCET, V344, P1105 ELSHABRAWI Y, 2001, ANN RHEUM DIS S1, V60, P144 ELSHABRAWI Y, 2002, ARTHRITIS RHEUM, V46, P2821, DOI 10.1002/art.10469 ELSHABRAWI Y, 2002, OPHTHALMOLOGY, V109, P2342 EMERY P, 2001, ARTHRITIS RHEUM S, V44, S82 ERKAN D, 2001, ARTHRITIS RHEUM S, V44, S83 ESCHER JC, 2002, J PEDIATR GASTR NUTR, V34, P420 ESTERS N, 2002, AM J GASTROENTEROL, V97, P1458 FAHEY SM, 2002, ARTHRITIS RHEUM S, V46, S323 FARRELL RJ, 2000, AM J GASTROENTEROL, V95, P3490 FASANMADE A, 2002, GASTROENTEROLOGY S1, V122, A617 FASANMADE AA, 2002, CLIN PHARMACOL THER, V71, P99 FEAGAN B, 2002, GASTROENTEROLOGY S1, V122, A603 FEAGAN B, 2002, GASTROENTEROLOGY S1, V122, A615 FEAGAN BG, 2002, AM J GASTROENTEROL S, V97, S264 FELETAR MH, 2002, ARTHRITIS RHEUM S, V46, SY15 FIECHTNER J, 2001, ARTHRITIS RHEUM S, V44, S222 FISKE S, 2002, P WORLD C DERM PAR F, P1061 FLEISCHMANN R, 2002, P AM AC DERM NEW ORL FLEISHER MR, 2001, AM J GASTROENTEROL S, V96, S291 FLEISHNER MR, 2002, P AM AC DERM NEW ORL FORSTER A, 2002, ARTHRITIS RHEUM S, V46, S511 FOSTER EN, 2002, GASTROENTEROLOGY S1, V122, A618 FRIEDMAN S, 2001, INFLAMM BOWEL DIS, V7, P1 FRIES W, 2002, AM J GASTROENTEROL, V97, P499 GARCIAPORRUA A, 2002, RHEUMATOLOGY, V41, P234 GARRETT S, 1994, J RHEUMATOL, V21, P2286 GAYLIS N, UNPUB INFLIXIMAB TRE GEBOES K, 2002, GASTROENTEROLOGY S1, V122, A150 GEYER AS, 2000, ARCH DERMATOL, V136, P459 GILLETT HR, 2002, GASTROENTEROLOGY, V122, P800 GLAZIER KD, 2002, AM J GASTROENTEROL S, V97, S262 GOOSSENS PH, 2001, ANN RHEUM DIS, V60, P637 GORMAN JD, 2002, NEW ENGL J MED, V346, P1349 GOTTENBERG JE, 2002, ARTHRITIS RHEUM S, V46, S71 GOTTLIEB AB, 2002, P AM AC DERM NEW ORL GOTTLIEB AG, 2002, P WORLD C DERM PAR F, P1973 GU JR, 2002, ARTHRITIS RHEUM S, V46, S435 HADI A, 2002, RHEUMATOLOGY, V41, P114 HADIGAN C, 1999, J PEDIAT GASTROENTER, V29, P525 HANAUER SB, 2002, LANCET, V359, P1541 HASSARD PV, 2001, GASTROENTEROLOGY, V120, P995 HOMMES DW, 2002, INFLAMM BOWEL DIS, V8, P81 HONAKEN VEA, 2002, ARTHRITIS RHEUM S, V46, S480 HONKANEN V, 2001, ARTHRITIS RHEUM S, V44, S292 HUFSTUTTER JE, 2002, ARTHRITIS RHEUM S, V46, S326 HUMENIUK JM, 2002, P WORLD C DERM PAR F, P1679 HYAMS JS, 2000, J PEDIATR, V137, P192 ISERN R, 2001, ANN RHEUM DIS S1, V60, P170 JENKINSON TR, 1994, J RHEUMATOL, V21, P1694 KAISER MJ, 2001, JOINT BONE SPINE, V68, P525 KAVANAUGH A, 1999, ARTHRITIS RHEUM, V42, S78 KAVANAUGH A, 2000, J RHEUMATOL, V27, P841 KAVANAUGH A, 2001, ARTHRITIS RHEUM S, V44, S221 KAVANAUGH A, 2002, ANN RHEUM DIS S1, V61, P342 KAVANAUGH AF, 2002, ARTHRITIS RHEUM S, V46, S535 KEANE J, 2002, NEW ENGL J MED, V346, P623 KELLNER H, 2002, ARTHRITIS RHEUM S, V46, S431 KENNEDY P, 2002, GUT, V50, A71 KEYSTONE E, 2001, ARTHRITIS RHEUM S, V44, S81 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 2002, ANN INTERN MED, V136, P896 KIELY PDW, 2002, RHEUMATOLOGY, V41, P631 KIMURA Y, 2001, ARTHRITIS RHEUM S, V44, S272 KIRBY B, 2001, CLIN EXP DERMATOL, V26, P27 KOROKNAY A, 2002, ARTHRITIS RHEUM, V46, S434 KRAETSCH HG, 2001, ANN RHEUM DIS S3, V60, P55 KRUITHOF E, 2002, ANN RHEUM DIS, V61, P207 KRUITHOF E, 2002, ANN RHEUM DIS, V61, P470 KRUITHOF E, 2002, ARTHRITIS RHEUM S, V46, S430 KUGATHASAN S, 2002, AM J GASTROENTEROL, V97, P1408 LAMPRECHT P, 2002, ARTHRITIS RHEUM S, V46, S186 LAUTERMANN D, 2002, CLIN EXP RHEUMAT S28, V20, S11 LEE DM, 2001, LANCET, V358, P903 LICHTENSTEIN DR, 2002, INFLAMM BOWEL DIS, V8, P237 LICHTENSTEIN GR, 2002, AM J GASTROENTEROL S, V97, S254 LICHTENSTEIN GR, 2002, AM J GASTROENTEROL S, V97, S259 LICHTENSTEIN GR, 2002, AM J GASTROENTEROL S, V97, S264 LICHTENSTEIN GR, 2002, GASTROENTEROLOGY S1, V122, A613 LICHTENSTEIN GR, 2002, GASTROENTEROLOGY S1, V122, A615 LIMOVA M, 2002, P AM AC DERM NEW ORL LIPSKY P, 1998, ARTHRITIS RHEUM S, V41, S364 LIPSKY P, 1999, ARTHRITIS RHEUM S, V42, P401 LIPSKY PE, 2000, NEW ENGL J MED, V343, P1594 LODHAVIA PJ, 2002, AM J GASTROENTEROL S, V97, S180 LORENZ HM, 1996, J IMMUNOL, V156, P1646 LORENZ HM, 2000, J RHEUMATOL, V27, P304 MACKAY K, 1998, ARTHRITIS RHEUM, V41, P2263 MAINI R, 1999, LANCET, V354, P1932 MAINI RN, 1998, ARTHRITIS RHEUM, V41, P1552 MAINI RN, 2001, ANN RHEUM DIS S1, V60, P169 MAKSYMOWYCH WP, 2001, ARTHRITIS RHEUM S, V44, S82 MAKSYMOWYCH WP, 2002, J RHEUMATOL, V29, P959 MAMULA P, 2002, J PEDIATR GASTR NUTR, V34, P307 MANG R, 2002, DERMATOLOGY, V204, P156 MARZOORTEGA H, 2001, ARTHRITIS RHEUM, V44, P2112 MARZOORTEGA H, 2003, ANN RHEUM DIS, V62, P74 MASATLIOGLU S, 2002, ARTHRITIS RHEUM S, V46, S481 MCCABE RP, 1996, GASTROENTEROLOGY S, V110, A962 MEASE P, 2001, ARTHRITIS RHEUM S, V44, S90 MENTER A, 2002, P AM AC DERM NEW ORL MORTIMORE M, 2001, INTERN MED J, V31, P146 NIKOLAUS S, 2000, LANCET, V356, P1475 NOSSENT HC, 2001, ARTHRITIS RHEUM S, V44, S369 OGILVIE ALJ, 2001, BRIT J DERMATOL, V144, P587 OQUINN RP, 2002, ARCH DERMATOL, V138, P644 ORTIZSANTAMARIA V, 2002, ARTHRITIS RHEUM S, V46, S71 PALEOLOG EM, 1996, ARTHRITIS RHEUM, V39, P1082 PARSI MA, 2002, GASTROENTEROL S, V97, S265 PATO E, 2001, ARTHRITIS RHEUM S, V44, S90 PINCHBECK BR, 1988, CAN J GASTROENTEROL, V2, P53 PLEVY S, 2002, P AM AC DERM NEW ORL PRESENT DH, 1999, NEW ENGL J MED, V340, P1398 QUINN M, 2002, ARTHRITIS RHEUM S, V46, S519 QUINN MA, 2001, ARTHRITIS RHEUM, V44, P2947 QUINN MA, 2002, ARTHRITIS RHEUM S, V46 REZAIAN MM, 1999, ARTHRITIS RHEUM, V42, P1779 RICART E, 1999, GASTROENTEROLOGY, V117, P429 RIDLEY D, 2002, ANN RHEUM DIS S1, V61, P184 RIVKINA AM, 2002, AM J HEALTH-SYST PH, V59, P1271 ROBERTSON LP, 2001, RHEUMATOLOGY, V40, P473 ROZENBAUM M, 2002, ANN RHEUM DIS, V61, P283 RUBENSTEIN JH, 2002, J CLIN GASTROENTEROL, V35, P151 RUGIERO M, UNPUB INFLIXIMAB TRE RUTGEERTS P, UNPUB COMP SCHEDULED RUTGEERTS P, 1999, GASTROENTEROLOGY, V117, P761 RUTGEERTS P, 2002, GASTROENTEROLOGY S1, V122, A618 RUZICKA T, 2001, Z HAUTKRANKHEITEN, V76, P232 SABATE JM, 2002, ALIMENT PHARM THERAP, V16, P1117 SAMPLE C, 2002, CAN J GASTROENTEROL, V16, P165 SANDS B, 2002, AM J GASTROENTEROL S, V97, S258 SANDS B, 2002, GASTROENTEROLOGY, V122 SANDS BE, 2001, INFLAMM BOWEL DIS, V7, P83 SCALLON B, 2002, J PHARMACOL EXP THER, V301, P418 SCALLON BJ, 1995, CYTOKINE, V7, P251 SCHIMIZZI G, 2002, P FED CLIN IMM SAN F SCHIMIZZI GF, 2001, ARTHRITIS RHEUM S, V44, S82 SCHOLMERICH J, 2000, HEPATO-GASTROENTEROL, V47, P101 SCHWARTZMAN S, 2002, ARTHRITIS RHEUM S, V46, S326 SCOTT JW, 2002, ANN RHEUM DIS S1, V61, P97 SERRANO MS, 2001, ANN PHARMACOTHER, V35, P823 SFIKAKIS PP, 2001, LANCET, V358, P295 SFIKARIS PP, 2002, ARTHRITIS RHEUM S, V46, S181 SHCOPF RE, 2002, J AM ACAD DERMATOL, V46, P886 SHERGY W, 2002, ANN RHEUM DIS S1, V61, P178 SHERGY WJ, 2001, ARTHRITIS RHEUM, V44, S81 SIDIROPOULOS P, 2002, ANN RHEUM DIS S1, V61, P306 SINGRI P, 2002, ARCH DERMATOL, V138, P657 SMITH SR, 2002, ARTHRITIS RHEUM, V46, P309 STCLAIR EW, 2001, ARTHRITIS RHEUM, V44, S214 STEINFELD SD, 2001, ARTHRITIS RHEUM, V44, P2371 STEVENS MP, 2002, P WORLD C DERM PAR F, P2029 STONE M, 2001, J RHEUMATOL, V28, P1605 SU CY, 2002, AM J GASTROENTEROL, V97, P2577 SULLIVAN TP, 2002, P WORLD C DERM PAR F SWEISS NJ, 2002, ARTHRITIS RHEUM S, V46, S324 TAK PP, 1996, ARTHRITIS RHEUM, V39, P1077 TAN MH, 2001, ARCH DERMATOL, V137, P930 TARGAN SR, 1997, NEW ENGL J MED, V337, P1029 TAYLOR PC, 2000, ARTHRITIS RHEUM, V43, P38 TAYLOR PC, 2001, ARTHRITIS RHEUM S, V44, S152 TAYLOR PC, 2002, ARTHRITIS RHEUM S, V46, S334 TENHOVE T, 2002, GUT, V50, P206 TESSNOW K, 2002, GASTROENTEROLOGY S1, V122, A616 TOMERO E, 2002, ARTHRITIS RHEUM, V46, S70, DOI 10.1093/rheumatology/keh443 TRAVIS SPL, 2001, GUT, V49, P725 TRIOLO G, 2002, ANN RHEUM DIS, V61, P560 ULFGREN AK, 2000, ARTHRITIS RHEUM, V43, P2391 URBANSKY K, 2002, ARTHRITIS RHEUM S, V46, S573 VANDENBOSCH F, 2000, ANN RHEUM DIS, V59, P428 VANDENBOSCH F, 2002, ARTHRITIS RHEUM, V46, P755 VANDENBOSCH, 2002, ARTHRITIS RHEUM S, V46, S430 VANDERHEIJDE D, 1997, ARTHRITIS RHEUM S, V40, S62 VANDERHEIJDE DM, 2001, ARTHRITIS RHEUM S, V44, S80 VANDERHOOF JA, 2002, J PEDIATR GASTR NUTR, V34, P312 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDULLEMEN HM, 1995, GASTROENTEROLOGY, V109, P129 VANVOLLENHOVEN RF, 2002, ARTHRITIS RHEUM S, V46, S535 VASILIAUSKAS E, 1999, J PEDIAT GASTROENTER, V29, P525 VOIGTLANDER C, 2001, ARCH DERMATOL, V137, P1571 WEINBERG AM, 2002, AM J GASTROENTEROL S, V97, S255 WEISS JE, ARTHRITIS RHEUM S, V46, S310 WOLFE F, 2002, ARTHRITIS RHEUM S, V46, S534 WOLFE F, 2002, ARTHRITIS RHEUM S, V46, S90 WONG JB, 2002, ARTHRITIS RHEUM S, V46, S337 WOUTERS C, 2002, ANN RHEUM DIS, V61, P241 YEE AMF, 2001, ANN INTERN MED, V135, P27 YELIN E, 1987, ARTHRITIS RHEUM, V30, P507 ZHOU J, 2002, ARTHRITIS RHEUM S, V46, S381 ZINK A, 2001, ANN RHEUM DIS, V60, P199
NR	246
TC	13
PU	ASHLEY PUBLICATIONS LTD
PI	LONDON
PA	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE, FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND
SN	1471-2598
J9	EXPERT OPIN BIOL THER
JI	Expert Opin. Biol. Ther.
PD	FEB
PY	2003
VL	3
IS	1
BP	141
EP	168
PG	28
SC	Biotechnology & Applied Microbiology; Medicine, Research & Experimental
GA	650LU
UT	ISI:000181266000013
ER

---

PT	J
AU	Votsis, GN Drosopoulos, AI Kollias, SD
TI	A modular approach to facial feature segmentation on real sequences
SO	SIGNAL PROCESSING-IMAGE COMMUNICATION
LA	English
DT	Article
DE	facial feature extraction; optimal segmentation; seed growing; active contours; dominant angle; feature labeling
ID	TEXTURED COLOR IMAGES; UNSUPERVISED SEGMENTATION; STOCHASTIC RELAXATION; DEFORMABLE TEMPLATES; FEATURE-EXTRACTION; FACE RECOGNITION; MODELS; EXPRESSIONS
AB	In this paper a modular approach of gradual confidence for facial feature extraction over real video frames is presented. The problem is being dealt under general imaging conditions and soft presumptions. The proposed methodology copes with large variations in the appearance of diverse subjects, as well as of the same subject in various instances within real video sequences. Areas of the face that statistically seem to be outstanding form an initial set of regions that are likely to include information about the features of interest. Enhancement of these regions produces closed objects, which reveal-through the use of a fuzzy system-a dominant angle, i.e. the facial rotation angle. The object set is restricted using the dominant angle. An exhaustive search is performed among all candidate objects, matching a pattern that models the relative position of the eyes and the mouth. Labeling of the winner features can be used to evaluate the features extracted and provide feedback in an iterative framework. A subset of the MPEG-4 facial definition or facial animation parameter set can be obtained. This gradual feature revelation is performed under optimization for each step, producing a posteriori knowledge about the face and leading to a step-by-step visualization of the features in search. (C) 2002 Elsevier Science B.V. All rights reserved.
C1	Natl Tech Univ Athens, Dept Elect & Comp Engn, GR-15773 Athens, Greece.
RP	Votsis, GN, Natl Tech Univ Athens, Dept Elect & Comp Engn, Iroon Polytechniou 9,Zografou, GR-15773 Athens, Greece.
CR	AHLBERG J, 1999, IEEE T CIRCUITS SYST, V93, P405 AVRITHIS Y, 2000, IEEE INT C MULT EXP BLACK MJ, 1997, PROC CVPR IEEE, P561 BOUMAN CA, 1994, IEEE T IMAGE PROCESS, V3, P162 BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042 CHELLAPPA R, 1995, P IEEE, V83, P705 COHEN LD, 1991, CVGIP-IMAG UNDERSTAN, V53, P211 COWIE R, 2001, IEEE SIGNAL PROC MAG, V18, P32 DARRELL TJ, 1993, 197 MIT MED LAB VIS DELBIMBO A, 1997, IEEE T PATTERN ANAL, V19, P121 DELIGNON Y, 1997, IEEE T IMAGE PROCESS, V6, P1364 DENG YN, 2001, IEEE T PATTERN ANAL, V23, P800 DOULAMIS AD, 2000, IEEE T NEURAL NETWOR, V11, P137 EISERT P, 1997, P IEEE INT C IM PROC ESSA IA, 1997, IEEE T PATTERN ANAL, V19, P757 GEMAN S, 1984, IEEE T PATTERN ANAL, V6, P721 HARMON LD, 1981, PATTERN RECOGN, V13, P97 JAIN AK, 1996, IEEE T PATTERN ANAL, V18, P267 JIA XG, 1995, IEEE T PATTERN ANAL, V17, P1167 KANADE T, 1973, PICTURE PROCESSING C KARPOUZIS K, 1998, MACHINE GRAPHICS VIS, V7, P75 KASS M, 1988, INT J COMPUT VISION, V1, P321 LANGAN DA, 1998, IEEE T IMAGE PROCESS, V7, P180 LOW BK, 1997, P IEEE INT C IM PROC LUENBERGER DJ, 1984, LINER NONLINEAR PROG MA WY, 1997, PROC CVPR IEEE, P744 MATSUMOTO Y, 1999, P IEEE WORKSH REAL T MCINERNEY T, 1995, P 5 INT C COMP VIS I, P840 MCKENNA SJ, 1997, LECT NOTES COMPUTER METAXAS D, 1999, P IEEE WORKSH REAL T NIKOLAIDIS A, 1998, P NOBLESSE WORKSH NO PANJWANI DK, 1995, IEEE T PATTERN ANAL, V17, P939 PAPOULIS A, 1991, PROBABILITY RANDOM V, P86 PENTLAND A, 1994, IEEE C COMP VIS PATT POTZSCH M, 1996, NETWORK-COMP NEURAL, V7, P341 RADEVA P, 1995, INT C COMP AN IM PRO RAOUZAIOU A, 2002, EURASIP J APPL S OCT SAMAL A, 1992, PATTERN RECOGN, V25, P65 SCLAROFF S, 2001, IEEE T PATTERN ANAL, V23, P475 SENIOR AW, 1999, P IEEE WORKSH REAL T SHAFARENKO L, 1997, IEEE T IMAGE PROCESS, V6, P1530 SHI JB, 2000, IEEE T PATTERN ANAL, V22, P888 SOBOTTKA K, 1998, SIGNAL PROCESS-IMAGE, V12, P263 STAIB LH, 1992, IEEE T PATTERN ANAL, V14, P1061 TIAN Y, 1999, CMURITR9918 TSAPATSOULIS N, 2001, PATTERN ANAL APPL, V4, P93 TSAPATSOULIS N, 2002, MPEG 4 FACIAL ANIMAT TSECHPENAKIS G, 2001, INT WORKSH VER LOW B TSEKERIDOU S, 1998, P 9 EUR SIGN PROC C, V1, P315 WANG JP, 1998, IEEE T PATTERN ANAL, V20, P619 YOW KC, 1996, P 2 INT C AUT FAC GE YUILLE AL, 1992, INT J COMPUT VISION, V8, P99 ZHU SC, 1996, IEEE T PATTERN ANAL, V18, P884
NR	53
TC	1
PU	ELSEVIER SCIENCE BV
PI	AMSTERDAM
PA	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN	0923-5965
J9	SIGNAL PROCESS-IMAGE COMMUN
JI	Signal Process.-Image Commun.
PD	JAN
PY	2003
VL	18
IS	1
BP	67
EP	89
PG	23
SC	Engineering, Electrical & Electronic
GA	646PQ
UT	ISI:000181043800005
ER

---

PT	J
AU	Moricz, F
TI	Tauberian conditions, under which statistical convergence follows from statistical summability (C, 1)
SO	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
DE	statistical convergence; statistical summability (C,1); one-sided and two-sided Tauberian conditions; slow decrease (or increase); slow oscillation
AB	J.A. Fridly and M.K. Khan have recently extended Hardy's and Landau's Tauberian theorems to the case of statistical convergence, which was introduced by H. Fast in 1951. Let (x(k): k = 0, 1, 2,.. be a sequence of real or complex numbers and set an : = (n + 1)(-1) Sigma(k=0)(n) x(k) for n = 0, 1, 2,.... We present necessary and sufficient conditions, under which st-limx(k) = L follows from st-limsigma(n) = L, where L is a finite number. If (xk) is a sequence of real numbers, then these are one-sided Tauberian conditions. If (x(k)) is a sequence of complex numbers, then these are two-sided Tauberian conditions. In particular, our conditions are satisfied if (xk) is statistically slowly decreasing (or increasing) in the case of real sequences; or if (xk) is statistically slowly oscillating in the case of complex sequences. Even these special sufficient conditions imply those given by Fridy and Khan. (C) 2002 Elsevier Science (USA). All rights reserved.
C1	Univ Szeged, Bolyai Inst, H-6720 Szeged, Hungary.
RP	Moricz, F, Univ Szeged, Bolyai Inst, Aradi Vertanuk Tere 1, H-6720 Szeged, Hungary.
CR	FAST H, 1951, C MATH, V2, P241 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 2000, P AM MATH SOC, V128, P2347 HARDY GH, 1910, P LOND MATH SOC, V8, P310 LANDAU E, 1910, PRAC MAT FIZ, V21, P97 SCHMIDT R, 1925, MATH Z, V22, P89 SCHOENBERG IJ, 1959, AM MATH MONTHLY, V66, P361
NR	7
TC	2
PU	ACADEMIC PRESS INC ELSEVIER SCIENCE
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0022-247X
J9	J MATH ANAL APPL
JI	J. Math. Anal. Appl.
PD	NOV 1
PY	2002
VL	275
IS	1
BP	277
EP	287
PG	11
SC	Mathematics, Applied; Mathematics
GA	622YD
UT	ISI:000179674700018
ER

---

PT	J
AU	Holman, R Berger, MPF
TI	Optimal calibration designs for tests of polytomously scored items described by item response theory models
SO	JOURNAL OF EDUCATIONAL AND BEHAVIORAL STATISTICS
LA	English
DT	Article
DE	"divide-by-total models"; D-optimal designs; item response theory; polytomous items sequential designs
ID	SEQUENTIAL SAMPLING DESIGNS; PARAMETERS
AB	This article examines calibration designs, which maximize the determinant of Fisher's information matrix on the item parameters (D-optimal), for sets of polytomously scored items. These items were analyzed using a number of item response theory (IRT) models, which are members of the "divide-by-total" family, including the nominal categories model, the rating scale model, the unidimensional polytomous Rasch model and the partial credit model. We extend the known results for dichotomous items, both singly and in tests to polytomous items. The structure of Fisher's information matrix is examined in order to gain insights into the structure of D-optimal calibration designs for IRT models. A theorem giving an upper bound for the number of support points for such models is proved. A lower bound is also given. Finally, we examine a set of items, which have been analyzed using a number of different models. The locally D-optimal calibration design for each analysis is calculated using an exact numerical and a sequential procedure. The results are discussed both in general and in relation to each other.
C1	Acad Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands. Maastricht Univ, Dept Methodol & Stat, NL-6200 MD Maastricht, Netherlands.
RP	Holman, R, Acad Med Ctr, Dept Clin Epidemiol & Biostat, Amsterdam, Netherlands.
CR	ANDERSEN EB, 1996, HDB MODERN ITEM RESP ANDRICH D, 1978, BRIT J MATH STAT PSY, V26, P31 ATKINSON AC, 1992, OPTIMAL EXPT DESIGNS BERGER MPF, 1991, APPL PSYCH MEAS, V15, P293 BERGER MPF, 1992, OBJECTIVE MEASUREMEN BERGER MPF, 1992, PSYCHOMETRIKA, V57, P521 BERGER MPF, 1994, J EDUC STAT, V19, P43 BERGER MPF, 2000, PSYCHOMETRIKA, V65, P377 BOCK RD, 1972, PSYCHOMETRIKA, V37, P29 CHALONER K, 1989, J STAT PLAN INFER, V21, P191 FELLING A, 1987, RELIG DUTCH SOC 85 D HEINEN AGJ, 1996, LATENT CLASS DISCRET JONES DH, 1994, PSYCHOMETRIKA, V59, P59 KHAN MK, 1988, J STATISTICAL PLANNI, V18, P83 MASTERS GN, 1982, PSYCHOMETRIKA, V47, P149 MASTERS GN, 1996, HDB MODERN ITEM RESP MURAKI E, 1992, APPL PSYCH MEAS, V16, P159 ORTEGA JM, 1987, MATRIX THEORY RASCH G, 1961, 4TH P BERK S MATH ST, V4, P321 STOCKING ML, 1990, PSYCHOMETRIKA, V55, P461 THISSEN D, 1982, PSYCHOMETRIKA, V47, P397 THISSEN D, 1986, PSYCHOMETRIKA, V51, P567 VALE CD, 1986, APPL PSYCH MEAS, V10, P333 WINGERSKY MS, 1984, APPL PSYCH MEAS, V8, P347 WYNN HP, 1970, ANN MATH STAT, V41, P1655
NR	25
TC	1
PU	AMER EDUCATIONAL RESEARCH ASSOC
PI	WASHINGTON
PA	1230 17TH ST NW, WASHINGTON, DC 20036-3078 USA
SN	1076-9986
J9	J EDUC BEHAV STAT
JI	J. Educ. Behav. Stat.
PD	WIN
PY	2001
VL	26
IS	4
BP	361
EP	380
PG	20
SC	Education & Educational Research; Social Sciences, Mathematical Methods
GA	622FX
UT	ISI:000179637100001
ER

---

PT	J
AU	Zeng, XM Gupta, V
TI	Rate of convergence of Baskakov-Bezier type operators for locally bounded functions
SO	COMPUTERS & MATHEMATICS WITH APPLICATIONS
LA	English
DT	Article
DE	rate of convergence; operator of probabilistic type; Lebesgue-Stieltjes integral
AB	In this paper, we introduce Baskakov-Bezier operator B-n,B-alpha which is an operator of probabilistic type. We study the rate of convergence of the operator B-n,B-alpha for locally bounded functions by using some inequalities and results of probability theory. Our estimate is essentially the best possible. (C) 2002 Elsevier Science Ltd. All rights reserved.
C1	Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China. Netaji Subhas Inst Technol, Sch Appl Sci, New Delhi 110045, India.
RP	Zeng, XM, Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
CR	CHANDRA RK, 1983, IMMUNOL TODAY, V4, P322 CHENG F, 1983, J APPROX THEORY, V39, P259 GUO SS, 1989, J APPROX THEORY, V58, P90 GUPTA V, 1994, APPROX THEORY ITS AP, V10, P74 GUPTA V, 1999, J MATH ANAL APPL, V233, P476 KHAN MK, 1989, J APPROX THEORY, V57, P90 LOEVE M, 1977, PROBABILITY THEORY I OMEY E, 1996, THEOR PROBAB APPL, V41, P219 SHIRYAYEV AN, 1984, PROBABILITY WANG Y, 1991, B AUSTR MATH SOC, V44, P177 ZENG XM, 1998, J APPROX THEORY, V95, P369 ZENG XM, 1998, J MATH ANAL APPL, V219, P364 ZENG XM, 1998, J MATH ANAL APPL, V226, P309 ZENG XM, 2001, J INEQUAL APPL, V6, P363
NR	14
TC	5
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0898-1221
J9	COMPUT MATH APPL
JI	Comput. Math. Appl.
PD	NOV-DEC
PY	2002
VL	44
IS	10-11
BP	1445
EP	1453
PG	9
SC	Computer Science, Interdisciplinary Applications; Mathematics, Applied
GA	620JT
UT	ISI:000179530800015
ER

---

PT	J
AU	Sieper, J Braun, J Rudwaleit, M Boonen, A Zink, A
TI	Ankylosing spondylitis: an overview
SO	ANNALS OF THE RHEUMATIC DISEASES
LA	English
DT	Article
ID	C-REACTIVE PROTEIN; JUVENILE-ONSET SPONDYLOARTHROPATHIES; GUIDED CORTICOSTEROID INJECTION; ERYTHROCYTE SEDIMENTATION-RATE; X-RAY TREATMENT; RHEUMATOID-ARTHRITIS; WORK DISABILITY; DOUBLE-BLIND; SERONEGATIVE SPONDYLARTHROPATHIES; HLA-B27 POLYMORPHISM
AB	Ankylosing spondylitis (AS) is a complex, potentially debilitating disease that is insidious in onset, progressing to radiological sacroiliitis over several years. Patients with symptomatic AS lose productivity owing to work disability and unemployment, have a substantial use of healthcare resources, and reduced quality of life. The pathogenesis of AS is poorly understood. However, immune mediated mechanisms involving human leucocyte antigen (HLA)-B27, inflammatory cellular infiltrates, cytokines (for example, tumour necrosis factor alpha and interleukin 10), and genetic and environmental factors are thought to have key roles. The detection of sacroiliitis by radiography, magnetic resonance imaging, or computed tomography in the presence of clinical manifestations is diagnostic for AS, although the presence of inflammatory back pain plus at least two other typical features of spondyloarthropathy (for example, enthesitis and uveitis) is highly predictive of early AS. Non-steroidal anti-inflammatory drugs (NSAIDs) effectively relieve inflammatory symptoms and are presently first line drug treatment. However, NSAID treatment has only a symptomatic effect and probably does not alter the disease course. For symptoms refractory to NSAIDs, second line treatments, including corticosteroids and various disease modifying antirheumatic drugs, are employed but are of limited benefit. Emerging biological therapies target the inflammatory processes underlying AS, and thus, may favourably alter the disease process, in addition to providing symptom relief.
C1	Free Univ Berlin, UKBF, Dept Gastroenterol & Rheumatol, D-12200 Berlin, Germany. Deutsch Rheumaforschungszentrum Berlin, Forsch Bereich Epidemiol, Berlin, Germany. Univ Hosp Maastricht, Div Rheumatol, Dept Internal Med, Maastricht, Netherlands. Univ Berlin, Klinikum Benjamin Franklin, Med Klin 1, Berlin, Germany. Free Univ Berlin, Dept Gastroenterol & Rheumatol, D-1000 Berlin, Germany. Rheumazentrum Ruhrgebiet, Herne, Germany.
RP	Sieper, J, Free Univ Berlin, UKBF, Dept Gastroenterol & Rheumatol, Hindenburgdamm 30, D-12200 Berlin, Germany.
CR	2000, STEDMANS MED DICT AHVONEN P, 1969, ACTA RHEUMATOL SCAND, V15, P232 ALTAN L, 2001, SCAND J RHEUMATOL, V30, P255 AMOR B, 1994, J RHEUMATOL, V21, P1883 ARNETT FC, 1987, B RHEUM DIS, V37, P1 ARNETT FC, 1993, J COLL PHYSICIANS SU, V22, P207 BALL EJ, 2001, JOINT BONE SPINE, V68, P378 BALL J, 1971, ANN RHEUM DIS, V30, P213 BARLOW JH, 2001, ARTHRIT RHEUM-ARTHR, V45, P424 BAUER W, 1942, T ASSOC AM PHYSICIAN, V57, P307 BECHTEREW W, 1993, NEUROL ZENTRALBE, V12, P426 BENEDEK TG, 1969, J A EINSTEIN MED CTR, V17, P100 BENJAMIN M, 2001, J ANAT 5, V199, P503 BENJAMIN SB, 1981, HEPATOLOGY, V1, P255 BENNETT PH, 1966, P 3 INT S POP STUD R, P305 BIASI D, 2000, CLIN RHEUMATOL, V19, P114 BIRD HA, 1986, PHARMATHERAPEUTICA, V4, P457 BLUM U, 1996, J RHEUMATOL, V23, P2107 BOLLOW M, 2000, ANN RHEUM DIS, V59, P135 BOONEN A, 2001, ANN RHEUM DIS, V60, P1033 BOONEN A, 2001, ANN RHEUM DIS, V60, P353 BOONEN A, 2001, J RHEUMATOL, V28, P1056 BOONEN A, 2002, ANN RHEUM DIS, V61, P429 BOYER GS, 1994, J RHEUMATOL, V21, P2292 BRAUN J, 1994, ARTHRITIS RHEUM, V37, P1039 BRAUN J, 1996, J RHEUMATOL, V23, P659 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 1999, ARTHRITIS RHEUM, V42, P2039 BRAUN J, 2000, Z RHEUMATOL, V59, P117 BRAUN J, 2002, LANCET, V359, P1187 BRAUNSTEIN EM, 1982, RADIOLOGY, V144, P91 BREBAN M, 1998, ANN MED INTERNE, V149, P142 BREWERTON DA, 1973, LANCET, V2, P996 BROPHY S, 2001, J RHEUMATOL, V28, P2283 BROPHY S, 2001, J RHEUMATOL, V28, P2667 BROWN MA, 1997, ARTHRITIS RHEUM, V40, P1823 BURGOSVARGAS R, 1989, J RHEUMATOL, V16, P186 BURGOSVARGAS R, 1997, RHEUM DIS CLIN N AM, V23, P569 BYWATERS EGL, 1984, SPONDYLOARTHROPATHIE, P43 CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613 CALIN A, 1983, JCR-J CLIN RHEUMATOL, V23, P301 CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186 CHOU CT, 2001, CHIN MED J ENGL, V114, P212 COLOMBO MR, 1559, ANATOMICA VENICE CONNOR B, 1693, LETT ECRITE MONSIEUR, P17 CONNOR B, 1695, DISSERTATIONNES MED, P206 CONNOR B, 1695, PHILOS T, V19, P21 COOPER NJ, 2000, RHEUMATOLOGY, V39, P28 DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218 DOUGADOS M, 1995, ARTHRITIS RHEUM, V38, P618 DOUGADOS M, 1998, BAILLIERE CLIN RHEUM, V12, P717 DOUGADOS M, 1999, J RHEUMATOL, V26, P971 DOUGADOS M, 1999, RHEUMATOLOGY, V38, P235 DUCHMANN R, 1999, GUT, V44, P774 EBRINGER RW, 1978, ANN RHEUM DIS, V37, P146 FELDTKELLER E, 1999, Z RHEUMATOL, V58, P21 FELLMAN J, 1991, SCHWEIZ RUNDSCH MED, V80, P576 FELTKAMP TEW, 2001, CURR OPIN RHEUMATOL, V13, P285 FORESTIER J, 1956, ANKYLOSING SPONDYLIT FORESTIER J, 1964, RHEUMATISM J CHARTER, V20, P28 FRANCOIS RJ, 1995, ANN RHEUM DIS, V54, P615 FRANCOIS RJ, 2000, ANN RHEUM DIS, V59, P997 FRANCOIS RJ, 2000, ARTHRITIS RHEUM, V43, P2011 FRANCOIS RJ, 2001, CURR OPIN RHEUMATOL, V13, P255 FRANSSEN MJ, 1986, CLIN RHEUMATOL, V5, P210 GASTON JSH, 1989, CLIN EXP IMMUNOL, V76, P348 GONZALEZROCES S, 1997, TISSUE ANTIGENS, V49, P116 GOOD A, 1977, CURR MED RES OPIN, V5, P117 GRAN JT, 1985, ANN RHEUM DIS, V44, P359 GUNAYDIN I, 2000, J RHEUMATOL, V27, P424 HAMMER RE, 1990, CELL, V63, P1099 HART FD, 1959, ANN RHEUM DIS, V18, P15 HART FD, 1965, BRIT MED J, V5473, P1281 HOYLE E, 2000, ARTHRITIS RHEUM, V43, P1353 HUKUDA S, 2001, J RHEUMATOL, V28, P554 INMAN WHW, 1977, BRIT MED J, V1, P1500 JARDETZKY TS, 1991, NATURE, V353, P326 JIMENEZBALDERAS EJ, 1993, J RHEUMATOL, V20, P2069 JIMENEZBALDERAS FJ, 1989, REV MEX REUMATOL, V4, P17 KAIPIANENSEPPANEN O, 1997, J RHEUMATOL, V24, P496 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1987, J RHEUMATOL, V14, P118 LALOUX L, 2001, ANN RHEUM DIS, V60, P316 LANGMAN MJ, 1999, JAMA-J AM MED ASSOC, V282, P1929 LAVAL SH, 2001, AM J HUM GENET, V68, P918 LOCKIE LM, 1986, CLIN THER, V8, P398 LOMEN PL, 1986, AM J MED, V80, P120 MADDEN DR, 1991, NATURE, V353, P321 MAKIIKOLA O, 1991, CLIN EXP IMMUNOL, V84, P472 MAKSYMOWYCH WP, 2000, J RHEUMATOL, V27, P2295 MARIE P, 1898, REV MED, V18, P285 MARTINEZBORRA J, 2000, ARTHRITIS RHEUM, V43, P485 MAU W, 1988, J RHEUMATOL, V15, P1109 MAUGARS Y, 1996, BRIT J RHEUMATOL, V35, P767 MCBRYDE AM, 1973, NC MED J, V34, P34 MENA HR, 1977, EUR J CLIN PHARMACOL, V11, P263 MIELANTS H, 1987, J RHEUMATOL, V14, P456 MIELANTS H, 1987, J RHEUMATOL, V14, P466 MIELANTS H, 1996, BAILLIERE CLIN RHEUM, V10, P147 MOLL JMH, 1974, MEDICINE, V53, P343 MORELAND LW, 2001, J RHEUMATOL, V28, P1431 MORI K, 2000, RHEUMATOLOGY, V39, P530 OOSTVEEN J, 1999, J RHEUMATOL, V26, P1953 PACHECOTENA C, 2001, RHEUMATOLOGY, V40, P920 PALFERMAN TG, 1991, EUR J RHEUMATOL INFL, V11, P23 PARONEN I, 1948, ACTA MED SCAND S212, V131, P1 PETERS ND, 1992, SCAND J RHEUMATOL, V21, P134 RESNICK D, 1976, RADIOLOGY, V119, P293 REVEILLE JD, 2001, CURR OPIN RHEUMATOL, V13, P265 RUDWALEIT M, 2001, ANN RHEUM DIS, V60, P36 RUDWALEIT M, 2001, CURR OPIN RHEUMATOL, V13, P250 RUFFER MA, 1921, STUDIES PALEOPATHOPH RUOF J, 1999, J RHEUMATOL, V26, P966 SAMPAIOBARROS PD, 2000, SCAND J RHEUMATOL, V29, P160 SCHLOSSTEIN L, 1973, NEW ENGL J MED, V288, P704 SCHMITT E, 1983, HEALTH PHYS S1, V44, P197 SCHWARZER AC, 1990, CURR MED RES OPIN, V11, P648 SIEPER J, 1995, ARTHRITIS RHEUM, V38, P1547 SIEPER J, 2000, ARTHRITIS RHEUM, V43, P720 SIMON AK, 1994, P NATL ACAD SCI USA, V91, P8562 SIMON LS, 1999, JAMA-J AM MED ASSOC, V282, P1921 SMITH PG, 1982, BRIT MED J, V284, P449 SPOORENBERG A, 1999, J RHEUMATOL, V26, P980 STAFFORD L, 2002, INTERN MED J, V32, P40 STANDEL W, 1985, EUR J RHEUMATOL INFL, V8, P28 STRUMPELL A, 1897, DTSCH Z NERVENH, V11, P338 TAGGART A, 1996, ARTHRITIS RHEUM, V39, P1400 TAYLOR HG, 1991, BRIT J RHEUMATOL, V30, P330 THIEL A, 2000, ARTHRITIS RHEUM, V43, P2834 THOMSON GTD, 2000, J RHEUMATOL, V27, P714 UNDERWOOD MR, 1995, BRIT J RHEUMATOL, V34, P1074 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDERLINDEN SM, 1984, ARTHRITIS RHEUM, V27, P241 VANGERWEN F, 1978, ANN RHEUM DIS, V37, P85 WARD MM, 1999, ARTHRIT CARE RES, V12, P247 WARD MM, 2001, J RHEUMATOL, V28, P315 WARD MM, 2002, ARTHRITIS RHEUM, V46, P223 WEISS HA, 1994, INT J CANCER, V59, P327 WEISS HA, 1995, RADIAT RES, V142, P1 WICK RR, 1983, HEALTH PHYS, V44, P187 WRIGHT V, 1976, SERONEGATIVE POLYART ZEIDLER H, 1992, RHEUM DIS CLIN N AM, V18, P187 ZINK A, 2000, J RHEUMATOL, V27, P613
NR	143
TC	50
PU	BRITISH MED JOURNAL PUBL GROUP
PI	LONDON
PA	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN	0003-4967
J9	ANN RHEUM DIS
JI	Ann. Rheum. Dis.
PD	DEC
PY	2002
VL	61
SU	Suppl. 3
BP	8
EP	18
PG	11
SC	Rheumatology
GA	619RE
UT	ISI:000179489500003
ER

---

PT	J
AU	Khan, MA Ball, EJ
TI	Genetic aspects of ankylosing spondylitis
SO	BEST PRACTICE & RESEARCH IN CLINICAL RHEUMATOLOGY
LA	English
DT	Article
DE	HLA-B27; ankylosing spordylitis; spondyloarthropathies; subtypes; alleles; polymorphism; HLA-B*2705; genetic counselling
ID	HLA-B27 SUBTYPES; CLINICAL-FEATURES; PEPTIDE ANTIGENS; TNF-ALPHA; POLYMORPHISM; SUSCEPTIBILITY; SPONDYLOARTHROPATHY; NECROSIS; DISEASE; MHC
AB	There is substantial evidence strongly favouring a direct role for HLA-B27 in genetic susceptibility to ankylosing spondylitis (AS) and related spondyloarthropathies (SPA), although the underlying molecular basis has yet to be identified. HLA-B27 itself is a serologic specificity that encompasses 26 different alleles that encode 24 different subtypes - HLA-B*2701 to B*2725, with the exclusion of B*2722. [The B*2722 allele was deleted as an official WHO allele in April 2002, with a note that the reference cell has been shown to have the same sequence as B*2706. Thus, from now on, with this deletion of B*2722, there will be a "hole" among the HLA-B*2701 to B*2725 group of alleles]. The 24 HLA-B27 alleles (subtypes) seem to have evolved from the most widespread subtype, B*2705. Two B27 alleles have been reported to lack association with AS: B*2706 among Southeast Asian populations, and B*2709 among Sardinians. The distinction between the disease-associated subtypes and those that are not disease-associated may provide some clues to the actual role of HLA-B27 in disease pathogenesis. Genetic family studies in populations of European descent indicate that HLA-B27 contributes only 16 % of the total genetic risk for the disease. The genes in the Major Histocompatibility Complex (MHC) as a whole, that includes HLA-B27, account for about half of the genetic susceptibility for AS. This clearly indicates the presence of additional disease predisposing genes in the MHC region on chromosome 6, and genome-wide studies have identified many areas of interest on other chromosomes that may contain additional disease predisposing genes. Additional studies emanating from the recent mapping of the human genome is expected to lead to better understanding of the genetic basis of these and other rheumatic diseases. Genetic counselling and the use of HLA-B27 typing as an aid to diagnosis are also reviewed.
C1	Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Div Rheumatol,Dept Med, Cleveland, OH 44106 USA.
RP	Khan, MA, Case Western Reserve Univ, Sch Med, MetroHlth Med Ctr, Div Rheumatol,Dept Med, Cleveland, OH 44106 USA.
CR	ALLEN RL, 1999, J IMMUNOL, V162, P5045 ALVAREZ I, 2000, CURR OPIN RHEUMATOL, V12, P248 BALL EJ, 2001, JOINT BONE SPINE, V68, P378 BANARES A, 1998, RHEUM DIS CLIN N AM, V24, P771 BAUDOIN P, 2000, ARTHRITIS RHEUM, V43, P2818 BECK S, 1999, NATURE, V401, P921 BJORKMAN PJ, 1987, NATURE, V329, P506 BREWERTON DA, 1973, LANCET, V1, P904 BROWN MA, 1997, ARTHRITIS RHEUM, V40, P1823 BROWN MA, 1998, ARTHRITIS RHEUM, V41, P460 BROWN MA, 2000, HUM MOL GENET, V9, P1563 CALIN A, 1998, SPONDYLARTHRITIDES CARSWELL EA, 1975, P NATL ACAD SCI USA, V72, P3666 COLBERT RA, 2000, MOL MED TODAY, V6, P224 COLBERT RA, 2001, ARTHRITIS RHEUMATI S, V44 COLLADOESCOBAR MD, 2000, J RHEUMATOL, V27, P1461 DAMATO M, 1995, EUR J IMMUNOL, V25, P3199 FALGARONE G, 2001, ARTHRITIS RHEUMATI S, V44 FIORILLO MT, 1997, EUR J IMMUNOL, V27, P368 GARCIA F, 1997, TISSUE ANTIGENS 1, V49, P215 GARCIAFERNANDEZ S, 2001, TISSUE ANTIGENS, V58, P259 GARRETT TPJ, 1989, NATURE, V342, P692 GONZALEZ S, 1999, CURR OPIN RHEUMATOL, V11, P257 GONZALEZROCES S, 1997, TISSUE ANTIGENS, V49, P116 GU J, 2001, ARTHRITIS RHEUMATI S, V44 HAJEER AH, 2001, HUM IMMUNOL, V62, P1191 HOYLE E, 2000, ARTHRITIS RHEUM, V43, P1353 JARDETZKY TS, 1991, NATURE, V353, P326 KHAN MA, 1977, ARTHRITIS RHEUM, V20, P909 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1984, PROGR CLIN RHEUMATOL, V1, P145 KHAN MA, 1988, RHEUMATOLOGY KHAN MA, 1995, CURR OPIN RHEUMATOL, V7, P263 KHAN MA, 1998, SPONDYLARTHRITIDES, P17 KHAN MA, 2000, CURR OPIN RHEUMATOL, V12, P235 KHAN MA, 2000, J RHEUMATOL, V27, P1110 LAMAS JR, 1999, ARTHRITIS RHEUM, V42, P1975 LAVAL SH, 2001, AM J HUM GENET, V68, P916 LOPEZLARREA C, 1995, TISSUE ANTIGENS, V45, P169 MADDEN DR, 1992, CELL, V70, P1035 MAKSYMOWYCH WP, 2000, J RHEUMATOL, V27, P183 MARDJUADI A, 1999, CLIN RHEUMATOL, V18, P442 MARTI M, 2001, TISSUE ANTIGENS, V58, P351 MARTINEZBORRA J, 2000, HUM IMMUNOL, V61, P131 MATSUMURA M, 1992, SCIENCE, V257, P927 MAY E, 2001, ARTHRITIS RHEUMATI S, V44 MCGARRY F, 1999, J RHEUMATOL, V26, P1110 MILICIC A, 2000, GENES IMMUN, V1, P418 MORI K, 2000, RHEUMATOLOGY, V39, P530 NASUTION AR, 1997, J RHEUMATOL, V24, P1111 PATO E, 2000, J RHEUMATOL, V27, P2198 REN EC, 1997, TISSUE ANTIGENS, V49, P67 REVEILLE JD, 2001, ARHTRITIS RHEUMATI S, V44, P1111 REVEILLE JD, 2001, CURR OPIN RHEUMATOL, V13, P265 RICCIVITIANI L, 2000, J RHEUMATOL, V27, P2193 ROJO S, 1987, J IMMUNOL, V139, P831 RUDWALEIT M, 2001, CURR OPIN RHEUMATOL, V13, P250 SAIDNAHAL R, 2002, ANN RHEUM DIS, V61, P201 SESMA L, 2002, J BIOL CHEM MARPMID 11978783 SUDARSONO D, 1999, J RHEUMATOL, V26, P1534 TSAI WC, 2001, ARTHRITIS RHEUMATI S, V44 VANDERLINDEN SJ, 2000, KELLEYS TXB RHEUMATO, P1039 VANDERLINDEN SM, 1984, J RHEUMATOL, V11, P727 VERJANS GMGM, 1991, ARTHRITIS RHEUM, V34, P486 VERJANS GMGM, 1994, CLIN EXP IMMUNOL, V97, P45 WITTER K, 2001, TISSUE ANTIGENS, V58, P263
NR	66
TC	17
PU	BAILLIERE TINDALL
PI	LONDON
PA	24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN	1521-6942
J9	BEST PRACT RES CLIN RHEUMATOL
JI	Best Pract. Res. Clin. Rheumatol.
PD	SEP
PY	2002
VL	16
IS	4
BP	675
EP	690
PG	16
SC	Rheumatology
GA	608XX
UT	ISI:000178874000013
ER

---

PT	J
AU	Khan, MA
TI	Thoughts concerning the early diagnosis of ankylosing spondylitis and related diseases
SO	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
LA	English
DT	Article
DE	ankylosing spondylitis; early diagnosis; HLB-27
ID	UNDIFFERENTIATED SPONDYLOARTHROPATHIES; HLA-B27 POLYMORPHISM; BACK-PAIN; SACROILIITIS; CRITERIA; SPONDYLARTHROPATHY; MANIFESTATIONS; CLASSIFICATION; RADIOGRAPHY; COMMUNITY
AB	The diagnosis of ankylosing spondylitis is mainly based on a radiograph of the sacroiliac joints. Thus, this is the standard imaging test. However, in the early phase of disease, conventional radiographs are often too insensitive to show sacroiliitis. In this clinical situation, HLA B27 testing and new imaging modalities such as magnetic resonance imaging may be helpful. Early forms of AS can be initially classified as undifferentiated spondyloarthritis. All subsets of spondyloarthritides may evolve later into AS. Since AS in association with psoriasis and chronic inflammatory bowel diseases is often HLA B27-negative, this test is of limited value under these circumstances. The usefulness of testing for HLA B27 and its subtypes differs among ethnic and racial groups. The value of this test for diagnosis depends on the individual pre-test probability in each setting.
C1	Case Western Reserve Univ, Cleveland, OH 44106 USA.
RP	Khan, MA, Metrohlth Med Ctr, Div Rheumatol, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.
CR	BALL EJ, 2001, JOINT BONE SPINE, V68, P378 BANARES A, 1998, RHEUM DIS CLIN N AM, V24, P771 BERGFELDT L, 1997, ANN INTERN MED 1, V127, P621 BLACKBURN WD, 1988, AM J MED, V85, P766 BOLLOW M, 1998, SKELETAL RADIOL, V27, P606 BOYER GS, 1997, ARCH INTERN MED, V157, P2111 BOYER GS, 1999, J RHEUMATOL, V26, P1537 BRAUN J, 1998, RHEUM DIS CLIN N AM, V24, P697 CALIN A, 1998, SPONDYLARTHRITIDES, P1 CASSIDY JT, 2001, TXB PEDIAT RHEUMATOL COLLANTES E, 2000, JOINT BONE SPINE, V67, P516 DAMATO M, 1995, DIS MARKERS, V12, P215 DEYO RA, 2001, NEW ENGL J MED, V344, P363 DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218 ERTURK M, 1997, REV RHUM, V64, P293 FELDTKELLER E, IN PRESS RHEUMATOL I FELTKAMP TEW, 2001, CURR OPIN RHEUMATOL, V13, P285 GRANFORS K, 2002, ARTHRITIS RHEUM, V43, P606 HUPPERTZ HI, 2000, PEDIATR CARDIOL, V21, P141 JEVTIC V, 2000, SKELETAL RADIOL, V29, P27 KHAN MA, 1977, ARTHRITIS RHEUM, V20, P909 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1984, PROGR CLIN RHEUMATOL, V1, P145 KHAN MA, 1984, SPONDYLARTHROPATHIES, P323 KHAN MA, 1985, ARTHRITIS RHEUM, V28, P40 KHAN MA, 1990, SEMIN ARTHRITIS RHEU, V20, P107 KHAN MA, 1995, CURR OPIN RHEUMATOL, V7, P263 KHAN MA, 1998, RHEUMATOLOGY KHAN MA, 2000, J RHEUMATOL, V27, P1110 KHAN MA, 2002, ANN INTERN MED, V136, P896 KHAN MA, 2002, IN PRESS BAILLIERES KIDD BL, 1988, BR J RHEUMATOL, V27, P230 KIM TH, 1997, SCAND J RHEUMATOL, V26, P218 KUMAR A, 2001, RHEUMATOL INT, V20, P221 MADER R, 1999, SEMIN ARTHRITIS RHEU, V29, P191 MAU W, 1988, J RHEUMATOL, V15, P1109 MCGONAGLE D, 1999, CURR OPIN RHEUMATOL, V11, P244 MOLL JMH, 1974, MEDICINE, V53, P343 NASUTION AR, 1997, J RHEUMATOL, V24, P1111 OLIVIERI I, 2001, CURR OPIN RHEUMATOL, V13, P280 OLIVIERI I, 2002, ARTHRITIS RHEUM, V46, P553 OOSTVEEN J, 1999, J RHEUMATOL, V26, P1953 PATO E, 2000, J RHEUMATOL, V27, P2198 ROLDAN CA, 1998, J AM COLL CARDIOL, V32, P1397 SIEPER J, 2002, ARTHRITIS RHEUM, V46, P319 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDERLINDEN SJ, 2000, KELLEYS TXB RHEUMATO, P1039 YAGAN R, 1990, SPINE STATE ART REV, V4, P561 YU W, 1998, SKELETAL RADIOL, V27, P311 ZEIDLER H, 1992, RHEUM DIS CLIN N AM, V18, P187
NR	50
TC	9
PU	CLINICAL & EXPER RHEUMATOLOGY
PI	PISA
PA	VIA SANTA MARIA 31, 56126 PISA, ITALY
SN	0392-856X
J9	CLIN EXP RHEUMATOL
JI	Clin. Exp. Rheumatol.
PD	NOV-DEC
PY	2002
VL	20
IS	6
SU	Suppl. 28
BP	S6
EP	S10
PG	5
SC	Rheumatology
GA	605WQ
UT	ISI:000178700400003
ER

---

PT	J
AU	Braun, J Pincus, T
TI	Mortality, course of disease and prognosis of patients with ankylosing spondylitis
SO	CLINICAL AND EXPERIMENTAL RHEUMATOLOGY
LA	English
DT	Article
DE	ankylosing spondylitis; prognosis; mortality; radiation
ID	SINGLE TREATMENT COURSE; ATOMIC-BOMB SURVIVORS; X-RAY TREATMENT; RHEUMATOID-ARTHRITIS; PREDICTIVE FACTORS; CANCER MORTALITY; WORK DISABILITY; PREVALENCE; OSTEOPOROSIS; INDEX
AB	Patients with ankylosing spondylitis (AS) have about a 50% increased risk of mortality on the basis of the limited amount of data available. There is some evidence that the progression of disease is strongest in the first 10 years of disease but it is also clear that the disease keeps on being active for further decades. The overall burden of disease is similar to rheumatoid arthritis but the overall disease duration of AS is longer. Prognostic factors have also not been studied extensively in AS but it seems clear that early hip involvement indicates a worse outcome. The same is true for early limitation of spinal mobility, laboratory evidence of ongoing disease activity (ESR, hypergammaglobulinemia), peripheral arthritis and dactylitis. The significance of organ involvement for the prognosis, especially in the kidney in the form of amyloidosis, and in the heart and lungs, is less clear. Radiation therapy of the spine, which had been performed quite extensively informer decades, has been associated with a mean radiation dose of about double that of atomic bomb survivors and an increased risk of leukemia and mortality. This therapy has been largely abandoned nowadays. Elder rheumatologists report however that the clinical improvement of irradiated patients has been partly impressive.
C1	St Josefs Hosp, Rheumazentrum Ruhrgebiet, D-44652 Herne, Germany. Vanderbilt Univ, Ctr Med, Div Rheumatol & Immunol, Dept Med, Nashville, TN 37232 USA.
RP	Braun, J, St Josefs Hosp, Rheumazentrum Ruhrgebiet, D-44652 Herne, Germany.
CR	AMOR B, 1994, J RHEUMATOL, V21, P1883 BERGFELDT L, 1982, AM J MED, V73, P187 BERGFELDT L, 1987, ACTA MED SCAND, V222, P293 BERGFELDT L, 1997, ANN INTERN MED 1, V127, P621 BOONEN A, 2001, ANN RHEUM DIS, V60, P353 BOONEN A, 2002, ANN RHEUM DIS, V61, P429 BOONEN A, 2002, ANN RHEUM DIS, V61, P658 BRANDT J, 2000, ARTHRITIS RHEUM, V43, P1346 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 2002, LANCET, V359, P1187 BROPHY S, 2002, J RHEUMATOL, V29, P1236 BROWN WM, 1965, BRIT MED J, V5474, P1327 CARBONE LD, 1992, ARTHRITIS RHEUM, V35, P1476 CARETTE S, 1983, ARTHRITIS RHEUM, V26, P186 CARTER ET, 1979, ARTHRITIS RHEUM, V22, P365 CLAUDEPIERRE P, 1995, BRIT J RHEUMATOL, V34, P1139 COOPER C, 1994, J RHEUMATOL, V21, P1877 DARBY SC, 1985, J NATL CANCER I, V75, P1 DARBY SC, 1987, BRIT J CANCER, V55, P179 DONNELLY S, 1994, ANN RHEUM DIS, V53, P117 ELMAGHRAOUI A, 1999, J RHEUMATOL, V26, P2205 FELDTKELLER E, 1999, Z RHEUMATOL, V58, P21 GARRETT S, 1994, J RHEUMATOL, V21, P2286 GARRETT S, 1994, J RHEUMATOL, V21, P2286 GORMAN JD, 2002, NEW ENGL J MED, V346, P1349 GRAHAM B, 1989, SPINE, V14, P803 GRAN JT, 1985, ANN RHEUM DIS, V44, P359 GRAN JT, 1997, BRIT J RHEUMATOL, V36, P766 GRATACOS J, 1999, ARTHRITIS RHEUM, V42, P2319 HAMERSMA J, 2001, ARTHRITIS RHEUM, V44, P1396 KHAN MA, 1981, J RHEUMATOL, V8, P86 KOCH W, 1969, VERH DTSCH GES RHEUM, V1, P132 LEHTINEN K, 1980, SCAND J RHEUMATOL, V9, P145 LEHTINEN K, 1983, SCAND J RHEUMATOL, V12, P3 LEHTINEN K, 1983, SCAND J RHEUMATOL, V12, P5 LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174 LITTLE MP, 1999, RADIAT RES, V152, P280 MACKAY K, 1998, ARTHRITIS RHEUM, V41, P2263 MACKAY K, 2000, J RHEUMATOL, V27, P2866 MYLLYKANGASLUOSUJARVI R, 1998, BRIT J RHEUMATOL, V37, P688 NEKOLLA EA, 2000, RADIAT RES, V153, P93 PINCUS T, 1984, ARTHRITIS RHEUM, V27, P864 RADFORD EP, 1977, NEW ENGL J MED, V297, P572 RALSTON SH, 1990, BRIT MED J, V300, P563 SARAUX A, 1999, J RHEUMATOL, V26, P2622 SMITH PG, 1982, BRIT MED J, V284, P449 WARD MM, 1999, ARTHRIT CARE RES, V12, P247 WEISS HA, 1994, INT J CANCER, V59, P327 WEISS HA, 1995, RADIAT RES, V142, P1 WICK RR, 1999, RADIAT RES S, V152, S8 WILL R, 1989, LANCET, V2, P1483 ZINK A, 2000, J RHEUMATOL, V27, P613 ZINK A, 2001, ANN RHEUM DIS, V60, P199
NR	53
TC	21
PU	CLINICAL & EXPER RHEUMATOLOGY
PI	PISA
PA	VIA SANTA MARIA 31, 56126 PISA, ITALY
SN	0392-856X
J9	CLIN EXP RHEUMATOL
JI	Clin. Exp. Rheumatol.
PD	NOV-DEC
PY	2002
VL	20
IS	6
SU	Suppl. 28
BP	S16
EP	S22
PG	7
SC	Rheumatology
GA	605WQ
UT	ISI:000178700400005
ER

---

PT	J
AU	Gao, YS Leung, MKH
TI	Combined classification of multiple views using facial corners
SO	INTERNATIONAL JOURNAL OF PATTERN RECOGNITION AND ARTIFICIAL INTELLIGENCE
LA	English
DT	Article
DE	combined classification; multiple view; fusion; face recognition; facial corner; point matching
ID	MODIFIED HAUSDORFF DISTANCE; FACE PROFILE RECOGNITION; EDGE-DETECTION; NEURAL-NETWORK
AB	The profile view of a face provides a complementary structure that is not seen in the frontal view. The classification system combining both frontal and profile views of faces can improve the classification accuracy. And it would be more foolproof because it is difficult to fool the profile face identification by a mask. This paper proposes a new face recognition approach, which can be applied on both frontal and profile faces, to build a robust combined multiple view face identification system. The recognition employs a novel facial corner coding and matching method, and integrates the outline and interior facial parts in the profile matching. The proposed multiview modified Hausdorff distance fuses multiple views of faces to achieve an improved system performance.
C1	Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore.
RP	Gao, YS, Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore.
CR	AIBARA T, 1993, OPT ENG, V32, P861 BERGHOLM F, 1987, IEEE T PATTERN ANAL, V9, P726 BICHSEL M, 1991, THESIS EIDGENOSSISCH BOYER KL, 1992, SPIE, V1708, P353 BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042 CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679 CHEN G, 1995, IEEE T SYST MAN CYB, V25, P636 COX IJ, 1996, COMPUTER VISION PATT DUBUISSON MP, 1994, P 12 INT C PATT REC, P566 HARMON LD, 1977, COMPUTER GRAPHICS IM, V6, P135 HARMON LD, 1978, PATTERN RECOGN, V10, P301 HARMON LD, 1981, PATTERN RECOGN, V13, P97 HEATH M, 1998, COMPUT VIS IMAGE UND, V69, P38 HEATH MD, 1997, IEEE T PATTERN ANAL, V19, P1338 HUTTENLOCHER DP, 1993, IEEE T PATTERN ANAL, V15, P850 IVERSON LA, 1995, IEEE T PATTERN ANAL, V17, P982 KAUFMAN GJ, 1976, IEEE T SYST MAN CYB, V6, P113 KAYA Y, 1972, FRONTIERS PATTERN RE KOTROPOULOS C, 2000, IEEE T MULTIMEDIA, V2, P14 KUNG SY, 1995, IEEE T NEURAL NETWOR, V6, P170 LADES M, 1993, IEEE T COMPUT, V42, P300 LAWRENCE S, 1997, IEEE T NEURAL NETWOR, V8, P98 LEUNG MK, 1990, PATTERN RECOGN, V23, P69 LIN SH, 1997, IEEE T NEURAL NETWOR, V8, P114 MANJUNATH BS, 1992, P IEEE COMP SOC C CO, P373 MARR D, 1980, P ROY SOC LOND B BIO, V207, P187 MARR D, 1981, VISION COMPUTATIONAL NALWA VS, 1986, IEEE T PATTERN ANAL, V8, P699 NEVATIA R, 1980, COMPUT GRAPHICS IMAG, V13, P257 PENTLAND A, 1994, P IEEE C COMP VIS PA, P84 ROBERTS LG, 1965, OPTICAL ELECTROOPTIC, P159 ROTHWELL CA, 1995, INT S COMP VIS COR G, P395 SAMARIA F, 1993, IMAGE PROCESSING THE SOBEL IE, 1970, THESIS STANFORD U TAKACS B, 1998, PATTERN RECOGN, V31, P1873 TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71 WISKOTT L, 1996, NEUROIMAGE 2, V4, S14 WU CJ, 1990, PATTERN RECOGN, V23, P255 YU K, 1995, P INT WORKSH AUT FAC, P208 YU K, 1996, P IEEE INT C IM PROC, P491
NR	40
TC	0
PU	WORLD SCIENTIFIC PUBL CO PTE LTD
PI	SINGAPORE
PA	JOURNAL DEPT PO BOX 128 FARRER ROAD, SINGAPORE 912805, SINGAPORE
SN	0218-0014
J9	INT J PATTERN RECOGNIT ARTI I
JI	Int. J. Pattern Recognit. Artif. Intell.
PD	AUG
PY	2002
VL	16
IS	5
BP	589
EP	602
PG	14
SC	Computer Science, Artificial Intelligence
GA	592YQ
UT	ISI:000177964800005
ER

---

PT	J
AU	Gadjiev, AD Orhan, C
TI	Some approximation theorems via statistical convergence
SO	ROCKY MOUNTAIN JOURNAL OF MATHEMATICS
LA	English
DT	Article
DE	statistical convergence; positive linear operator; the Korovkin theorem; Weierstrass approximation theorem
AB	In this paper we prove some Korovkin and Weierstrass type approximation theorems via statistical convergence. We are also concerned with the order of statistical convergence of a sequence of positive linear operators.
C1	Azerbaijan Acad Sci, Inst Math & Mech, Baku, Azerbaijan.
RP	Gadjiev, AD, Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
CR	ALTOMARE F, 1994, KOROVKIN TYPE APPROX CONNOR JS, 1988, ANALYSIS, V8, P47 ERDOS P, 1989, P LOND MATH SOC, V59, P417 FAST H, 1951, C MATH, V2, P241 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1993, J MATH ANAL APPL, V173, P497 FRIDY JA, 1998, J MATH ANAL APPL, V228, P73 GADZIEV AD, 1974, SOV MATH DOKL, V15, P1433 KOROVKIN PP, 1960, LINEAR OPERATORS THE MILLER HI, 1995, T AM MATH SOC, V347, P1811 PEHLIVAN S, 2000, OPTIMIZATION, V48, P93 SALAT T, 1980, MATH SLOVACA, V30, P139 SCHOENBERG IJ, 1959, AM MATH MONTHLY, V66, P361 ZYGMUND A, 1979, TRIGONOMETRIC SERIES
NR	14
TC	16
PU	ROCKY MT MATH CONSORTIUM
PI	TEMPE
PA	ARIZ STATE UNIV, DEPT MATH, TEMPE, AZ 85287-1904 USA
SN	0035-7596
J9	ROCKY MT J MATH
JI	Rocky Mt. J. Math.
PD	SPR
PY	2002
VL	32
IS	1
BP	129
EP	138
PG	10
SC	Mathematics
GA	568QZ
UT	ISI:000176555000008
ER

---

PT	J
AU	Khan, MA
TI	Update on spondyloarthropathies
SO	ANNALS OF INTERNAL MEDICINE
LA	English
DT	Review
ID	INFLAMMATORY-BOWEL-DISEASE; COMPLICATING ANKYLOSING-SPONDYLITIS; RANDOMIZED CONTROLLED TRIAL; REACTIVE ARTHRITIS; PSORIATIC-ARTHRITIS; REITERS-SYNDROME; RHEUMATOID-ARTHRITIS; CLINICAL-FEATURES; CROHNS-DISEASE; DOUBLE-BLIND
AB	Spondyloarthropathies are a cluster of Interrelated and overlapping chronic Inflammatory rheumatic diseases that primarily include ankylosing spondylitis, reactive arthritis, and the arthritis associated with psoriasis and inflammatory bowel diseases. The primary pathologic sites are the entheses (the sites of bony insertion of ligaments and tendons); the axial skeleton, including the sacroiliac joints; the limb joints; and some nonarticular structures, such as the gut skin, eye, and aortic valve. Although spondyloarthropathles are not associated with rheumatoid factor, they show a strong association with HLA-1327; however, this association varies markedly among various spondyloarthropathles and among ethnic groups. The most widely used classification criterion, from the European Spondyloarthropathy Study Group, encompasses the currently recognized wider disease spectrum, with a sensitivity and specificity that generally exceed 85%. Spondyloarthropathies occur in genetically predisposed persons and are triggered by environmental factors, but the cellular and molecular mechanisms of Inflammation are not yet fully understood. Chlamyclial and many enterobacterial infections can trigger reactive arthritis, but an infectious trigger for ankylosing spondylitis has not yet been established. HLA-1327 Itself is involved In enhancing genetic susceptibility, but the underlying molecular basis Is still unknown; additional genes include the putative susceptibility genes for Crohn disease, ulcerative colitis, and psoriasis. A specific susceptibility gene for Crohn disease, NOD2, Is located on chromosome 16q12, and one of the candidate genes for psoriasis, PSORS1, has been mapped to a 60-kb fragment on chromosome 6p, which Is telomeric to the HLA-C locus. This paper reviews the efficacy of anti-tumor necrosis factor-a therapy and other therapeutic advances.
C1	Case Western Reserve Univ, Metrohlth Med Ctr, Div Rheumatol, Cleveland, OH 44109 USA.
RP	Khan, MA, Case Western Reserve Univ, Metrohlth Med Ctr, Div Rheumatol, 2500 Metrohlth Dr, Cleveland, OH 44109 USA.
CR	AHLSTROM H, 1990, ARTHRITIS RHEUM, V33, P1763 ALARANTA H, 2002, CLIN EXP RHEUMATOL, V20, P66 ALARFAJ A, 2001, CLIN EXP RHEUMATOL, V19, P184 ALHARBI SA, 1996, EUR J IMMUNOGENET, V23, P67 ALVAREZ I, 2000, CURR OPIN RHEUMATOL, V12, P248 AMOR B, 1998, RHEUM DIS CLIN N AM, V24, P677 BAFIARES A, 1998, RHEUM DIS CLIN N AM, V24, P771 BAKKER C, 1994, J RHEUMATOL, V21, P264 BALL EJ, 2001, JOINT BONE SPINE, V68, P378 BARDIN T, 1992, ARTHRITIS RHEUM, V35, P190 BARTON AC, 2001, J RHEUMATOL, V28, P3 BENJAMIN M, 2001, J ANAT 5, V199, P503 BERGFELDT L, 1997, ANN INTERN MED 1, V127, P621 BHALERAO J, 1998, HUM MOL GENET, V7, P1537 BLACKBURN WD, 1988, AM J MED, V85, P766 BOLLOW M, 1998, J RHEUMATOL, V25, P556 BOLLOW M, 2000, ANN RHEUM DIS, V59, P135 BOYER GS, 1997, ARCH INTERN MED, V157, P2111 BOYER GS, 1999, J RHEUMATOL, V26, P1537 BRANDT J, 2000, ARTHRITIS RHEUM, V43, P1346 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 BRAUN J, 1998, RHEUM DIS CLIN N AM, V24, P697 BRAUN J, 2000, ANN RHEUM DIS, V59, P985 BRAUN J, 2001, CURR OPIN RHEUMATOL, V13, P245 BRAUN J, 2002, LANCET, V35, P1187 BREBAN M, 1999, ARTHRITIS RHEUM, V42, P580 BREWERTON DA, 1973, LANCET, V1, P904 BROWN MA, 1996, ANN RHEUM DIS, V55, P268 BROWN MA, 1997, ARTHRITIS RHEUM, V40, P1823 BRUCE IN, 2001, RHEUMATOLOGY, V40, P363 BULSTRODE SJ, 1987, BRIT J RHEUMATOL, V26, P40 CALABRESE L, 2000, AM J MED, V108, P487 CALIN A, 1998, SPONDYLARTHRITIDES, P1 CASSIDY JT, 2001, TXB PEDIAT RHEUMATOL COLBERT RA, 2000, J RHEUMATOL, V27, P1107 COLLANTES E, 2000, JOINT BONE SPINE, V67, P516 DAWES PT, 1988, POSTGRAD MED J, V64, P27 DEVLAM K, 2000, J RHEUMATOL, V27, P2860 DOUGADOS M, 1998, THERAPY SYSTEMIC RHE, P375 DOUGADOS M, 2002, IN PRESS ANN RHEUM D DUCHMANN R, 2001, CLIN EXP IMMUNOL, V123, P315 EBRINGER A, 2000, J MED MICROBIOL, V49, P305 EDWARDS JCW, 2000, IMMUNOL TODAY, V21, P256 ERTURK M, 1997, REV RHUM, V64, P293 FELDTKELLER E, 2000, CURR OPIN RHEUMATOL, V12, P239 FINKELSTEIN JA, 1999, SPINAL CORD, V37, P444 FIORILLO MT, 2000, J CLIN INVEST, V106, P47 FRANCOIS RJ, 2000, ARTHRITIS RHEUM, V43, P2011 FRANCOIS RJ, 2001, CURR OPIN RHEUMATOL, V13, P255 FRYDEN A, 1990, BRIT MED J, V301, P1299 GARCIA F, 1997, TISSUE ANTIGENS, V49, P23 GORMAN JD, 2002, NEW ENGL J MED, V346, P1349 GRAN JT, 1985, ANN RHEUM DIS, V44, P359 GRANFORS K, 2002, ARTHRITIS RHEUM, V46, P606 GRATACOS J, 1999, ARTHRITIS RHEUM, V42, P2319 HAMPE J, 2001, LANCET, V357, P1925 HANNU T, 1999, RHEUMATOLOGY, V38, P411 HIDDING A, 1994, ARTHRIT CARE RES, V7, P90 HOHLER T, 2001, CURR OPIN RHEUMATOL, V13, P273 HUGHES RA, 1994, SEMIN ARTHRITIS RHEU, V24, P190 HUGOT JP, 2001, NATURE, V411, P599 HUKUDA S, 2001, J RHEUMATOL, V28, P554 HUPPERTZ HI, 2000, PEDIATR CARDIOL, V21, P141 INMAN RD, 2000, CURR OPIN RHEUMATOL, V12, P254 KANAKOUDITSAKALIDOU F, 1998, SCAND J RHEUMATOL, V27, P431 KEAT A, 1999, ADV EXP MED BIOL, V455, P201 KHAN MA, 1977, ARTHRITIS RHEUM, V20, P909 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1984, PROGR CLIN RHEUMATOL, V1, P145 KHAN MA, 1985, ARTHRITIS RHEUM, V28, P40 KHAN MA, 1990, SEMIN ARTHRITIS RHEU, V20, P107 KHAN MA, 1992, SPONDYLOARTROPATHIES KHAN MA, 1995, CURR OPIN RHEUMATOL, V7, P263 KHAN MA, 1998, ATLAS RHEUMATOLOGY KHAN MA, 1998, RHEUMATOLOGY KHAN MA, 1999, CONNS CURRENT THERAP, P944 KHAN MA, 2000, J RHEUMATOL, V27, P1110 KHARE SD, 1998, CURR OPIN RHEUMATOL, V10, P282 KIDD BL, 1988, BR J RHEUMATOL, V27, P230 KIM TH, 1997, SCAND J RHEUMATOL, V26, P218 KOH WH, 1997, J RHEUMATOL, V24, P2158 KRAAG G, 1990, J RHEUMATOL, V17, P228 LALOUX L, 2001, ANN RHEUM DIS, V60, P316 LANGE U, 2001, OSTEOPOROSIS INT, V12, P1031 LAUHIO A, 1991, ARTHRITIS RHEUM, V34, P6 LAVAL SH, 2001, AM J HUM GENET, V68, P918 LORIG KR, 1993, ARTHRITIS RHEUM, V36, P439 LOVELL DJ, 2000, NEW ENGL J MED, V342, P763 MADER R, 1999, SEMIN ARTHRITIS RHEU, V29, P191 MAKSYMOWYCH WP, 2000, J RHEUMATOL, V27, P2295 MAKSYMOWYCH WP, 2001, J RHEUMATOL, V28, P144 MAKSYMOWYCH WP, 2002, ARTHRITIS RHEUM, V46, P766 MARTINEZBORRA J, 2000, HUM IMMUNOL, V61, P131 MCGONAGLE D, 1998, LANCET, V352, P1137 MCGONAGLE D, 1999, CURR OPIN RHEUMATOL, V11, P244 MEASE PJ, 2000, LANCET, V356, P385 MIJIYAWA M, 2000, CURR OPIN RHEUMATOL, V12, P281 MITRA D, 2000, RHEUMATOLOGY, V39, P85 MOLL JMH, 1973, SEM ARTHRITIS RHEUM, V3, P55 MOLL JMH, 1974, MEDICINE, V53, P343 NAIR RP, 2000, AM J HUM GENET, V66, P1833 NASUTION AR, 1997, J RHEUMATOL, V24, P1111 NESHER G, 1999, J RHEUMATOL, V26, P1638 NJOBVU P, 2000, J RHEUMATOL, V27, P1699 OGURA Y, 2001, NATURE, V411, P603 OLIVIERI I, 2001, CURR OPIN RHEUMATOL, V13, P280 OLIVIERI I, 2002, ARTHRITIS RHEUM, V46, P553 PAL B, 1998, CLIN RHEUMATOL, V17, P306 PATO E, 2000, J RHEUMATOL, V27, P2198 POOLE AR, 1998, AM J MED SCI, V316, P228 QUEIRO R, 2000, CLIN RHEUMATOL, V19, P445 RESNICK D, 1981, CLIN NUCL MED, V6, P213 REVEILLE JD, 2001, CURR OPIN RHEUMATOL, V13, P265 ROLDAN CA, 1998, J AM COLL CARDIOL, V32, P1397 ROYCHAUDHRY B, 2001, RHEUMATOLOGY S1, V40, P43 SAIDNAHAL R, 2000, ARTHRITIS RHEUM, V43, P1356 SAIDNAHAL R, 2002, ANN RHEUM DIS, V61, P201 SALMI M, 2001, J IMMUNOL, V166, P4650 SARAUX A, 1999, J RHEUMATOL, V26, P2622 SCHWARTZENBERG JM, 1999, J RHEUMATOL, V26, P933 SCOFIELD RH, 1993, P NATL ACAD SCI USA, V90, P9330 SHIH TTF, 2001, J COMPUT ASSIST TOMO, V25, P164 SIEPER J, 1999, ARTHRITIS RHEUM, V42, P1386 SIEPER J, 2002, ARTHRITIS RHEUM, V46, P319 SMALE S, 2001, ARTHRITIS RHEUM, V44, P2728 SPOORENBERG A, 1999, J RHEUMATOL, V26, P980 TAUROG JD, 1999, IMMUNOL REV, V169, P209 TICO N, 1998, SPINAL CORD, V36, P349 TOIVANEN A, 1993, CLIN EXP RHEUMATOL, V11, P301 VANDENBOSCH F, 2002, ARTHRITIS RHEUM, V46, P755 VANDERHEIJDE D, 1999, J RHEUMATOL, V26, P945 VANDERHEIJDE D, 1999, J RHEUMATOL, V26, P951 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDERLINDEN S, 1998, RHEUM DIS CLIN N AM, V24, P663 VANDERLINDEN SM, 1988, J RHEUMATOL, V15, P836 WAKEFIELD D, 1999, ARTHRITIS RHEUM, V42, P1894 WENDLING D, 2000, JOINT BONE SPINE, V67, P259 WINCHESTER R, 1987, ANN INTERN MED, V106, P19 WINCHESTER R, 1999, CURR OPIN RHEUMATOL, V11, P251 YU D, 2000, KELLEYS TXB RHEUMATO, P1039 ZABRANIECKI L, 2001, JOINT BONE SPINE, V68, P106 ZEIDLER H, 1992, RHEUM DIS CLIN N AM, V18, P187
NR	142
TC	97
PU	AMER COLL PHYSICIANS
PI	PHILADELPHIA
PA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA
SN	0003-4819
J9	ANN INTERN MED
JI	Ann. Intern. Med.
PD	JUN 18
PY	2002
VL	136
IS	12
BP	896
EP	907
PG	12
SC	Medicine, General & Internal
GA	563JL
UT	ISI:000176252500007
ER

---

PT	J
AU	Hedayat, AS Yan, B Pezzuto, JM
TI	Optimum designs for estimating EDp based on raw optical density data
SO	JOURNAL OF STATISTICAL PLANNING AND INFERENCE
LA	English
DT	Article
DE	nonlinear model; efficient designs; robustness; skewed models; inforination matrix; EDp-optimal; dose-response analysis; drug discovery
ID	BINARY DATA
AB	For raw optical density (ROD) data, such as those generated in biological assays employing an ELISA plate reader, EDp-optinial designs are identified for a family of homogeneous non-linear models with two parameters, In every case, the theoretical EDp-optimal design is a design with one or two support points. These theoretical optimal designs might not be suitable for many practical applications. To overcome this shortcoming, we have specified EDp-optimal designs within the class of k-point equally spaced and uniform designs. The efficiency robustness of these designs with respect to initial nominal values of the parameters have been investigated. (C) 2002 Elsevier Science B.V. All rights reserved.
C1	Univ Illinois, Dept Math Stat & Comp Sci, Chicago, IL 60607 USA. Univ Illinois, Dept Med Chem & Pharmacognosy, Chicago, IL 60607 USA.
CR	ABDELBASIT KM, 1983, J AM STAT ASSOC, V78, P90 CHERNOFF H, 1972, SEQUENTIAL ANAL OPTI ELFVING G, 1952, ANN MATH STAT, V23, P255 FEDOROV VV, 1972, THEORY OPTIMAL EXPT FINNEY DJ, 1964, STAT METHOD BIOL ASS FINNEY DJ, 1977, APPL STATIST, V26, P312 FORD I, 1992, J R STAT SOC B, V54, P569 GAUDARD MA, 1993, STAT SINICA, V3, P233 HEDAYAT AS, 1997, J AM STAT ASSOC, V92, P1132 KARPINSKI KF, 1990, BIOMETRICS, V46, P381 KHAN MK, 1988, J STATISTICAL PLANNI, V18, P83 LIKHITWITAYAWUI.K, 1993, J NAT PRODUCTS, V56, P30 MINKIN S, 1987, J AM STAT ASSOC, V82, P1098 MINKIN S, 1993, J AM STAT ASSOC, V88, P410 SITTER RR, 1993, SCAND J STAT, V20, P329 SUFFNESS M, 1991, METHODS PLANT BIOCH, V6, P71 TSUTAKAWA R, 1980, APPL STATIST, V29, P25 WHITE LV, 1973, BIOMETRIKA, V60, P345 WU CFJ, 1988, OPTIMAL DESIGN ANAL, P213
NR	19
TC	2
PU	ELSEVIER SCIENCE BV
PI	AMSTERDAM
PA	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN	0378-3758
J9	J STATIST PLAN INFER
JI	J. Stat. Plan. Infer.
PD	MAY 1
PY	2002
VL	104
IS	1
BP	161
EP	174
PG	14
SC	Statistics & Probability
GA	544GM
UT	ISI:000175149900009
ER

---

PT	J
AU	Sieper, J Rudwaleit, M Braun, J van der Heijde, D
TI	Diagnosing reactive arthritis - Role of clinical setting in the value of serologic and microbiologic assays
SO	ARTHRITIS AND RHEUMATISM
LA	English
DT	Review
ID	4TH INTERNATIONAL-WORKSHOP; CHLAMYDIA-TRACHOMATIS DNA; POLYMERASE-CHAIN-REACTION; SYNOVIAL-FLUID; UNDIFFERENTIATED OLIGOARTHRITIS; PRELIMINARY CRITERIA; HEALTHY POPULATIONS; REITERS-SYNDROME; NUCLEIC-ACIDS; DOUBLE-BLIND
C1	Free Univ Berlin, Klinikum Benjamin Franklin, D-12200 Berlin, Germany. German Rheumatol Res Ctr, Berlin, Germany. Univ Hosp Maastricht, Maastricht, Netherlands. Limburgs Univ Ctr, Diepenbeek, Belgium.
RP	Sieper, J, Free Univ Berlin, Klinikum Benjamin Franklin, Hindenburgdamm 30, D-12200 Berlin, Germany.
CR	*CDCP, 1999, MMWR-MORBID MORTAL W, V47, P2 AMOR B, 1983, CLIN RHEUMATOL, V2, P315 BAS S, 1995, ARTHRITIS RHEUM, V38, P1005 BAS S, 1996, BRIT J RHEUMATOL, V35, P542 BAS S, 1997, BRIT J RHEUMATOL, V36, P198 BAS S, 1998, BRIT J RHEUMATOL, V37, P1054 BAS S, 2001, J CLIN MICROBIOL, V39, P1368 BRANIGAN PJ, 1996, ARTHRITIS RHEUM, V39, P1740 BRAUN J, 2000, J RHEUMATOL, V27, P2185 BREWERTON DA, 1973, LANCET, V2, P996 CALIN A, 1984, SPONDYLARTHROPATHIES, P119 CLEGG DO, 1999, ARTHRITIS RHEUM, V42, P2325 DOUGADOS M, 1991, ARTHRITIS RHEUM, V34, P1218 ELGABALAWY HS, 1999, ARTHRITIS RHEUM, V42, P1696 FENDLER C, 2001, ANN RHEUM DIS, V60, P337 FREISE J, 2001, ANN RHEUM DIS, V60, P140 GAYDOS CA, 1998, NEW ENGL J MED, V339, P739 GRANFORS K, 1980, J INFECT DIS, V141, P424 GRANFORS K, 1998, ARTHRITIS RHEUM, V41, P855 HANNU T, 1999, RHEUMATOLOGY, V38, P411 HULSEMANN JL, 1995, CLIN EXP RHEUMATOL, V13, P37 ISOMAKI O, 1989, LANCET, V1, P1411 KEAT AC, 1980, ANN RHEUM DIS, V39, P431 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1992, RHEUM DIS CLIN N AM, V18, P1 KHAN MA, 1998, SPONDYLARTHRITIDES, P17 KINGSLEY G, 1996, ANN RHEUM DIS, V55, P564 KUIPERS JG, 1999, ANN RHEUM DIS, V58, P103 KVIEN TK, 1994, J RHEUMATOL, V21, P115 LAUHIO A, 1991, ARTHRITIS RHEUM, V34, P6 MAKIIKOLA O, 1991, J INFECT DIS, V164, P1141 MAKIIKOLA O, 1993, BRIT J RHEUMATOL, V32, P262 MAKIIKOLA O, 1997, RHEUMATOL INT, V16, P227 MATTILA L, 1994, BRIT J RHEUMATOL, V33, P1136 PACHECOTENA C, 1999, J RHEUMATOL, V26, P1338 RABENAU H, 1997, LANCET, V349, P1024 RICH E, 1996, ARTHRITIS RHEUM, V39, P1172 SACKETT DL, 1991, CLIN EPIDEMIOLOGY BA, P69 SCHUMACHER HR, 1999, ARTHRITIS RHEUM, V42, P1281 SIEPER J, 1992, J RHEUMATOL, V19, P1236 SIEPER J, 1996, BAILLIERE CLIN RHEUM, V10, P105 SIEPER J, 1998, BRIT J RHEUMATOL, V37, P717 SIEPER J, 1999, ARTHRITIS RHEUM, V42, P1386 SIEPER J, 1999, J RHEUMATOL, V26, P1222 SIEPER J, 2000, ARTHRITIS RHEUM, V43, P720 WILKINSON NZ, 1998, ARTHRITIS RHEUM, V41, P845 WILLKENS RF, 1981, ARTHRITIS RHEUM, V24, P844
NR	47
TC	33
PU	WILEY-LISS
PI	NEW YORK
PA	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN	0004-3591
J9	ARTHRITIS RHEUM
JI	Arthritis Rheum.
PD	FEB
PY	2002
VL	46
IS	2
BP	319
EP	327
PG	9
SC	Rheumatology
GA	520MN
UT	ISI:000173785800006
ER

---

PT	J
AU	Gavrea, I
TI	On global smoothness preservation by Bernstein operators
SO	JOURNAL OF COMPUTATIONAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
DE	global smoothness preservation; best constants; Bernstein operator; second-order modulus
ID	LIPSCHITZ CONTINUOUS FUNCTION; CONSTANTS
AB	We investigate the global smoothness preservation by Bernstein operators measured by second-order modulus of smoothness and give a partial answer for a conjecture raised by H. H. Gonska in 1998.
C1	Tech Univ Cluj Napoca, Cluj Napoca, Romania.
RP	Gavrea, I, Tech Univ Cluj Napoca, Str C Diacoviciu 15, Cluj Napoca, Romania.
CR	ADELL J, 1997, P INT C APPR OPT ROM, P147 ANASTASSIOU GA, 1991, ANALYSIS, V11, P43 BROWN BM, 1987, J APPROX THEORY, V49, P196 GAVREA I, 1988, RES SEMINAR FAC MATH, V88, P175 GAVREA I, 1993, STUD U BABES BOLYAI, V38, P41 GONSKA HH, 1993, P 1 INT C NUM AN, P61 GONSKA HH, 1998, SCHRIFTENREIHE FACHB KHAN MK, 1989, J APPROX THEORY, V59, P307 KRATZ W, 1988, J APPROX THEORY, V54, P326 LINDVALL T, 1982, MATH SCI, V7, P127 ZHOU DX, 1995, RESULTS MATH, V28, P169
NR	11
TC	0
PU	KLUWER ACADEMIC/PLENUM PUBL
PI	NEW YORK
PA	233 SPRING ST, NEW YORK, NY 10013 USA
SN	1521-1398
J9	J COMPUT ANAL APPL
JI	J. Comput. Anal. Appl.
PD	JUL
PY	2001
VL	3
IS	3
BP	249
EP	257
PG	9
SC	Computer Science, Theory & Methods; Mathematics, Applied
GA	512QT
UT	ISI:000173335600005
ER

---

PT	J
AU	Gao, YS Leung, MKH
TI	Human face profile recognition using attributed string
SO	PATTERN RECOGNITION
LA	English
DT	Article
DE	attributed string; curve matching; face recognition; profile; syntactic; structural
ID	2D SHAPE-RECOGNITION; MATCHING TECHNIQUES
AB	A new attributed string matching method for human face profile recognition is proposed in this work. It is a novel idea to apply structural and syntactic technique on face profile matching. The approach works on a chain of profile line segments and highlights the favor of curve matching by suppressing the operations of insert and delete. The technique relies mainly on the merge and change operations of string to tackle the inconsistency problem of feature point detection. A quadratic penalty function is proposed to prohibit large angle changes and overmerging. The method produces very encouraging results and is found to be suitable for similar shape classification. (C) 2001 Pattern Recognition Society. Published by Elsevier Science Ltd. All rights reserved.
C1	Nanyang Technol Univ, Ctr Graph & Imaging Technol, Singapore 639798, Singapore. Nanyang Technol Univ, Sch Comp Engn, Singapore 639798, Singapore.
RP	Gao, YS, Nanyang Technol Univ, Ctr Graph & Imaging Technol, Singapore 639798, Singapore.
CR	AIBARA T, 1993, OPT ENG, V32, P861 AKIMOTO TA, 1990, P IAPR WORKSH MACH V, P291 BUNKE H, 1993, PATTERN RECOGN, V26, P1797 BUNKE H, 1994, HDB PATTERN RECOGNIT, P163 CAMPOS JC, 1993, PATTERN RECOGN, V26, P819 CORTELAZZO G, 1994, PATTERN RECOGN, V27, P1005 DINSTEIN I, 1991, PATTERN RECOGN, V24, P929 DOERMANN D, 1993, MACH VISION APPL, V26, P495 FU KS, 1982, SYNTACTIC PATTERN RE GAO Y, 1999, IEEE 2 WORKSH AUT ID, P173 HARMON LD, 1977, COMPUTER GRAPHICS IM, V6, P135 HARMON LD, 1978, PATTERN RECOGN, V10, P301 HARMON LD, 1981, PATTERN RECOGN, V13, P97 KAUFMAN GJ, 1976, IEEE T SYST MAN CYB, V6, P113 LEUNG MK, 1990, PATTERN RECOGN, V23, P69 MAES M, 1991, PATTERN RECOGN, V24, P433 NISHIDA H, 1996, IEEE T PATTERN ANAL, V18, P400 RATTARANGSI A, 1992, IEEE T PATTERN ANAL, V14, P430 TAKACS B, 1998, PATTERN RECOGN, V31, P1873 TING AT, 1998, THESIS NANYANG TECHN TSAI WH, 1985, IEEE T PATTERN ANAL, V7, P453 WU CJ, 1990, PATTERN RECOGN, V23, P255 YU K, 1995, P INT WORKSH AUT FAC, P208 YU K, 1996, P IEEE INT C IM PROC, P491
NR	24
TC	2
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0031-3203
J9	PATT RECOG
JI	Pattern Recognit.
PD	FEB
PY	2002
VL	35
IS	2
BP	353
EP	360
PG	8
SC	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic
GA	507AV
UT	ISI:000173005000005
ER

---

PT	J
AU	Turk, M
TI	A random walk through Eigenspace
SO	IEICE TRANSACTIONS ON INFORMATION AND SYSTEMS
LA	English
DT	Article
DE	face recognition; eigenfaces; computer vision
ID	TEMPORAL CORTEX; FACE RECOGNITION; EIGENFACES; TEMPLATES; MODELS; CELLS
AB	It has been over a decade since the "Eigenfaces" approach to automatic face recognition, and other appearance-based methods, made an impression on the computer vision research community and helped spur interest in vision systems being used to support biometrics and human-computer interface. In this paper I give a personal view of the original motivation fur the work, some of the strengths and limitation of the approach, and progress in the years since. Appearance-based approaches to recognition complement feature- or shape-based approaches, and a practical face recognition system should have elements of both. Eigenfaces is not a general approach to recognition, but rather one tool out of many to be applied and evaluated in the appropriate context.
C1	Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA.
RP	Turk, M, Univ Calif Santa Barbara, Dept Comp Sci, Santa Barbara, CA 93106 USA.
CR	BELHUMEUR PN, 1997, IEEE T PATTERN ANAL, V19, P711 BICHSEL M, 1996, P 2 INT C AUT FAC GE, P128 BLEDSOE WW, 1966, MAN MACHINE FACIAL R BRUCE V, 1988, RECOGNIZING FACES BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042 BURT PJ, 1988, P IEEE, V76, P1006 BURTON AM, 1998, LOCALIST CONNECTIONI, P75 BURTON AM, 1999, COGNITIVE SCI, V23, P1 CRAW I, 1995, P INT WORKSH AUT FAC, P53 DESIMONE R, 1991, J COGNITIVE NEUROSCI, V3, P1 EZZAT T, 1996, P 2 INT C AUT FAC GE, P116 FINLAYSON GD, 1996, P 3 INT WORKSH IM SI FLEMMING M, 1990, P INT NEUR NETW C PA GEORGHIADES AS, 1998, IEEE C COMPUTER VISI GORDON GG, 1991, THESIS HARVARD U GORDON GG, 1995, P INT WORKSH AUT FAC, P47 GRIMSON WEL, 1990, OBJECT RECOGNITION C HARMON LD, 1981, PATTERN RECOGN, V13, P97 JOLLIFFE IT, 1986, PRINCIPAL COMPONENT KANADE T, 1973, PICTURE PROCESSING S KELLY MD, 1970, AI130 STANF ART INT KENDRICK KM, 1987, SCIENCE, V236, P448 KIRBY M, 1990, IEEE T PATTERN ANAL, V12, P103 LADES M, 1993, IEEE T COMPUT, V42, P300 LAMDAN Y, 1988, P 2 INT C COMP VIS, P238 LANITIS A, 1995, P 5 INT C COMP VIS, P368 LANITIS A, 1997, IEEE T PATTERN ANAL, V19, P743 LAPRESTE JT, 1988, NATO ASI SERIES F, V45 LEE JC, 1990, P IEEE INT C COMP VI, P722 LEE TW, 1998, INDEPENDENT COMPONEN LEONARDIS A, 2000, COMPUT VIS IMAGE UND, V78, P99 LI Y, 2000, P IEEE INT C AUT FAC, P300 MARR D, 1982, VISION MOGHADDAM B, 1998, P IEEE INT C AUT FAC, P30 MUMFORD D, 1991, J COGNITIVE NEUROSCI, V3, P87 MURASE H, 1995, INT J COMPUT VISION, V14, P5 PENEV PS, 2000, P 4 INT C AUT FAC GE, P264 PERRETT DI, 1982, EXP BRAIN RES, V47, P329 SIROVICH L, 1987, J OPT SOC AM A, V4, P519 TURK M, 1990, P IAPR WORKSH MACH V, P267 TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71 TURK M, 1991, THESIS MASSACHUSETTS VALENTIN D, 1994, PATTERN RECOGN, V27, P1209 WURTZ RP, 1992, APPL NEURAL NETWORKS, P181 YUILLE AL, 1992, INT J COMPUT VISION, V8, P99 ZHAO L, 1999, PATTERN RECOGN, V32, P547
NR	46
TC	11
PU	IEICE-INST ELECTRONICS INFORMATION COMMUNICATIONS ENG
PI	TOKYO
PA	KIKAI-SHINKO-KAIKAN BLDG MINATO-KU SHIBAKOEN 3 CHOME, TOKYO, 105, JAPAN
SN	0916-8532
J9	IEICE TRANS INFORM SYST
JI	IEICE Trans. Inf. Syst.
PD	DEC
PY	2001
VL	E84D
IS	12
BP	1586
EP	1595
PG	10
SC	Computer Science, Information Systems; Computer Science, Software Engineering
GA	504UM
UT	ISI:000172874300002
ER

---

PT	J
AU	Grant, SFA Thorleifsson, G Frigge, ML Thorsteinsson, J Gunnlaugsdottir, B Geirsson, AJ Gudmundsson, M Vikingsson, A Erlendsson, K Valsson, J Jonsson, H Gudbjartsson, DF Stefansson, K Gulcher, JR Steinsson, K
TI	The inheritance of rheumatoid arthritis in Iceland
SO	ARTHRITIS AND RHEUMATISM
LA	English
DT	Article
ID	FAMILIAL AGGREGATION; ASSOCIATION; POPULATION; DISEASE; SUSCEPTIBILITY; NATIONWIDE; PREVALENCE; GENETICS; LINKAGE; TWIN
AB	Objective. Rheumatoid arthritis (RA) is the most common form of inflammatory arthritis. Although there is a large body of evidence suggesting that RA is immune mediated, the etiology remains unresolved. Twin studies have shown disease concordance rates of similar to 15% in monozygotic twins and 4% in dizygotic twins, while the estimated risk ratio for siblings of RA patients ranges from 5 to 8. Our goal was to use genealogic data from Iceland to further investigate the genetic component of RA. Methods. Data were obtained from a population-based, computerized genealogy database that was developed to examine multigenerational relationships among individuals in the relatively homogeneous population of Iceland. Using an algorithm, the minimum founder test, we calculated the least number of founders required to account for a list of RA patients, and compared it with 1,000 sets of same-sized matched control groups. In addition, we estimated the kinship coefficient and risk ratios for relatives of the RA patients. Results. Several familial clustering tests demonstrated that the RA patients were more related to each other than were the average control set of Icelanders. A significantly fewer number of founders was necessary to account for our patient list than for the random sets of matched controls (P < 0.001), and the average pairwise identity-by-descent sharing was greater among the patients than among the control sets (P < 0.001). In addition, there was an increased risk of RA in first- and second-degree relatives of the patients; e.g., for siblings, the risk ratio was 4.38 (95% confidence interval 3.26-5.67), and for uncles/aunts, the risk ratio was 1.95 (95% confidence interval 1.52-2.43). Conclusion. The familial component of RA is shown to extend beyond the nuclear family, thus providing stronger evidence for a significant genetic component to RA.
C1	deCODE Genet, IS-110 Reykjavik, Iceland. Natl Univ Hosp Iceland, Reykjavik, Iceland. Duke Univ, Durham, NC USA.
RP	Gulcher, JR, deCODE Genet, Lynghals 1, IS-110 Reykjavik, Iceland.
CR	AHO K, 1986, J RHEUMATOL, V13, P899 ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315 BARRERA P, 1999, RHEUMATOLOGY, V38, P415 CORNELIS F, 1998, P NATL ACAD SCI USA, V95, P10746 DEIGHTON CM, 1989, CLIN GENET, V36, P178 DEIGHTON CM, 1991, ANN RHEUM DIS, V50, P62 DEIGHTON CM, 1992, ANN RHEUM DIS, V51, P182 DELJUNCO DJ, 1984, AM J EPIDEMIOL, V119, P813 GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205 GUDMUNDSSON H, 2000, EUR J HUM GENET, V8, P743 GULCHER J, 1998, CLIN CHEM LAB MED, V36, P523 GULCHER JR, 2000, EUR J HUM GENET, V8, P739 GUO SW, 1998, AM J HUM GENET, V63, P252 HELGASON A, 2000, AM J HUM GENET, V66, P999 HOCHBERG MC, 1990, SEMIN ARTHRITIS RHEU, V19, P294 INGVARSSON T, 2000, ARTHRITIS RHEUM, V43, P2785 JARVINEN P, 1994, SEMIN ARTHRITIS RHEU, V24, P19 JONES MA, 1996, ANN RHEUM DIS, V55, P89 KHAN MA, 1986, DIS MARKERS, V4, P77 KOUMANTAKI Y, 1997, J RHEUMATOL, V24, P1522 LAWRENCE JS, 1970, ANN RHEUM DIS, V29, P357 LAWRENCE RC, 1989, J RHEUMATOL, V16, P427 LINOS A, 1980, AM J EPIDEMIOL, V111, P87 LYNN AH, 1995, AM J HUM GENET, V57, P150 MACGREGOR AJ, 1994, J RHEUMATOL, V21, P1420 MACGREGOR AJ, 2000, ARTHRITIS RHEUM, V43, P30 PAYAMI H, 1986, TISSUE ANTIGENS, V27, P57 PRITCHARD MH, 1992, BRIT J RHEUMATOL, V31, P395 PRITCHARD MH, 1994, BRIT J RHEUMATOL, V33, P475 RICE JA, 1995, MATH STAT DATA ANAL RIGBY AS, 1993, GENET EPIDEMIOL, V10, P311 RISCH N, 1987, AM J HUM GENET, V40, P1 RISCH N, 1990, AM J HUM GENET, V46, P222 ROPES MW, 1958, B RHEUM DIS, V9, P175 SELDIN MF, 1999, ARTHRITIS RHEUM, V42, P1071 SHIOZAWA S, 1998, INT IMMUNOL, V10, P1891 SIGUROARDOTTIR S, 2000, AM J HUM GENET, V66, P1599 SILMAN AJ, 1993, BRIT J RHEUMATOL, V32, P903 STASTNY P, 1978, NEW ENGL J MED, V298, P869 THOMAS DJB, 1983, ANN RHEUM DIS, V42, P297 WEEKS DE, 1988, AM J HUM GENET, V42, P315 WOLFE F, 1988, BRIT J RHEUMATOL S2, V27, P150 YAMASHITA TS, 1986, DIS MARKERS, V4, P113
NR	43
TC	15
PU	WILEY-LISS
PI	NEW YORK
PA	DIV JOHN WILEY & SONS INC, 605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN	0004-3591
J9	ARTHRITIS RHEUM
JI	Arthritis Rheum.
PD	OCT
PY	2001
VL	44
IS	10
BP	2247
EP	2254
PG	8
SC	Rheumatology
GA	498CB
UT	ISI:000172491300007
ER

---

PT	S
AU	Liposcak, Z Loncaric, S
TI	A scale-space approach to face recognition from profiles
SO	COMPUTER ANALYSIS OF IMAGES AND PATTERNS
SE	LECTURE NOTES IN COMPUTER SCIENCE
LA	English
DT	Article
ID	MACHINE
AB	A method for face recognition using profile images based on the scale-space filtering is presented in this paper. A grey-level image of profile is thresholded to produce a binary, black and white image, the black corresponding to face region. A pre-processing step then extracts the outline curve of the front portion of the silhouette that bounds the face image. From this curve, a set of twelve fiducial marks is automatically identified using scale-space filtering with varying the scale parameter. A set of twenty-one feature characteristics is derived from these fiducial marks. After normalising the feature characteristics using two selected fiducial marks, the Euclidean distance measure is used for measuring the similarity of the feature vectors derived from the outline profiles. Experiments were performed on a total of 150 profiles of thirty persons. Experimental results are presented and discussed. Finally, recognition rates and conclusions are given.
C1	Univ Zagreb, Fac Elect & Comp Engn, Dept Elect Syst & Informat Proc, Zagreb 41000, Croatia.
RP	Liposcak, Z, Univ Zagreb, Fac Elect & Comp Engn, Dept Elect Syst & Informat Proc, Unska 3, Zagreb 41000, Croatia.
CR	CHELLAPPA R, 1995, P IEEE, V83, P705 HARMON LD, 1977, COMPUTER GRAPHICS IM, V6, P135 HARMON LD, 1981, PATTERN RECOGN, V13, P97 LONCARIC S, 1998, PATTERN RECOGN, V31, P983 PARKER JR, 1998, ALGORITHMS IMAGE PRO PIGEON S, 1999, THESIS UCL WITKIN AP, 1983, P INT JOINT C ART IN, P1019 WU CJ, 1990, PATTERN RECOGN, V23, P255
NR	8
TC	0
PU	SPRINGER-VERLAG BERLIN
PI	BERLIN
PA	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN	0302-9743
J9	LECT NOTE COMPUT SCI
PY	1999
VL	1689
BP	243
EP	250
PG	8
SC	Computer Science, Theory & Methods
GA	BS63Y
UT	ISI:000170663200030
ER

---

PT	J
AU	Perez-Palomares, A
TI	Preservation properties by Bernstein-type operators. A probabilistic approach
SO	COMPUTERS & MATHEMATICS WITH APPLICATIONS
LA	English
DT	Article
DE	Bernstein-type operators; preservation properties; dual operator; derived operator; coupling techniques
ID	LIPSCHITZ CONTINUOUS FUNCTION; INEQUALITIES; CONSTANTS
AB	In this paper, we are concerned with preservation properties of first- and second-order by Bernstein-type operators which preserve monotone functions. We obtain characterizations of the preservation of nondecreasing right-continuous functions, first- and second-order modulus of smoothness, Lipschitz classes of first- and second-order, uniform and absolute continuity, and convexity. These kinds of problems lead us to consider the notions of dual and derived operators. We give a simple unified approach based on stochastic orders and probabilistic coupling techniques, in the sense that we represent the operators under consideration in terms of stochastic processes. The preceding results are illustrated by considering well-known Bernstein-type operators, such as generalized Bernstein-Kantorovich, generalized Szasz-Kantorovich, Gamma, and Beta operators. (C) 2001 Elsevier Science Ltd. All rights reserved.
C1	Univ Zaragoza, Fac Ciencias, Dept Metodos Estadist, E-50009 Zaragoza, Spain.
RP	Perez-Palomares, A, Univ Zaragoza, Fac Ciencias, Dept Metodos Estadist, E-50009 Zaragoza, Spain.
CR	ADELL JA, 1993, STOCH PROC APPL, V48, P1 ADELL JA, 1995, COMPUT MATH APPL, V30, P1 ADELL JA, 1996, CONSTR APPROX, V12, P489 ADELL JA, 1996, J MATH ANAL APPL, V200, P663 ADELL JA, 1998, J APPROX THEORY, V93, P128 ADELL JA, 1999, ADV APPL PROBAB, V31, P492 ALTOMARE F, 1994, KOROVKIN TYPE APPROX ANASTASSIOU GA, 1991, ANALYSIS, V11, P43 BASKAKOV VA, 1957, DOKL AKAD NAUK SSSR, V113, P249 BROWN BM, 1987, J APPROX THEORY, V49, P196 BUTZER PL, 1954, P AM MATH SOC, V5, P547 COTTIN C, 1993, REND CIRC MAT PALE S, V33, P259 DITZIAN Z, 1987, MODULI SMOOTHNESS DITZIAN Z, 1993, J ANAL MATH, V1, P60 FELLER W, 1971, INTRO PROBABILITY TH, V2 JOHNSON NL, 1969, DISCRETE DISTRIBUTIO KAMAE T, 1977, ANN PROBAB, V5, P899 KHAN MK, 1989, J APPROX THEORY, V59, P307 KRATZ W, 1988, J APPROX THEORY, V54, P326 LINDVALL T, 1982, MATH SCI, V7, P127 LUPAS A, 1995, RESULTS MATH, V16, P277 MACHE DH, 1994, J APPROX THEORY, V78, P321 MUHLBACH G, 1970, REV ROUMAINE MATH PU, V15, P1235 POPOVICIU T, 1935, MATH CLUJ, V10, P49 SCHUMAKER LL, 1981, SPLINE FUNCTIONS BAS SHAKED M, 1988, ADV APPL PROBAB, V20, P427 SHAKED M, 1994, STOCHASTIC ORDERS IT STANCU DD, 1968, REV ROUMAINE MATH PU, V13, P1173 STOYAN D, 1983, COMP METHODS QUEUES SZEKLI R, 1995, LECT NOTES STAT, V97 TOTIK V, 1994, J APPROX THEORY, V76, P369 VORONOVSKAJA EV, 1932, DOKL AKAD NAUK SSSR, P79 WINTER BB, 1997, J MATH ANAL APPL, V205, P471 ZHOU DX, 1995, RESULTS MATH, V28, P169 ZHUK VV, 1989, VESTNIK LENINGRAD U, V1, P25
NR	35
TC	0
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0898-1221
J9	COMPUT MATH APPL
JI	Comput. Math. Appl.
PD	JUL
PY	2001
VL	42
IS	1-2
BP	141
EP	155
PG	15
SC	Computer Science, Interdisciplinary Applications; Mathematics, Applied
GA	441DL
UT	ISI:000169215700015
ER

---

PT	J
AU	Georghiades, AS Belhumeur, PN Kriegman, DJ
TI	From few to many: Illumination cone models for face recognition under variable lighting and pose
SO	IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE
LA	English
DT	Article
DE	face recognition; image-based rendering; appearance-based vision; face modeling; illumination and pose modeling; lighting; illumination cones; generative models
ID	NEURAL-NETWORK; IMAGE; OBJECT; MOTION; IDENTIFICATION; INFORMATION; EIGENFACES; ALGORITHMS; SHAPE
AB	We present a generative appearance-based method for recognizing human faces under variation in lighting and viewpoint. Our method exploits the fact that the set of images of an object in fixed pose, but under all possible illumination conditions, is a convex cone in the space of images. Using a small number of training images of each face taken with different lighting directions, the shape and albedo of the face can be reconstructed. In turn, this reconstruction serves as a generative model that can be used to render-or synthesize-images of the face under novel poses and illumination conditions. The pose space is then sampled and, for each pose. the corresponding illumination cone is approximated by a low-dimensional linear subspace whose basis vectors are estimated using the generative model. Our recognition algorithm assigns to a test image the identity of the closest approximated illumination cone (based on Euclidean distance within the image space). We test our face recognition method on 4,050 images from the Yale Face Database B; these images contain 405 viewing conditions (9 poses x 45 illumination conditions) for 10 individuals. The method performs almost without error, except on the most extreme lighting directions, and significantly outperforms popular recognition methods that do not use a generative model.
C1	Yale Univ, Dept Elect Engn, New Haven, CT 06520 USA. Yale Univ, Dept Comp Sci, New Haven, CT 06520 USA. Univ Illinois, Dept Comp Sci, Urbana, IL 61801 USA. Univ Illinois, Beckman Inst, Urbana, IL 61801 USA.
RP	Georghiades, AS, Yale Univ, Dept Elect Engn, 51 Prospect St,POB 208285, New Haven, CT 06520 USA.
CR	BELHUMEUR P, 1997, P IEEE C COMP VIS PA, P1040 BELHUMEUR PN, 1997, IEEE T PATTERN ANAL, V19, P711 BELHUMEUR PN, 1998, INT J COMPUT VISION, V28, P245 BEYMER D, 1995, P INT C COMP VIS, P500 BEYMER DJ, 1994, P IEEE C COMP VIS PA, P756 BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042 CHELLAPPA R, 1995, P IEEE, V83, P705 CHEN HF, 2000, PROC CVPR IEEE, P254 CHEN Q, 1995, P 5 INT C COMP VIS M, P591 COOTES TF, 1998, P EUR C COMP VIS, V2, P484 COOTES TF, 2000, P INT C FAC GEST REC, P227 COX JF, 1996, ADV INT ST, V3, P1 CRAW I, 1992, P 2 EUR C COMP VIS, P92 EDWARDS G, 1999, P INT C COMP VIS, P137 EDWARDS G, 1999, P INT C COMP VIS, P137 EPSTEIN R, 1995, P PHYS BAS MOD WORKS FRANKOT RT, 1988, IEEE T PATTERN ANAL, V10, P439 FROMHERZ T, 1998, TR98027 U CAL ICSI I GEORGHIADES A, 1999, P IEEE WORKSH MULT M, P47 GEORGHIADES AS, 1998, PROC CVPR IEEE, P52 GEORGHIADES AS, 2000, P IEEE C FAC GEST RE, P277 GOLDSTEIN AJ, 1971, P IEEE, V59, P748 GOVINDARAJU V, 1996, INT J COMPUT VISION, V19, P129 HALLINAN P, 1994, P IEEE C COMP VIS PA, P995 HALLINAN P, 1995, THESIS HARVARD U HALLINAN P, 1999, 2 3 DIMENSIONAL PATT HARMON LD, 1978, PATTERN RECOGN, V10, P301 HARMON LD, 1981, PATTERN RECOGN, V13, P97 HAYAKAWA H, 1994, J OPT SOC AM A, V11, P3079 HORN B, 1986, COMPUTER VISION HUANG FJ, 2000, P 4 IEEE INT C AUT F, P245 JACOBS D, 1997, P IEEE C COMP VIS PA JUELL P, 1996, PATTERN RECOGN, V29, P781 KANADE T, 1973, THESIS KYOTO U KANADE T, 1977, COMPUTER RECOGNITION KAUFMAN GJ, 1976, IEEE T SYST MAN CYB, V6, P113 LAMBERT J, 1760, PHOTOMETRIA SIVE MEN LANITIS A, 1995, P 5 INT C COMP VIS, P368 LANITIS A, 1997, IEEE T PATTERN ANAL, V19, P743 LEE CH, 1996, PATTERN RECOGN, V29, P1877 LEUNG TK, 1995, P 5 INT C COMP VIS, P637 LI SZ, 1999, IEEE T NEURAL NETWOR, V10, P439 LI Y, 2000, P IEEE INT C AUT FAC, P300 MOGHADDAM B, 1995, P INT C COMP VIS, P786 MOGHADDAM B, 1997, IEEE T PATTERN ANAL, V19, P696 MOSES Y, 1994, P EUR C COMP VIS, P286 MURASE H, 1995, INT J COMPUT VISION, V14, P5 NAYAR S, 1996, P INT WORKSH OBJ REP, P165 OTOOLE AJ, 1997, PERCEPTION, V26, P75 PENTLAND A, 1994, P IEEE C COMP VIS PA, P84 PENTLAND A, 2000, IEEE T PATTERN ANAL, V22, P107 PHILLIPS P, 1997, AUDIO VIDEOBASED BIO PHILLIPS P, 1998, IMAGE VISUAL COMPUTI, V16 PHILLIPS PJ, 1997, PROC CVPR IEEE, P137 POGGIO T, 1994, P IM UND WORKSH, V2, P843 RIKLINRAVIV T, 1999, P IEEE C COMP VIS PA, V2, P566 ROWLEY HA, 1998, IEEE T PATTERN ANAL, V20, P23 ROWLEY HA, 1998, PROC CVPR IEEE, P38 SAMIL A, 1992, PATTERN RECOGN, V25, P65 SAMIL A, 1995, PATTERN RECOGN, V9, P845 SHASHUA A, 1992, THESIS MIT CAMBRIDGE SHASHUA A, 1997, INT J COMPUT VISION, V21, P99 SHUM HY, 1995, IEEE T PATTERN ANAL, V17, P854 SIROVITCH L, 1987, J OPT SOC AM A, V2, P519 SIVLER W, 1980, THESIS MIT CAMBRIDGE TOMASI C, 1992, INT J COMPUT VISION, V9, P137 TURK M, 1991, J COGNITIVE NEUROSCI, V3, P71 VETTER T, 1997, IEEE T PATTERN ANAL, V19, P733 VETTER T, 1998, INT J COMPUT VISION, V28, P103 WISKOTT L, 1997, IEEE T PATTERN ANAL, V19, P775 WOODHAM RJ, 1981, ARTIF INTELL, V17, P117 YANG M, 2000, P IEEE INT C AUT FAC, P196 YILLE A, 1997, P IEEE C COMP VIS PA, P158 YOW KC, 1997, IMAGE VISION COMPUT, V15, P713 YU Y, 1998, P SIGGRAPH 98, P207 ZHAO W, 1999, CARTR914 U MAR CTR A ZHAO WY, 2000, P IEEE INT C AUT FAC, P285
NR	77
TC	135
PU	IEEE COMPUTER SOC
PI	LOS ALAMITOS
PA	10662 LOS VAQUEROS CIRCLE, PO BOX 3014, LOS ALAMITOS, CA 90720-1314 USA
SN	0162-8828
J9	IEEE TRANS PATT ANAL MACH INT
JI	IEEE Trans. Pattern Anal. Mach. Intell.
PD	JUN
PY	2001
VL	23
IS	6
BP	643
EP	660
PG	18
SC	Computer Science, Artificial Intelligence; Engineering, Electrical & Electronic
GA	438DC
UT	ISI:000169037600008
ER

---

PT	J
AU	Zeng, XM Cheng, FF
TI	On the rates of approximation of Bernstein type operators
SO	JOURNAL OF APPROXIMATION THEORY
LA	English
DT	Article
ID	BOUNDED VARIATION; CONVERGENCE; POLYNOMIALS
AB	Asymptotic behavior of two Bernstein-type operators is studied in this paper. In the first case, the rate of convergence of a Bcrnstein operator for a bounded function f is studied at points x where f(x + ) and f( x-) exist. In the second case, the rate of convergence of a Szasz operator for a function f whose derivative is of bounded variation is studied at points x where f(x+) and f(x-) exist. Estimates of the rate of convergence are obtained For both cases and the estimates are the best possible for continuous points. (C) 2001 Academic Press.
C1	Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China. Univ Kentucky, Dept Comp Sci, Lexington, KY 40506 USA.
RP	Zeng, XM, Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
CR	BOJANIC R, 1989, J MATH ANAL APPL, V141, P136 BOJANIC R, 1991, ATT SEM MAT U MOD, V39, P495 CHENG F, 1983, J APPROX THEORY, V39, P259 CHENG F, 1984, J APPROX THEORY, V40, P226 FELLER W, INTRO PROBABILITY TH GUO SS, 1989, J APPROX THEORY, V58, P90 LORENTZ GG, 1953, BERNSTEIN POLYNOMIAL ZENG XM, 1998, J APPROX THEORY, V95, P369 ZENG XM, 1998, J MATH ANAL APPL, V226, P309
NR	9
TC	5
PU	ACADEMIC PRESS INC
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0021-9045
J9	J APPROX THEOR
JI	J. Approx. Theory
PD	APR
PY	2001
VL	109
IS	2
BP	242
EP	256
PG	15
SC	Mathematics
GA	421AR
UT	ISI:000168040400005
ER

---

PT	J
AU	Laivoranta-Nyman, S Luukkainen, R Hakala, M Hannonen, P Mottonen, T Yli-Kerttula, U Ilonen, J Toivanen, A
TI	Differences between female and male patients with familial rheumatoid arthritis
SO	ANNALS OF THE RHEUMATIC DISEASES
LA	English
DT	Article
ID	HLA; JAPANESE; DISEASE; ASSOCIATION; SEX
AB	Objective-To determine whether there are genetic differences between female and male patients with familial rheumatoid arthritis (RA). Methods-45 men and 119 women from 78 families with RA who all had at least one first degree relative with RA were compared. HLA-DRB1 alleles were analysed, including DRB1*04 subtypes and associations of DRB1*04 haplotypes with DQB1*0301 or DQB1*0302 alleles, the age of the patients at disease onset, the presence of rheumatoid factor (RF), joint erosions, and rheumatoid nodules. Results-HLA-DRB1*13 allele (the subtype allele of DR6, reported to be protective against the development of RA) was found in 14/119 (12%) of female but in none of the male patients (p=0.036). The HLA-DR4 allele was found slightly more often in men than women patients with familial RA (31/45 (69%) v 75/119 (63%), NS). Men were also more often RF positive than women (44/45 (98%) v 98/117 (84%); p=0.031). On the other hand, the mean age at onset of RA was significantly lower in the female group (40.4 years) than in men (46.6 years, p=0.0044). Conclusion-The results indicate that there is stronger genetic background in familial male than female patients with RA in the genetic susceptibility defined by the studied HLA antigens. However, the earlier age of onset of the disease in female group and the increased proportion of women with RA indicate that there are additional sex related predisposing factors enhanced in familial cases.
C1	Univ Turku, Turku Immunol Ctr, Med Res Lab, FIN-20520 Turku, Finland. Univ Turku, Dept Virol, FIN-20520 Turku, Finland. Univ Turku, Dept Med, FIN-20520 Turku, Finland. Univ Turku, Dept Med Microbiol, FIN-20520 Turku, Finland. Univ Turku, Cent Hosp, FIN-20520 Turku, Finland. Satalinna Hosp, Dept Rheumatol, Satalinna, Finland. Oulu Univ Hosp, Dept Med, Div Rheumatol, Oulu, Finland. Jyvaskyla Cent Hosp, Dept Med, Jyvaskyla, Finland. Tampere Univ Hosp, Dept Med, Tampere, Finland.
RP	Laivoranta-Nyman, S, Univ Turku, Turku Immunol Ctr, Med Res Lab, Tykistokatu 6A, FIN-20520 Turku, Finland.
CR	AMETT FC, 1988, ARTHRITIS RHEUM, V31, P315 DEIGHTON CM, 1992, J RHEUMATOL, V19, P237 JARAQUEMADA D, 1986, ANN RHEUM DIS, V45, P627 KHAN MA, 1988, TISSUE ANTIGENS, V31, P254 LAIVORANTANYMAN S, 2000, ANN RHEUM DIS, V59, P173 LAWRENCE JS, 1970, ANN RHEUM DIS, V29, P357 LYNN AH, 1995, AM J HUM GENET, V57, P150 MAEDA H, 1981, ANN RHEUM DIS, V40, P299 OHTA N, 1982, HUM IMMUNOL, V5, P123 RIGBY AS, 1991, GENET EPIDEMIOL, V8, P153 SANDERS PA, 1987, J RHEUMATOL, V14, P718 VANZEBEN D, 1991, ARTHRITIS RHEUM, V34, P822 WAKITANI S, 1997, BRIT J RHEUMATOL, V36, P630 WEYAND CM, 1998, ARTHRITIS RHEUM, V41, P817 ZANELLI E, 1998, IMMUNOGENETICS, V48, P394
NR	15
TC	5
PU	BRITISH MED JOURNAL PUBL GROUP
PI	LONDON
PA	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN	0003-4967
J9	ANN RHEUM DIS
JI	Ann. Rheum. Dis.
PD	APR
PY	2001
VL	60
IS	4
BP	413
EP	415
PG	3
SC	Rheumatology
GA	411KF
UT	ISI:000167498700021
ER

---

PT	J
AU	Mathew, T Sinha, BK
TI	Optimal designs for binary data under logistic regression
SO	JOURNAL OF STATISTICAL PLANNING AND INFERENCE
LA	English
DT	Article
DE	A-optimality; D-optimality; E-optimality; information matrix; weak supermajorization
AB	A unified approach is presented for the derivation of D- and A-optimal designs for binary data under the two-parameter logistic regression model. The optimal design is constructed for the estimation of several pairs of parameters. The E-optimal design is also obtained in some cases. (C) 2001 Elsevier Science B.V. All rights reserved. MSG: 62J02; 62K05.
C1	Univ Maryland, Dept Math & Stat, Baltimore, MD 21250 USA. Indian Stat Inst, Calcutta 700035, W Bengal, India.
CR	ABDELBASIT KM, 1983, J AM STAT ASSOC, V78, P90 BONDAR JV, 1983, CANAD J STATIST, V11, P325 FORD I, 1992, J R STAT SOC B, V54, P569 HEDAYAT AS, 1997, J AM STAT ASSOC, V92, P1132 KHAN MK, 1988, J STATISTICAL PLANNI, V18, P83 MARSHALL AW, 1979, INEQUALITIES THEORY MINKIN S, 1987, J AM STAT ASSOC, V82, P1098 PUKELSHEIM F, 1993, OPTIMAL DESIGN EXPT SITTER RR, 1993, SCAND J STAT, V20, P329 WU CFJ, 1988, OPTIMAL DESIGN ANAL, P213
NR	10
TC	5
PU	ELSEVIER SCIENCE BV
PI	AMSTERDAM
PA	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN	0378-3758
J9	J STATIST PLAN INFER
JI	J. Stat. Plan. Infer.
PD	FEB 1
PY	2001
VL	93
IS	1-2
BP	295
EP	307
PG	13
SC	Statistics & Probability
GA	400FH
UT	ISI:000166861200019
ER

---

PT	J
AU	Toussirot, E Wendling, D
TI	Therapeutic advances in ankylosing spondylitis
SO	EXPERT OPINION ON INVESTIGATIONAL DRUGS
LA	English
DT	Review
DE	ankylosing spondylitis; TNF-alpha; treatment
ID	DISEASE-ACTIVITY; DOUBLE-BLIND; SERONEGATIVE SPONDYLARTHROPATHIES; DRUG-TREATMENT; SULFASALAZINE; PLACEBO; METHOTREXATE; INDEX; BATH; MELOXICAM
AB	Ankylosing spondylitis (AS) is a systemic inflammatory rheumatic disease involving spinal and sacroiliac joints. This condition is responsible for back pain, stiffness, but also loss of functional capacity with socio-economic consequences. The management of AS includes patient education, rest, a programme of regular physical exercise, together with the use of NSAIDs. Second-line treatments are required in cases of severe or refractory AS, however only sulfasalazine has proven to benefit AS patients with peripheral arthritis. In spite of this management, the disease may not be adequately controlled, mainly for patients with refractory axial disease, enthesopathy or extra-articular features. Thus, new innovative treatments are needed for AS. It is likely that the new NSAIDs or COX-2 specific inhibitors will certainly take the place of the conventional NSAIDs, with regard to their superior tolerability. Methotrexate is a therapeutic option for AS treatment, but its usefulness in this disease remains to be established in adequate controlled studies. Finally, the TNE-alpha targeting drugs, namely thalidomide and the anti-TNF-alpha mAb, infliximab, have given promising results in the treatment of severe and/or refractory AS patients, however further controlled studies are required. In addition, the long-term use (efficacy and tolerability) of these two agents deserves attention.
C1	Univ Besancon, Hop Jean Minjoz, Dept Rheumatol, F-25030 Besancon, France.
RP	Toussirot, E, Univ Besancon, Hop Jean Minjoz, Dept Rheumatol, Blvd A Fleming, F-25030 Besancon, France.
CR	AMOR B, 1984, ANN INTERN MED, V101, P878 BIASI D, 2000, CLIN RHEUMATOL, V19, P114 BOSIFERRAZ M, 1990, J RHEUMATOL, V17, P1782 BOSIFERRAZ M, 1991, J RHEUMATOL, V18, P146 BRANDT J, 2000, ARTHRITIS RHEUM, V43, P1346 BRAUN J, 1995, ARTHRITIS RHEUM, V38, P499 BRAUN J, 2000, ANN RHEUM DIS, V59, P404 BREBAN M, 1999, ARTHRITIS RHEUM, V42, P580 BROWN MA, 1997, ARTHRITIS RHEUM, V40, P1823 CALIN A, 1988, J RHEUMATOL, V15, P1234 CALIN A, 1990, J RHEUMATOL, V17, P801 CALIN A, 1994, J RHEUMATOL, V21, P2281 CALIN A, 1998, SPONDYLARTHRITIDES, P1 CLEGG DO, 1996, ARTHRITIS RHEUM, V39, P2004 CLEGG DO, 1999, ARTHRITIS RHEUM, V42, P2325 CORRAL LG, 1999, ANN RHEUM DIS S1, V58, P1107 CREEMERS MCW, 1994, SEMIN ARTHRITIS RHEU, V24, P71 CREEMERS MCW, 1995, J RHEUMATOL, V22, P1104 CUELLAR ML, 1996, CURR OPIN RHEUMATOL, V8, P288 DEKKERSAEYS BJ, 2000, J RHEUMATOL, V27, P723 DOUGADOS M, 1986, BRIT MED J, V293, P911 DOUGADOS M, 1995, ARTHRITIS RHEUM, V38, P618 DOUGADOS M, 2000, ANN RHEUM DIS S, V59, P204 FURST DE, 1997, SEMIN ARTHRITIS R S1, V26, P21 GARRETT S, 1994, J RHEUMATOL, V21, P2286 GRAN JT, 1992, DRUGS, V44, P585 GRAN JT, 1997, BRIT J RHEUMATOL, V36, P766 GRATACOS J, 1994, BRIT J RHEUMATOL, V33, P927 HANDLER RP, 1989, ARTHRITIS RHEUM, V32, P234 JACKSON CG, 1995, TREATMENT RHEUMATIC, P79 JENKINSON TR, 1994, J RHEUMATOL, V21, P1694 KHAN MA, 1981, J RHEUMATOL, V8, P86 KHAN MA, 2000, CURR OPIN RHEUMATOL, V12, P235 LAURENT R, 1990, BAILLIERE CLIN RHEUM, V4, P387 LEHTINEN K, 1993, ANN RHEUM DIS, V52, P174 LITTLE H, 1988, J RHEUMATOL, V15, P1179 MAKSYMOWYCH WP, 1998, J RHEUMATOL, V25, P714 MAKSYMOWYCH WP, 1999, ARTHRITIS RHEUM S9, V42, S376 MAUGARS Y, 1996, BRIT J RHEUMATOL, V35, P767 MCCREDIE J, 1999, J BONE JOINT SURG B, V81, P9 NISSILA M, 1988, ARTHRITIS RHEUM, V31, P1111 NOBLE S, 1996, DRUGS, V51, P424 OSTENDORF B, 1995, ARTHRITIS RHEUM S, V38, S203 RAMOSREMUS C, 1993, CURR OPIN RHEUMATOL, V5, P408 ROUSSOU E, 1997, J RHEUMATOL, V24, P908 SAMPAIOBARROS PD, 2000, SCAND J RHEUMATOL, V29, P160 SAMPAIOSBARROS P, 1993, REV ESP RHEUMATOL S1, V20, P485 TAGGART A, 1996, ARTHRITIS RHEUM, V39, P1400 THOMSON GTD, 2000, J RHEUMATOL, V27, P714 TOIVANEN A, 1995, CURR OPIN RHEUMATOL, V7, P279 TOUSSIROT E, 1996, REV MED INTERNE, V17, P333 TOUSSIROT E, 1998, DRUGS, V56, P225 TOUSSIROT E, 2000, CLIN EXP RHEUMAT S21, V18, S16 VANDENBOSCH F, 2000, ANN RHEUM DIS, V59, P428 VANDERLINDEN S, 1984, ARTHRITIS RHEUM, V27, P361 VANDERLINDEN S, 1998, RHEUM DIS CLIN N AM, V24, P663 VANE JR, 1996, IMPROVED NONSTEROID, P1 WENDLING D, 2000, JOINT BONE SPINE, V67, P259 WOLLHEIM FA, 1993, TXB RHEUMATOLOGY, P943
NR	59
TC	2
PU	ASHLEY PUBLICATIONS LTD
PI	LONDON
PA	UNITEC HOUSE, 3RD FL, 2 ALBERT PLACE FINCHLEY CENTRAL, LONDON N3 1QB, ENGLAND
SN	1354-3784
J9	EXPERT OPIN INVESTIG DRUGS
JI	Expert Opin. Investig. Drugs
PD	JAN
PY	2001
VL	10
IS	1
BP	21
EP	29
PG	9
SC	Pharmacology & Pharmacy
GA	396DZ
UT	ISI:000166622200002
ER

---

PT	J
AU	Fine, KD Do, K Schulte, K Ogunji, F Guerra, R Osowski, L McCormack, J
TI	High prevalence of celiac sprue-like HLA-DQ genes and enteropathy in patients with the microscopic colitis syndrome
SO	AMERICAN JOURNAL OF GASTROENTEROLOGY
LA	English
DT	Article
ID	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INFLAMMATORY BOWEL-DISEASE; COLLAGENOUS COLITIS; LYMPHOCYTIC COLITIS; ANTIENDOMYSIAL ANTIBODIES; AUTOIMMUNE-DISEASES; REFRACTORY SPRUE; CHRONIC DIARRHEA; TRANSGENIC RATS; GLUTEN
AB	OBJECTIVE: Celiac sprue is associated with specific HLA-DQ genes (mainly DQ2). Because there are epidemiological and histopathological similarities between celiac sprue and microscopic colitis, we hypothesized that these syndrome may share an HLA genetic predisposition and pathogenesis. METHODS: The HLA-DQ genes of 25 patients with celiac sprue, 53 patients with the microscopic colitis syndrome, and 429 normal controls were typed and compared. Serum was analyzed for antigliadin and antiendomysial antibodies. Small intestinal biopsies were analyzed for signs of histopathology. RESULTS: HLA-DQ2 or DQ1,3 (the latter as DQ1,7,DQ1,8, or DQ1,9) were seen more frequently in both patient groups relative to controls. In patients with the microscopic colitis syndrome, serological tests for celiac sprue were weakly positive in 17%; mild inflammation of the small intestine without villous atrophy was present in 43%, and inflammation plus partial or subtotal villous atrophy was present in 27%. CONCLUSIONS: A shared set of predisposing HLA-DQ genes account for the epidemiological overlap of celiac sprue and microscopic colitis. Mild to moderate mononuclear cell inflammation of the small intestine, often accompanied by partial or subtotal villous atrophy, is frequent in patients with the microscopic colitis syndrome. Although further studies will be necessary to determine if this enteropathy is induced by dietary gluten, we speculate that the small intestinal but not colonic histopathology in patients with microscopic colitis is caused by immunological gluten sensitivity. (C) 2000 by Am. Cell. of Gastroenterology.
C1	Intestinal Hlth Inst, Dallas, TX 75228 USA. Baylor Univ, Med Ctr, Dept Pathol, Div GI Res, Dallas, TX USA. Baylor Univ, Med Ctr, Transplant Immunol Lab, Dallas, TX USA. So Methodist Univ, Stat Sci Ctr, Dept Biostat, Dallas, TX 75275 USA.
RP	Fine, KD, Intestinal Hlth Inst, 10851 Ferguson Rd,Suite B, Dallas, TX 75228 USA.
CR	AHMED SA, 1999, ENVIRON HEALTH PE S5, V107, P681 BAO F, 1999, J AUTOIMMUN, V13, P143 BOHR J, 1996, GUT, V39, P846 BOYKO EJ, 1994, AM J EPIDEMIOL, V140, P268 BREEN EG, 1987, GUT, V28, P364 CARROCCIO A, 1996, SCAND J GASTROENTERO, V31, P759 DAVIES NM, 1995, DIS COLON RECTUM, V38, P1311 DEMARCHI M, 1983, GUT, V24, P706 DUBOIS RN, 1989, JAMA-J AM MED ASSOC, V262, P935 FALCHUK ZM, 1972, J CLIN INVEST, V51, P1602 FINE K, 1999, GASTROENTEROLOGY 2, V116, A880 FINE KD, 1997, GASTROENTEROLOGY, V112, P1830 FINE KD, 1998, GASTROENTEROLOGY, V114, P29 FINE KD, 1998, HUM PATHOL, V29, P1433 GAIRDIELLO FM, 1990, DIGEST DIS SCI, V35, P257 GARCIALAFUENTE A, 1997, AM J PHYSIOL-GASTR L, V272, G10 GERBASEDELIMA M, 1997, PEDIATR ALLERGY IMMU, V8, P150 GIARDIELLO FM, 1992, DIGEST DIS SCI, V37, P496 HAMMER RE, 1990, CELL, V63, P1099 HOPKINS KA, 1994, AM SOC HISTOCOMPATIB ISENBERG DA, 1994, CLIN EXP RHEUMAT S11, V12, S19 KAUFMANN HJ, 1987, ANN INTERN MED, V107, P513 KERTTULA TO, 1996, ARTHRITIS RHEUM, V39, P1733 KHAN MA, 1982, ANN INTERN MED, V96, P70 LAZENBY AJ, 1989, HUM PATHOL, V20, P18 LEE E, 1992, GASTROENTEROLOGY, V103, P1790 LERNER A, 1994, CLIN EXP IMMUNOL, V95, P78 LILLIENFELD DE, 1994, FDN EPIDEMIOLOGY MICHALSKI JP, 1996, TISSUE ANTIGENS, V47, P127 MOSNIER JF, 1996, AM J GASTROENTEROL, V91, P709 PICARELLI A, 1996, GASTROENTEROLOGY, V111, P608 RATH HC, 1996, J CLIN INVEST, V98, P945 READ NW, 1980, GASTROENTEROLOGY, V78, P264 RIDDELL RH, 1992, GUT, V33, P683 ROUBENOFF R, 1989, J RHEUMATOL, V16, P1229 SLOTH H, 1991, J INTERN MED, V229, P443 SOLLID LM, 1989, J EXP MED, V169, P345 SOLLID LM, 1993, GASTROENTEROLOGY, V105, P910 SYLWESTROWICZ T, 1989, AM J GASTROENTEROL, V84, P763 TONAI R, 1994, AM SOC HISTOCOMPATIB VALDIMARSSON T, 1996, DIGEST DIS SCI, V41, P83 VARTDAL F, 1996, EUR J IMMUNOL, V26, P2764 VENTURA A, 1999, GASTROENTEROLOGY, V117, P297 ZINS BJ, 1995, AM J GASTROENTEROL, V90, P1394
NR	44
TC	29
PU	ELSEVIER SCIENCE INC
PI	NEW YORK
PA	655 AVENUE OF THE AMERICAS, NEW YORK, NY 10010 USA
SN	0002-9270
J9	AMER J GASTROENTEROL
JI	Am. J. Gastroenterol.
PD	AUG
PY	2000
VL	95
IS	8
BP	1974
EP	1982
PG	9
SC	Gastroenterology & Hepatology
GA	343KN
UT	ISI:000088701700022
ER

---

PT	J
AU	Pantic, M Rothkrantz, LJM
TI	Expert system for automatic analysis of facial expressions
SO	IMAGE AND VISION COMPUTING
LA	English
DT	Article
DE	intelligent multi-modal user interface; hybrid facial feature extraction; facial action tracking; facial expression emotional classification
ID	RECOGNITION; EMOTIONS; FACES
AB	This paper discusses our expert system called integrated System for Facial Expression Recognition (ISFER), which performs recognition and emotional classification of human facial expression from a still full-face image. The system consists of two major parts. The first one is the ISFER Workbench, which forms a framework for hybrid facial feature detection. Multiple feature detection techniques are applied in parallel. The redundant information is used to define unambiguous face geometry containing no missing or highly inaccurate data. The second part of the system is its inference engine called HERCULES, which converts low level face geometry into high level facial actions, and then this into highest level weighted emotion labels. (C) 2000 Elsevier Science B.V. All rights reserved.
C1	Delft Univ Technol, Dept Knowledge Based Syst, Fac Informat Technol & Syst, NL-2600 AJ Delft, Netherlands.
RP	Pantic, M, Delft Univ Technol, Dept Knowledge Based Syst, Fac Informat Technol & Syst, POB 356, NL-2600 AJ Delft, Netherlands.
CR	BASSILI JN, 1978, J EXPT PSYCHOL HUMAN, V4, P373 BLACK MJ, 1997, INT J COMPUT VISION, V25, P23 BOYLE EA, 1994, LANG SPEECH, V37, P1 BRUCE V, 1986, RECOGNISING FACES COHN J, 1998, 3 IEEE INT C AUT FAC, P396 EKMAN P, 1975, UNMASKING FACE EKMAN P, 1978, FACIAL ACTION CODING EKMAN P, 1982, EMOTION HUMAN FACE ESSA IA, 1997, IEEE T PATTERN ANAL, V19, P757 FRIDLUND AJ, 1987, NONVERBAL BEHAV COMM, P143 GLASSNER AS, 1993, GRAPHICS GEMS HARALICK RM, 1992, COMPUTER ROBOT VISIO HARMON LD, 1981, PATTERN RECOGN, V13, P97 IZARD CE, 1971, FACE EMOTION KASS M, 1987, 1 INT C COMP VIS, P259 KATO M, 1991, VISUAL COMPUTING, P39 KEARNEY GD, 1993, COGNITIVE SCI, V17, P589 KOBAYASHI H, 1997, IEEE SYS MAN CYBERN, P3732 LAW T, 1994, IEEE T PATTERN ANAL, V18 LIEN JJ, 1998, 3 IEEE INT C AUT FAC, P390 LUCAS BD, 1981, 7 INT JOINT C ART IN, P674 MEHRABIAN A, 1968, PSYCHOL TODAY, V2, P53 MORISHIMA S, 1993, IEEE INT WORKSH ROB, P188 MORISHIMA S, 1995, MODELLING FACIAL EXP, P251 OROURKE J, 1994, COMPUTATIONAL GEOMET PANTIC M, 1998, EUROMEDIA 98 SCS INT, P86 REINDERS MJT, 1997, 3 ANNC ASCI DELFT, P85 RITTER GX, 1996, HDB COMPUTER VISION ROTHKRANTZ LJM, 1998, EUROMEDIA 98 SCS INT, P94 RUSSELL JA, 1994, PSYCHOL BULL, V115, P102 STEPHENSON GM, 1976, BRIT J SOC CLIN PSYC, V15, P113 TERZOPOULOS D, 1993, IEEE T PATTERN ANAL, V15, P569 THALMANN NM, 1998, P IEEE, V86, P870 VANDAM A, 1995, COMPUTER GRAPHICS AL VANVARK RJ, 1995, MED 95 SCS INT GHENT, P108 VINCENT JM, 1992, NEURAL NETWORKS SPEE, P13 WILLIAMS DJ, 1992, CVGIP-IMAG UNDERSTAN, V55, P14 WOJDEL JC, 1998, 8 INT C ART NEUR NET, P833 WOJDEL JC, 1999, 5 ANN C ASCI DELFT WU YT, 1998, 6 IEEE INT C COMP VI, P992 YAMADA H, 1993, APPL COGNITIVE PSYCH, V7, P257 YANG J, 1996, WORKSH APPL COMP VIS, P142 ZHAO J, 1996, INT C NEUR INF PROC, V1, P454
NR	43
TC	21
PU	ELSEVIER SCIENCE BV
PI	AMSTERDAM
PA	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN	0262-8856
J9	IMAGE VISION COMPUT
JI	Image Vis. Comput.
PD	AUG
PY	2000
VL	18
IS	11
BP	881
EP	905
PG	25
SC	Computer Science, Artificial Intelligence; Computer Science, Software Engineering; Computer Science, Theory & Methods; Engineering, Electrical & Electronic; Optics
GA	338HC
UT	ISI:000088412200002
ER

---

PT	J
AU	Mijiyawa, M Oniankitan, O Khan, MA
TI	Spondyloarthropathies in sub-Saharan Africa
SO	CURRENT OPINION IN RHEUMATOLOGY
LA	English
DT	Review
ID	IMMUNODEFICIENCY-VIRUS INFECTION; CYTOTOXIC T-CELLS; REITERS-SYNDROME; ANKYLOSING-SPONDYLITIS; HIV DISEASE; ACQUIRED IMMUNODEFICIENCY; THIRD-WORLD; HLA; PROGRESSION; POPULATION
AB	HLA-B27 is virtually absent in most of the sub-Saharan Africa populations, and ankylosing spondylitis is rare; only a few patients have been reported from central and southern Africa. HLA-B27 was present in only one of 17 patients (6%). The disease shows clinical features that are similar to those observed in white HLA-B27-negative patients with ankylosing spondylitis; ie, the disease onset is later compared with HLA-B27-positive patients, the patients rarely get acute anterior uveitis as one of the extra-articular manifestations, and familial occurrence of ankylosing spondylitis is rarely observed. There is a virtual absence of ankylosing spondylitis even in the west African countries of Gambia and Senegal, where 3% to 6% of the general population has HLA-B27. The epidemic of HIV infection in sub-Saharan Africa in recent years, however, has been associated with a dramatic upsurge in the prevalence of spondyloarthropathies other than ankylosing spondylitis, primarily reactive arthritis and undifferentiated forms of the disease, and less often psoriatic arthritis. HLA-B27, because of its rarity and virtual lack of association with the observed cases of spondyloarthropathy in this population, cannot be used as an aid to diagnosis of spondyloarthropathy in black Africans. Conversely, HIV infection is increasingly showing such a strong association with reactive arthritis, psoriatic arthritis, and undifferentiated spondyloarthropathies in sub-Saharan African populations that any patient with acute or chronic inflammatory arthritis may need to be tested for possible HIV infection. More research is needed on the evaluation of risk and protective factors in sub-Saharan African populations to better delineate the relative importance of genetic and environmental factors in the pathogenesis of spondyloarthropathies. (C) 2000 Lippincott Williams & Wilkins, Inc.
C1	CHU Tokoin Lome, Serv Rhumatol, Lome, Togo. Case Western Reserve Univ, Sch Med, Dept Med, Cleveland, OH 44106 USA.
RP	Mijiyawa, M, Boite Postale 80627, Lome, Togo.
CR	1994, AIDS, V8, P911 2000, FINANCIAL TIMES 0114 AUBRY P, 1984, MED TROP, V44, P269 BLANCHE P, 1993, J RHEUMATOL, V20, P2123 BROWN MA, 1997, ANN RHEUM DIS, V56, P68 BURCH VC, 1999, J RHEUMATOL, V26, P2195 CAO YZ, 1995, NEW ENGL J MED, V332, P201 CHALMERS IM, 1980, ARTHRITIS RHEUM, V23, P1366 CUELLAR ML, 1999, J RHEUMATOL, V26, P2071 DUTOIT ED, 1988, TISSUE ANTIGENS, V31, P109 DUVIC M, 1987, ARCH DERMATOL, V123, P1622 GORE SM, 1999, QJM-MON J ASSOC PHYS, V92, P609 HILL AVS, 1991, LANCET, V337, P640 HILL AVS, 1996, NAT MED, V2, P395 HILL AVS, 1998, ANNU REV IMMUNOL, V16, P593 IOANNIDIS JPA, 1998, NAT MED, V4, P536 ITESCU S, 1992, J ACQ IMMUN DEF SYND, V5, P37 JOHNSON TM, 1985, NEW ENGL J MED, V313, P1415 KALIDI I, 1988, TISSUE ANTIGENS, V31, P98 KASLOW RA, 1990, LANCET, V335, P927 KASLOW RA, 1996, NAT MED, V2, P405 KHAN MA, 1977, ARTHRITIS RHEUM, V20, P909 KHAN MA, 1977, J RHEUMATOL S3, V4, P39 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1984, SPONDYLARTHROPATHIES, P323 KHAN MA, 1985, ADV INFLAMMAT RES, V9, P91 KHAN MA, 1998, SPONDYLARTHRITIDES, P17 LAU CS, 1998, RHEUM DIS CLIN N AM, V24, P753 LEDER RO, 1997, INT J DERMATOL, V36, P911 MANN DL, 1998, J INFECT DIS, V178, P1799 MBAYO K, 1998, CLIN RHEUMATOL, V17, P309 MCNEIL AJ, 1996, QJM-MON J ASSOC PHYS, V89, P177 METHVEN PG, 1985, S AFR MED J, V68, P597 MIJIYAWA M, 1993, J RHEUMATOL, V20, P1167 NJOBVU P, 1998, J RHEUMATOL, V25, P1553 NJOBVU PD, 1999, ARTHRITIS RHEUM S, V42, S398 NJOBVU PD, 1999, J RHEUMATOL, V26, P2074 OHNO S, 1992, P NATL ACAD SCI USA, V89, P4643 OKOYE RC, 1989, TISSUE ANTIGENS, V33, P445 PANTALEO G, 1995, NEW ENGL J MED, V332, P209 REVEILLE JD, 1990, ARTHRITIS RHEUM, V33, P1574 ROWLANDJONES S, 1995, NAT MED, V1, P59 SAHMOUD T, 1993, AIDS, V7, P497 SEEDAT YK, 1982, S AFR MED J, V61, P289 STEIN CM, 1996, J RHEUMATOL, V23, P506 STEIN M, 1990, J RHEUMATOL, V17, P1337 WILSON D, 1999, LANCET, V354, P1893 WINCHESTER R, 1987, ANN INTERN MED, V106, P19 WRIGHT JP, 1986, S AFR MED J, V70, P10
NR	49
TC	23
PU	LIPPINCOTT WILLIAMS & WILKINS
PI	PHILADELPHIA
PA	530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN	1040-8711
J9	CURR OPIN RHEUMATOL
JI	CURR. OPIN. RHEUMATOL.
PD	JUL
PY	2000
VL	12
IS	4
BP	281
EP	286
PG	6
SC	Rheumatology
GA	329LT
UT	ISI:000087909000008
ER

---

PT	J
AU	Zeng, XM
TI	On the rate of convergence of two Bernstein-Bezier type operators for bounded variation functions, II
SO	JOURNAL OF APPROXIMATION THEORY
LA	English
DT	Article
ID	POLYNOMIALS
AB	The rates of convergence of two Bernstein-Bezier type operators B-n((alpha)) and L-n((alpha)) for functions of bounded variation have been studied for the case alpha greater than or equal to 1 by the author and A. Piriou (1998. J. Approx. Theory 95, 369-387). In this paper the other ease 0 < alpha < 1 is treated and asymptotically optimal estimations of B-n((alpha)) and L-n((alpha)) for functions of bounded variation are obtained. Besides. some interesting behaviors of the operators B-n((alpha)) and L-n((alpha)) for monotone functions and functions of bounded variation are also given. (C) 2000 Academic Press.
C1	Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
RP	Zeng, XM, Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
CR	BEZIER P, 1983, NUMERICAL CONTROL MA, V1, P322 BOJANIC R, 1981, J APPROX THEORY, V31, P67 BOJANIC R, 1989, J MATH ANAL APPL, V141, P136 CHANG G, 1983, J COMPUT MATH, V1, P322 CHENG F, 1983, J APPROX THEORY, V39, P259 CHENG F, 1984, J APPROX THEORY, V40, P226 DEVORE RA, 1972, LECT NOTES MATH GUO SS, 1989, J APPROX THEORY, V58, P90 LIU Z, 1986, APPROX THEORY APPL, V2, P105 LORENTZ GG, 1953, BERNSTEIN POLYNOMIAL ZENG XM, 1998, J APPROX THEORY, V95, P369 ZENG XM, 1998, J MATH ANAL APPL, V219, P364
NR	12
TC	2
PU	ACADEMIC PRESS INC
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0021-9045
J9	J APPROX THEOR
JI	J. Approx. Theory
PD	JUN
PY	2000
VL	104
IS	2
BP	330
EP	344
PG	15
SC	Mathematics
GA	324NE
UT	ISI:000087627600008
ER

---

PT	J
AU	Fridy, JA Khan, MK
TI	Statistical extensions of some classical Tauberian theorems
SO	PROCEEDINGS OF THE AMERICAN MATHEMATICAL SOCIETY
LA	English
DT	Article
DE	statistical convergence; Tauberian theorems
AB	Hardy's well-known Tauberian theorem for Cesaro means says that if the sequence x satisfies lim Cx = L and Delta x(k) = O(1/k), then lim x = L. In this paper it is shown that the hypothesis lim Cx = L can be replaced by the weaker assumption of the statistical limit: st-lim Cx = L, i.e., for every epsilon >0, lim n(-1)\{k less than or equal to n : \(Cx)(k) - L\ greater than or equal to epsilon}\ = 0. Similarly, the "one-sided" Tauberian theorem of Landau and Schmidt's Tauberian theorem for the Abel method are extended by replacing lim Cx and lim Ax with st-lim Cx and st-lim Ax, respectively. The Hardy-Littlewood Tauberian theorem for Borel summability is also extended by replacing lim(t)(Bx)(t) = L, where t is a continuous parameter, with lim(n)(Bx)(n) = L, and further replacing it by (B*)-st-lim B*x = L, where B* is the Borel matrix method.
C1	Kent State Univ, Dept Math & Comp Sci, Kent, OH 44242 USA.
RP	Fridy, JA, Kent State Univ, Dept Math & Comp Sci, Kent, OH 44242 USA.
CR	ARMITAGE DH, 1990, ANALYSIS, V10, P177 BINGHAM NH, 1981, ANN PROBAB, V9, P221 FAST H, 1951, C MATH, V2, P241 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1998, J MATH ANAL APPL, V228, P73 HARDY GH, 1910, P LOND MATH SOC, V8, P310 HARDY GH, 1910, REND CIRC MAT PALERM, V41, P36 HARDY GH, 1914, P LOND MATH SOC, V13, P174 HARDY GH, 1949, DIVERGENT SERIES KNOPP K, 1923, MATH Z, V18, P125 LANDAU E, 1910, PRAC MAT FIZ, V21, P97 LITTLEWOOD JE, 1910, P LOND MATH SOC, V9, P434 POWELL RE, 1972, SUMMABILITY THEORY A SCHMIDT R, 1925, MATH Z, V22, P89
NR	14
TC	7
PU	AMER MATHEMATICAL SOC
PI	PROVIDENCE
PA	201 CHARLES ST, PROVIDENCE, RI 02940-2213 USA
SN	0002-9939
J9	PROC AMER MATH SOC
JI	Proc. Amer. Math. Soc.
PY	2000
VL	128
IS	8
BP	2347
EP	2355
PG	9
SC	Mathematics, Applied; Mathematics
GA	318VH
UT	ISI:000087304300017
ER

---

PT	J
AU	Duarte, D Yin, SZ
TI	Illumination-invariant face recognition using composite filters synthesized by simulated annealing
SO	OPTICAL ENGINEERING
LA	English
DT	Article
DE	filters; face recognition; simulated annealing; composite filters; 3-D scanners/digitizers
ID	IDENTIFICATION; IMAGE
AB	The design of composite filters for illumination-invariant face recognition is discussed. As 3-D profiles have been extensively used as a way to ensure this behavior, the two main constraints of 3-D analysis (i.e., 3-D profile acquisition and the 3-D face-matching computational requirements) are considered. The first limitation is solved using a 3-D acquisition system based on the projection of structured color light, which provides reliable 3-D data with a very simple setup. The second shortcoming is tackled by limiting the recognition task to 2-D complexity, so the computational cost is reduced. With the 3-D profile information available, 2-D training set images that correspond to different illumination conditions are derived for the synthesis of a 2-D composite filter using the simulated annealing algorithm. The experimental results confirm the potentiality of the proposed method. Additionally, the concept of "average face" is presented and its feasibility as an appropriate method for the recognition of a target from a set of objects is supported by experimental results. (C) 2000 Society of Photo-Optical Instrumentation Engineers. [S0091-3286(00)02005-5].
C1	Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
RP	Duarte, D, Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
CR	ADINI Y, 1997, IEEE T PATTERN ANAL, V19, P721 ANDRADE RA, 1996, P SOC PHOTO-OPT INS, V2754, P198 BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042 CARTOUX JY, 1989, P WORKSH INT 3D SCEN, P194 COOMBES A, 1992, P SOC PHOTO-OPT INS, V1766, P307 FOLEY J, 1996, COMPUTER GRAPHICS PR, P721 HARMON LD, 1981, PATTERN RECOGN, V13, P97 KARUNARATNE PV, 1997, P SOC PHOTO-OPT INS, V3077, P202 KONDO T, 1999, PATTERN RECOGN, V32, P1707 KOUZANI AZ, 1998, P IEEE INT C SYST MA, V5, P4240 KUNG SY, 1995, P 5 IEEE WORKSH NEUR, P323 LI CT, 1998, OPT COMMUN, V146, P285 LU MZ, 1996, OPT ENG, V35, P2710 NAGAMINE T, 1992, P 11 IAPR INT C PATT, P324 NASUI M, 1990, ITEJ TECH REP, V14, P7 OTOOLE AJ, 1993, J OPT SOC AM A, V10, P405 ROBINSON DW, 1993, INTERFEROGRAM ANAL D, P54 SHASHUA A, 1997, INT J COMPUT VISION, V21, P99 TANIGUCHI M, 1995, APPL OPTICS, V34, P1379 TISTARELLI M, 1997, PATTERN RECOGN LETT, V18, P933 TURK MA, 1991, P SOC PHOTO-OPT INS, V1381, P43 YUILLE A, 1989, P IEEE COMP SOC C CO, P104
NR	22
TC	4
PU	SPIE-INT SOCIETY OPTICAL ENGINEERING
PI	BELLINGHAM
PA	1000 20TH ST, BELLINGHAM, WA 98225 USA
SN	0091-3286
J9	OPT ENG
JI	Opt. Eng.
PD	MAY
PY	2000
VL	39
IS	5
BP	1252
EP	1259
PG	8
SC	Optics
GA	313FZ
UT	ISI:000086990800020
ER

---

PT	J
AU	Radstake, TRDJ Barrera, P Albers, JMC Swinkels, HL van de Putte, LBA van Riel, PLCM
TI	Familial vs sporadic rheumatoid arthritis (RA). A prospective study in an early RA inception cohort
SO	RHEUMATOLOGY
LA	English
DT	Article
DE	rheumatoid arthritis; familial aggregation; early RA inception cohort
ID	DISEASE SEVERITY; PROGNOSTIC FACTORS; HLA-DRB1 GENES; SUSCEPTIBILITY; ASSOCIATION; NATIONWIDE; DAMAGE; HLA; CONCORDANCE; PROGRESSION
AB	Objectives. To study potential differences in demographic, process and outcome variables between familial and sporadic rheumatoid arthritis (RA) in an early RA inception cohort. Methods. In 1998, we ascertained the familial status of all collaborative patients in a large early RA inception cohort at our department. Familial RA was defined by the presence of at least two siblings fulfilling the American College of Rheumatology criteria for RA. Baseline demographic data and prospectively recorded disease activity variables, therapies and radiological damage during the first 6 yr of disease were included in the analysis. A regression analysis was performed to assess whether familial clustering is a prognostic factor. Results. We identified 142 patients with sporadic and 36 with familial RA. The most striking difference between these groups was the larger sibship size in multicase families (8.2 +/- 2.5 vs 5.5 +/- 2.8; P < 0.0001). Age at onset was similar in both groups, although males with familiar RA were younger at disease onset than those with sporadic RA (median 50 vs 57 yr; P = 0.03). No differences were found in gender, presence of rheumatoid factor (RF), antinuclear factor and HLA-DR typing or in disease activity, interventions and outcome over 6 yr of follow-up. Early radiological damage and disease activity, but not familial history of RA were prognostic for X-ray damage. Conclusion. We show that sibship size is the only relevant risk factor for familial RA. No differences in genotypic and phenotypic characteristics, disease severity or radiological damage were observed among familial and sporadic RA. Familial history of RA is not a poor prognostic factor. This prospective study confirms previous cross-sectional findings in the Dutch population.
C1	Univ Nijmegen Hosp, Dept Rheumatol, NL-6500 HB Nijmegen, Netherlands.
RP	Barrera, P, Univ Nijmegen Hosp, Dept Rheumatol, POB 9101, NL-6500 HB Nijmegen, Netherlands.
CR	AHO K, 1986, J RHEUMATOL, V13, P899 AMETT FC, 1988, ARTHRITIS RHEUM, V31, P315 BARRERA P, 1999, RHEUMATOLOGY, V38, P415 COMBE B, 1995, BR J RHEUMATOL, V34, P529 DEIGHTON CM, 1989, CLIN GENET, V36, P178 DEIGHTON CM, 1991, ANN RHEUM DIS, V50, P62 DEIGHTON CM, 1992, ANN RHEUM DIS, V51, P182 DEIGHTON CM, 1992, ANN RHEUM DIS, V51, P943 DEIGHTON CM, 1992, J RHEUMATOL, V19, P237 DELJUNCO DJ, 1984, AM J EPIDEMIOL, V119, P813 EBERHARDT K, 1996, ANN RHEUM DIS, V55, P34 GRENNAN DM, 1984, Q J MED, V53, P479 HALL FC, 1996, QJM-MON J ASSOC PHYS, V89, P821 JONES MA, 1996, ANN RHEUM DIS, V55, P89 KHAN MA, 1983, TISSUE ANTIGENS, V21, P35 KHAN MA, 1988, TISSUE ANTIGENS, V31, P254 KWOH CK, 1996, AM J EPIDEMIOL, V144, P15 LESLIE RDG, 1994, ACTA GENET MED GEMEL, V43, P71 LYNN AH, 1995, AM J HUM GENET, V57, P150 MACGREGOR AJ, 1994, J RHEUMATOL, V21, P1420 PREVOO MLL, 1993, BRIT J RHEUMATOL, V32, P589 REVEILLE JD, 1996, ARTHRITIS RHEUM, V39, P1802 RIGBY AS, 1993, GENET EPIDEMIOL, V10, P311 SANDERS PA, 1987, J RHEUMATOL, V14, P718 SILMAN AJ, 1986, RHEUMATOL INT, V6, P233 SILMAN AJ, 1993, BRIT J RHEUMATOL, V32, P903 SUAREZALMAZOR ME, 1995, J RHEUMATOL, V22, P2027 VANDERHEIJDE DM, 1989, LANCET, V1, P1036 VANDERHEIJDE DMFM, 1992, BRIT J RHEUMATOL, V31, P519 VANDERHEIJDE DMFM, 1995, J RHEUMATOL, V22, P1792 VANGESTEL AM, 1997, BAILLIERE CLIN RHEUM, V11, P49 WAGNER U, 1997, ARTHRITIS RHEUM, V40, P341 WALKER DJ, 1985, ANN RHEUM DIS, V44, P519 WEYAND CM, 1992, ANN INTERN MED, V117, P801 WEYAND CM, 1997, MED CLIN N AM, V81, P29 WOLFE F, 1988, BRIT J RHEUMATOL S2, V27, P150 WOLFE K, 1988, J RHEUMATOL, V15, P400 WORDSWORTH P, 1995, BRIT MED BULL, V51, P249
NR	38
TC	10
PU	OXFORD UNIV PRESS
PI	OXFORD
PA	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN	1462-0324
J9	RHEUMATOLOGY
JI	RHEUMATOLOGY
PD	MAR
PY	2000
VL	39
IS	3
BP	267
EP	273
PG	7
SC	Rheumatology
GA	307LB
UT	ISI:000086653800008
ER

---

PT	J
AU	Demirci, K Orhan, C
TI	Bounded multipliers of bounded A-statistically convergent sequences
SO	JOURNAL OF MATHEMATICAL ANALYSIS AND APPLICATIONS
LA	English
DT	Article
ID	INCLUSION THEOREMS; SUMMABILITY; SPACES
AB	in this paper we provide an alternate proof of a result of Kline. It claims that the set of all A-statistically convergent sequences cannot be given a locally convex FK topology where A is a nonnegative regular matrix whose rows spread. We also study the bounded multiplier space of all bounded A-statistically convergent sequences, and using the "beta Nprogram" we give an analogue of a result of Fridy and Miller for bounded multipliers. (C) 1999 Academic Press.
C1	Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
RP	Demirci, K, Ankara Univ, Fac Sci, Dept Math, TR-06100 Ankara, Turkey.
CR	ATALLA R, 1970, P AM MATH SOC, V26, P437 BENNETT G, 1973, CAN J MATH, V25, P511 BENNETT G, 1973, PAC J MATH, V46, P17 CONNOR J, 1989, CAN MATH BULL, V32, P194 CONNOR J, 1993, ANN NY ACAD SCI, V704, P80 CONNOR J, 1993, PAC J MATH, V157, P201 CONNOR J, 1996, J MATH ANAL APPL, V197, P392 CONNOR JS, 1988, ANALYSIS, V8, P47 DURAN JP, 1972, DUKE MATH J, V39, P497 ERDOS P, 1989, P LOND MATH SOC, V59, P417 FAST H, 1951, C MATH, V2, P241 FREEDMAN AR, 1981, PAC J MATH, V95, P293 FRIDY JA, 1985, ANALYSIS, V5, P301 FRIDY JA, 1991, ANALYSIS, V11, P59 FRIDY JA, 1993, J MATH ANAL APPL, V173, P497 FRIDY JA, 1993, PAC J MATH, V160, P43 FRIDY JA, 1998, J MATH ANAL APPL, V228, P73 GILLMAN L, 1976, RINGS CONTINUOUS FUN HILL JD, 1968, CAN J MATH, V20, P410 KLINE JL, 1995, THESIS OHIO U MADDOX IJ, 1988, MATH P CAMBRIDGE PHI, V104, P141 MILLER HI, 1995, T AM MATH SOC, V347, P1811 NIVEN I, 1980, INTRO THEORY NUMBERS PETERSEN G, 1966, REGULAR MATRIX TRANS RATH D, 1996, J ANAL, V4, P23 WALKER RC, 1974, STONE CECH COMPACTIF WILANSKY A, 1984, SUMMABILITY FUNCTION ZYGMUND A, 1979, TRIGONOMETRIC SERIES
NR	28
TC	3
PU	ACADEMIC PRESS INC
PI	SAN DIEGO
PA	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN	0022-247X
J9	J MATH ANAL APPL
JI	J. Math. Anal. Appl.
PD	JUL 1
PY	1999
VL	235
IS	1
BP	122
EP	129
PG	8
SC	Mathematics, Applied; Mathematics
GA	305ZA
UT	ISI:000086570600006
ER

---

PT	S
AU	Ragab, ME Darwish, AM Abed, EM Shaheen, SI
TI	Face recognition using principal component analysis applied to an Egyptian face database
SO	MULTIPLE APPROACHES TO INTELLIGENT SYSTEMS, PROCEEDINGS
SE	LECTURE NOTES IN ARTIFICIAL INTELLIGENCE
LA	English
DT	Article
ID	IDENTIFICATION
AB	Although face recognition is highly race-orientated, to-date there is no Egyptian database of face images for research purposes. This paper serves two purposes. First we present the efforts undertaken to build the first Egyptian face database (over 1100 images). Second we present a variant algorithm based on principal component analysis (PCA) but adjusted to Egyptian environment. In order to conduct face recognition research under realistic circumstances, no restrictions have been composed on volunteers (eyeglasses, moustaches, beards, and veils (hijab)). Furthermore, photos, for each volunteer, were taken during two sessions that are two months apart (March and May). Meanwhile, multiple light sources have been used. More than 100 experiments have been carried out to evaluate the approach under different conditions. A new pentagon-shaped mask has been devised, which has proven suitable to enhance the recognition rate.
C1	Elect Res Inst, Giza 12411, Egypt. Cairo Univ, Dept Comp Engn, Giza 12613, Egypt.
RP	Ragab, ME, Elect Res Inst, Tahrir St, Giza 12411, Egypt.
CR	BUHMANN J, 1990, P INT JOINT C NEUR N, P411 COSTEN N, 1996, AUTOMATIC FACE RECOG DIECKMANN U, 1997, PATTERN RECOGN LETT, V18, P827 HARMON LD, 1977, COMPUTER GRAPHICS IM, V6, P135 HARMON LD, 1978, PATTERN RECOGN, V10, P301 HARMON LD, 1981, PATTERN RECOGN, V13, P97 JAIN AK, 1989, FUNDAMENTALS DIGITAL KANADE T, 1977, COMPUTER RECOGNITION KAUFMAN GJ, 1976, IEEE T SYST MAN CYB, V6, P113 KAYA Y, 1972, FRONTIERS PATTERN RE, P265 KRIBY M, 1990, IEEE T PATTERN ANAL, V12 PENTLAND A, 1994, P IEEE INT C COMP VI RAGAB ME, THESIS CAIRO U SIROVICH L, 1987, J OPT SOC AM A, V4, P519 TURK M, 1991, P IEEE C COMP VIS PA, P586 WU CJ, 1990, PATTERN RECOGN, V23, P255 YOSHITOMI Y, 1997, P 6 IEEE INT WORKSH, P374 ZHANG J, 1997, P IEEE, V85, P1423
NR	18
TC	0
PU	SPRINGER-VERLAG BERLIN
PI	BERLIN
PA	HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN	0302-9743
J9	LECT NOTE ARTIF INTELL
PY	1999
VL	1611
BP	540
EP	549
PG	10
SC	Computer Science, Artificial Intelligence
GA	BP88G
UT	ISI:000086482000058
ER

---

PT	J
AU	Zeng, XM
TI	Rates of approximation of bounded variation functions by two generalized Meyer-Konig and Zeller type operators
SO	COMPUTERS & MATHEMATICS WITH APPLICATIONS
LA	English
DT	Article
DE	Meyer-Konig and Zeller type operators; rate of convergence; functions of bounded variation; Lebesgue-Stieltjes integration
ID	CONVERGENCE
AB	In this paper, the approximation behaviours of two generalized Meyer-Konig and Zeller type operators M-n,M-alpha(f, x) and (M) over cap(n,alpha)(f, x) are studied. By means of the decomposition technique of functions of bounded variation and the method of Bojanic [1], Bojanic and Vuilleumier [2]1 and Cheng [3], together with some results from probability theory and the exact bound of Meyer-Konig and Zeller operators basis functions, the rates of convergence of these two operators for functions of bounded variation are obtained. (C) 2000 Elsevier Science Ltd. All rights reserved.
C1	Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
RP	Zeng, XM, Xiamen Univ, Dept Math, Xiamen 361005, Peoples R China.
CR	ABEL U, 1995, J APPROX THEORY, V82, P352 BECKER M, 1978, MATH Z, V160, P195 BEZIER P, 1972, NUMERICAL CONTROL MA BOJANIC R, 1979, PUBL I MATH BELGRADE, V26, P57 BOJANIC R, 1981, J APPROX THEORY, V31, P67 CHANG G, 1983, J COMPUTATIONAL MATH, V1, P259 CHEN W, 1988, CHINESE J CONT MATH, V9, P193 CHENEY EW, 1964, CAN J MATH, V16, P241 CHENG F, 1983, J APPROX THEORY, V39, P259 CHENG F, 1984, J APPROX THEORY, V40, P226 DEVORE RA, 1972, LECT NOTES MATH, V293 GUO S, 1987, J APPROX THEORY, V51, P183 GUO S, 1989, J APPROX THEORY, V59, P183 GUO SS, 1989, J APPROX THEORY, V58, P90 LOEVE M, 1977, PROBABILITY THEOREM, V1 MAIER V, 1981, J APPROX THEORY, V32, P27 MEYERKONIG W, 1960, STUD MATH, V19, P89 MULLER MW, 1978, STUD MATH, V63, P81 SHIRYAYEV AN, 1984, PROBABILITY ZENG XM, 1998, J APPROX THEORY, V95, P369 ZENG XM, 1998, J MATH ANAL APPL, V219, P364
NR	21
TC	5
PU	PERGAMON-ELSEVIER SCIENCE LTD
PI	OXFORD
PA	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN	0898-1221
J9	COMPUT MATH APPL
JI	Comput. Math. Appl.
PD	MAY
PY	2000
VL	39
IS	9-10
BP	1
EP	13
PG	13
SC	Computer Science, Interdisciplinary Applications; Mathematics, Applied
GA	303DL
UT	ISI:000086405500001
ER

---

PT	J
AU	Laivoranta-Nyman, S Mottonen, T Luukkainen, R Hakala, M Yli-Kerttula, U Hannonen, P Tuokko, J Toivanen, A Ilonen, J
TI	Immunogenetic differencies between patients with familial and non-familial rheumatoid arthritis
SO	ANNALS OF THE RHEUMATIC DISEASES
LA	English
DT	Article
ID	MULTICASE FAMILIES; DISEASE SEVERITY; HLA; ASSOCIATION; SUSCEPTIBILITY; HLA-DRB1; ALLELES; RISK; MANIFESTATIONS; HETEROZYGOSITY
AB	Objective-To search for possible immunogenetic differencies between the patients with familial and non-familial rheumatoid arthritis (RA). Methods-The study compared 129 familial RA patients with 217 non-familial patients for the frequencies of HLA-DR antigens including DR4 subtypes, DR4-DQB1*0301 and DR4-DQB1*0302 haplotypes and HLA-B27 antigen as well as the age of disease onset and existence of rheumatoid factor or joint erosions. Results-Two major differences between familial and non-familial groups were found: firstly, familial RA patients had increased frequency of HLA-DR4 as compared with the non-familial RA group (68.2 v 54.8%; p = 0.019). Secondly, the mean age at onset of RA was significantly lower in the familial than in the sporadic RA patients (42.0 v 46.5 years; p = 0.0020) and the difference still remained when the DR4 positive and negative subgroups were compared separately. Conclusion-These results confirm the more prominent association with HLA-DR4 in familial than in the non-familial cases and suggest that accumulation of HLA risk genes may, at least partly, explain the familial occurrence of the disease. Other susceptibility genes may also be concentrated in multiplex case families as suggested by an earlier age at the onset of RA in both HLA-DR4 positive and negative familial patients.
C1	Jyvaskyla Cent Hosp, Dept Med, Jyvaskyla, Finland. Tampere Univ Hosp, Dept Med, Tampere, Finland. Oulu Univ Hosp, Dept Med, Div Rheumatol, Oulu, Finland. Satalinna Hosp, Dept Rheumatol, Satalinna, Finland. Univ Turku, Turku Immunol Ctr, Turku, Finland. Univ Turku, Dept Virol, Turku, Finland. Univ Turku, Dept Med Microbiol, Turku, Finland. Univ Turku, Dept Med, Turku, Finland. Univ Turku, Cent Hosp, Turku, Finland.
RP	Laivoranta-Nyman, S, Univ Turku, Med Res Lab, Tykistokatu 6A, FIN-20520 Turku, Finland.
CR	AHO K, 1986, J RHEUMATOL, V13, P899 ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315 DEBLECOURT JJ, 1961, ANN RHEUM DIS, V20, P215 DEIGHTON CM, 1989, CLIN GENET, V36, P178 DEIGHTON CM, 1991, ANN RHEUM DIS, V50, P62 DEIGHTON CM, 1992, J RHEUMATOL, V19, P237 DELJUNCO DJ, 1984, AM J EPIDEMIOL, V119, P813 FALK CT, 1987, ANN HUM GENET, V51, P227 GRENNAN DM, 1984, Q J MED, V53, P479 GRENNAN DM, 1986, ANN RHEUM DIS, V45, P126 HAFEZ M, 1991, BRIT J RHEUMATOL, V30, P181 HAKALA M, 1997, ANN MED, V29, P291 HAZELTON RA, 1982, Q J MED, V51, P336 HIETARINTA M, 1994, BRIT J RHEUMATOL, V33, P323 HILLARBY MC, 1991, TISSUE ANTIGENS, V37, P39 ILONEN J, 1991, HUM IMMUNOL, V30, P7 ISOMAKI H, 1974, LANCET, V2, P1212 KHAN MA, 1983, TISSUE ANTIGENS, V21, P35 KHAN MA, 1986, DIS MARKERS, V4, P67 KHAN MA, 1986, DIS MARKERS, V4, P77 LAWRENCE JS, 1970, ANN RHEUM DIS, V29, P357 MACGREGOR A, 1995, J RHEUMATOL, V22, P1032 MCDERMOTT M, 1986, DIS MARKERS, V4, P103 MCDONAGH JE, 1997, BRIT J RHEUMATOL, V36, P322 MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215 MOTTONEN T, 1998, ANN RHEUM DIS, V57, P533 NEJENTSEV S, IN PRESS DIABET MED OLERUP O, 1992, TISSUE ANTIGENS, V39, P225 OLLIER W, 1986, DIS MARKERS, V4, P85 RANTAPAADAHLQVI.S, 1985, SCAND J RHEUMATOL, V14, P375 RIGBY AS, 1992, SCAND J RHEUMATOL, V21, P68 SANDERS PA, 1987, J RHEUMATOL, V14, P718 SILMAN A, 1989, TISSUE ANTIGENS, V33, P15 SILMAN AJ, 1987, ANN RHEUM DIS, V46, P135 SJOROOS M, 1995, BIOTECHNIQUES, V18, P870 STASTNY P, 1976, J CLIN INVEST, V57, P1148 STASTNY P, 1978, NEW ENGL J MED, V298, P869 TANEJA V, 1993, J RHEUMATOL, V20, P253 THOMSON W, 1993, ANN RHEUM DIS, V52, P539 TODA Y, 1994, ANN RHEUM DIS, V53, P587 TUOKKO J, 1997, ANN RHEUM DIS, V56, P37 VALIMAA L, 1998, J IMMUNOL METHODS, V219, P131 VANDERHORSTBRUINSMA IE, 1999, HUM IMMUNOL, V60, P152 WASMUTH AG, 1972, ANN RHEUM DIS, V31, P85 WEYAND CM, 1992, ANN INTERN MED, V117, P801 WEYAND CM, 1992, J CLIN INVEST, V89, P2033 WEYAND CM, 1995, CURR OPIN RHEUMATOL, V7, P206 WINCHESTER R, 1994, ADV IMMUNOL, V56, P389 WORDSWORTH P, 1992, AM J HUM GENET, V51, P585
NR	49
TC	8
PU	BRITISH MED JOURNAL PUBL GROUP
PI	LONDON
PA	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN	0003-4967
J9	ANN RHEUM DIS
JI	Ann. Rheum. Dis.
PD	MAR
PY	2000
VL	59
IS	3
BP	173
EP	177
PG	5
SC	Rheumatology
GA	292CU
UT	ISI:000085777200004
ER

---

PT	J
AU	Gal, SG Szabados, J
TI	On the preservation of global smoothness by some interpolation operators
SO	STUDIA SCIENTIARUM MATHEMATICARUM HUNGARICA
LA	English
DT	Article
DE	interpolation operator; smoothness; modulus of continuity
ID	LIPSCHITZ CONTINUOUS FUNCTION; POLYNOMIALS; CONSTANTS
C1	Univ Oradea, Dept Matemat, RO-3700 Oradea, Romania. MTA Renyi Alfred Matemat, Kutatointezete, H-1364 Budapest, Hungary.
RP	Gal, SG, Univ Oradea, Dept Matemat, Str Armatei Romane 5, RO-3700 Oradea, Romania.
CR	ADELL JA, 1994, APPROXIMATION PROBAB, P1 ADELL JA, 1996, GLOBAL SMOOTHNESS PR ADELL JA, 1997, APPROXIMATION OPTIMI, V1, P147 ANASTASSIOU GA, 1991, ANALYSIS, V11, P43 BARI NK, 1956, T MOSK MAT OBSHCH, V5, P483 BERMAN DL, 1958, USP MAT NAUK, V13, P143 BLOOM WR, 1981, J APPROX THEORY, V31, P59 BROWN BM, 1987, J APPROX THEORY, V49, P196 CHENEY EW, 1966, INTRO APPROXIMATION CISMASIU CS, 1987, SEM NUM STAT CALC CL, P129 COTTIN C, 1993, REND CIRC MAT PALE S, V33, P259 DELLAVECCHIA B, 1989, B UNIONE MAT ITAL, V3, P125 GONSKA HH, 1993, SEM IT TIB POP EC FU HAJEK O, 1965, AM MATH MONTHLY, V72, P681 KHAN MK, 1989, J APPROX THEORY, V59, P307 KRATZ W, 1988, J APPROX THEORY, V54, P326 LINDVALL T, 1982, MATH SCI, V7, P127 MASTROIANNI G, 1993, RENDICONTI CIRC MATH, V33, P375 NATANSON IP, 1964, CONSTRUCTIVE FUNCTIO, V1 NATANSON IP, 1965, CONSTRUCTIVE FUNCTIO, V2 NATANSON IP, 1965, CONSTRUCTIVE FUNCTIO, V3 STECHKIN SB, 1951, IZV AKAD NAUK SSSR M, V15, P219 SZABADOS J, 1973, ACTA MATH ACAD SCI H, V24, P399 SZABADOS J, 1990, INTERPOLATION FUNCTI SZABADOS J, 1991, APPROX THEORY APPL, V7, P63 TIMAN AF, 1960, THEORY APPROXIMATION ZYGMUND A, 1955, TRIGONOMETRICAL SERI
NR	27
TC	0
PU	AKADEMIAI KIADO
PI	BUDAPEST
PA	PO BOX 245, H-1519 BUDAPEST, HUNGARY
SN	0081-6906
J9	STUD SCI MATH HUNG
JI	Stud. Sci. Math. Hung.
PY	1999
VL	35
IS	3-4
BP	397
EP	414
PG	18
SC	Mathematics
GA	283JE
UT	ISI:000085272000011
ER

---

PT	J
AU	Mader, R
TI	Atypical clinical presentation of ankylosing spondylitis
SO	SEMINARS IN ARTHRITIS AND RHEUMATISM
LA	English
DT	Review
DE	ankylosing spondylitis; clinical manifestations; pain
ID	REITERS-SYNDROME; PREVALENCE; SACROILIITIS; DISEASE; MEN; ARTHROPATHY; ONSET; RISK; W27
AB	Objectives: To describe a subgroup of patients with ankylosing spondylitis (AS), whose disease evolved without the characteristic inflammatory back pain or significant disability. Methods: Three patients who were diagnosed in their late 5th decade of life as having AS are described. Information about asymptomatic cases of AS or patients who were unaware of their disease was gathered from case reports and from studies involving HLA-B27-positive individuals. Another source of information derived from studies that investigated conditions known to be a complication of AS, such as heart block or aortic regurgitation. Results: The data collected from the literature suggest that 1.5% to 10% of the patients with AS are asymptomatic or have very mild disease, These patients are diagnosed late in the course of the disease. Conclusions: Because of the mild nature of the symptoms, the real prevalence of atypical AS is unknown, The information gathered from the literature allows to delineate 4 subgroups of patients with AS: (1) Classic AS with characteristic clinical and radiographic manifestations; (2) Asymptomatic AS with characteristic radiographic findings; (3) Asymptomatic AS with extra-articular features as the presenting manifestations; (4) Symptomatic AS without radiographic supporting evidence, Patients with asymptomatic or mild symptoms deserve more attention, because a better understanding of the factors that affect the expression of pain in different individuals may generate better pain control therapies. Copyright (C) 1999 by W.B. Saunders Company.
C1	Ha Emek Med Ctr, Rheumat Dis Unit, IL-18101 Afula, Israel. Technion Israel Inst Technol, Bruce Rappaport Fac Med, IL-31096 Haifa, Israel.
RP	Mader, R, Ha Emek Med Ctr, Rheumat Dis Unit, IL-18101 Afula, Israel.
CR	BENNETT PH, 1967, B RHEUM DIS, V17, P453 BERGFELDT L, 1982, AM J MED, V73, P187 BLACKBURN WD, 1988, AM J MED, V85, P766 BRAUN J, 1998, ARTHRITIS RHEUM, V41, P58 CALIN A, 1975, NEW ENGL J MED, V293, P835 CALIN A, 1977, J RHEUMATOL, V4, P277 CALIN A, 1977, JAMA-J AM MED ASSOC, V237, P2613 CLEGG DO, 1996, ARTHRITIS RHEUM, V39, P2004 COHEN LM, 1976, ANN INTERN MED, V84, P1 DEKKERSAEYS BJ, 1978, ANN RHEUM DIS, V37, P33 EVERSMEYER WH, 1978, JAMA-J AM MED ASSOC, V240, P2652 FERDOUTSIS M, 1995, RESPIRATION, V62, P286 GRAN JT, 1985, CLIN RHEUMATOL, V4, P161 HARVIE JN, 1976, AM J ROENTGENOL, V127, P579 HUAUX JP, 1977, J RHEUMATOL S, V3, P60 JAJIC I, 1968, ANN RHEUM DIS, V27, P1 JIMENEZBALDERAS EJ, 1993, J RHEUMATOL, V20, P2069 KENNEDY LG, 1993, J RHEUMATOL, V20, P1900 KHAN MA, 1982, ANN INTERN MED, V96, P70 KHAN MA, 1985, ARTHRITIS RHEUM, V28, P40 LECLERCQ SA, 1983, J RHEUMATOL, V10, P629 LECLERCQ SA, 1984, J RHEUMATOL, V11, P327 LITTLE H, 1974, ARTHRITIS RHEUM, V17, P487 MASSON G, 1985, ANN RHEUM DIS, V44, P860 METZGER AL, 1975, ARTHRITIS RHEUM, V18, P111 MILLER MH, 1984, J RHEUMATOL, V11, P507 SANDORFI N, 1997, J RHEUMATOL, V24, P187 THE HSG, 1985, BR J RHEUMATOL, V24, P242 TUCKER CR, 1982, AM J CARDIOL, V49, P680 WILL R, 1992, ANN RHEUM DIS, V51, P1102
NR	30
TC	4
PU	W B SAUNDERS CO
PI	PHILADELPHIA
PA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399 USA
SN	0049-0172
J9	SEMIN ARTHRITIS RHEUM
JI	Semin. Arthritis Rheum.
PD	DEC
PY	1999
VL	29
IS	3
BP	191
EP	196
PG	6
SC	Rheumatology
GA	268CP
UT	ISI:000084397000007
ER

---

PT	J
AU	Adell, JA Perez-Palomares, A
TI	Stochastic orders in preservation properties by Bernstein-type operators
SO	ADVANCES IN APPLIED PROBABILITY
LA	English
DT	Article
DE	stochastic order; preservation properties; Bernstein-type operators; derived process; dual process; bidensity; subordinator
ID	LIPSCHITZ CONTINUOUS FUNCTION; STATISTICS; CONSTANTS; CONVEXITY
AB	In this paper, we arts concerned with preservation properties of first and second order by an operator L representable in terms of a stochastic process Z with non-decreasing right-continuous piths. We introduce the derived operator D of L and the derived process V of Z in order to characterize the preservation of absolute continuity and convexity. To obtain different characterizations of the preservation of convexity, we introduce two kinds of duality, the first referring to the process Z and the second to the derived process V. We illustrate the preceding results by considering some examples of interest both in probability and in approximation theory - namely, mixtures, centred subordinators, Bernstein polynomials and beta operators. In most of them, we End bidensities to describe the duality between the derived processes. A unified approach based on stochastic orders is given.
C1	Univ Zaragoza, Fac Ciencias, Dept Metodos Estadist, E-50009 Zaragoza, Spain.
RP	Adell, JA, Univ Zaragoza, Fac Ciencias, Dept Metodos Estadist, E-50009 Zaragoza, Spain.
CR	ABATE J, 1996, ADV APPL PROBAB, V28, P75 ADELL JA, 1993, STOCH PROC APPL, V48, P1 ADELL JA, 1996, CONSTR APPROX, V12, P489 ALTOMARE F, 1994, KOROVKIN TYPE APPROX BARBOUR AD, 1991, J APPL PROBAB, V28, P278 BROWN BM, 1987, J APPROX THEORY, V49, P196 COTTIN C, 1993, REND CIRC MAT PALE S, V33, P259 DITZIAN Z, 1987, MODULI SMOOTHNESS HU TZ, 1996, J APPL PROBAB, V33, P156 JOHNSON NL, 1969, DISCRETE DISTRIBUTIO KALLENBERG O, 1997, FDN MODERN PROBABILI KERTZ RP, 1992, ISR J MATH, V77, P129 KHAN MK, 1989, J APPROX THEORY, V59, P307 KRATZ W, 1988, J APPROX THEORY, V54, P326 KWIECINSKI A, 1996, ANN APPL PROBAB, V6, P1211 LINDVALL T, 1982, MATH SCI, V7, P127 PEREZPALOMARES A, 1999, UNPUB PRESERVATION P SHAKED M, 1988, ADV APPL PROBAB, V20, P427 SHAKED M, 1990, ADV APPL PROBAB, V22, P160 SHAKED M, 1994, STOCHASTIC ORDERS IT STOYAN D, 1983, COMP METHODS QUEUES SZEKLI R, 1995, LECT NOTES STAT, V97 WHITT W, 1986, MATH OPER RES, V11, P608 WINTER BB, 1997, J MATH ANAL APPL, V205, P471 ZHOU DX, 1995, RESULTS MATH, V28, P169
NR	25
TC	2
PU	APPLIED PROBABILITY TRUST
PI	SHEFFIELD
PA	THE UNIVERSITY, SCHOOL MATHEMATICS STATISTICS, SHEFFIELD S3 7RH, ENGLAND
SN	0001-8678
J9	ADVAN APPL PROBAB
JI	Adv. Appl. Probab.
PD	JUN
PY	1999
VL	31
IS	2
BP	492
EP	509
PG	18
SC	Statistics & Probability
GA	251HD
UT	ISI:000083438800010
ER

---

PT	J
AU	Yin, SZ Duarte, D Purwosumarto, P
TI	Design of rotation, illumination, and texture-invariant composite filters from range images using simulated annealing for face recognition
SO	MICROWAVE AND OPTICAL TECHNOLOGY LETTERS
LA	English
DT	Article
DE	optical filter; optical imaging; 3-D imaging
ID	IDENTIFICATION
AB	In this paper, the design of composite filters from range images using the simulated annealing technique for robust face recognition is discussed. Due to the use of range images as the training set for the synthesis of composite filters, besides the out-of-plane rotation invariance, the designed composite filters are also inherently insensitive to the variation in the illumination and texture of the object. In addition, since the cor-relation operation can be done in the 2-D domain, the required processing time for 3-D range data is also substantially reduced. The experimental results show that the maximum responses of the antitarget are always less than the minimum response of the target even in the case where multiple faces are involved, which demonstrates the feasibility of the proposed technique. (C) 1999 John Wiley & Sons, Inc.
C1	Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
RP	Yin, SZ, Penn State Univ, Dept Elect Engn, University Pk, PA 16802 USA.
CR	ANDRADE RA, 1996, P SOC PHOTO-OPT INS, V2754, P198 BRUNELLI R, 1993, IEEE T PATTERN ANAL, V15, P1042 CARTOUX JY, 1989, P WORKSH INT 3D SCEN, P194 CASASENT D, 1984, APPL OPTICS, V23, P1620 CAULFIELD HJ, 1980, APPL OPTICS, V19, P181 COOMBES A, 1992, SPIE NEURAL STOCHAST, V1766, P307 HARMON LD, 1981, PATTERN RECOGN, V13, P97 KARUNARATNE PV, 1997, P SOC PHOTO-OPT INS, V3077, P202 KUNG SY, 1995, P 5 IEEE WORKSH NEUR, P323 LI CT, 1998, OPT COMMUN, V146, P285 LU M, 1996, OPT ENG, V35 MAHALANOBIS A, 1987, APPL OPTICS, V26, P3633 NASUI M, 1990, ITEJ TECH REP, V14, P7 OTOOLE AJ, 1993, J OPT SOC AM A, V10, P405 ROBINSON DW, 1993, INTERFEROGRAM ANAL D, P54 TANIGUCHI M, 1995, APPL OPTICS, V34, P1379 TISTARELLI M, 1997, PATTERN RECOGN LETT, V18, P933 TURK MA, 1991, P SOC PHOTO-OPT INS, V1381, P43 VANDERLUGT A, 1964, IEEE T INFORM THEORY, V10, P138 YUILLE A, 1989, P IEEE COMP SOC C CO, P104
NR	20
TC	0
PU	JOHN WILEY & SONS INC
PI	NEW YORK
PA	605 THIRD AVE, NEW YORK, NY 10158-0012 USA
SN	0895-2477
J9	MICROWAVE OPT TECHNOL LETT
JI	Microw. Opt. Technol. Lett.
PD	NOV 5
PY	1999
VL	23
IS	3
BP	151
EP	155
PG	5
SC	Engineering, Electrical & Electronic; Optics
GA	244JT
UT	ISI:000083048600007
ER

---

PT	J
AU	Toussirot, E Bahjaoui-Bouhaddi, M Poncet, JC Cappelle, S Henriet, MT Wendling, D Regnard, J
TI	Abnormal autonomic cardiovascular control in ankylosing spondylitis
SO	ANNALS OF THE RHEUMATIC DISEASES
LA	English
DT	Article
ID	SYSTEMIC LUPUS-ERYTHEMATOSUS; DOWN BED-REST; RHEUMATOID-ARTHRITIS; NERVOUS-SYSTEM; SPONTANEOUS BAROREFLEX; SJOGRENS-SYNDROME; HEART; SENSITIVITY; PLASMA; HUMANS
AB	Objective-This study was aimed at assessing the contribution of the autonomic nervous system to adjustments of cardiovascular function in patients with ankylosing spondylitis (AS). Methods-In 18 AS patients (mean age: 34.9; mean disease duration: 6.4 years) and 13 healthy controls (mean age: 31.7) the changes of heart rate (HR) with deep breathing (E/I ratio) and standing up (30/15 ratio) were recorded. The slope of cardiac baroreflex, the times series of blood pressure and HR values upon lying and standing, and venous plasma concentrations of catecholami